{
"cv1": {
"id": "cv1",
"bookId": "cv",
"question": "Optimal pretest probability of CAD for stress testing",
"answer": "Intermediate (10%-90%)",
"relatedSectionId": "mk19_b_cv_s2_2_1"
},
"cv2": {
"id": "cv2",
"bookId": "cv",
"question": "Baseline ECG abnormalities that warrant imaging along with stress testing",
"answer": "ST segment depression, LVH, LBBB, digitalis effect, preexcitation, paced beats",
"relatedSectionId": "mk19_b_cv_s2_2_1"
},
"cv3": {
"id": "cv3",
"bookId": "cv",
"question": "Diagnostic test for CAD when LBBB is present",
"answer": "Vasodilator stress myocardial perfusion imaging",
"relatedSectionId": "mk19_b_cv_s2_2_1_2"
},
"cv4": {
"id": "cv4",
"bookId": "cv",
"question": "Drug infused during pharmacologic stress echocardiography",
"answer": "Dobutamine",
"relatedSectionId": "mk19_b_cv_s2_2_1_2_1"
},
"cv5": {
"id": "cv5",
"bookId": "cv",
"question": "Hypotension, back pain, and drop in hemoglobin level after femoral artery access for cardiac catheterization",
"answer": "Retroperitoneal hemorrhage",
"relatedSectionId": "mk19_b_cv_s2_2_4"
},
"cv6": {
"id": "cv6",
"bookId": "cv",
"question": "Asymptomatic murmurs that require TTE evaluation",
"answer": "Grade ≥3/6, late systolic or holosystolic, diastolic, or continuous",
"relatedSectionId": "mk19_b_cv_s2_3"
},
"cv7": {
"id": "cv7",
"bookId": "cv",
"question": "Imaging test for endocarditis and suspicion of myocardial abscess",
"answer": "TEE",
"relatedSectionId": "mk19_b_cv_s2_3"
},
"cv8": {
"id": "cv8",
"bookId": "cv",
"question": "Imaging to distinguish different subtypes of cardiac amyloid",
"answer": "99m-Technetium pyrophosphate scintigraphy",
"relatedSectionId": "mk19_b_cv_s2_3"
},
"cv9": {
"id": "cv9",
"bookId": "cv",
"question": "Initial diagnostic test for syncope when arrhythmia is suspected",
"answer": "Resting ECG",
"relatedSectionId": "mk19_b_cv_s2_4"
},
"cv10": {
"id": "cv10",
"bookId": "cv",
"question": "Diagnostic testing option for infrequent symptomatic palpitations or syncope",
"answer": "Event recorder",
"relatedSectionId": "mk19_b_cv_s2_4"
},
"cv11": {
"id": "cv11",
"bookId": "cv",
"question": "Alternative to aspirin in patients with CAD",
"answer": "Clopidogrel",
"relatedSectionId": "mk19_b_cv_s3_1_2_1"
},
"cv12": {
"id": "cv12",
"bookId": "cv",
"question": "Indications for ACE inhibitor therapy in stable angina",
"answer": "CKD, diabetes, previous MI, or LVEF ≤40%",
"relatedSectionId": "mk19_b_cv_s3_1_2_1"
},
"cv13": {
"id": "cv13",
"bookId": "cv",
"question": "Specific β-blockers associated with reduced mortality in patients with HFrEF",
"answer": "Bisoprolol, metoprolol succinate, carvedilol",
"relatedSectionId": "mk19_b_cv_s3_1_2_2"
},
"cv14": {
"id": "cv14",
"bookId": "cv",
"question": "Class of calcium channel blockers to avoid in HF",
"answer": "Nondihydropyridine",
"relatedSectionId": "mk19_b_cv_s3_1_2_2"
},
"cv15": {
"id": "cv15",
"bookId": "cv",
"question": "Strategy to avoid nitrate tolerance",
"answer": "12-Hour nitrate-free interval",
"relatedSectionId": "mk19_b_cv_s3_1_2_2"
},
"cv16": {
"id": "cv16",
"bookId": "cv",
"question": "Drug class to avoid during nitrate therapy",
"answer": "Phosphodiesterase-5 inhibitors",
"relatedSectionId": "mk19_b_cv_s3_1_2_2"
},
"cv17": {
"id": "cv17",
"bookId": "cv",
"question": "Drugs requiring ranolazine dosage reduction with concurrent administration",
"answer": "Verapamil, diltiazem",
"relatedSectionId": "mk19_b_cv_s3_1_2_2"
},
"cv18": {
"id": "cv18",
"bookId": "cv",
"question": "Treatment of stable angina refractory to optimal medical therapy",
"answer": "PCI or CABG",
"relatedSectionId": "mk19_b_cv_s3_1_3_2"
},
"cv19": {
"id": "cv19",
"bookId": "cv",
"question": "Improves survival in multivessel CAD and LV dysfunction",
"answer": "CABG",
"relatedSectionId": "mk19_b_cv_s3_1_3_3"
},
"cv20": {
"id": "cv20",
"bookId": "cv",
"question": "Improves survival in multivessel CAD and diabetes",
"answer": "CABG",
"relatedSectionId": "mk19_b_cv_s3_1_3_3"
},
"cv21": {
"id": "cv21",
"bookId": "cv",
"question": "Minimum duration of DAPT after bare mental stent placement for stable CAD",
"answer": "1 month",
"relatedSectionId": "mk19_b_cv_s3_1_3_4"
},
"cv22": {
"id": "cv22",
"bookId": "cv",
"question": "Duration of DAPT following CABG for stable CAD",
"answer": "12 months",
"relatedSectionId": "mk19_b_cv_s3_1_3_4"
},
"cv23": {
"id": "cv23",
"bookId": "cv",
"question": "Coronary plaque rupture, platelet adhesion, aggregation, acute thrombosis",
"answer": "STEMI",
"relatedSectionId": "mk19_b_cv_s3_2_2_1"
},
"cv24": {
"id": "cv24",
"bookId": "cv",
"question": "P2Y<sub>12</sub> inhibitor with dyspnea as side effect",
"answer": "Ticagrelor",
"relatedSectionId": "mk19_b_cv_s3_2_2_2_1"
},
"cv25": {
"id": "cv25",
"bookId": "cv",
"question": "Chest pain and pulseless electrical activity 3 days after STEMI",
"answer": "Ventricular free wall rupture",
"relatedSectionId": "mk19_b_cv_s3_2_2_3"
},
"cv26": {
"id": "cv26",
"bookId": "cv",
"question": "Cause of acute severe mitral regurgitation after STEMI",
"answer": "Papillary muscle rupture",
"relatedSectionId": "mk19_b_cv_s3_2_2_3"
},
"cv27": {
"id": "cv27",
"bookId": "cv",
"question": "Indications for immediate invasive treatment in non–ST-elevation ACS",
"answer": "Hemodynamic instability, refractory chest pain, HF, arrhythmias",
"relatedSectionId": "mk19_b_cv_s3_2_3_2"
},
"cv28": {
"id": "cv28",
"bookId": "cv",
"question": "Role of thrombolytic therapy in non–ST-elevation ACS",
"answer": "None",
"relatedSectionId": "mk19_b_cv_s3_2_4"
},
"cv29": {
"id": "cv29",
"bookId": "cv",
"question": "Contraindications to early β-blocker therapy after STEMI",
"answer": "Cardiogenic shock, hypotension, conduction disturbance",
"relatedSectionId": "mk19_b_cv_s3_2_4"
},
"cv30": {
"id": "cv30",
"bookId": "cv",
"question": "Duration of DAPT after ACS",
"answer": "At least 12 months",
"relatedSectionId": "mk19_b_cv_s3_2_4_1"
},
"cv31": {
"id": "cv31",
"bookId": "cv",
"question": "Timing of ACE inhibitor initiation after STEMI",
"answer": "Within 24 hours",
"relatedSectionId": "mk19_b_cv_s3_2_4_3_2"
},
"cv32": {
"id": "cv32",
"bookId": "cv",
"question": "Indications for aldosterone antagonist after STEMI",
"answer": "LVEF ≤40% and either HF symptoms or diabetes",
"relatedSectionId": "mk19_b_cv_s3_2_4_3_2"
},
"cv33": {
"id": "cv33",
"bookId": "cv",
"question": "ACS in a young woman during the peripartum period",
"answer": "Spontaneous coronary artery dissection",
"relatedSectionId": "mk19_b_cv_s3_2_5"
},
"cv34": {
"id": "cv34",
"bookId": "cv",
"question": "Causes of coronary vasospasm",
"answer": "Spontaneous, methamphetamine, cocaine, 5-FU, bromocriptine",
"relatedSectionId": "mk19_b_cv_s3_2_5"
},
"cv35": {
"id": "cv35",
"bookId": "cv",
"question": "Syndrome of angina, abnormal stress test results, normal coronary arteries",
"answer": "Cardiac syndrome X (microvascular angina)",
"relatedSectionId": "mk19_b_cv_s3_2_5"
},
"cv36": {
"id": "cv36",
"bookId": "cv",
"question": "Most common cause of HFpEF",
"answer": "Hypertension",
"relatedSectionId": "mk19_b_cv_s4_1"
},
"cv37": {
"id": "cv37",
"bookId": "cv",
"question": "BP target for HF prevention",
"answer": "&lt;130/80 mm Hg",
"relatedSectionId": "mk19_b_cv_s4_2"
},
"cv38": {
"id": "cv38",
"bookId": "cv",
"question": "Lab test to distinguish cardiac from pulmonary causes of dyspnea",
"answer": "BNP or NT-proBNP",
"relatedSectionId": "mk19_b_cv_s4_3_2"
},
"cv39": {
"id": "cv39",
"bookId": "cv",
"question": "Noncardiac causes of elevated BNP levels",
"answer": "CKD, older age, female sex, ARNI therapy",
"relatedSectionId": "mk19_b_cv_s4_3_2"
},
"cv40": {
"id": "cv40",
"bookId": "cv",
"question": "Impact of obesity on BNP levels",
"answer": "Lowers",
"relatedSectionId": "mk19_b_cv_s4_3_2"
},
"cv41": {
"id": "cv41",
"bookId": "cv",
"question": "Primary diagnostic test for evaluation of HF",
"answer": "Echocardiography",
"relatedSectionId": "mk19_b_cv_s4_3_2"
},
"cv42": {
"id": "cv42",
"bookId": "cv",
"question": "ACE inhibitor alternative with reduced mortality and CHF hospitalization",
"answer": "Valsartan-sacubitril",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_2"
},
"cv43": {
"id": "cv43",
"bookId": "cv",
"question": "Complication if ACE inhibitor is discontinued &lt;36 hours before valsartan-sacubitril is started",
"answer": "Angioedema",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_2"
},
"cv44": {
"id": "cv44",
"bookId": "cv",
"question": "Drugs indicated for all NYHA functional classes of HFrEF",
"answer": "β-Blockers and ACE inhibitors",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_3"
},
"cv45": {
"id": "cv45",
"bookId": "cv",
"question": "Indication for aldosterone antagonist for HFrEF",
"answer": "NYHA functional class II-IV symptoms or after acute MI",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_5"
},
"cv47": {
"id": "cv47",
"bookId": "cv",
"question": "Alternative treatment for patients with HFrEF intolerant of ACE inhibitors or ARBs",
"answer": "Isosorbide dinitrate-hydralazine",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_6"
},
"cv48": {
"id": "cv48",
"bookId": "cv",
"question": "Loop diuretic with increased bioavailability and longer half-life",
"answer": "Torsemide or bumetanide",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_7"
},
"cv49": {
"id": "cv49",
"bookId": "cv",
"question": "Risk factors for digoxin toxicity",
"answer": "Impaired kidney function, older age, female sex",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_9"
},
"cv50": {
"id": "cv50",
"bookId": "cv",
"question": "Calcium channel blockers contraindicated in patients with HFrEF",
"answer": "Nondihydropyridine Ca++ channel blockers, such as verapamil and diltiazem",
"relatedSectionId": "mk19_b_cv_s4_4_1_1_10"
},
"cv51": {
"id": "cv51",
"bookId": "cv",
"question": "HF indications for ICD placement",
"answer": "LVEF ≤35%, NYHA functional class II-III symptoms",
"relatedSectionId": "mk19_b_cv_s4_4_1_2_1"
},
"cv52": {
"id": "cv52",
"bookId": "cv",
"question": "Indications for CRT",
"answer": "EF ≤35%, NYHA functional class ≥II, sinus rhythm, and LBBB with QRS duration ≥150 ms",
"relatedSectionId": "mk19_b_cv_s4_4_1_2_2"
},
"cv53": {
"id": "cv53",
"bookId": "cv",
"question": "Indications for sleep assessment in HF",
"answer": "NYHA functional class II-IV with excessive daytime sleepiness",
"relatedSectionId": "mk19_b_cv_s4_4_1_3"
},
"cv55": {
"id": "cv55",
"bookId": "cv",
"question": "Vasoactive drug treatment of HF-related cardiogenic shock",
"answer": "Dobutamine or milrinone",
"relatedSectionId": "mk19_b_cv_s4_4_3_1"
},
"cv56": {
"id": "cv56",
"bookId": "cv",
"question": "Treatment of end-stage HF in nontransplant candidates",
"answer": "LVAD",
"relatedSectionId": "mk19_b_cv_s4_4_4_1"
},
"cv57": {
"id": "cv57",
"bookId": "cv",
"question": "Procedure to detect asymptomatic cardiac transplant rejection",
"answer": "Endomyocardial biopsy",
"relatedSectionId": "mk19_b_cv_s4_4_4_2"
},
"cv58": {
"id": "cv58",
"bookId": "cv",
"question": "Cardiomyopathy associated with apical dyskinesis or ballooning",
"answer": "Takotsubo (stress) cardiomyopathy",
"relatedSectionId": "mk19_b_cv_s4_5_1"
},
"cv59": {
"id": "cv59",
"bookId": "cv",
"question": "Fever, myalgia, and respiratory symptoms followed by HF",
"answer": "Viral myocarditis",
"relatedSectionId": "mk19_b_cv_s4_5_2"
},
"cv60": {
"id": "cv60",
"bookId": "cv",
"question": "Treatment of tachycardia-mediated cardiomyopathy",
"answer": "Heart rate control with drugs or catheter ablation",
"relatedSectionId": "mk19_b_cv_s4_5_5"
},
"cv61": {
"id": "cv61",
"bookId": "cv",
"question": "Extracardiac condition associated with nocturnal bradycardia or conduction disturbance",
"answer": "Sleep apnea",
"relatedSectionId": "mk19_b_cv_s5_2_1"
},
"cv62": {
"id": "cv62",
"bookId": "cv",
"question": "Treatment of symptomatic bradycardia without reversible cause",
"answer": "Pacemaker",
"relatedSectionId": "mk19_b_cv_s5_2_4"
},
"cv63": {
"id": "cv63",
"bookId": "cv",
"question": "Atrial fibrillation indication for pacemaker implantation",
"answer": "Permanent atrial fibrillation with symptomatic bradycardia",
"relatedSectionId": "mk19_b_cv_s5_2_4"
},
"cv64": {
"id": "cv64",
"bookId": "cv",
"question": "Drugs to inhibit SVT induction and block AV conduction",
"answer": "β-Blockers and nondihydropyridine calcium channel blockers",
"relatedSectionId": "mk19_b_cv_s5_3_2"
},
"cv65": {
"id": "cv65",
"bookId": "cv",
"question": "Organs affected by amiodarone toxicity",
"answer": "Liver, lung, thyroid, eye",
"relatedSectionId": "mk19_b_cv_s5_3_2"
},
"cv66": {
"id": "cv66",
"bookId": "cv",
"question": "Elevated resting heart rate, exaggerated increase with activity",
"answer": "Inappropriate sinus tachycardia",
"relatedSectionId": "mk19_b_cv_s5_4"
},
"cv67": {
"id": "cv67",
"bookId": "cv",
"question": "Orthostatic intolerance and excessive tachycardia, worse with standing",
"answer": "Postural orthostatic tachycardia syndrome",
"relatedSectionId": "mk19_b_cv_s5_4"
},
"cv68": {
"id": "cv68",
"bookId": "cv",
"question": "Most common tachycardia, typically related to physiologic demand",
"answer": "Sinus tachycardia",
"relatedSectionId": "mk19_b_cv_s5_4"
},
"cv69": {
"id": "cv69",
"bookId": "cv",
"question": "Initial nondrug treatment of SVT",
"answer": "Vagal maneuvers",
"relatedSectionId": "mk19_b_cv_s5_5_1"
},
"cv70": {
"id": "cv70",
"bookId": "cv",
"question": "Rapidly acting drug therapy for SVT",
"answer": "Adenosine",
"relatedSectionId": "mk19_b_cv_s5_5_1"
},
"cv71": {
"id": "cv71",
"bookId": "cv",
"question": "SVT with short PR interval and slurred QRS upstroke",
"answer": "AVRT",
"relatedSectionId": "mk19_b_cv_s5_5_3"
},
"cv72": {
"id": "cv72",
"bookId": "cv",
"question": "Wolff-Parkinson-White syndrome first-line treatment",
"answer": "Catheter ablation",
"relatedSectionId": "mk19_b_cv_s5_5_3"
},
"cv73": {
"id": "cv73",
"bookId": "cv",
"question": "Underlying risk factor predisposing to multifocal atrial tachycardia",
"answer": "Severe pulmonary disease",
"relatedSectionId": "mk19_b_cv_s5_5_4"
},
"cv74": {
"id": "cv74",
"bookId": "cv",
"question": "Treatment for AF-related hemodynamic instability",
"answer": "Cardioversion",
"relatedSectionId": "mk19_b_cv_s5_6_2"
},
"cv75": {
"id": "cv75",
"bookId": "cv",
"question": "Long-term anticoagulant for valvular AF",
"answer": "Warfarin",
"relatedSectionId": "mk19_b_cv_s5_6_3_1_2"
},
"cv76": {
"id": "cv76",
"bookId": "cv",
"question": "Baseline testing before initiation of NOAC therapy for chronic AF",
"answer": "Kidney and liver function testing",
"relatedSectionId": "mk19_b_cv_s5_6_3_1_4"
},
"cv77": {
"id": "cv77",
"bookId": "cv",
"question": "Treatment of recurrent symptomatic AF",
"answer": "Catheter ablation with pulmonary vein isolation",
"relatedSectionId": "mk19_b_cv_s5_6_3_3"
},
"cv78": {
"id": "cv78",
"bookId": "cv",
"question": "Sawtooth pattern seen in leads II, III, and aVF on ECG",
"answer": "Atrial flutter",
"relatedSectionId": "mk19_b_cv_s5_7"
},
"cv79": {
"id": "cv79",
"bookId": "cv",
"question": "Definitive treatment of atrial flutter",
"answer": "Catheter ablation",
"relatedSectionId": "mk19_b_cv_s5_7"
},
"cv80": {
"id": "cv80",
"bookId": "cv",
"question": "Treatment of PVC-induced cardiomyopathy",
"answer": "Catheter ablation",
"relatedSectionId": "mk19_b_cv_s5_8_1"
},
"cv81": {
"id": "cv81",
"bookId": "cv",
"question": "Wide-complex tachycardia in patients with structural heart disease",
"answer": "Ventricular tachycardia",
"relatedSectionId": "mk19_b_cv_s5_8_2"
},
"cv82": {
"id": "cv82",
"bookId": "cv",
"question": "Drug classes commonly associated with QT prolongation",
"answer": "Macrolides, fluoroquinolones, antipsychotics, antidepressants",
"relatedSectionId": "mk19_b_cv_s5_9"
},
"cv83": {
"id": "cv83",
"bookId": "cv",
"question": "Drug therapy for inherited long QT syndrome",
"answer": "β-Blocker",
"relatedSectionId": "mk19_b_cv_s5_9"
},
"cv84": {
"id": "cv84",
"bookId": "cv",
"question": "ST-segment coving in leads V<sub>1</sub>-V<sub>3</sub>, VF, cardiac arrest",
"answer": "Brugada syndrome",
"relatedSectionId": "mk19_b_cv_s5_9"
},
"cv85": {
"id": "cv85",
"bookId": "cv",
"question": "Imaging test for suspected arrhythmogenic RV cardiomyopathy/dysplasia",
"answer": "CMR imaging",
"relatedSectionId": "mk19_b_cv_s5_9"
},
"cv86": {
"id": "cv86",
"bookId": "cv",
"question": "Nonischemic cardiomyopathy ICD indications",
"answer": "LVEF ≤35% and NYHA functional class II-III symptoms",
"relatedSectionId": "mk19_b_cv_s5_10_3"
},
"cv87": {
"id": "cv87",
"bookId": "cv",
"question": "Treatment of cardiac device infection",
"answer": "Extraction, pocket debridement, antibiotics",
"relatedSectionId": "mk19_b_cv_s5_10_3"
},
"cv88": {
"id": "cv88",
"bookId": "cv",
"question": "Effect of medical therapy for valvular heart disease on survival",
"answer": "None",
"relatedSectionId": "mk19_b_cv_s6_1"
},
"cv89": {
"id": "cv89",
"bookId": "cv",
"question": "Late-peaking systolic murmur, diminished S<sub>2</sub>, delayed and diminished carotid upstroke",
"answer": "Severe aortic stenosis",
"relatedSectionId": "mk19_b_cv_s6_2_1"
},
"cv90": {
"id": "cv90",
"bookId": "cv",
"question": "Primary imaging modality to evaluate aortic stenosis",
"answer": "TTE",
"relatedSectionId": "mk19_b_cv_s6_2_1"
},
"cv91": {
"id": "cv91",
"bookId": "cv",
"question": "TEE criteria for severe aortic stenosis",
"answer": "Valve area ≤1.0 cm<sup>2</sup>, peak velocity &gt;4 m/s, mean gradient &gt;40 mm Hg",
"relatedSectionId": "mk19_b_cv_s6_2_1"
},
"cv92": {
"id": "cv92",
"bookId": "cv",
"question": "Test for low-flow, low-gradient aortic stenosis",
"answer": "Dobutamine echocardiography",
"relatedSectionId": "mk19_b_cv_s6_2_1"
},
"cv93": {
"id": "cv93",
"bookId": "cv",
"question": "Life-prolonging therapy for severe aortic stenosis",
"answer": "Aortic valve replacement",
"relatedSectionId": "mk19_b_cv_s6_2_2"
},
"cv94": {
"id": "cv94",
"bookId": "cv",
"question": "Primary symptoms of severe aortic stenosis",
"answer": "Dyspnea, angina, syncope",
"relatedSectionId": "mk19_b_cv_s6_2_2"
},
"cv95": {
"id": "cv95",
"bookId": "cv",
"question": "Bounding peripheral pulses, diastolic decrescendo murmur along the sternal border",
"answer": "Aortic regurgitation",
"relatedSectionId": "mk19_b_cv_s6_3_1"
},
"cv97": {
"id": "cv97",
"bookId": "cv",
"question": "Surgical indications for chronic aortic regurgitation",
"answer": "Symptoms, LVEF &lt;55%, LV dilatation",
"relatedSectionId": "mk19_b_cv_s6_3_2"
},
"cv98": {
"id": "cv98",
"bookId": "cv",
"question": "Medical therapy for chronic aortic regurgitation and hypertension",
"answer": "Dihydropyridine calcium channel blockers, ACE inhibitors, or ARBs",
"relatedSectionId": "mk19_b_cv_s6_3_2"
},
"cv99": {
"id": "cv99",
"bookId": "cv",
"question": "Treatment of acute aortic regurgitation due to aortic dissection",
"answer": "Emergent surgical repair",
"relatedSectionId": "mk19_b_cv_s6_3_2"
},
"cv100": {
"id": "cv100",
"bookId": "cv",
"question": "Valve abnormality associated with aortic coarctation",
"answer": "Bicuspid aortic valve",
"relatedSectionId": "mk19_b_cv_s6_4"
},
"cv101": {
"id": "cv101",
"bookId": "cv",
"question": "Diastolic opening snap and rumble at cardiac apex",
"answer": "Mitral stenosis",
"relatedSectionId": "mk19_b_cv_s6_5_1"
},
"cv102": {
"id": "cv102",
"bookId": "cv",
"question": "Contraindications for percutaneous balloon mitral commissurotomy to treat mitral stenosis",
"answer": "Left atrial thrombus, moderate mitral regurgitation, severely calcified valve",
"relatedSectionId": "mk19_b_cv_s6_5_2"
},
"cv103": {
"id": "cv103",
"bookId": "cv",
"question": "Indications for warfarin anticoagulation in moderate to severe mitral stenosis",
"answer": "Atrial fibrillation, left atrial thrombus, or systemic embolization",
"relatedSectionId": "mk19_b_cv_s6_5_2"
},
"cv104": {
"id": "cv104",
"bookId": "cv",
"question": "Physical finding in chronic mitral regurgitation",
"answer": "Blowing holosystolic murmur at apex",
"relatedSectionId": "mk19_b_cv_s6_6_1"
},
"cv105": {
"id": "cv105",
"bookId": "cv",
"question": "Treatment of chronic severe mitral regurgitation with LV dysfunction or dilation",
"answer": "Mitral valve repair",
"relatedSectionId": "mk19_b_cv_s6_6_2"
},
"cv106": {
"id": "cv106",
"bookId": "cv",
"question": "Indications for repair in chronic severe primary mitral regurgitation",
"answer": "Symptoms, EF &gt;30%, and/or LV end-systolic diameter ≥40 mm",
"relatedSectionId": "mk19_b_cv_s6_6_2"
},
"cv107": {
"id": "cv107",
"bookId": "cv",
"question": "Treatment of symptomatic chronic severe mitral regurgitation in nonsurgical candidates",
"answer": "Transcatheter mitral valve",
"relatedSectionId": "mk19_b_cv_s6_6_2"
},
"cv108": {
"id": "cv108",
"bookId": "cv",
"question": "Holosystolic murmur along left sternal border that increases with inspiration",
"answer": "Tricuspid regurgitation",
"relatedSectionId": "mk19_b_cv_s6_7"
},
"cv109": {
"id": "cv109",
"bookId": "cv",
"question": "Drug treatment for right-sided HF in tricuspid regurgitation",
"answer": "Loop diuretics and aldosterone antagonists",
"relatedSectionId": "mk19_b_cv_s6_7"
},
"cv110": {
"id": "cv110",
"bookId": "cv",
"question": "Most common cause of tricuspid stenosis",
"answer": "Rheumatic disease",
"relatedSectionId": "mk19_b_cv_s6_7"
},
"cv111": {
"id": "cv111",
"bookId": "cv",
"question": "Recommended aortic valve type for patients younger than 50 years",
"answer": "Mechanical",
"relatedSectionId": "mk19_b_cv_s6_8"
},
"cv112": {
"id": "cv112",
"bookId": "cv",
"question": "Recommended heart valve type for patients older than 65 years",
"answer": "Bioprosthesis",
"relatedSectionId": "mk19_b_cv_s6_8"
},
"cv113": {
"id": "cv113",
"bookId": "cv",
"question": "Echocardiography follow-up interval after valve bioprosthesis",
"answer": "TTE at 5 years, then annually starting at 10 years after valve replacement",
"relatedSectionId": "mk19_b_cv_s6_8"
},
"cv114": {
"id": "cv114",
"bookId": "cv",
"question": "INR goal for mechanical aortic valve and no additional risk factors",
"answer": "2.5",
"relatedSectionId": "mk19_b_cv_s6_8"
},
"cv115": {
"id": "cv115",
"bookId": "cv",
"question": "Target INR for mechanical mitral prosthetic valve",
"answer": "3.0 (range, 2.5-3.5)",
"relatedSectionId": "mk19_b_cv_s6_8"
},
"cv116": {
"id": "cv116",
"bookId": "cv",
"question": "Most common cause of culture-negative endocarditis",
"answer": "Pre-culture antibiotic administration",
"relatedSectionId": "mk19_b_cv_s6_9_1"
},
"cv117": {
"id": "cv117",
"bookId": "cv",
"question": "Most common bacteria in endocarditis 60-365 days after prosthetic valve surgery",
"answer": "Coagulase-negative staphylococci",
"relatedSectionId": "mk19_b_cv_s6_9_1"
},
"cv118": {
"id": "cv118",
"bookId": "cv",
"question": "Treatment of infective endocarditis complicated by heart block",
"answer": "Surgery",
"relatedSectionId": "mk19_b_cv_s6_9_1"
},
"cv119": {
"id": "cv119",
"bookId": "cv",
"question": "Typical murmur of hypertrophic cardiomyopathy",
"answer": "Systolic murmur that increases with Valsalva and standing",
"relatedSectionId": "mk19_b_cv_s7_1_2"
},
"cv120": {
"id": "cv120",
"bookId": "cv",
"question": "Most common ECG findings in hypertrophic cardiomyopathy",
"answer": "Increased QRS voltage, left atrial enlargement, LV conduction abnormalities, pathologic Q waves",
"relatedSectionId": "mk19_b_cv_s7_1_2"
},
"cv121": {
"id": "cv121",
"bookId": "cv",
"question": "Initial imaging test for hypertrophic cardiomyopathy",
"answer": "Doppler echocardiography",
"relatedSectionId": "mk19_b_cv_s7_1_2"
},
"cv122": {
"id": "cv122",
"bookId": "cv",
"question": "Treatment to prevent SCD in high-risk patients with hypertrophic cardiomyopathy",
"answer": "ICD",
"relatedSectionId": "mk19_b_cv_s7_1_3"
},
"cv123": {
"id": "cv123",
"bookId": "cv",
"question": "First-line drugs for symptomatic hypertrophic cardiomyopathy",
"answer": "Nonvasodilating β-blockers (not carvedilol, labetalol)",
"relatedSectionId": "mk19_b_cv_s7_1_4"
},
"cv124": {
"id": "cv124",
"bookId": "cv",
"question": "TTE surveillance frequency in asymptomatic hypertrophic cardiomyopathy",
"answer": "Every 1-2 years",
"relatedSectionId": "mk19_b_cv_s7_1_4_1"
},
"cv125": {
"id": "cv125",
"bookId": "cv",
"question": "Concentric ventricular wall thickness with low QRS voltage",
"answer": "Cardiac amyloidosis",
"relatedSectionId": "mk19_b_cv_s7_2"
},
"cv126": {
"id": "cv126",
"bookId": "cv",
"question": "Novel protein stabilizer therapy for patients with transthyretin amyloid cardiac amyloidosis",
"answer": "Tafamidis",
"relatedSectionId": "mk19_b_cv_s7_2"
},
"cv127": {
"id": "cv127",
"bookId": "cv",
"question": "Cardiac biomarker elevated in restrictive cardiomyopathy, normal in constrictive pericarditis",
"answer": "BNP",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv128": {
"id": "cv128",
"bookId": "cv",
"question": "Management of constrictive pericarditis",
"answer": "Surgical pericardiectomy",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv129": {
"id": "cv129",
"bookId": "cv",
"question": "Predisposition to constrictive pericarditis",
"answer": "Prior cardiac surgery, pericarditis, chest radiation",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv130": {
"id": "cv130",
"bookId": "cv",
"question": "RV failure, normal BNP, pericardial thickening",
"answer": "Constrictive pericarditis",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv131": {
"id": "cv131",
"bookId": "cv",
"question": "Echocardiographic findings in restrictive cardiomyopathy",
"answer": "Biatrial enlargement; diastolic dysfunction; normal LV size, thickness, function",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv132": {
"id": "cv132",
"bookId": "cv",
"question": "Condition characterized by ventricular interdependence",
"answer": "Constrictive pericarditis",
"relatedSectionId": "mk19_b_cv_s7_3_1_1"
},
"cv133": {
"id": "cv133",
"bookId": "cv",
"question": "Treatment of atrial myxoma",
"answer": "Surgical excision",
"relatedSectionId": "mk19_b_cv_s7_4"
},
"cv134": {
"id": "cv134",
"bookId": "cv",
"question": "Primary cardiac tumor of older age associated with stroke",
"answer": "Papillary fibroelastoma",
"relatedSectionId": "mk19_b_cv_s7_4"
},
"cv135": {
"id": "cv135",
"bookId": "cv",
"question": "Diagnostic criteria for acute pericarditis",
"answer": "Two of the following: chest pain, pericardial rub, typical ECG changes, effusion",
"relatedSectionId": "mk19_b_cv_s8_1_1"
},
"cv136": {
"id": "cv136",
"bookId": "cv",
"question": "ECG findings of acute pericarditis",
"answer": "Multiple-lead ST-segment elevation and PR-segment depression in lead II",
"relatedSectionId": "mk19_b_cv_s8_1_1"
},
"cv137": {
"id": "cv137",
"bookId": "cv",
"question": "Treatment of acute pericarditis",
"answer": "NSAIDs plus colchicine",
"relatedSectionId": "mk19_b_cv_s8_1_2"
},
"cv138": {
"id": "cv138",
"bookId": "cv",
"question": "Treatment of recurrent or autoimmune pericarditis",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_b_cv_s8_1_2"
},
"cv139": {
"id": "cv139",
"bookId": "cv",
"question": "Hypotension, pulsus paradoxus, electrical alternans",
"answer": "Cardiac tamponade",
"relatedSectionId": "mk19_b_cv_s8_2_2_1"
},
"cv140": {
"id": "cv140",
"bookId": "cv",
"question": "Treatment of cardiac tamponade",
"answer": "Pericardiocentesis or surgical drainage",
"relatedSectionId": "mk19_b_cv_s8_2_2_2"
},
"cv141": {
"id": "cv141",
"bookId": "cv",
"question": "Bridging therapy for hemodynamic instability in cardiac tamponade",
"answer": "Normal saline infusion",
"relatedSectionId": "mk19_b_cv_s8_2_2_2"
},
"cv142": {
"id": "cv142",
"bookId": "cv",
"question": "Treatment of chronic pericardial constriction",
"answer": "Pericardiectomy",
"relatedSectionId": "mk19_b_cv_s8_3_2"
},
"cv143": {
"id": "cv143",
"bookId": "cv",
"question": "Treatment of transient constrictive pericarditis",
"answer": "NSAIDs plus colchicine",
"relatedSectionId": "mk19_b_cv_s8_3_2"
},
"cv144": {
"id": "cv144",
"bookId": "cv",
"question": "Treatment of asymptomatic PFO",
"answer": "No treatment required",
"relatedSectionId": "mk19_b_cv_s9_2"
},
"cv145": {
"id": "cv145",
"bookId": "cv",
"question": "Fixed split S<sub>2</sub>, right axis deviation, incomplete RBBB",
"answer": "Ostium secundum ASD",
"relatedSectionId": "mk19_b_cv_s9_3_3"
},
"cv146": {
"id": "cv146",
"bookId": "cv",
"question": "Continuous murmur heard beneath left clavicle",
"answer": "PDA",
"relatedSectionId": "mk19_b_cv_s9_5_2"
},
"cv147": {
"id": "cv147",
"bookId": "cv",
"question": "Characteristic features of Eisenmenger PDA",
"answer": "Clubbing, oxygen desaturation affecting the feet but not the hands",
"relatedSectionId": "mk19_b_cv_s9_5_2"
},
"cv148": {
"id": "cv148",
"bookId": "cv",
"question": "Pulmonary stenosis, short stature, neck webbing, hypertelorism",
"answer": "Noonan syndrome",
"relatedSectionId": "mk19_b_cv_s9_6_1"
},
"cv149": {
"id": "cv149",
"bookId": "cv",
"question": "Upper extremity hypertension, radial-femoral pulse delay, infraclavicular systolic murmur",
"answer": "Aortic coarctation",
"relatedSectionId": "mk19_b_cv_s9_7_2"
},
"cv150": {
"id": "cv150",
"bookId": "cv",
"question": "Classic radiographic findings of aortic coarctation",
"answer": "Rib notching and the “figure 3” sign",
"relatedSectionId": "mk19_b_cv_s9_7_3"
},
"cv151": {
"id": "cv151",
"bookId": "cv",
"question": "Indications for intervention in aortic coarctation",
"answer": "Systolic pressure gradient ≥20 mm Hg or evidence of collateral flow",
"relatedSectionId": "mk19_b_cv_s9_7_4"
},
"cv152": {
"id": "cv152",
"bookId": "cv",
"question": "Common CVD after coarctation repair",
"answer": "Hypertension",
"relatedSectionId": "mk19_b_cv_s9_7_5"
},
"cv153": {
"id": "cv153",
"bookId": "cv",
"question": "Most common structural disorder after TOF repair",
"answer": "Pulmonary regurgitation",
"relatedSectionId": "mk19_b_cv_s9_8"
},
"cv154": {
"id": "cv154",
"bookId": "cv",
"question": "Severe pulmonary hypertension with cardiac shunt reversal (right-to-left shunting)",
"answer": "Eisenmenger syndrome",
"relatedSectionId": "mk19_b_cv_s9_9_2"
},
"cv155": {
"id": "cv155",
"bookId": "cv",
"question": "Most common genetic conditions that require screening for aortic disease",
"answer": "Marfan and Ehlers-Danlos syndromes",
"relatedSectionId": "mk19_b_cv_s10_2_1"
},
"cv156": {
"id": "cv156",
"bookId": "cv",
"question": "Leading cause of death in patients with TAA",
"answer": "Ruptured aneurysm",
"relatedSectionId": "mk19_b_cv_s10_2_1"
},
"cv157": {
"id": "cv157",
"bookId": "cv",
"question": "Management of TAA with diameter &lt;5.0 cm",
"answer": "β-Blockers with target BP &lt;130/80 mm Hg",
"relatedSectionId": "mk19_b_cv_s10_2_2"
},
"cv158": {
"id": "cv158",
"bookId": "cv",
"question": "Indications for AAA repair",
"answer": "Symptoms, size ≥5.5 cm, expansion &gt;0.5 cm/year",
"relatedSectionId": "mk19_b_cv_s10_3_2"
},
"cv159": {
"id": "cv159",
"bookId": "cv",
"question": "Aortic atheroma treatment",
"answer": "Antiplatelet agent and statin",
"relatedSectionId": "mk19_b_cv_s10_4"
},
"cv160": {
"id": "cv160",
"bookId": "cv",
"question": "Imaging method of choice to diagnose TAA",
"answer": "CT angiography",
"relatedSectionId": "mk19_b_cv_s10_5_2"
},
"cv161": {
"id": "cv161",
"bookId": "cv",
"question": "First-line treatment of acute aortic dissection without shock",
"answer": "IV β-blocker",
"relatedSectionId": "mk19_b_cv_s10_5_3"
},
"cv162": {
"id": "cv162",
"bookId": "cv",
"question": "Target systolic BP for acute aortic dissection",
"answer": "≤120 mm Hg within 1 hour",
"relatedSectionId": "mk19_b_cv_s10_5_3"
},
"cv163": {
"id": "cv163",
"bookId": "cv",
"question": "Management of type B aortic dissection",
"answer": "IV β-blocker",
"relatedSectionId": "mk19_b_cv_s10_5_3"
},
"cv164": {
"id": "cv164",
"bookId": "cv",
"question": "Acute type A aortic dissection treatment",
"answer": "Surgical repair",
"relatedSectionId": "mk19_b_cv_s10_5_3"
},
"cv165": {
"id": "cv165",
"bookId": "cv",
"question": "Indications for emergent surgery in acute aortic dissection",
"answer": "Shock, type A aortic dissection, type A intramural hematoma",
"relatedSectionId": "mk19_b_cv_s10_5_3"
},
"cv166": {
"id": "cv166",
"bookId": "cv",
"question": "Indications for ABI measurement",
"answer": "Exertional leg symptoms, nonhealing leg ulcers, atypical leg symptoms",
"relatedSectionId": "mk19_b_cv_s11_1"
},
"cv167": {
"id": "cv167",
"bookId": "cv",
"question": "Leg pain at rest and skin ulceration",
"answer": "Critical limb ischemia",
"relatedSectionId": "mk19_b_cv_s11_2"
},
"cv168": {
"id": "cv168",
"bookId": "cv",
"question": "ABI value diagnostic of PAD",
"answer": "≤0.90",
"relatedSectionId": "mk19_b_cv_s11_3_2"
},
"cv169": {
"id": "cv169",
"bookId": "cv",
"question": "Diagnostic test for PAD if ABI &gt;1.4",
"answer": "Toe-brachial index",
"relatedSectionId": "mk19_b_cv_s11_3_2"
},
"cv170": {
"id": "cv170",
"bookId": "cv",
"question": "Drug therapy for all patients with PAD",
"answer": "Antiplatelets and statins",
"relatedSectionId": "mk19_b_cv_s11_4_1"
},
"cv171": {
"id": "cv171",
"bookId": "cv",
"question": "Drug therapy to improve symptoms of PAD despite antiplatelet and statin therapy",
"answer": "Cilostazol",
"relatedSectionId": "mk19_b_cv_s11_4_2"
},
"cv172": {
"id": "cv172",
"bookId": "cv",
"question": "Treatment of life-limiting claudication unresponsive to medical therapy",
"answer": "Endovascular (preferred) or surgical revascularization",
"relatedSectionId": "mk19_b_cv_s11_5"
},
"cv173": {
"id": "cv173",
"bookId": "cv",
"question": "Immediate diagnostic test for acute limb ischemia",
"answer": "Invasive angiography",
"relatedSectionId": "mk19_b_cv_s11_6"
},
"cv174": {
"id": "cv174",
"bookId": "cv",
"question": "The “6 P's” of acute limb ischemia",
"answer": "Paresthesia, pain, pallor, pulselessness, poikilothermia (coolness), paralysis",
"relatedSectionId": "mk19_b_cv_s11_6"
},
"cv175": {
"id": "cv175",
"bookId": "cv",
"question": "Cardiac toxicity of anthracyclines",
"answer": "Irreversible dilated cardiomyopathy",
"relatedSectionId": "mk19_b_cv_s12_2"
},
"cv176": {
"id": "cv176",
"bookId": "cv",
"question": "Cardiac toxicity of trastuzumab",
"answer": "Reversible LV dysfunction",
"relatedSectionId": "mk19_b_cv_s12_2"
},
"cv177": {
"id": "cv177",
"bookId": "cv",
"question": "Primary CV side effect of bevacizumab",
"answer": "Hypertension",
"relatedSectionId": "mk19_b_cv_s12_2"
},
"cv178": {
"id": "cv178",
"bookId": "cv",
"question": "New onset of LV dysfunction at the end of pregnancy or after delivery",
"answer": "Peripartum cardiomyopathy",
"relatedSectionId": "mk19_b_cv_s13_3_1"
},
"cv179": {
"id": "cv179",
"bookId": "cv",
"question": "Vascular complication of Marfan syndrome during pregnancy",
"answer": "Aortic dissection and rupture",
"relatedSectionId": "mk19_b_cv_s13_3_2"
},
"cv180": {
"id": "cv180",
"bookId": "cv",
"question": "Preferred hypertension drugs for pregnant patients",
"answer": "Labetalol and methyldopa",
"relatedSectionId": "mk19_b_cv_s13_3_3"
},
"en1": {
"id": "en1",
"bookId": "en",
"question": "DM diagnostic tests",
"answer": "HgbA<sub>1c</sub>, FBG, OGTT; random glucose if hyperglycemic symptoms",
"relatedSectionId": "mk19_b_en_s1_1_2"
},
"en2": {
"id": "en2",
"bookId": "en",
"question": "T1DM antibody testing in new diagnosis",
"answer": "GAD65, tyrosine phosphatases IA-2",
"relatedSectionId": "mk19_b_en_s1_1_3_1_2"
},
"en3": {
"id": "en3",
"bookId": "en",
"question": "Diseases associated with acanthosis nigricans",
"answer": "Insulin resistance/DM, malignancy",
"relatedSectionId": "mk19_b_en_s1_1_3_2_1"
},
"en4": {
"id": "en4",
"bookId": "en",
"question": "Test when preprandial glucose is normal but HgbA<sub>1c</sub> is elevated",
"answer": "Postprandial glucose level",
"relatedSectionId": "mk19_b_en_s1_1_4_2"
},
"en5": {
"id": "en5",
"bookId": "en",
"question": "ACP-recommended goal HgbA<sub>1c</sub> in most patients with T2DM",
"answer": "7% to 8%",
"relatedSectionId": "mk19_b_en_s1_1_4_5"
},
"en6": {
"id": "en6",
"bookId": "en",
"question": "HgbA<sub>1c</sub> level below which to consider deintensifying pharmacologic therapy",
"answer": "6.5%",
"relatedSectionId": "mk19_b_en_s1_1_4_5"
},
"en7": {
"id": "en7",
"bookId": "en",
"question": "Recommended mode of insulin delivery for T1DM not at HgbA<sub>1c</sub> goal",
"answer": "CSII",
"relatedSectionId": "mk19_b_en_s1_1_4_5_1"
},
"en8": {
"id": "en8",
"bookId": "en",
"question": "T2DM medications beneficial in heart failure",
"answer": "SGLT2 inhibitors",
"relatedSectionId": "mk19_b_en_s1_1_4_5_2"
},
"en9": {
"id": "en9",
"bookId": "en",
"question": "eGFR contraindication to metformin therapy",
"answer": "&lt;30 mL/min/1.73 m<sup>2</sup>",
"relatedSectionId": "mk19_b_en_s1_1_4_5_2"
},
"en10": {
"id": "en10",
"bookId": "en",
"question": "Frequency of HgbA<sub>1c</sub> assessment in T2DM not at glycemic goal",
"answer": "3 months",
"relatedSectionId": "mk19_b_en_s1_1_4_5_2"
},
"en11": {
"id": "en11",
"bookId": "en",
"question": "Treatment of hyperglycemia in hospitalized, fasting patients",
"answer": "Basal and correction insulin",
"relatedSectionId": "mk19_b_en_s1_3"
},
"en12": {
"id": "en12",
"bookId": "en",
"question": "Inpatient glucose threshold for insulin initiation",
"answer": "180 mg/dL",
"relatedSectionId": "mk19_b_en_s1_3"
},
"en13": {
"id": "en13",
"bookId": "en",
"question": "Drug class associated with euglycemic ketoacidosis",
"answer": "SGLT2 inhibitors",
"relatedSectionId": "mk19_b_en_s1_4_1"
},
"en14": {
"id": "en14",
"bookId": "en",
"question": "Recommended initial antihypertensive medications in T2DM",
"answer": "ACE inhibitors or ARBs; dihydropyridine CCBs; thiazides",
"relatedSectionId": "mk19_b_en_s1_5_1"
},
"en15": {
"id": "en15",
"bookId": "en",
"question": "Diabetic proliferative retinopathy treatment",
"answer": "Photocoagulation or intravitreal anti-VEGF",
"relatedSectionId": "mk19_b_en_s1_5_2"
},
"en16": {
"id": "en16",
"bookId": "en",
"question": "Timing of DM-related dilated eye exams during pregnancy",
"answer": "Every trimester",
"relatedSectionId": "mk19_b_en_s1_5_2"
},
"en17": {
"id": "en17",
"bookId": "en",
"question": "Treatment of DM-related macular edema",
"answer": "Intravitreal anti-VEGF",
"relatedSectionId": "mk19_b_en_s1_5_2"
},
"en18": {
"id": "en18",
"bookId": "en",
"question": "UACR cutoff for consideration of ACE inhibitor/ARB in T2DM with hypertension",
"answer": "UACR ≥30 mg/g",
"relatedSectionId": "mk19_b_en_s1_5_3"
},
"en19": {
"id": "en19",
"bookId": "en",
"question": "Drugs for diabetic peripheral neuropathy",
"answer": "Pregabalin, duloxetine, gabapentin",
"relatedSectionId": "mk19_b_en_s1_5_4"
},
"en20": {
"id": "en20",
"bookId": "en",
"question": "Treatment of hypoglycemic unawareness",
"answer": "Relax glycemic targets, modify hypoglycemia-inducing therapies",
"relatedSectionId": "mk19_b_en_s1_7_1"
},
"en21": {
"id": "en21",
"bookId": "en",
"question": "Indication for insulinoma localization imaging in hypoglycemia",
"answer": "After confirmation of endogenous hyperinsulinism",
"relatedSectionId": "mk19_b_en_s1_7_2"
},
"en22": {
"id": "en22",
"bookId": "en",
"question": "Diagnosis suggested by small or absent pituitary gland on MRI",
"answer": "Empty sella syndrome",
"relatedSectionId": "mk19_b_en_s2_3"
},
"en23": {
"id": "en23",
"bookId": "en",
"question": "Impact of chronic opioid therapy on gonadal function",
"answer": "Hypogonadotropic hypogonadism",
"relatedSectionId": "mk19_b_en_s2_3_1_2"
},
"en24": {
"id": "en24",
"bookId": "en",
"question": "Endocrine side effect of checkpoint inhibitor drugs",
"answer": "Hypophysitis",
"relatedSectionId": "mk19_b_en_s2_3_1_2"
},
"en25": {
"id": "en25",
"bookId": "en",
"question": "Most common optic chiasm compression–related visual field defect",
"answer": "Bitemporal hemianopsia",
"relatedSectionId": "mk19_b_en_s2_3_2"
},
"en26": {
"id": "en26",
"bookId": "en",
"question": "Tests for pituitary hypersecretion in all pituitary incidentalomas",
"answer": "Prolactin and IGF-1 levels",
"relatedSectionId": "mk19_b_en_s2_3_3"
},
"en27": {
"id": "en27",
"bookId": "en",
"question": "Hormone replacement for all patients with panhypopituitarism",
"answer": "T<sub>4</sub> and cortisol",
"relatedSectionId": "mk19_b_en_s2_4_1"
},
"en28": {
"id": "en28",
"bookId": "en",
"question": "Morning cortisol level strongly suggestive of deficiency",
"answer": "&lt;3 µg/dL",
"relatedSectionId": "mk19_b_en_s2_4_2"
},
"en29": {
"id": "en29",
"bookId": "en",
"question": "Morning cortisol level that rules out deficiency",
"answer": "&gt;15 µg/dL",
"relatedSectionId": "mk19_b_en_s2_4_2"
},
"en30": {
"id": "en30",
"bookId": "en",
"question": "Monitoring in secondary hypothyroidism",
"answer": "Free T<sub>4</sub> measurement",
"relatedSectionId": "mk19_b_en_s2_4_3"
},
"en31": {
"id": "en31",
"bookId": "en",
"question": "Treatment of central diabetes insipidus",
"answer": "Desmopressin",
"relatedSectionId": "mk19_b_en_s2_4_6"
},
"en32": {
"id": "en32",
"bookId": "en",
"question": "Nonpituitary endocrine cause of hyperprolactinemia",
"answer": "Hypothyroidism",
"relatedSectionId": "mk19_b_en_s2_5_1"
},
"en33": {
"id": "en33",
"bookId": "en",
"question": "Treatment of symptomatic hyperprolactinemia",
"answer": "Dopamine agonist",
"relatedSectionId": "mk19_b_en_s2_5_1"
},
"en34": {
"id": "en34",
"bookId": "en",
"question": "Prolactin level suggestive of macroprolactinoma",
"answer": "&gt;200 ng/mL",
"relatedSectionId": "mk19_b_en_s2_5_1"
},
"en35": {
"id": "en35",
"bookId": "en",
"question": "Initial test for suspected acromegaly",
"answer": "IGF-1 level",
"relatedSectionId": "mk19_b_en_s2_5_3"
},
"en36": {
"id": "en36",
"bookId": "en",
"question": "Diagnosis suggested by hyperthyroidism, elevated TSH, and elevated free T<sub>4</sub>",
"answer": "TSH-secreting adenoma",
"relatedSectionId": "mk19_b_en_s2_5_4"
},
"en37": {
"id": "en37",
"bookId": "en",
"question": "Treatment of ACTH-secreting pituitary adenoma",
"answer": "Surgical resection",
"relatedSectionId": "mk19_b_en_s2_5_6"
},
"en38": {
"id": "en38",
"bookId": "en",
"question": "Treatment following adrenalectomy for Cushing syndrome",
"answer": "Glucocorticoid replacement",
"relatedSectionId": "mk19_b_en_s3_2_1"
},
"en39": {
"id": "en39",
"bookId": "en",
"question": "Initial imaging test for ACTH-independent Cushing syndrome",
"answer": "Adrenal CT or MRI",
"relatedSectionId": "mk19_b_en_s3_2_1"
},
"en40": {
"id": "en40",
"bookId": "en",
"question": "Invasive test to confirm source of hyperaldosteronism",
"answer": "Adrenal vein sampling",
"relatedSectionId": "mk19_b_en_s3_2_2"
},
"en41": {
"id": "en41",
"bookId": "en",
"question": "Most common manifestation of primary aldosteronism",
"answer": "Hypertension",
"relatedSectionId": "mk19_b_en_s3_2_2"
},
"en42": {
"id": "en42",
"bookId": "en",
"question": "Most reliable case-detection test for primary aldosteronism",
"answer": "PAC/PRA",
"relatedSectionId": "mk19_b_en_s3_2_2"
},
"en43": {
"id": "en43",
"bookId": "en",
"question": "Initial localization study of choice for primary aldosteronism",
"answer": "Dedicated adrenal CT",
"relatedSectionId": "mk19_b_en_s3_2_2"
},
"en44": {
"id": "en44",
"bookId": "en",
"question": "Drug class used before adrenalectomy for pheochromocytoma",
"answer": "α-Receptor blocker",
"relatedSectionId": "mk19_b_en_s3_2_3"
},
"en45": {
"id": "en45",
"bookId": "en",
"question": "Diagnosis suggested by rapid-onset virilization, menstrual irregularities",
"answer": "Androgen-secreting adrenal tumor",
"relatedSectionId": "mk19_b_en_s3_2_4"
},
"en46": {
"id": "en46",
"bookId": "en",
"question": "Treatment of adrenal mass &gt;4 cm",
"answer": "Resection",
"relatedSectionId": "mk19_b_en_s3_2_5"
},
"en47": {
"id": "en47",
"bookId": "en",
"question": "Most common cause of primary adrenal insufficiency",
"answer": "Autoimmune adrenalitis (Addison disease)",
"relatedSectionId": "mk19_b_en_s3_3_1_1"
},
"en48": {
"id": "en48",
"bookId": "en",
"question": "Antibody test for autoimmune adrenalitis",
"answer": "21-hydoxylase antibodies",
"relatedSectionId": "mk19_b_en_s3_3_1_2"
},
"en49": {
"id": "en49",
"bookId": "en",
"question": "Diagnosis suggested by low cortisol, elevated ACTH",
"answer": "Primary adrenal insufficiency",
"relatedSectionId": "mk19_b_en_s3_3_1_2"
},
"en50": {
"id": "en50",
"bookId": "en",
"question": "Treatment of primary adrenal insufficiency",
"answer": "Glucocorticoid and mineralocorticoid replacement",
"relatedSectionId": "mk19_b_en_s3_3_1_3"
},
"en51": {
"id": "en51",
"bookId": "en",
"question": "Order of drugs in treatment of adrenal crisis and hypothyroidism",
"answer": "Hydrocortisone, then T<sub>4</sub>",
"relatedSectionId": "mk19_b_en_s3_3_1_3"
},
"en52": {
"id": "en52",
"bookId": "en",
"question": "Screening test for mild autonomous cortisol excess in adrenal incidentaloma",
"answer": "1-mg overnight dexamethasone suppression test",
"relatedSectionId": "mk19_b_en_s3_4"
},
"en53": {
"id": "en53",
"bookId": "en",
"question": "Test for thyroid nodule with suppressed TSH",
"answer": "Thyroid scintigraphy",
"relatedSectionId": "mk19_b_en_s4_3_1"
},
"en54": {
"id": "en54",
"bookId": "en",
"question": "Test for thyroid nodule with normal TSH",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_b_en_s4_3_1"
},
"en55": {
"id": "en55",
"bookId": "en",
"question": "First lab test for thyroid nodule",
"answer": "TSH level",
"relatedSectionId": "mk19_b_en_s4_3_5"
},
"en56": {
"id": "en56",
"bookId": "en",
"question": "Strongest environmental risk factor for thyroid cancer",
"answer": "Radiation",
"relatedSectionId": "mk19_b_en_s4_3_5"
},
"en57": {
"id": "en57",
"bookId": "en",
"question": "Electrolyte abnormality following thyroid surgery",
"answer": "Hypocalcemia (from parathyroid injury)",
"relatedSectionId": "mk19_b_en_s4_3_5"
},
"en58": {
"id": "en58",
"bookId": "en",
"question": "Thyroid cancer associated with MEN types 2A and 2B",
"answer": "Medullary",
"relatedSectionId": "mk19_b_en_s4_3_5"
},
"en59": {
"id": "en59",
"bookId": "en",
"question": "Genetic testing for medullary thyroid cancer",
"answer": "<i>RET</i> proto-oncogene",
"relatedSectionId": "mk19_b_en_s4_3_5"
},
"en60": {
"id": "en60",
"bookId": "en",
"question": "Vitamin that interferes with thyroid function assay",
"answer": "Biotin",
"relatedSectionId": "mk19_b_en_s4_4"
},
"en61": {
"id": "en61",
"bookId": "en",
"question": "Diagnosis suggested by tender/painful thyroid, elevated free T<sub>4</sub>, suppressed TSH",
"answer": "Subacute thyroiditis",
"relatedSectionId": "mk19_b_en_s4_5_1_1"
},
"en62": {
"id": "en62",
"bookId": "en",
"question": "Diagnosis suggested by hyperthyroidism, diffusely enlarged thyroid",
"answer": "Graves disease",
"relatedSectionId": "mk19_b_en_s4_5_1_2_1"
},
"en63": {
"id": "en63",
"bookId": "en",
"question": "Treatment of Graves ophthalmopathy",
"answer": "Glucocorticoids, surgery, teprotumumab",
"relatedSectionId": "mk19_b_en_s4_5_1_2_1"
},
"en64": {
"id": "en64",
"bookId": "en",
"question": "Treatment of toxic adenoma",
"answer": "Radioactive iodine or surgery",
"relatedSectionId": "mk19_b_en_s4_5_1_3"
},
"en65": {
"id": "en65",
"bookId": "en",
"question": "Treatment of adrenergic symptoms in thyrotoxic patients",
"answer": "β-blockers",
"relatedSectionId": "mk19_b_en_s4_5_1_3"
},
"en66": {
"id": "en66",
"bookId": "en",
"question": "Initial treatment of Graves disease",
"answer": "Methimazole or propylthiouracil",
"relatedSectionId": "mk19_b_en_s4_5_1_3"
},
"en67": {
"id": "en67",
"bookId": "en",
"question": "Diagnosis suggested by methimazole use, fever, sore throat",
"answer": "Agranulocytosis",
"relatedSectionId": "mk19_b_en_s4_5_1_3_1"
},
"en68": {
"id": "en68",
"bookId": "en",
"question": "Contraindications to <sup>131</sup>I therapy",
"answer": "Pregnancy, significant Graves ophthalmopathy",
"relatedSectionId": "mk19_b_en_s4_5_1_3_1"
},
"en69": {
"id": "en69",
"bookId": "en",
"question": "Most common cause of subclinical hyperthyroidism",
"answer": "Toxic multinodular goiter",
"relatedSectionId": "mk19_b_en_s4_5_1_4"
},
"en70": {
"id": "en70",
"bookId": "en",
"question": "Most common cause of primary hypothyroidism",
"answer": "Hashimoto thyroiditis (chronic lymphocytic thyroiditis)",
"relatedSectionId": "mk19_b_en_s4_5_2_2_1"
},
"en71": {
"id": "en71",
"bookId": "en",
"question": "TSH level indication for subclinical hypothyroidism treatment",
"answer": "&gt;20 µU/mL",
"relatedSectionId": "mk19_b_en_s4_5_2_2_2"
},
"en72": {
"id": "en72",
"bookId": "en",
"question": "Contraindications to initial full-dose thyroid hormone replacement",
"answer": "Age ≥65 years, CVD",
"relatedSectionId": "mk19_b_en_s4_5_2_3"
},
"en73": {
"id": "en73",
"bookId": "en",
"question": "Treatment of thyroid hormone deficiency",
"answer": "Levothyroxine",
"relatedSectionId": "mk19_b_en_s4_5_2_3"
},
"en74": {
"id": "en74",
"bookId": "en",
"question": "Thyroid effects of amiodarone",
"answer": "Hypothyroidism, hyperthyroidism, thyroiditis",
"relatedSectionId": "mk19_b_en_s4_5_3"
},
"en75": {
"id": "en75",
"bookId": "en",
"question": "Empiric levothyroxine dose change during pregnancy",
"answer": "30% increase",
"relatedSectionId": "mk19_b_en_s4_6"
},
"en76": {
"id": "en76",
"bookId": "en",
"question": "Frequency of TSH measurement in pregnant patient with hypothyroidism",
"answer": "Every 4 weeks for first half of pregnancy and at 30 weeks",
"relatedSectionId": "mk19_b_en_s4_6"
},
"en77": {
"id": "en77",
"bookId": "en",
"question": "Treatment of nonthyroidal illness syndrome",
"answer": "Observation",
"relatedSectionId": "mk19_b_en_s4_7"
},
"en78": {
"id": "en78",
"bookId": "en",
"question": "Thyroid storm treatment",
"answer": "β-blockers, PTU, glucocorticoids, and potassium iodide",
"relatedSectionId": "mk19_b_en_s4_8_1"
},
"en79": {
"id": "en79",
"bookId": "en",
"question": "First drug administered in treatment of myxedema coma",
"answer": "Hydrocortisone",
"relatedSectionId": "mk19_b_en_s4_9"
},
"en80": {
"id": "en80",
"bookId": "en",
"question": "Diagnosis suggested by primary amenorrhea, short stature",
"answer": "Turner syndrome",
"relatedSectionId": "mk19_b_en_s5_2_1_1"
},
"en81": {
"id": "en81",
"bookId": "en",
"question": "Most common cause of primary amenorrhea",
"answer": "Gonadal dysgenesis (e.g., Turner syndrome)",
"relatedSectionId": "mk19_b_en_s5_2_1_1"
},
"en82": {
"id": "en82",
"bookId": "en",
"question": "First test in patients with secondary amenorrhea",
"answer": "Pregnancy test",
"relatedSectionId": "mk19_b_en_s5_2_1_2"
},
"en83": {
"id": "en83",
"bookId": "en",
"question": "Uterine cause of secondary amenorrhea",
"answer": "Intrauterine adhesions (Asherman syndrome)",
"relatedSectionId": "mk19_b_en_s5_2_1_2"
},
"en84": {
"id": "en84",
"bookId": "en",
"question": "Diagnosis suggested by secondary amenorrhea, elevated FSH, low estradiol",
"answer": "Turner syndrome, POI",
"relatedSectionId": "mk19_b_en_s5_2_2"
},
"en85": {
"id": "en85",
"bookId": "en",
"question": "Initial tests in nonpregnant women with secondary amenorrhea",
"answer": "FSH, TSH, free thyroxine, and prolactin levels",
"relatedSectionId": "mk19_b_en_s5_2_2"
},
"en86": {
"id": "en86",
"bookId": "en",
"question": "Hormonal treatment of POI",
"answer": "Estrogen-progestin therapy until age 51 years",
"relatedSectionId": "mk19_b_en_s5_2_3"
},
"en87": {
"id": "en87",
"bookId": "en",
"question": "Most common cause of hirsutism and androgen excess in women",
"answer": "PCOS",
"relatedSectionId": "mk19_b_en_s5_3_1"
},
"en88": {
"id": "en88",
"bookId": "en",
"question": "Initial pharmacologic treatment of PCOS",
"answer": "Combined oral contraceptive",
"relatedSectionId": "mk19_b_en_s5_3_1_2"
},
"en89": {
"id": "en89",
"bookId": "en",
"question": "Pharmacologic PCOS treatment when fertility desired",
"answer": "Clomiphene citrate or letrozole",
"relatedSectionId": "mk19_b_en_s5_3_1_2"
},
"en90": {
"id": "en90",
"bookId": "en",
"question": "Timing of infertility evaluation in women younger than 35 years",
"answer": "≥1 year of regular unprotected intercourse",
"relatedSectionId": "mk19_b_en_s5_4"
},
"en91": {
"id": "en91",
"bookId": "en",
"question": "First step in evaluation of female infertility",
"answer": "Assessment of ovulatory function",
"relatedSectionId": "mk19_b_en_s5_4"
},
"en92": {
"id": "en92",
"bookId": "en",
"question": "Diagnosis suggested by low testosterone, normal LH and FSH",
"answer": "Secondary (pituitary) hypogonadism",
"relatedSectionId": "mk19_b_en_s5_5_1"
},
"en93": {
"id": "en93",
"bookId": "en",
"question": "Diagnosis suggested by tall stature, small testes, primary hypogonadism",
"answer": "Klinefelter syndrome (47,XXY)",
"relatedSectionId": "mk19_b_en_s5_5_1"
},
"en94": {
"id": "en94",
"bookId": "en",
"question": "Test following male hypogonadism diagnosis",
"answer": "LH level",
"relatedSectionId": "mk19_b_en_s5_5_1_3"
},
"en95": {
"id": "en95",
"bookId": "en",
"question": "Lab test diagnostic criteria for male hypogonadism",
"answer": "Two low 8 <small>AM</small> serum total testosterone measurements",
"relatedSectionId": "mk19_b_en_s5_5_1_3"
},
"en96": {
"id": "en96",
"bookId": "en",
"question": "Treatment in biochemically proven hypogonadism",
"answer": "Testosterone therapy",
"relatedSectionId": "mk19_b_en_s5_5_2"
},
"en97": {
"id": "en97",
"bookId": "en",
"question": "Diagnosis suggested by acne, gynecomastia, small testes, low gonadotropins, erythrocytosis",
"answer": "Anabolic steroid abuse",
"relatedSectionId": "mk19_b_en_s5_6"
},
"en98": {
"id": "en98",
"bookId": "en",
"question": "Risks of testosterone therapy in the absence of deficiency",
"answer": "CVD, prostate cancer, VTE, mortality",
"relatedSectionId": "mk19_b_en_s5_7"
},
"en99": {
"id": "en99",
"bookId": "en",
"question": "Hormonal or surgical therapy to adapt the patient's body to experienced gender",
"answer": "Gender-affirming treatment",
"relatedSectionId": "mk19_b_en_s6"
},
"en100": {
"id": "en100",
"bookId": "en",
"question": "Feminizing gender-affirming hormone therapy",
"answer": "Estradiol and androgen blocker",
"relatedSectionId": "mk19_b_en_s6_1_1_1"
},
"en101": {
"id": "en101",
"bookId": "en",
"question": "Test for vitamin D deficiency",
"answer": "25-hydroxyvitamin D measurement",
"relatedSectionId": "mk19_b_en_s7_1"
},
"en102": {
"id": "en102",
"bookId": "en",
"question": "Initial testing for hypercalcemia",
"answer": "Serum calcium and PTH levels",
"relatedSectionId": "mk19_b_en_s7_2_2"
},
"en103": {
"id": "en103",
"bookId": "en",
"question": "Common hyperparathyroidism-related vitamin deficiency",
"answer": "Vitamin D",
"relatedSectionId": "mk19_b_en_s7_2_2_2_1"
},
"en104": {
"id": "en104",
"bookId": "en",
"question": "Bone indication for hyperparathyroidism-related parathyroidectomy",
"answer": "T-score ≤−2.5 or vertebral fracture",
"relatedSectionId": "mk19_b_en_s7_2_2_2_1"
},
"en105": {
"id": "en105",
"bookId": "en",
"question": "Test for familial hypocalciuric hypercalcemia",
"answer": "Urine calcium-creatinine ratio",
"relatedSectionId": "mk19_b_en_s7_2_2_3"
},
"en106": {
"id": "en106",
"bookId": "en",
"question": "Most common cause of familial hyperparathyroidism",
"answer": "MEN1",
"relatedSectionId": "mk19_b_en_s7_2_2_3_2"
},
"en107": {
"id": "en107",
"bookId": "en",
"question": "Most common cause of non–PTH-mediated hypercalcemia",
"answer": "Malignancy",
"relatedSectionId": "mk19_b_en_s7_2_2_4_1"
},
"en108": {
"id": "en108",
"bookId": "en",
"question": "Initial treatment of moderate to severe hypercalcemia",
"answer": "Aggressive hydration",
"relatedSectionId": "mk19_b_en_s7_2_3"
},
"en109": {
"id": "en109",
"bookId": "en",
"question": "Most common cause of hypoparathyroidism",
"answer": "Surgical injury",
"relatedSectionId": "mk19_b_en_s7_3_2_1"
},
"en110": {
"id": "en110",
"bookId": "en",
"question": "Electrolyte disorder causing functional hypoparathyroidism",
"answer": "Magnesium deficiency",
"relatedSectionId": "mk19_b_en_s7_3_2_1"
},
"en111": {
"id": "en111",
"bookId": "en",
"question": "Cause of hypocalcemia after first dose of bisphosphonate",
"answer": "Vitamin D deficiency",
"relatedSectionId": "mk19_b_en_s7_3_2_2"
},
"en112": {
"id": "en112",
"bookId": "en",
"question": "Most common cause of acquired hypocalcemia",
"answer": "CKD",
"relatedSectionId": "mk19_b_en_s7_3_2_2"
},
"en113": {
"id": "en113",
"bookId": "en",
"question": "Age-related indication for osteoporosis screening in average-risk postmenopausal women",
"answer": "Age ≥65 years",
"relatedSectionId": "mk19_b_en_s7_4_1_3"
},
"en114": {
"id": "en114",
"bookId": "en",
"question": "Diagnosis of osteoporosis in postmenopausal women and men aged &gt;50 years",
"answer": "T-score ≤−2.5 or fragility fracture (especially hip or vertebral compression fracture)",
"relatedSectionId": "mk19_b_en_s7_4_1_3"
},
"en115": {
"id": "en115",
"bookId": "en",
"question": "Most common cause of osteomalacia",
"answer": "Severe and prolonged vitamin D deficiency",
"relatedSectionId": "mk19_b_en_s7_4_1_4_1"
},
"en116": {
"id": "en116",
"bookId": "en",
"question": "Prophylaxis for glucocorticoid-related osteoporosis",
"answer": "Oral bisphosphonate, denosumab",
"relatedSectionId": "mk19_b_en_s7_4_1_6"
},
"en117": {
"id": "en117",
"bookId": "en",
"question": "Initial duration of oral bisphosphonate therapy for low-risk osteoporosis",
"answer": "5 years",
"relatedSectionId": "mk19_b_en_s7_4_1_6_1"
},
"en118": {
"id": "en118",
"bookId": "en",
"question": "Bone complications of bisphosphonates",
"answer": "Osteonecrosis of jaw, atypical femur fracture",
"relatedSectionId": "mk19_b_en_s7_4_1_6_1"
},
"en119": {
"id": "en119",
"bookId": "en",
"question": "Treatment needed after denosumab or teriparatide discontinuation",
"answer": "Alternative antiresorptive therapy (e.g., oral bisphosphonate)",
"relatedSectionId": "mk19_b_en_s7_4_1_6_3"
},
"en120": {
"id": "en120",
"bookId": "en",
"question": "Teriparatide treatment duration",
"answer": "2 years",
"relatedSectionId": "mk19_b_en_s7_4_1_6_4"
},
"en121": {
"id": "en121",
"bookId": "en",
"question": "Osteoporosis testing interval in low-risk patient with T-score of −1 to −2",
"answer": "3 to 5 years",
"relatedSectionId": "mk19_b_en_s7_4_1_7"
},
"en122": {
"id": "en122",
"bookId": "en",
"question": "Treatment of Paget disease of bone",
"answer": "Single dose of zoledronic acid",
"relatedSectionId": "mk19_b_en_s7_4_3"
},
"gi1": {
"id": "gi1",
"bookId": "gi",
"question": "Diagnosis suggested by dysphagia, late regurgitation of undigested food",
"answer": "Pharyngoesophageal (Zenker) diverticulum",
"relatedSectionId": "mk19_a_gi_s1_1_1_1"
},
"gi2": {
"id": "gi2",
"bookId": "gi",
"question": "Test for oropharyngeal dysphagia",
"answer": "Modified barium swallow and video fluoroscopy",
"relatedSectionId": "mk19_a_gi_s1_1_1_1"
},
"gi3": {
"id": "gi3",
"bookId": "gi",
"question": "Diagnosis suggested by dysphagia to solids alone",
"answer": "Mechanical obstruction",
"relatedSectionId": "mk19_a_gi_s1_1_1_2"
},
"gi4": {
"id": "gi4",
"bookId": "gi",
"question": "Diagnosis suggested by dysphagia to liquids",
"answer": "Motility disorder",
"relatedSectionId": "mk19_a_gi_s1_1_1_2"
},
"gi5": {
"id": "gi5",
"bookId": "gi",
"question": "Diagnostic study for uncomplicated GERD",
"answer": "Empiric PPI",
"relatedSectionId": "mk19_a_gi_s1_2_1_1"
},
"gi6": {
"id": "gi6",
"bookId": "gi",
"question": "Supporting test for GERD extraesophageal manifestations",
"answer": "Ambulatory pH monitoring",
"relatedSectionId": "mk19_a_gi_s1_2_1_1"
},
"gi7": {
"id": "gi7",
"bookId": "gi",
"question": "Treatment duration of PPI in uncomplicated GERD",
"answer": "8 weeks; then lowest dose possible with annual attempt to discontinue",
"relatedSectionId": "mk19_a_gi_s1_2_1_2_2"
},
"gi8": {
"id": "gi8",
"bookId": "gi",
"question": "Primary treatment for eosinophilic esophagitis",
"answer": "PPI and/or swallowed topical glucocorticoids",
"relatedSectionId": "mk19_a_gi_s1_2_2"
},
"gi9": {
"id": "gi9",
"bookId": "gi",
"question": "Endoscopic findings in eosinophilic esophagitis",
"answer": "Rings and furrows, luminal narrowing",
"relatedSectionId": "mk19_a_gi_s1_2_2"
},
"gi10": {
"id": "gi10",
"bookId": "gi",
"question": "Diagnostic criteria for <i>Candida</i> esophagitis",
"answer": "Symptoms plus oral candidiasis",
"relatedSectionId": "mk19_a_gi_s1_2_3"
},
"gi11": {
"id": "gi11",
"bookId": "gi",
"question": "Initial diagnostic test for achalasia",
"answer": "Barium esophagography",
"relatedSectionId": "mk19_a_gi_s1_2_5_1_1"
},
"gi12": {
"id": "gi12",
"bookId": "gi",
"question": "Diagnosis to exclude in achalasia",
"answer": "Tumor at GE junction (pseudoachalasia)",
"relatedSectionId": "mk19_a_gi_s1_2_5_1_1"
},
"gi13": {
"id": "gi13",
"bookId": "gi",
"question": "Indication for Barrett esophagus screening in women",
"answer": "None",
"relatedSectionId": "mk19_a_gi_s1_3_1_1"
},
"gi14": {
"id": "gi14",
"bookId": "gi",
"question": "Treatment for Barrett esophagus with dysplasia",
"answer": "Endoscopic mucosal resection, radiofrequency ablation",
"relatedSectionId": "mk19_a_gi_s1_3_1_2"
},
"gi15": {
"id": "gi15",
"bookId": "gi",
"question": "Treatment for all patients with Barrett esophagus",
"answer": "PPI",
"relatedSectionId": "mk19_a_gi_s1_3_1_2"
},
"gi16": {
"id": "gi16",
"bookId": "gi",
"question": "First-line therapy for functional dyspepsia",
"answer": "PPI",
"relatedSectionId": "mk19_a_gi_s2_1_2"
},
"gi17": {
"id": "gi17",
"bookId": "gi",
"question": "Indication for dyspepsia testing in patients aged &lt;60 years",
"answer": "Noninvasive <i>H. pylori</i> testing",
"relatedSectionId": "mk19_a_gi_s2_1_2"
},
"gi18": {
"id": "gi18",
"bookId": "gi",
"question": "Indication for upper endoscopy for dyspepsia",
"answer": "Age &gt;60 years",
"relatedSectionId": "mk19_a_gi_s2_1_2"
},
"gi19": {
"id": "gi19",
"bookId": "gi",
"question": "Most common causes of PUD",
"answer": "NSAIDs and <i>H. pylori</i>",
"relatedSectionId": "mk19_a_gi_s2_2_1"
},
"gi20": {
"id": "gi20",
"bookId": "gi",
"question": "When to restart aspirin for secondary CV prevention in bleeding peptic ulcer",
"answer": "1-7 days after PPI start and bleeding cessation",
"relatedSectionId": "mk19_a_gi_s2_2_2"
},
"gi21": {
"id": "gi21",
"bookId": "gi",
"question": "Indications for repeat endoscopy for gastric ulcer",
"answer": "Persistent symptoms, ulcer of unknown cause, no biopsy at initial endoscopy",
"relatedSectionId": "mk19_a_gi_s2_2_2"
},
"gi22": {
"id": "gi22",
"bookId": "gi",
"question": "Medications causing false-negative noninvasive <i>H. pylori</i> tests",
"answer": "PPIs, antibiotics",
"relatedSectionId": "mk19_a_gi_s2_3_2"
},
"gi23": {
"id": "gi23",
"bookId": "gi",
"question": "Core principle in treating relapsed <i>H. pylori</i> infection",
"answer": "Use different antibiotics",
"relatedSectionId": "mk19_a_gi_s2_3_3"
},
"gi24": {
"id": "gi24",
"bookId": "gi",
"question": "<i>H. pylori</i> eradication tests",
"answer": "Urea breath test, fecal antigen test, gastric biopsy",
"relatedSectionId": "mk19_a_gi_s2_3_4"
},
"gi25": {
"id": "gi25",
"bookId": "gi",
"question": "Diseases associated with autoimmune gastritis",
"answer": "Pernicious anemia, iron deficiency, SIBO, gastric cancer",
"relatedSectionId": "mk19_a_gi_s2_4_2"
},
"gi26": {
"id": "gi26",
"bookId": "gi",
"question": "PUD prevention in at-risk patients who must take NSAIDs",
"answer": "COX-2 inhibitor plus PPI",
"relatedSectionId": "mk19_a_gi_s2_5_2"
},
"gi27": {
"id": "gi27",
"bookId": "gi",
"question": "Common symptoms of gastroparesis",
"answer": "Nausea, vomiting, upper abdominal pain, early satiety",
"relatedSectionId": "mk19_a_gi_s2_6_1"
},
"gi28": {
"id": "gi28",
"bookId": "gi",
"question": "Gastric emptying tests",
"answer": "Scintigraphy, wireless capsule, gastric emptying breath test",
"relatedSectionId": "mk19_a_gi_s2_6_2"
},
"gi29": {
"id": "gi29",
"bookId": "gi",
"question": "Gastroparesis initial diagnostic test",
"answer": "Upper endoscopy",
"relatedSectionId": "mk19_a_gi_s2_6_2"
},
"gi30": {
"id": "gi30",
"bookId": "gi",
"question": "Gastroparesis drug treatment",
"answer": "Metoclopramide",
"relatedSectionId": "mk19_a_gi_s2_6_3"
},
"gi31": {
"id": "gi31",
"bookId": "gi",
"question": "Treatment for gastric adenoma and large gastric hyperplastic polyp",
"answer": "Resection",
"relatedSectionId": "mk19_a_gi_s2_7_1"
},
"gi32": {
"id": "gi32",
"bookId": "gi",
"question": "Gastric cancer screening indications",
"answer": "FAP, Lynch syndrome",
"relatedSectionId": "mk19_a_gi_s2_8_2"
},
"gi33": {
"id": "gi33",
"bookId": "gi",
"question": "Diagnosis suggested by postprandial vasomotor symptoms, abdominal pain, diarrhea",
"answer": "Dumping syndrome",
"relatedSectionId": "mk19_a_gi_s2_9"
},
"gi34": {
"id": "gi34",
"bookId": "gi",
"question": "Dumping syndrome treatment",
"answer": "Frequent small meals",
"relatedSectionId": "mk19_a_gi_s2_9"
},
"gi35": {
"id": "gi35",
"bookId": "gi",
"question": "Acute pancreatitis initial diagnostic imaging test",
"answer": "Abdominal ultrasonography",
"relatedSectionId": "mk19_a_gi_s3_1_1"
},
"gi36": {
"id": "gi36",
"bookId": "gi",
"question": "Indication for early CT in suspected acute pancreatitis",
"answer": "Diagnostic uncertainty",
"relatedSectionId": "mk19_a_gi_s3_1_1"
},
"gi37": {
"id": "gi37",
"bookId": "gi",
"question": "Acute pancreatitis lab tests predicting poor outcome",
"answer": "Elevated hematocrit and BUN",
"relatedSectionId": "mk19_a_gi_s3_1_2"
},
"gi38": {
"id": "gi38",
"bookId": "gi",
"question": "Cholecystectomy timing after biliary pancreatitis",
"answer": "Before hospital discharge",
"relatedSectionId": "mk19_a_gi_s3_1_3"
},
"gi39": {
"id": "gi39",
"bookId": "gi",
"question": "Nutritional approach in severe acute pancreatitis",
"answer": "Early enteral feeding",
"relatedSectionId": "mk19_a_gi_s3_1_3"
},
"gi40": {
"id": "gi40",
"bookId": "gi",
"question": "Acute pancreatitis fluid resuscitation rate",
"answer": "250-500 mL/h",
"relatedSectionId": "mk19_a_gi_s3_1_3"
},
"gi41": {
"id": "gi41",
"bookId": "gi",
"question": "Role of routine antibiotics in acute pancreatitis",
"answer": "None",
"relatedSectionId": "mk19_a_gi_s3_1_3"
},
"gi42": {
"id": "gi42",
"bookId": "gi",
"question": "Indications for drainage of pancreatic pseudocysts",
"answer": "Significant symptoms, infection",
"relatedSectionId": "mk19_a_gi_s3_1_4"
},
"gi43": {
"id": "gi43",
"bookId": "gi",
"question": "Indications for ERCP in chronic pancreatitis",
"answer": "None",
"relatedSectionId": "mk19_a_gi_s3_2_1"
},
"gi44": {
"id": "gi44",
"bookId": "gi",
"question": "Chronic pancreatitis steatorrhea treatment",
"answer": "Pancreatic enzymes",
"relatedSectionId": "mk19_a_gi_s3_2_2"
},
"gi45": {
"id": "gi45",
"bookId": "gi",
"question": "Key lifestyle modifications in chronic pancreatitis",
"answer": "Smoking cessation, alcohol abstinence",
"relatedSectionId": "mk19_a_gi_s3_2_2"
},
"gi46": {
"id": "gi46",
"bookId": "gi",
"question": "Diagnosis suggested by painless jaundice, “sausage-shaped” pancreas",
"answer": "Autoimmune pancreatitis",
"relatedSectionId": "mk19_a_gi_s3_3_1"
},
"gi47": {
"id": "gi47",
"bookId": "gi",
"question": "Conditions associated with autoimmune pancreatitis",
"answer": "Sclerosing cholangitis, sclerosing sialadenitis, retroperitoneal fibrosis",
"relatedSectionId": "mk19_a_gi_s3_3_1"
},
"gi48": {
"id": "gi48",
"bookId": "gi",
"question": "Autoimmune pancreatitis treatment",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_a_gi_s3_3_2"
},
"gi49": {
"id": "gi49",
"bookId": "gi",
"question": "Preferred test for histologic confirmation of pancreatic cancer",
"answer": "EUS-guided FNAB",
"relatedSectionId": "mk19_a_gi_s3_4_3"
},
"gi50": {
"id": "gi50",
"bookId": "gi",
"question": "Watery diarrhea infectious agents",
"answer": "<i>C. difficile</i>, viruses, <i>E. coli</i>, cholera, cryptosporidia, <i>G. duodenalis</i>",
"relatedSectionId": "mk19_a_gi_s4_1_2_1"
},
"gi51": {
"id": "gi51",
"bookId": "gi",
"question": "Dysentery or bloody diarrhea infectious agents",
"answer": "<i>Campylobacter</i>, hemorrhagic <i>E. coli</i>, <i>E. histolytica</i>, <i>Shigella</i>, <i>Salmonella</i>",
"relatedSectionId": "mk19_a_gi_s4_1_2_1"
},
"gi52": {
"id": "gi52",
"bookId": "gi",
"question": "Most common causes of chronic diarrhea",
"answer": "IBS-D, functional causes, medications",
"relatedSectionId": "mk19_a_gi_s4_1_3_1"
},
"gi53": {
"id": "gi53",
"bookId": "gi",
"question": "Diagnosis suggested by large-volume watery diarrhea despite fasting",
"answer": "Secretory diarrhea",
"relatedSectionId": "mk19_a_gi_s4_1_3_2_1"
},
"gi54": {
"id": "gi54",
"bookId": "gi",
"question": "Colitis with symptoms similar to IBS and celiac disease",
"answer": "Microscopic colitis",
"relatedSectionId": "mk19_a_gi_s4_1_4"
},
"gi55": {
"id": "gi55",
"bookId": "gi",
"question": "Microscopic colitis causative drugs",
"answer": "NSAIDs, SSRIs, PPIs",
"relatedSectionId": "mk19_a_gi_s4_1_4"
},
"gi56": {
"id": "gi56",
"bookId": "gi",
"question": "Preferred celiac disease screening test",
"answer": "Anti–tissue transglutaminase IgA antibody",
"relatedSectionId": "mk19_a_gi_s4_2_1"
},
"gi57": {
"id": "gi57",
"bookId": "gi",
"question": "Gold standard celiac disease diagnostic test",
"answer": "Duodenal biopsy",
"relatedSectionId": "mk19_a_gi_s4_2_1"
},
"gi58": {
"id": "gi58",
"bookId": "gi",
"question": "Serologic test for celiac disease in IgA deficiency",
"answer": "Anti–deamidated gliadin peptide IgG antibodies or tissue transglutaminase IgG antibodies",
"relatedSectionId": "mk19_a_gi_s4_2_1"
},
"gi59": {
"id": "gi59",
"bookId": "gi",
"question": "Bone test to consider at time of celiac disease diagnosis",
"answer": "DEXA",
"relatedSectionId": "mk19_a_gi_s4_2_3"
},
"gi60": {
"id": "gi60",
"bookId": "gi",
"question": "ARB associated with celiac-like enteropathy",
"answer": "Olmesartan",
"relatedSectionId": "mk19_a_gi_s4_2_4"
},
"gi61": {
"id": "gi61",
"bookId": "gi",
"question": "Common cause of refractory celiac disease",
"answer": "Continued gluten exposure",
"relatedSectionId": "mk19_a_gi_s4_2_4"
},
"gi62": {
"id": "gi62",
"bookId": "gi",
"question": "Rash pathognomonic for celiac disease",
"answer": "Dermatitis herpetiformis",
"relatedSectionId": "mk19_a_gi_s4_2_5"
},
"gi63": {
"id": "gi63",
"bookId": "gi",
"question": "SIBO diagnostic criteria",
"answer": "Symptoms plus positive breath test; improvement with empiric treatment",
"relatedSectionId": "mk19_a_gi_s4_3_1"
},
"gi64": {
"id": "gi64",
"bookId": "gi",
"question": "Effect of tobacco use on IBD risk",
"answer": "Increased Crohn disease risk, decreased ulcerative colitis risk",
"relatedSectionId": "mk19_a_gi_s4_4_1"
},
"gi65": {
"id": "gi65",
"bookId": "gi",
"question": "Diagnosis suggested by continuous colonic inflammation beginning at anorectal verge, extending proximally",
"answer": "Ulcerative colitis",
"relatedSectionId": "mk19_a_gi_s4_4_2"
},
"gi66": {
"id": "gi66",
"bookId": "gi",
"question": "Diagnosis suggested by fistula, perianal disease, strictures, abscess",
"answer": "Crohn disease",
"relatedSectionId": "mk19_a_gi_s4_4_2_2"
},
"gi67": {
"id": "gi67",
"bookId": "gi",
"question": "Bowel segment most commonly affected in Crohn disease",
"answer": "Ileocecal area",
"relatedSectionId": "mk19_a_gi_s4_4_2_2"
},
"gi68": {
"id": "gi68",
"bookId": "gi",
"question": "Most common dermatologic manifestations of IBD",
"answer": "Erythema nodosum, pyoderma gangrenosum",
"relatedSectionId": "mk19_a_gi_s4_4_3"
},
"gi69": {
"id": "gi69",
"bookId": "gi",
"question": "Crohn disease colonoscopy finding",
"answer": "Mucosal inflammation with skip areas",
"relatedSectionId": "mk19_a_gi_s4_4_4"
},
"gi70": {
"id": "gi70",
"bookId": "gi",
"question": "IBD diagnostic test",
"answer": "Colonoscopy with biopsy",
"relatedSectionId": "mk19_a_gi_s4_4_4"
},
"gi71": {
"id": "gi71",
"bookId": "gi",
"question": "Diagnosis suggested by fever, tachycardia, hypotension, leukocytosis, colonic dilation",
"answer": "Toxic megacolon",
"relatedSectionId": "mk19_a_gi_s4_4_5"
},
"gi72": {
"id": "gi72",
"bookId": "gi",
"question": "Mild to moderate ulcerative colitis induction treatment",
"answer": "Oral and topical 5-ASAs",
"relatedSectionId": "mk19_a_gi_s4_4_5_1"
},
"gi73": {
"id": "gi73",
"bookId": "gi",
"question": "Test required before use of thiopurines",
"answer": "<i>TPMT</i> genotype or phenotype assay",
"relatedSectionId": "mk19_a_gi_s4_4_5_1_3"
},
"gi75": {
"id": "gi75",
"bookId": "gi",
"question": "Preferred induction treatment for ulcerative colitis unresponsive to 5-ASA",
"answer": "Infliximab",
"relatedSectionId": "mk19_a_gi_s4_4_5_1_4"
},
"gi76": {
"id": "gi76",
"bookId": "gi",
"question": "Role of systemic glucocorticoids in IBD",
"answer": "Induction of remission, not maintenance therapy",
"relatedSectionId": "mk19_a_gi_s4_4_5_2_2"
},
"gi77": {
"id": "gi77",
"bookId": "gi",
"question": "Treatment for Crohn disease resistant to glucocorticoids or immunomodulators",
"answer": "Anti-TNF agents",
"relatedSectionId": "mk19_a_gi_s4_4_5_2_4"
},
"gi78": {
"id": "gi78",
"bookId": "gi",
"question": "Indications for surgery in Crohn disease",
"answer": "Medically refractory fistula, fibrotic stricture with obstructive symptoms, refractory symptoms, cancer",
"relatedSectionId": "mk19_a_gi_s4_4_5_3"
},
"gi79": {
"id": "gi79",
"bookId": "gi",
"question": "Colon cancer screening frequency in IBD",
"answer": "8 years after diagnosis, every 1-3 years",
"relatedSectionId": "mk19_a_gi_s4_4_6"
},
"gi80": {
"id": "gi80",
"bookId": "gi",
"question": "Most common cause of secondary constipation",
"answer": "Medications",
"relatedSectionId": "mk19_a_gi_s4_5"
},
"gi81": {
"id": "gi81",
"bookId": "gi",
"question": "Best initial radiographic study for constipation",
"answer": "Abdominal flat-plate radiography",
"relatedSectionId": "mk19_a_gi_s4_5_1"
},
"gi82": {
"id": "gi82",
"bookId": "gi",
"question": "Diagnoses to exclude in suspected IBS-D",
"answer": "Giardiasis, celiac disease, IBD",
"relatedSectionId": "mk19_a_gi_s4_6_1"
},
"gi83": {
"id": "gi83",
"bookId": "gi",
"question": "IBS dietary restrictions",
"answer": "Avoidance of trigger foods, gluten, dairy, and FODMAPs",
"relatedSectionId": "mk19_a_gi_s4_6_2"
},
"gi84": {
"id": "gi84",
"bookId": "gi",
"question": "IBS-C first-line treatment",
"answer": "Polyethylene glycol",
"relatedSectionId": "mk19_a_gi_s4_6_2_1"
},
"gi85": {
"id": "gi85",
"bookId": "gi",
"question": "IBS-D antibiotic treatment",
"answer": "Rifaximin",
"relatedSectionId": "mk19_a_gi_s4_6_2_2"
},
"gi86": {
"id": "gi86",
"bookId": "gi",
"question": "Colonoscopy timing after acute diverticulitis",
"answer": "After symptom resolution",
"relatedSectionId": "mk19_a_gi_s4_8"
},
"gi87": {
"id": "gi87",
"bookId": "gi",
"question": "Treatment for uncomplicated diverticulitis",
"answer": "Oral ciprofloxacin and metronidazole",
"relatedSectionId": "mk19_a_gi_s4_8"
},
"gi88": {
"id": "gi88",
"bookId": "gi",
"question": "Lifestyle change to prevent acute diverticulitis recurrence",
"answer": "High-fiber diet",
"relatedSectionId": "mk19_a_gi_s4_8"
},
"gi89": {
"id": "gi89",
"bookId": "gi",
"question": "Diagnosis suggested by severe abdominal pain out of proportion to physical exam findings",
"answer": "AMI",
"relatedSectionId": "mk19_a_gi_s4_9_1_1"
},
"gi90": {
"id": "gi90",
"bookId": "gi",
"question": "AMI preferred diagnostic test",
"answer": "CTA",
"relatedSectionId": "mk19_a_gi_s4_9_1_2"
},
"gi91": {
"id": "gi91",
"bookId": "gi",
"question": "Treatment for AMI",
"answer": "Surgery or endovascular intervention",
"relatedSectionId": "mk19_a_gi_s4_9_1_3"
},
"gi92": {
"id": "gi92",
"bookId": "gi",
"question": "Postprandial abdominal pain, fear of eating, weight loss",
"answer": "CMI",
"relatedSectionId": "mk19_a_gi_s4_9_2_1"
},
"gi93": {
"id": "gi93",
"bookId": "gi",
"question": "Angiographic findings suggesting CMI",
"answer": "&gt;70% stenosis of two of three mesenteric arteries",
"relatedSectionId": "mk19_a_gi_s4_9_2_2"
},
"gi94": {
"id": "gi94",
"bookId": "gi",
"question": "Diagnosis suggested by moderate cramping pain followed by bloody diarrhea",
"answer": "Colonic ischemia",
"relatedSectionId": "mk19_a_gi_s4_9_3_1"
},
"gi95": {
"id": "gi95",
"bookId": "gi",
"question": "Colonic ischemia imaging",
"answer": "Abdominal CT",
"relatedSectionId": "mk19_a_gi_s4_9_3_2"
},
"gi96": {
"id": "gi96",
"bookId": "gi",
"question": "Colonic ischemia treatment",
"answer": "Supportive care",
"relatedSectionId": "mk19_a_gi_s4_9_3_3"
},
"gi97": {
"id": "gi97",
"bookId": "gi",
"question": "Acute anal fissure treatment",
"answer": "Sitz bath and bulk laxatives",
"relatedSectionId": "mk19_a_gi_s4_10_1_2"
},
"gi98": {
"id": "gi98",
"bookId": "gi",
"question": "Treatment for refractory chronic anal fissure",
"answer": "Sphincterotomy or botulinum injection",
"relatedSectionId": "mk19_a_gi_s4_10_1_2"
},
"gi99": {
"id": "gi99",
"bookId": "gi",
"question": "Fecal incontinence initial test",
"answer": "Rectal examination",
"relatedSectionId": "mk19_a_gi_s4_10_2"
},
"gi100": {
"id": "gi100",
"bookId": "gi",
"question": "Anal cancer infectious risk factor",
"answer": "HPV",
"relatedSectionId": "mk19_a_gi_s4_10_3"
},
"gi101": {
"id": "gi101",
"bookId": "gi",
"question": "FAP genetic testing",
"answer": "<i>APC</i> gene testing",
"relatedSectionId": "mk19_a_gi_s5_2"
},
"gi102": {
"id": "gi102",
"bookId": "gi",
"question": "CRC chemoprevention recommendation",
"answer": "Low-dose aspirin in those aged 50-59 years at increased risk for CVD",
"relatedSectionId": "mk19_a_gi_s5_4"
},
"gi103": {
"id": "gi103",
"bookId": "gi",
"question": "Age to begin CRC screening if diagnosed in first-degree relative aged &lt;60 years",
"answer": "Age 40 years or 10 years before relative's diagnosis",
"relatedSectionId": "mk19_a_gi_s5_5"
},
"gi104": {
"id": "gi104",
"bookId": "gi",
"question": "Age to begin CRC screening if diagnosed in two first-degree relatives",
"answer": "Age 40 years or 10 years before youngest relative's diagnosis",
"relatedSectionId": "mk19_a_gi_s5_5"
},
"gi105": {
"id": "gi105",
"bookId": "gi",
"question": "Age to initiate colonoscopy in Lynch syndrome",
"answer": "Age 20-25 years or 10 years before earliest age of family CRC diagnosis",
"relatedSectionId": "mk19_a_gi_s5_5"
},
"gi106": {
"id": "gi106",
"bookId": "gi",
"question": "Timing of next colonoscopy after removal of adenoma ≥10 mm",
"answer": "3 years",
"relatedSectionId": "mk19_a_gi_s5_8"
},
"gi107": {
"id": "gi107",
"bookId": "gi",
"question": "Timing of colonoscopy after removal of 3-4 adenomas &lt;10 mm",
"answer": "3-5 years",
"relatedSectionId": "mk19_a_gi_s5_8"
},
"gi108": {
"id": "gi108",
"bookId": "gi",
"question": "Age to initiate screening for gastric cancer in Lynch syndrome",
"answer": "30-35 years",
"relatedSectionId": "mk19_a_gi_s5_9_1"
},
"gi109": {
"id": "gi109",
"bookId": "gi",
"question": "Age and interval for CRC screening in classic FAP",
"answer": "Age 10-12 years, repeated every 1-2 years",
"relatedSectionId": "mk19_a_gi_s5_9_2_1"
},
"gi110": {
"id": "gi110",
"bookId": "gi",
"question": "Recommended surveillance in serrated polyposis syndrome",
"answer": "Colonoscopy every 1-3 years, removal of polyps &gt;5 mm",
"relatedSectionId": "mk19_a_gi_s5_9_4"
},
"gi111": {
"id": "gi111",
"bookId": "gi",
"question": "Diagnostic criterion for acute hepatitis A",
"answer": "HAV IgM antibodies",
"relatedSectionId": "mk19_a_gi_s6_2_1"
},
"gi112": {
"id": "gi112",
"bookId": "gi",
"question": "Diagnosis suggested by normal ALT/AST, positive HBsAg, positive HBeAg, high HBV DNA",
"answer": "Hepatitis B infection immune-tolerant phase",
"relatedSectionId": "mk19_a_gi_s6_2_2"
},
"gi113": {
"id": "gi113",
"bookId": "gi",
"question": "Hepatitis B–associated vasculitides",
"answer": "Polyarteritis nodosa, cryoglobulinemia",
"relatedSectionId": "mk19_a_gi_s6_2_2"
},
"gi114": {
"id": "gi114",
"bookId": "gi",
"question": "Hepatitis B treatment indications",
"answer": "ALF, immune-active or reactivation phase, immunosuppression, cirrhosis",
"relatedSectionId": "mk19_a_gi_s6_2_2"
},
"gi115": {
"id": "gi115",
"bookId": "gi",
"question": "Hepatitis B first-line treatments",
"answer": "Entecavir or tenofovir",
"relatedSectionId": "mk19_a_gi_s6_2_2"
},
"gi116": {
"id": "gi116",
"bookId": "gi",
"question": "Hepatitis C–related vasculitis",
"answer": "Mixed cryoglobulinemia",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi117": {
"id": "gi117",
"bookId": "gi",
"question": "USPSTF hepatitis C screening indication",
"answer": "All patients aged 18-79 years",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi118": {
"id": "gi118",
"bookId": "gi",
"question": "Hepatitis C–related cryoglobulinemic vasculitis treatment",
"answer": "Hepatitis C antiviral therapy",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi119": {
"id": "gi119",
"bookId": "gi",
"question": "Diagnostic testing for chronic hepatitis C",
"answer": "HCV antibody followed by HCV RNA",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi120": {
"id": "gi120",
"bookId": "gi",
"question": "Hepatitis C treatment indication",
"answer": "All patients with infection (unless short life expectancy)",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi121": {
"id": "gi121",
"bookId": "gi",
"question": "Recommended hepatitis C pretreatment assessment",
"answer": "Fibrosis assessment with serologic biomarkers and/or elastography",
"relatedSectionId": "mk19_a_gi_s6_2_3"
},
"gi122": {
"id": "gi122",
"bookId": "gi",
"question": "Autoimmune hepatitis antibodies",
"answer": "ANA and smooth-muscle antibody",
"relatedSectionId": "mk19_a_gi_s6_3"
},
"gi123": {
"id": "gi123",
"bookId": "gi",
"question": "Treatment for autoimmune hepatitis",
"answer": "Prednisone, usually with azathioprine",
"relatedSectionId": "mk19_a_gi_s6_3"
},
"gi124": {
"id": "gi124",
"bookId": "gi",
"question": "Diagnosis suggested by fever, jaundice, tender hepatomegaly, alcohol abuse",
"answer": "Alcoholic hepatitis",
"relatedSectionId": "mk19_a_gi_s6_4"
},
"gi125": {
"id": "gi125",
"bookId": "gi",
"question": "Alcoholic hepatitis indications for prednisolone",
"answer": "MDF score &gt;32, MELD score &gt;20, or hepatic encephalopathy",
"relatedSectionId": "mk19_a_gi_s6_4"
},
"gi126": {
"id": "gi126",
"bookId": "gi",
"question": "Most common antibiotic causing cholestatic liver damage",
"answer": "Amoxicillin-clavulanate",
"relatedSectionId": "mk19_a_gi_s6_5"
},
"gi127": {
"id": "gi127",
"bookId": "gi",
"question": "Most common causes of drug-induced liver injury",
"answer": "Acetaminophen, amoxicillin-clavulanate, phenytoin, valproate",
"relatedSectionId": "mk19_a_gi_s6_5"
},
"gi128": {
"id": "gi128",
"bookId": "gi",
"question": "Indication for immediate referral to liver transplantation center",
"answer": "ALF",
"relatedSectionId": "mk19_a_gi_s6_6"
},
"gi129": {
"id": "gi129",
"bookId": "gi",
"question": "Most common cause of ALF",
"answer": "Acetaminophen overdose",
"relatedSectionId": "mk19_a_gi_s6_6"
},
"gi130": {
"id": "gi130",
"bookId": "gi",
"question": "Most common cause of abnormal liver test results",
"answer": "NAFLD",
"relatedSectionId": "mk19_a_gi_s6_7_1"
},
"gi131": {
"id": "gi131",
"bookId": "gi",
"question": "NAFLD treatment",
"answer": "Weight loss",
"relatedSectionId": "mk19_a_gi_s6_7_1"
},
"gi132": {
"id": "gi132",
"bookId": "gi",
"question": "Treatment for liver disease secondary to hereditary hemochromatosis",
"answer": "Phlebotomy",
"relatedSectionId": "mk19_a_gi_s6_7_3"
},
"gi133": {
"id": "gi133",
"bookId": "gi",
"question": "Diagnosis suggested by acute hepatitis and hemolytic anemia in young adult",
"answer": "Wilson disease",
"relatedSectionId": "mk19_a_gi_s6_7_4"
},
"gi134": {
"id": "gi134",
"bookId": "gi",
"question": "Diagnosis suggested by ALF and Coombs-negative hemolytic anemia in patient aged &lt; 40 years",
"answer": "Wilson disease",
"relatedSectionId": "mk19_a_gi_s6_7_4"
},
"gi135": {
"id": "gi135",
"bookId": "gi",
"question": "Diagnosis suggested by elevated alkaline phosphatase and positive antimitochondrial antibody",
"answer": "PBC",
"relatedSectionId": "mk19_a_gi_s6_8_1"
},
"gi136": {
"id": "gi136",
"bookId": "gi",
"question": "PBC treatment",
"answer": "Ursodeoxycholic acid",
"relatedSectionId": "mk19_a_gi_s6_8_1"
},
"gi137": {
"id": "gi137",
"bookId": "gi",
"question": "Screening indications for hepatocellular cancer in PBC",
"answer": "Male sex or cirrhosis",
"relatedSectionId": "mk19_a_gi_s6_8_1"
},
"gi138": {
"id": "gi138",
"bookId": "gi",
"question": "PSC ERCP indications",
"answer": "Cholangitis, increasing jaundice, worsening pruritis, dominant stricture",
"relatedSectionId": "mk19_a_gi_s6_8_2"
},
"gi139": {
"id": "gi139",
"bookId": "gi",
"question": "Bowel disease associated with PSC",
"answer": "IBD",
"relatedSectionId": "mk19_a_gi_s6_8_2"
},
"gi140": {
"id": "gi140",
"bookId": "gi",
"question": "PSC gold standard treatment",
"answer": "Liver transplantation",
"relatedSectionId": "mk19_a_gi_s6_8_2"
},
"gi141": {
"id": "gi141",
"bookId": "gi",
"question": "PSC cancer associations",
"answer": "Cholangiocarcinoma, colorectal, gallbladder",
"relatedSectionId": "mk19_a_gi_s6_8_2"
},
"gi142": {
"id": "gi142",
"bookId": "gi",
"question": "Test for esophageal varices in patients with cirrhosis",
"answer": "Upper endoscopy",
"relatedSectionId": "mk19_a_gi_s6_10_2"
},
"gi143": {
"id": "gi143",
"bookId": "gi",
"question": "Medical treatment for ascites",
"answer": "Sodium restriction, spironolactone, furosemide",
"relatedSectionId": "mk19_a_gi_s6_10_4"
},
"gi144": {
"id": "gi144",
"bookId": "gi",
"question": "Mandatory test in patients with cirrhosis with new-onset ascites",
"answer": "Diagnostic paracentesis",
"relatedSectionId": "mk19_a_gi_s6_10_4"
},
"gi145": {
"id": "gi145",
"bookId": "gi",
"question": "SBP prophylaxis after an episode of SBP",
"answer": "Long-term antibiotics",
"relatedSectionId": "mk19_a_gi_s6_10_5"
},
"gi146": {
"id": "gi146",
"bookId": "gi",
"question": "Ascites leukocyte count diagnostic for SBP",
"answer": "≥250/µL",
"relatedSectionId": "mk19_a_gi_s6_10_5"
},
"gi147": {
"id": "gi147",
"bookId": "gi",
"question": "Treatment for SBP and kidney dysfunction or significant hepatic dysfunction",
"answer": "Third-generation cephalosporin plus albumin",
"relatedSectionId": "mk19_a_gi_s6_10_5"
},
"gi148": {
"id": "gi148",
"bookId": "gi",
"question": "Common hepatic encephalopathy precipitants",
"answer": "Infection, GI bleeding, medications, volume depletion",
"relatedSectionId": "mk19_a_gi_s6_10_6"
},
"gi149": {
"id": "gi149",
"bookId": "gi",
"question": "Hepatic encephalopathy drug treatments",
"answer": "Lactulose (initial), rifaximin (second)",
"relatedSectionId": "mk19_a_gi_s6_10_6"
},
"gi150": {
"id": "gi150",
"bookId": "gi",
"question": "Diagnosis characterized by ESLD with portal hypertension, oliguric kidney failure, bland urine, low urine sodium",
"answer": "Hepatorenal syndrome",
"relatedSectionId": "mk19_a_gi_s6_10_7"
},
"gi151": {
"id": "gi151",
"bookId": "gi",
"question": "Hepatorenal syndrome treatment",
"answer": "Stop diuretics; start albumin; start midodrine and octreotide, or norepinephrine",
"relatedSectionId": "mk19_a_gi_s6_10_7"
},
"gi152": {
"id": "gi152",
"bookId": "gi",
"question": "Diagnosis characterized by cirrhosis-related orthodeoxia and platypnea",
"answer": "Hepatopulmonary syndrome",
"relatedSectionId": "mk19_a_gi_s6_10_8"
},
"gi153": {
"id": "gi153",
"bookId": "gi",
"question": "Hepatopulmonary syndrome test",
"answer": "Echocardiography with agitated saline",
"relatedSectionId": "mk19_a_gi_s6_10_8"
},
"gi154": {
"id": "gi154",
"bookId": "gi",
"question": "Cirrhosis-related bone disease and screening test",
"answer": "Osteoporosis, DEXA",
"relatedSectionId": "mk19_a_gi_s6_11"
},
"gi155": {
"id": "gi155",
"bookId": "gi",
"question": "Hepatic tumor associated with oral contraceptive agent in women",
"answer": "Hepatic adenoma",
"relatedSectionId": "mk19_a_gi_s6_12_2"
},
"gi156": {
"id": "gi156",
"bookId": "gi",
"question": "Management of hepatic adenoma in patient taking oral contraceptives",
"answer": "Discontinue oral contraceptives; CT/MRI every 6-12 months",
"relatedSectionId": "mk19_a_gi_s6_12_2"
},
"gi157": {
"id": "gi157",
"bookId": "gi",
"question": "Focal nodular hyperplasia treatment",
"answer": "None",
"relatedSectionId": "mk19_a_gi_s6_12_3"
},
"gi158": {
"id": "gi158",
"bookId": "gi",
"question": "Amebic liver abscess diagnostic tests",
"answer": "Liver imaging, <i>E. histolytica</i> serologic testing",
"relatedSectionId": "mk19_a_gi_s6_12_5_2"
},
"gi159": {
"id": "gi159",
"bookId": "gi",
"question": "Cirrhosis and HCC liver transplantation indications",
"answer": "Up to 3 tumors ≤3 cm or 1 tumor ≤5 cm, without vascular invasion or extrahepatic spread",
"relatedSectionId": "mk19_a_gi_s6_12_7"
},
"gi160": {
"id": "gi160",
"bookId": "gi",
"question": "HCC screening test in patients with cirrhosis",
"answer": "Ultrasonography ± alpha-fetoprotein measurement every 6 months",
"relatedSectionId": "mk19_a_gi_s6_12_7"
},
"gi161": {
"id": "gi161",
"bookId": "gi",
"question": "HCC screening in at-risk patients with hepatitis B infection and no cirrhosis",
"answer": "Ultrasonography ± alpha-fetoprotein measurement every 6 months",
"relatedSectionId": "mk19_a_gi_s6_12_7"
},
"gi162": {
"id": "gi162",
"bookId": "gi",
"question": "Liver transplantation indications",
"answer": "ALF, MELD score ≥15, or decompensated cirrhosis",
"relatedSectionId": "mk19_a_gi_s6_13"
},
"gi163": {
"id": "gi163",
"bookId": "gi",
"question": "Hepatitis B vertical transmission prevention drugs",
"answer": "Lamivudine, telbivudine, tenofovir",
"relatedSectionId": "mk19_a_gi_s6_14"
},
"gi164": {
"id": "gi164",
"bookId": "gi",
"question": "Diagnosis suggested by pruritus, mild AST/ALT elevations, second or third trimester",
"answer": "Intrahepatic cholestasis of pregnancy",
"relatedSectionId": "mk19_a_gi_s6_14"
},
"gi165": {
"id": "gi165",
"bookId": "gi",
"question": "Intrahepatic cholestasis of pregnancy treatment",
"answer": "Ursodeoxycholic acid",
"relatedSectionId": "mk19_a_gi_s6_14"
},
"gi166": {
"id": "gi166",
"bookId": "gi",
"question": "Diagnosis suggested by first trimester pregnancy, prolonged vomiting, elevated AST/ALT",
"answer": "Hyperemesis gravidarum",
"relatedSectionId": "mk19_a_gi_s6_14"
},
"gi167": {
"id": "gi167",
"bookId": "gi",
"question": "Treatment for HELLP syndrome and fatty liver of pregnancy",
"answer": "Delivery",
"relatedSectionId": "mk19_a_gi_s6_14"
},
"gi168": {
"id": "gi168",
"bookId": "gi",
"question": "Diagnosis suggested by hepatomegaly, caudate lobe hypertrophy, ascites, RUQ pain",
"answer": "Budd-Chiari syndrome",
"relatedSectionId": "mk19_a_gi_s6_15_2"
},
"gi169": {
"id": "gi169",
"bookId": "gi",
"question": "Cholecystectomy indications for asymptomatic gallstones",
"answer": "Gallstones &gt;3 cm, porcelain gallbladder, gallbladder polyp &gt;1 cm",
"relatedSectionId": "mk19_a_gi_s7_1"
},
"gi170": {
"id": "gi170",
"bookId": "gi",
"question": "Test for acute cholecystitis if high clinical likelihood but negative ultrasound",
"answer": "HIDA scan",
"relatedSectionId": "mk19_a_gi_s7_3"
},
"gi171": {
"id": "gi171",
"bookId": "gi",
"question": "Diagnosis suggested by RUQ pain without gallstones on ultrasound in critically ill patient",
"answer": "Acalculous cholecystitis",
"relatedSectionId": "mk19_a_gi_s7_4"
},
"gi172": {
"id": "gi172",
"bookId": "gi",
"question": "Diagnosis suggested by fever, RUQ abdominal pain, jaundice",
"answer": "Cholangitis",
"relatedSectionId": "mk19_a_gi_s7_6"
},
"gi173": {
"id": "gi173",
"bookId": "gi",
"question": "Obstructive cholangitis treatment",
"answer": "Antibiotics and ERCP",
"relatedSectionId": "mk19_a_gi_s7_6"
},
"gi174": {
"id": "gi174",
"bookId": "gi",
"question": "Most common causes of UGIB",
"answer": "PUD, varices, Mallory-Weiss tears",
"relatedSectionId": "mk19_a_gi_s8_2_1"
},
"gi175": {
"id": "gi175",
"bookId": "gi",
"question": "Transfusion threshold for UGIB in stable patient without CVD",
"answer": "7 g/dL",
"relatedSectionId": "mk19_a_gi_s8_2_3"
},
"gi176": {
"id": "gi176",
"bookId": "gi",
"question": "Primary variceal bleeding treatment",
"answer": "Octreotide and endoscopic therapy",
"relatedSectionId": "mk19_a_gi_s8_2_3_1"
},
"gi177": {
"id": "gi177",
"bookId": "gi",
"question": "Adjunctive drug treatment for patients with cirrhosis and GI bleeding",
"answer": "Antibiotics",
"relatedSectionId": "mk19_a_gi_s8_2_3_1"
},
"gi178": {
"id": "gi178",
"bookId": "gi",
"question": "Endoscopy timing for rapid UGIB",
"answer": "Within 24 hours",
"relatedSectionId": "mk19_a_gi_s8_2_3_2"
},
"gi179": {
"id": "gi179",
"bookId": "gi",
"question": "High-risk findings for PUD rebleeding",
"answer": "Active bleeding, nonbleeding visible vessels, adherent clots",
"relatedSectionId": "mk19_a_gi_s8_2_3_2"
},
"gi180": {
"id": "gi180",
"bookId": "gi",
"question": "Secondary drug prophylaxis for variceal bleeding",
"answer": "Nonselective β-blockers (propranolol, nadolol, carvedilol)",
"relatedSectionId": "mk19_a_gi_s8_2_3_3"
},
"gi181": {
"id": "gi181",
"bookId": "gi",
"question": "Duration of high-dose PPI therapy in bleeding PUD with high-risk endoscopic appearance",
"answer": "3 days",
"relatedSectionId": "mk19_a_gi_s8_2_3_3"
},
"gi182": {
"id": "gi182",
"bookId": "gi",
"question": "When to resume aspirin for secondary prevention of CVD in GI bleeding",
"answer": "As soon as possible after hemostasis",
"relatedSectionId": "mk19_a_gi_s8_2_3_3"
},
"gi183": {
"id": "gi183",
"bookId": "gi",
"question": "Preferred diagnostic tests in LGIB with instability or rapid ongoing bleeding",
"answer": "CTA; immediate upper endoscopy if no source on CT",
"relatedSectionId": "mk19_a_gi_s8_3_3"
},
"gi184": {
"id": "gi184",
"bookId": "gi",
"question": "Preferred diagnostic test in stable LGIB without rapid bleeding",
"answer": "Colonoscopy",
"relatedSectionId": "mk19_a_gi_s8_3_3"
},
"gi185": {
"id": "gi185",
"bookId": "gi",
"question": "Most common cause of small-bowel bleeding",
"answer": "Angiodysplasia",
"relatedSectionId": "mk19_a_gi_s8_4_1"
},
"gi186": {
"id": "gi186",
"bookId": "gi",
"question": "Test for small-bowel bleeding after negative upper and lower endoscopy in stable patient",
"answer": "Capsule endoscopy",
"relatedSectionId": "mk19_a_gi_s8_4_2_1"
},
"gi187": {
"id": "gi187",
"bookId": "gi",
"question": "Diagnostic test for hemodynamically significant or rapid small-bowel bleeding",
"answer": "CTA",
"relatedSectionId": "mk19_a_gi_s8_4_2_2"
},
"gm1": {
"id": "gm1",
"bookId": "gm",
"question": "Study type providing the highest level of evidence",
"answer": "Systematic review",
"relatedSectionId": "mk19_a_gm_s2_3_1"
},
"gm2": {
"id": "gm2",
"bookId": "gm",
"question": "Strongest clinical study design",
"answer": "Randomized controlled trial",
"relatedSectionId": "mk19_a_gm_s2_3_1_1"
},
"gm3": {
"id": "gm3",
"bookId": "gm",
"question": "Increase in disease probability with positive LRs of 2, 5, and 10",
"answer": "15%, 30%, and 45%",
"relatedSectionId": "mk19_a_gm_s2_3_3_2"
},
"gm4": {
"id": "gm4",
"bookId": "gm",
"question": "Number needed to treat calculation",
"answer": "1/absolute risk reduction",
"relatedSectionId": "mk19_a_gm_s2_3_3_4"
},
"gm5": {
"id": "gm5",
"bookId": "gm",
"question": "Components of patient decision-making capacity",
"answer": "Ability to understand information, consequences, and options and communicate choice",
"relatedSectionId": "mk19_a_gm_s3_3_2"
},
"gm6": {
"id": "gm6",
"bookId": "gm",
"question": "Substituted judgment",
"answer": "Surrogate care decisions based on patient's previously expressed preferences and values",
"relatedSectionId": "mk19_a_gm_s3_3_4"
},
"gm7": {
"id": "gm7",
"bookId": "gm",
"question": "Intervention when medical error is discovered",
"answer": "Error disclosure",
"relatedSectionId": "mk19_a_gm_s3_3_7"
},
"gm8": {
"id": "gm8",
"bookId": "gm",
"question": "Ethical distinction between withholding and withdrawing care",
"answer": "None",
"relatedSectionId": "mk19_a_gm_s3_4_1"
},
"gm9": {
"id": "gm9",
"bookId": "gm",
"question": "Responsibility when colleague is impaired and patient harm is possible",
"answer": "Report to appropriate authorities and identify appropriate sources of help",
"relatedSectionId": "mk19_a_gm_s3_6_2"
},
"gm10": {
"id": "gm10",
"bookId": "gm",
"question": "Clinical features requiring chest radiography for pneumonia in patient with cough",
"answer": "Abnormal vital signs or lung exam; altered mental status",
"relatedSectionId": "mk19_a_gm_s4_2_1"
},
"gm11": {
"id": "gm11",
"bookId": "gm",
"question": "Medication class most associated with acute cough",
"answer": "ACE inhibitors",
"relatedSectionId": "mk19_a_gm_s4_2_1"
},
"gm12": {
"id": "gm12",
"bookId": "gm",
"question": "Treatment of acute rhinosinusitis–related cough",
"answer": "Intranasal glucocorticoid",
"relatedSectionId": "mk19_a_gm_s4_2_1"
},
"gm13": {
"id": "gm13",
"bookId": "gm",
"question": "Severe subacute cough paroxysms and posttussive emesis",
"answer": "<i>Bordetella pertussis</i> infection",
"relatedSectionId": "mk19_a_gm_s4_2_2"
},
"gm14": {
"id": "gm14",
"bookId": "gm",
"question": "Most common causes of chronic cough",
"answer": "Smoking, ACE inhibitor use, UACS, GERD, asthma",
"relatedSectionId": "mk19_a_gm_s4_2_2"
},
"gm15": {
"id": "gm15",
"bookId": "gm",
"question": "Initial drug therapy for allergic rhinitis–associated UACS",
"answer": "Intranasal glucocorticoids",
"relatedSectionId": "mk19_a_gm_s4_2_2"
},
"gm16": {
"id": "gm16",
"bookId": "gm",
"question": "Treatment of medically unresponsive, unexplained chronic cough",
"answer": "Multimodal speech therapy, antitussives, gabapentin",
"relatedSectionId": "mk19_a_gm_s4_2_2"
},
"gm17": {
"id": "gm17",
"bookId": "gm",
"question": "Causes of peripheral vertigo",
"answer": "BPPV, vestibular neuronitis, labyrinthitis, Meniere disease, drugs, Ramsay Hunt syndrome, acoustic neuroma",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm18": {
"id": "gm18",
"bookId": "gm",
"question": "Recurrent brief vertigo worsened by positional changes",
"answer": "BPPV",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm19": {
"id": "gm19",
"bookId": "gm",
"question": "Diagnostic test for BPPV",
"answer": "Dix-Hallpike maneuver",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm20": {
"id": "gm20",
"bookId": "gm",
"question": "Therapy for BPPV",
"answer": "Epley maneuver",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm21": {
"id": "gm21",
"bookId": "gm",
"question": "Sudden-onset peripheral vertigo and hearing loss",
"answer": "Labyrinthitis",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm22": {
"id": "gm22",
"bookId": "gm",
"question": "Recurrent vertigo, tinnitus, hearing loss",
"answer": "Meniere disease",
"relatedSectionId": "mk19_a_gm_s4_3_2_1"
},
"gm23": {
"id": "gm23",
"bookId": "gm",
"question": "Clue to central vertigo",
"answer": "Abnormal neurologic findings",
"relatedSectionId": "mk19_a_gm_s4_3_2_2"
},
"gm24": {
"id": "gm24",
"bookId": "gm",
"question": "Evaluation of acute sustained vertigo with stroke risk factors",
"answer": "MRI",
"relatedSectionId": "mk19_a_gm_s4_3_2_2"
},
"gm25": {
"id": "gm25",
"bookId": "gm",
"question": "Nonspecific dizziness despite adequate evaluation",
"answer": "Persistent postural-perceptual dizziness",
"relatedSectionId": "mk19_a_gm_s4_3_5"
},
"gm26": {
"id": "gm26",
"bookId": "gm",
"question": "Treatment of persistent postural-perceptual dizziness",
"answer": "Vestibular and balance rehabilitation, SSRI/SNRI therapy",
"relatedSectionId": "mk19_a_gm_s4_3_5"
},
"gm27": {
"id": "gm27",
"bookId": "gm",
"question": "Nondrug interventions for dyspnea in chronic lung disease",
"answer": "Pulmonary rehabilitation, pursed lip and diaphragmatic breathing, fans",
"relatedSectionId": "mk19_a_gm_s4_4_2"
},
"gm28": {
"id": "gm28",
"bookId": "gm",
"question": "Pharmacologic palliation of medically unresponsive dyspnea",
"answer": "Oral opioids",
"relatedSectionId": "mk19_a_gm_s4_4_2"
},
"gm29": {
"id": "gm29",
"bookId": "gm",
"question": "Fatigue ≥6 months with reduction in activities, postexertional malaise, unrefreshing sleep, and orthostatic intolerance or cognitive impairment",
"answer": "Systemic exertion intolerance disease",
"relatedSectionId": "mk19_a_gm_s4_5_1"
},
"gm31": {
"id": "gm31",
"bookId": "gm",
"question": "Indications for polysomnography in insomnia",
"answer": "Presentation suggestive of sleep apnea, narcolepsy, or sleep movement disorder",
"relatedSectionId": "mk19_a_gm_s4_6_1"
},
"gm32": {
"id": "gm32",
"bookId": "gm",
"question": "First-line therapy for insomnia",
"answer": "CBT-I",
"relatedSectionId": "mk19_a_gm_s4_6_2_1"
},
"gm33": {
"id": "gm33",
"bookId": "gm",
"question": "Best drug choices for short-term relief of refractory insomnia",
"answer": "Zolpidem, eszopiclone, zaleplon",
"relatedSectionId": "mk19_a_gm_s4_6_2_2"
},
"gm34": {
"id": "gm34",
"bookId": "gm",
"question": "Common causes of drug-induced edema",
"answer": "Calcium channel blockers, thiazolidinediones, NSAIDs",
"relatedSectionId": "mk19_a_gm_s4_7"
},
"gm35": {
"id": "gm35",
"bookId": "gm",
"question": "Therapy for chronic venous insufficiency",
"answer": "Leg elevation, exercise, static compression, weight loss",
"relatedSectionId": "mk19_a_gm_s4_7_1"
},
"gm36": {
"id": "gm36",
"bookId": "gm",
"question": "Most common cause of lower extremity ulcers",
"answer": "Venous stasis",
"relatedSectionId": "mk19_a_gm_s4_7_2"
},
"gm37": {
"id": "gm37",
"bookId": "gm",
"question": "Symptoms that cannot be attributed to a specific medical cause",
"answer": "Medically unexplained symptoms",
"relatedSectionId": "mk19_a_gm_s4_8"
},
"gm38": {
"id": "gm38",
"bookId": "gm",
"question": "Initial steps in evaluating medically unexplained symptoms",
"answer": "Thorough history and physical exam; review of previous diagnostic evaluations",
"relatedSectionId": "mk19_a_gm_s4_8_1"
},
"gm39": {
"id": "gm39",
"bookId": "gm",
"question": "Syncope preceded by nausea and diaphoresis in healthy person",
"answer": "Neurally mediated (vasovagal) syncope",
"relatedSectionId": "mk19_a_gm_s4_9_1"
},
"gm40": {
"id": "gm40",
"bookId": "gm",
"question": "Clue to cardiac syncope",
"answer": "Sudden onset without prodrome",
"relatedSectionId": "mk19_a_gm_s4_9_1"
},
"gm41": {
"id": "gm41",
"bookId": "gm",
"question": "Features that favor seizure in patient with loss of consciousness",
"answer": "Posturing, involuntary head turning, tongue laceration",
"relatedSectionId": "mk19_a_gm_s4_9_1"
},
"gm42": {
"id": "gm42",
"bookId": "gm",
"question": "Essential physical exam component in syncope evaluation",
"answer": "Orthostatic BP measurement",
"relatedSectionId": "mk19_a_gm_s4_9_2"
},
"gm43": {
"id": "gm43",
"bookId": "gm",
"question": "Test for all patients with syncope",
"answer": "ECG",
"relatedSectionId": "mk19_a_gm_s4_9_2"
},
"gm44": {
"id": "gm44",
"bookId": "gm",
"question": "Indication for exercise stress testing for evaluation of syncope",
"answer": "Exertional syncope",
"relatedSectionId": "mk19_a_gm_s4_9_2"
},
"gm45": {
"id": "gm45",
"bookId": "gm",
"question": "Role of brain imaging and carotid ultrasonography in routine syncope evaluation",
"answer": "None",
"relatedSectionId": "mk19_a_gm_s4_9_2"
},
"gm46": {
"id": "gm46",
"bookId": "gm",
"question": "Worsening pain with opioid dosage escalation",
"answer": "Opioid-induced hyperalgesia",
"relatedSectionId": "mk19_a_gm_s5_1"
},
"gm47": {
"id": "gm47",
"bookId": "gm",
"question": "Therapy for all patients with chronic noncancer pain",
"answer": "Physical therapy",
"relatedSectionId": "mk19_a_gm_s5_3_1"
},
"gm48": {
"id": "gm48",
"bookId": "gm",
"question": "Initial therapy for musculoskeletal or inflammatory nociceptive pain",
"answer": "NSAIDs, acetaminophen",
"relatedSectionId": "mk19_a_gm_s5_3_2_1"
},
"gm49": {
"id": "gm49",
"bookId": "gm",
"question": "First-line drug treatment of chronic neuropathic pain",
"answer": "Gabapentinoids and duloxetine",
"relatedSectionId": "mk19_a_gm_s5_3_2_1"
},
"gm50": {
"id": "gm50",
"bookId": "gm",
"question": "Effects of long-term opioids for chronic noncancer pain",
"answer": "Worsened functional status, quality of life, and pain",
"relatedSectionId": "mk19_a_gm_s5_3_2_2"
},
"gm51": {
"id": "gm51",
"bookId": "gm",
"question": "Risk mitigation strategies for opioid use in chronic noncancer pain",
"answer": "Urine drug testing, surveillance of state prescription drug monitoring programs",
"relatedSectionId": "mk19_a_gm_s5_3_2_2_2"
},
"gm52": {
"id": "gm52",
"bookId": "gm",
"question": "Treatment of acute opioid overdose",
"answer": "Naloxone",
"relatedSectionId": "mk19_a_gm_s5_3_2_2_2"
},
"gm53": {
"id": "gm53",
"bookId": "gm",
"question": "When to offer opioid overdose prevention education and naloxone kits",
"answer": "Opioid dosage ≥50 MME/d, concurrent benzodiazepines, substance use disorder",
"relatedSectionId": "mk19_a_gm_s5_3_2_2_2"
},
"gm54": {
"id": "gm54",
"bookId": "gm",
"question": "Constipation prophylaxis for patients taking scheduled opioids",
"answer": "Senna or bisacodyl",
"relatedSectionId": "mk19_a_gm_s5_3_2_2_3"
},
"gm55": {
"id": "gm55",
"bookId": "gm",
"question": "Contraindication to initiating a long-acting opioid",
"answer": "Opioid-naïve patient",
"relatedSectionId": "mk19_a_gm_s5_3_3"
},
"gm56": {
"id": "gm56",
"bookId": "gm",
"question": "Impact of palliative medicine",
"answer": "Improved quality of life, symptoms, mood, and caregiver satisfaction",
"relatedSectionId": "mk19_a_gm_s6_1"
},
"gm57": {
"id": "gm57",
"bookId": "gm",
"question": "Timing of palliative medicine initiation for incurable/advanced disease",
"answer": "At time of diagnosis",
"relatedSectionId": "mk19_a_gm_s6_1"
},
"gm59": {
"id": "gm59",
"bookId": "gm",
"question": "Initial agent for radiation-induced vomiting",
"answer": "Serotonin antagonists (ondansetron, granisetron)",
"relatedSectionId": "mk19_a_gm_s6_3_3"
},
"gm60": {
"id": "gm60",
"bookId": "gm",
"question": "Recommendation for enteral/parenteral nutritional support at end of life",
"answer": "Avoid",
"relatedSectionId": "mk19_a_gm_s6_3_5"
},
"gm61": {
"id": "gm61",
"bookId": "gm",
"question": "Rapid-acting depression treatment useful at end of life",
"answer": "Methylphenidate",
"relatedSectionId": "mk19_a_gm_s6_3_6"
},
"gm62": {
"id": "gm62",
"bookId": "gm",
"question": "Treatment for acute pain (&lt;4 weeks' duration) from non–low back musculoskeletal injuries",
"answer": "Topical NSAIDs with or without menthol gel",
"relatedSectionId": "mk19_a_gm_s7_1"
},
"gm63": {
"id": "gm63",
"bookId": "gm",
"question": "Back pain, saddle anesthesia, bowel/bladder dysfunction",
"answer": "Cauda equina syndrome",
"relatedSectionId": "mk19_a_gm_s7_2_1_1"
},
"gm64": {
"id": "gm64",
"bookId": "gm",
"question": "Back pain “red flags” on exam",
"answer": "Fever, abnormal neurologic findings",
"relatedSectionId": "mk19_a_gm_s7_2_1_1"
},
"gm65": {
"id": "gm65",
"bookId": "gm",
"question": "Imaging for suspected cauda equina syndrome",
"answer": "MRI",
"relatedSectionId": "mk19_a_gm_s7_2_1_2"
},
"gm66": {
"id": "gm66",
"bookId": "gm",
"question": "Imaging for acute nonspecific low back pain",
"answer": "None",
"relatedSectionId": "mk19_a_gm_s7_2_1_2"
},
"gm67": {
"id": "gm67",
"bookId": "gm",
"question": "Acute back pain indications for imaging",
"answer": "Severe/progressive neurologic deficits; suspected infection, malignancy",
"relatedSectionId": "mk19_a_gm_s7_2_1_2"
},
"gm68": {
"id": "gm68",
"bookId": "gm",
"question": "Initial tests in patients with back pain if malignancy is suspected",
"answer": "Plain radiography and ESR measurement",
"relatedSectionId": "mk19_a_gm_s7_2_1_2"
},
"gm69": {
"id": "gm69",
"bookId": "gm",
"question": "Imaging for back pain with persistent radiculopathy",
"answer": "MRI",
"relatedSectionId": "mk19_a_gm_s7_2_1_2"
},
"gm70": {
"id": "gm70",
"bookId": "gm",
"question": "Nonpharmacologic therapies for acute low back pain",
"answer": "Physical therapy, local heat, massage, acupuncture, spinal manipulation",
"relatedSectionId": "mk19_a_gm_s7_2_2_1"
},
"gm71": {
"id": "gm71",
"bookId": "gm",
"question": "Medication for chronic low back pain unresponsive to nondrug treatment",
"answer": "NSAIDs",
"relatedSectionId": "mk19_a_gm_s7_2_2_2"
},
"gm72": {
"id": "gm72",
"bookId": "gm",
"question": "Initial drug therapy for acute low back pain",
"answer": "NSAIDs",
"relatedSectionId": "mk19_a_gm_s7_2_2_2"
},
"gm73": {
"id": "gm73",
"bookId": "gm",
"question": "Drugs used as adjuvant to NSAIDs for chronic low back pain",
"answer": "Nonbenzodiazepine muscle relaxants, duloxetine",
"relatedSectionId": "mk19_a_gm_s7_2_2_2"
},
"gm74": {
"id": "gm74",
"bookId": "gm",
"question": "Neck pain with decreased range of motion, normal neurologic findings",
"answer": "Cervical strain",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm75": {
"id": "gm75",
"bookId": "gm",
"question": "Neck pain, gait and coordination abnormalities",
"answer": "Cervical myelopathy",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm76": {
"id": "gm76",
"bookId": "gm",
"question": "Neck pain and dermatomal arm pain",
"answer": "Cervical radiculopathy",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm77": {
"id": "gm77",
"bookId": "gm",
"question": "Physical examination maneuver to rule out cervical radiculopathy",
"answer": "Spurling test",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm78": {
"id": "gm78",
"bookId": "gm",
"question": "Indications for plain radiography in patients with neck pain",
"answer": "Suspected trauma, infection, malignancy; 6-8 weeks of unresponsive pain",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm79": {
"id": "gm79",
"bookId": "gm",
"question": "Imaging for suspected cervical myelopathy",
"answer": "MRI",
"relatedSectionId": "mk19_a_gm_s7_3_1"
},
"gm80": {
"id": "gm80",
"bookId": "gm",
"question": "Treatments for musculoskeletal neck pain",
"answer": "Multimodal approach (range-of-motion exercise, physical therapy, ice/heat applications, analgesics)",
"relatedSectionId": "mk19_a_gm_s7_3_2"
},
"gm81": {
"id": "gm81",
"bookId": "gm",
"question": "Arm paresthesias/pain worsened with activity and arm elevation",
"answer": "Neurogenic thoracic outlet syndrome",
"relatedSectionId": "mk19_a_gm_s7_4_1_1"
},
"gm82": {
"id": "gm82",
"bookId": "gm",
"question": "Shoulder pain near deltoid insertion, worse with overhead activities",
"answer": "Rotator cuff disease",
"relatedSectionId": "mk19_a_gm_s7_4_2_2"
},
"gm83": {
"id": "gm83",
"bookId": "gm",
"question": "Positive painful arc and drop arm tests and weakness in shoulder external rotation",
"answer": "Rotator cuff tear",
"relatedSectionId": "mk19_a_gm_s7_4_2_2"
},
"gm84": {
"id": "gm84",
"bookId": "gm",
"question": "Rotator cuff disease surgical indication",
"answer": "Acute full-thickness tear",
"relatedSectionId": "mk19_a_gm_s7_4_2_2"
},
"gm85": {
"id": "gm85",
"bookId": "gm",
"question": "Chronic shoulder pain, loss of passive and active shoulder movement",
"answer": "Adhesive capsulitis",
"relatedSectionId": "mk19_a_gm_s7_4_2_3"
},
"gm86": {
"id": "gm86",
"bookId": "gm",
"question": "Adhesive capsulitis treatment",
"answer": "Intra-articular glucocorticoids, physical therapy",
"relatedSectionId": "mk19_a_gm_s7_4_2_3"
},
"gm87": {
"id": "gm87",
"bookId": "gm",
"question": "Elbow pain with flexion, paresthesia/numbness in 4<sup>th</sup> to 5<sup>th</sup> digits",
"answer": "Ulnar nerve entrapment",
"relatedSectionId": "mk19_a_gm_s7_4_3_3"
},
"gm88": {
"id": "gm88",
"bookId": "gm",
"question": "Posterior elbow swelling with normal range of motion",
"answer": "Olecranon bursitis",
"relatedSectionId": "mk19_a_gm_s7_4_3_4"
},
"gm89": {
"id": "gm89",
"bookId": "gm",
"question": "Fluid-filled swelling caused by herniated synovial tissue surrounding tendon sheaths or joints",
"answer": "Ganglion cyst",
"relatedSectionId": "mk19_a_gm_s7_4_4"
},
"gm90": {
"id": "gm90",
"bookId": "gm",
"question": "Pain at base of thumb elicited with Finkelstein test",
"answer": "De Quervain tendinopathy",
"relatedSectionId": "mk19_a_gm_s7_4_4"
},
"gm91": {
"id": "gm91",
"bookId": "gm",
"question": "Initial therapy for carpal tunnel syndrome",
"answer": "Activity modification and wrist splinting",
"relatedSectionId": "mk19_a_gm_s7_4_4_1"
},
"gm92": {
"id": "gm92",
"bookId": "gm",
"question": "Anterior hip pain associated with glucocorticoid use, SLE, sickle cell anemia, or alcohol use disorder",
"answer": "Osteonecrosis",
"relatedSectionId": "mk19_a_gm_s7_5_1_1"
},
"gm93": {
"id": "gm93",
"bookId": "gm",
"question": "Lateral hip pain of insidious onset, worse with climbing stairs and lying on side",
"answer": "Greater trochanteric pain syndrome",
"relatedSectionId": "mk19_a_gm_s7_5_1_1"
},
"gm94": {
"id": "gm94",
"bookId": "gm",
"question": "Initial management of GTPS",
"answer": "Activity modification, analgesia with acetaminophen or NSAIDs",
"relatedSectionId": "mk19_a_gm_s7_5_1_2"
},
"gm95": {
"id": "gm95",
"bookId": "gm",
"question": "Twisting injury, popping sound, rapid accumulation of knee effusion",
"answer": "ACL tear",
"relatedSectionId": "mk19_a_gm_s7_5_2_2"
},
"gm96": {
"id": "gm96",
"bookId": "gm",
"question": "Initial management of acute and chronic meniscal tears",
"answer": "Rest, ice, strengthening of quadriceps and hamstring muscles",
"relatedSectionId": "mk19_a_gm_s7_5_2_2"
},
"gm97": {
"id": "gm97",
"bookId": "gm",
"question": "Anterior knee pain after prolonged sitting, running, climbing",
"answer": "Patellofemoral pain syndrome",
"relatedSectionId": "mk19_a_gm_s7_5_2_3"
},
"gm98": {
"id": "gm98",
"bookId": "gm",
"question": "Anterior knee pain and swelling, preserved range of motion",
"answer": "Prepatellar bursitis",
"relatedSectionId": "mk19_a_gm_s7_5_2_4"
},
"gm99": {
"id": "gm99",
"bookId": "gm",
"question": "Required diagnostic test for prepatellar bursitis",
"answer": "Fluid aspiration and analysis",
"relatedSectionId": "mk19_a_gm_s7_5_2_4"
},
"gm100": {
"id": "gm100",
"bookId": "gm",
"question": "Localized pain over proximal medial tibia 2-3 cm below knee",
"answer": "Pes anserine bursitis",
"relatedSectionId": "mk19_a_gm_s7_5_2_4"
},
"gm101": {
"id": "gm101",
"bookId": "gm",
"question": "Lateral knee pain proximal to lateral femoral condyle after exercise",
"answer": "Iliotibial band syndrome",
"relatedSectionId": "mk19_a_gm_s7_5_2_9"
},
"gm102": {
"id": "gm102",
"bookId": "gm",
"question": "Treatment of asymptomatic popliteal cysts",
"answer": "None",
"relatedSectionId": "mk19_a_gm_s7_5_2_10"
},
"gm103": {
"id": "gm103",
"bookId": "gm",
"question": "Findings that rule out need for ankle imaging",
"answer": "Ability to walk 4 steps; no tenderness at posterior malleolus, navicular bone, 5<sup>th</sup> metatarsal",
"relatedSectionId": "mk19_a_gm_s7_5_3_1"
},
"gm104": {
"id": "gm104",
"bookId": "gm",
"question": "Drug cause of spontaneous Achilles tendon rupture",
"answer": "Fluoroquinolone use",
"relatedSectionId": "mk19_a_gm_s7_5_3_3"
},
"gm105": {
"id": "gm105",
"bookId": "gm",
"question": "Medial-inferior heel pain after prolonged rest, improved with walking",
"answer": "Plantar fasciitis",
"relatedSectionId": "mk19_a_gm_s7_5_3_3"
},
"gm106": {
"id": "gm106",
"bookId": "gm",
"question": "Initial treatment of plantar fasciitis",
"answer": "Weight loss, rest, stretching",
"relatedSectionId": "mk19_a_gm_s7_5_3_3"
},
"gm107": {
"id": "gm107",
"bookId": "gm",
"question": "Pain between metatarsal heads and sensation of walking on a pebble",
"answer": "Morton neuroma",
"relatedSectionId": "mk19_a_gm_s7_5_3_5"
},
"gm108": {
"id": "gm108",
"bookId": "gm",
"question": "Common secondary causes of LDL cholesterol elevation",
"answer": "Hypothyroidism, DM, nephrotic syndrome, glucocorticoid use",
"relatedSectionId": "mk19_a_gm_s8_1_1"
},
"gm109": {
"id": "gm109",
"bookId": "gm",
"question": "High-intensity statin therapy",
"answer": "Atorvastatin, 40-80 mg/d; rosuvastatin, 20-40 mg/d",
"relatedSectionId": "mk19_a_gm_s8_2_2"
},
"gm110": {
"id": "gm110",
"bookId": "gm",
"question": "ACC/AHA LDL cholesterol threshold for starting statin therapy for primary prevention regardless of other risk factors",
"answer": "≥190 mg/dL",
"relatedSectionId": "mk19_a_gm_s8_2_2_1"
},
"gm111": {
"id": "gm111",
"bookId": "gm",
"question": "Indications for high-intensity statin therapy for the primary prevention of ASCVD per AHA/ACC guidelines",
"answer": "LDL cholesterol level ≥190 mg/dL; age 40-75 years with 10-year ASCVD risk ≥20%",
"relatedSectionId": "mk19_a_gm_s8_2_2_1"
},
"gm112": {
"id": "gm112",
"bookId": "gm",
"question": "USPSTF criteria for starting statin therapy for primary prevention of ASCVD",
"answer": "≥1 ASCVD risk factor and a 10-year ASCVD risk ≥10%",
"relatedSectionId": "mk19_a_gm_s8_2_2_1"
},
"gm113": {
"id": "gm113",
"bookId": "gm",
"question": "First nonstatin added to statin therapy for secondary ASCVD prevention",
"answer": "Ezetimibe",
"relatedSectionId": "mk19_a_gm_s8_2_2_2"
},
"gm114": {
"id": "gm114",
"bookId": "gm",
"question": "AHA/ACC guideline treatment for cholesterol for secondary prevention of ASCVD in patients aged ≤75 years",
"answer": "High-intensity statin therapy",
"relatedSectionId": "mk19_a_gm_s8_2_2_2"
},
"gm115": {
"id": "gm115",
"bookId": "gm",
"question": "Criteria for adding to maximal statin therapy in secondary ASCVD prevention",
"answer": "LDL cholesterol level ≥70 mg/dL with multiple major ASCVD events/one major event with multiple high-risk conditions",
"relatedSectionId": "mk19_a_gm_s8_2_2_2"
},
"gm116": {
"id": "gm116",
"bookId": "gm",
"question": "Nonlipid laboratory testing before starting statin therapy",
"answer": "ALT level measurement",
"relatedSectionId": "mk19_a_gm_s8_2_2_3"
},
"gm117": {
"id": "gm117",
"bookId": "gm",
"question": "Criteria for assessing liver chemistries and muscle enzymes during statin therapy",
"answer": "Symptoms",
"relatedSectionId": "mk19_a_gm_s8_2_2_3"
},
"gm118": {
"id": "gm118",
"bookId": "gm",
"question": "Primary management of hypertriglyceridemia",
"answer": "Therapeutic lifestyle changes",
"relatedSectionId": "mk19_a_gm_s8_2_3"
},
"gm120": {
"id": "gm120",
"bookId": "gm",
"question": "Most effective drug therapy for hypertriglyceridemia",
"answer": "Fibrates",
"relatedSectionId": "mk19_a_gm_s8_2_3"
},
"gm121": {
"id": "gm121",
"bookId": "gm",
"question": "Symptom that must be present to diagnose major depression",
"answer": "Either depressed mood or anhedonia",
"relatedSectionId": "mk19_a_gm_s9_1_1_1_1"
},
"gm122": {
"id": "gm122",
"bookId": "gm",
"question": "USPSTF recommendation for peripartum depression prevention in at-risk patients",
"answer": "CBT or interpersonal therapy",
"relatedSectionId": "mk19_a_gm_s9_1_1_1_5"
},
"gm123": {
"id": "gm123",
"bookId": "gm",
"question": "Tool for assessing response to therapy in depression",
"answer": "PHQ-9",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm124": {
"id": "gm124",
"bookId": "gm",
"question": "First-line treatment options for major depressive disorder",
"answer": "CBT or second-generation antidepressants",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm125": {
"id": "gm125",
"bookId": "gm",
"question": "Common sexual side effects of SSRIs",
"answer": "Reduced libido, anorgasmia, delayed orgasm",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm126": {
"id": "gm126",
"bookId": "gm",
"question": "Antidepressants capable of causing the serotonin syndrome",
"answer": "SSRIs, SNRIs, bupropion, MAO inhibitors",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm127": {
"id": "gm127",
"bookId": "gm",
"question": "Management of depression partially responding to initial monotherapy",
"answer": "Increase drug dosage or add psychotherapy",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm128": {
"id": "gm128",
"bookId": "gm",
"question": "Management of depression not responding to initial monotherapy",
"answer": "Switch to or add another drug, with or without psychotherapy",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm129": {
"id": "gm129",
"bookId": "gm",
"question": "Recurrence criteria for long-term depression drug therapy",
"answer": "≥3 episodes of major depressive disorder",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm130": {
"id": "gm130",
"bookId": "gm",
"question": "Duration of drug therapy for initial episode of acute depression",
"answer": "4-9 months",
"relatedSectionId": "mk19_a_gm_s9_1_1_2"
},
"gm131": {
"id": "gm131",
"bookId": "gm",
"question": "Risk of prescribing antidepressant monotherapy in bipolar disorder",
"answer": "Precipitation of a manic episode",
"relatedSectionId": "mk19_a_gm_s9_1_2"
},
"gm132": {
"id": "gm132",
"bookId": "gm",
"question": "Excessive anxiety for ≥6 months causing functional impairment",
"answer": "Generalized anxiety disorder",
"relatedSectionId": "mk19_a_gm_s9_2_1"
},
"gm133": {
"id": "gm133",
"bookId": "gm",
"question": "Treatment of generalized anxiety disorder",
"answer": "CBT, SSRIs, SNRIs",
"relatedSectionId": "mk19_a_gm_s9_2_1"
},
"gm134": {
"id": "gm134",
"bookId": "gm",
"question": "Treatment of panic disorder",
"answer": "SSRIs/SNRIs, CBT, or both",
"relatedSectionId": "mk19_a_gm_s9_2_2"
},
"gm135": {
"id": "gm135",
"bookId": "gm",
"question": "Intrusive memories of a traumatic event",
"answer": "PTSD",
"relatedSectionId": "mk19_a_gm_s9_3"
},
"gm136": {
"id": "gm136",
"bookId": "gm",
"question": "Primary treatment of PTSD",
"answer": "CBT",
"relatedSectionId": "mk19_a_gm_s9_3"
},
"gm137": {
"id": "gm137",
"bookId": "gm",
"question": "Intrusive thoughts/impulses and repetitive behaviors",
"answer": "OCD",
"relatedSectionId": "mk19_a_gm_s9_4"
},
"gm138": {
"id": "gm138",
"bookId": "gm",
"question": "Initial treatment of OCD",
"answer": "CBT",
"relatedSectionId": "mk19_a_gm_s9_4"
},
"gm139": {
"id": "gm139",
"bookId": "gm",
"question": "Most effective smoking cessation pharmacotherapy",
"answer": "Varenicline with nicotine replacement therapy",
"relatedSectionId": "mk19_a_gm_s9_5_1"
},
"gm140": {
"id": "gm140",
"bookId": "gm",
"question": "Most effective nicotine replacement strategy",
"answer": "Combination of short- and long-acting forms",
"relatedSectionId": "mk19_a_gm_s9_5_1"
},
"gm141": {
"id": "gm141",
"bookId": "gm",
"question": "Smoking cessation drug contraindicated in seizure disorder",
"answer": "Bupropion",
"relatedSectionId": "mk19_a_gm_s9_5_1"
},
"gm142": {
"id": "gm142",
"bookId": "gm",
"question": "First-line drugs for alcohol dependence",
"answer": "Naltrexone and acamprosate",
"relatedSectionId": "mk19_a_gm_s9_5_2"
},
"gm143": {
"id": "gm143",
"bookId": "gm",
"question": "Major withdrawal symptoms within 48 hours of last alcoholic drink",
"answer": "Alcoholic hallucinosis and seizures",
"relatedSectionId": "mk19_a_gm_s9_5_2"
},
"gm144": {
"id": "gm144",
"bookId": "gm",
"question": "Autonomic activation and altered mental status ≥48 hours after last alcoholic drink",
"answer": "Delirium tremens",
"relatedSectionId": "mk19_a_gm_s9_5_2"
},
"gm145": {
"id": "gm145",
"bookId": "gm",
"question": "Recommended strategy for benzodiazepine treatment of alcohol withdrawal",
"answer": "Symptom-triggered approach (CIWA-Ar)",
"relatedSectionId": "mk19_a_gm_s9_5_2"
},
"gm146": {
"id": "gm146",
"bookId": "gm",
"question": "Recurrent nausea and vomiting relieved by prolonged hot showers",
"answer": "Cannabis hyperemesis syndrome",
"relatedSectionId": "mk19_a_gm_s9_5_3_1"
},
"gm147": {
"id": "gm147",
"bookId": "gm",
"question": "Chaotic interpersonal relationships, emotional lability, self-destructive behaviors",
"answer": "Borderline personality disorder",
"relatedSectionId": "mk19_a_gm_s9_6"
},
"gm148": {
"id": "gm148",
"bookId": "gm",
"question": "Management of somatic symptom disorder",
"answer": "Acknowledgment of symptoms, therapeutic relationship, CBT",
"relatedSectionId": "mk19_a_gm_s9_7_2"
},
"gm149": {
"id": "gm149",
"bookId": "gm",
"question": "Impulsive overeating with compensatory behaviors, low BMI",
"answer": "Anorexia nervosa, binging subtype",
"relatedSectionId": "mk19_a_gm_s9_8_1"
},
"gm150": {
"id": "gm150",
"bookId": "gm",
"question": "Impulsive overeating with compensatory behaviors, normal BMI",
"answer": "Bulimia nervosa",
"relatedSectionId": "mk19_a_gm_s9_8_1"
},
"gm151": {
"id": "gm151",
"bookId": "gm",
"question": "Impulsive overeating and loss of control over eating",
"answer": "Binge eating disorder",
"relatedSectionId": "mk19_a_gm_s9_8_1"
},
"gm152": {
"id": "gm152",
"bookId": "gm",
"question": "Treatment of anorexia nervosa",
"answer": "Psychotherapy, family therapy, and monitored dietary intake",
"relatedSectionId": "mk19_a_gm_s9_8_3"
},
"gm153": {
"id": "gm153",
"bookId": "gm",
"question": "Most effective treatment of bulimia nervosa",
"answer": "CBT",
"relatedSectionId": "mk19_a_gm_s9_8_3"
},
"gm154": {
"id": "gm154",
"bookId": "gm",
"question": "Early-adult onset of delusions, hallucinations, disorganized or catatonic behavior",
"answer": "Schizophrenia",
"relatedSectionId": "mk19_a_gm_s9_9"
},
"gm155": {
"id": "gm155",
"bookId": "gm",
"question": "First-line treatment of ADHD",
"answer": "Methylphenidate, amphetamine",
"relatedSectionId": "mk19_a_gm_s9_10"
},
"gm156": {
"id": "gm156",
"bookId": "gm",
"question": "Repetitive behaviors and difficulties in social interaction",
"answer": "Autism spectrum disorder",
"relatedSectionId": "mk19_a_gm_s9_11"
},
"gm157": {
"id": "gm157",
"bookId": "gm",
"question": "Elderly fall prevention interventions",
"answer": "Exercise, discontinuing/decreasing centrally acting medications, modifying home environment",
"relatedSectionId": "mk19_a_gm_s10_1_6"
},
"gm158": {
"id": "gm158",
"bookId": "gm",
"question": "Role of vitamin D supplementation in fall prevention",
"answer": "None",
"relatedSectionId": "mk19_a_gm_s10_1_6"
},
"gm159": {
"id": "gm159",
"bookId": "gm",
"question": "Essential geriatric prescribing principle",
"answer": "Frequent review of medication necessity",
"relatedSectionId": "mk19_a_gm_s10_4_1"
},
"gm160": {
"id": "gm160",
"bookId": "gm",
"question": "Urine leakage with coughing, sneezing, laughing",
"answer": "Stress urinary incontinence",
"relatedSectionId": "mk19_a_gm_s10_6_2"
},
"gm161": {
"id": "gm161",
"bookId": "gm",
"question": "Initial evaluation for overflow urinary incontinence",
"answer": "Ultrasonography for postvoid residual urine volume measurement",
"relatedSectionId": "mk19_a_gm_s10_6_2"
},
"gm162": {
"id": "gm162",
"bookId": "gm",
"question": "Urinary incontinence treatment in women with obesity",
"answer": "Weight loss",
"relatedSectionId": "mk19_a_gm_s10_6_3"
},
"gm163": {
"id": "gm163",
"bookId": "gm",
"question": "First-line therapy for stress urinary incontinence",
"answer": "Pelvic floor muscle training",
"relatedSectionId": "mk19_a_gm_s10_6_3_1"
},
"gm164": {
"id": "gm164",
"bookId": "gm",
"question": "Initial treatment of urge urinary incontinence",
"answer": "Bladder training and timed voiding",
"relatedSectionId": "mk19_a_gm_s10_6_3_2"
},
"gm165": {
"id": "gm165",
"bookId": "gm",
"question": "Treatment of functional urinary incontinence",
"answer": "Prompted voiding",
"relatedSectionId": "mk19_a_gm_s10_6_3_4"
},
"gm166": {
"id": "gm166",
"bookId": "gm",
"question": "Prophylactic device for pressure injury",
"answer": "Advanced static mattress or mattress overlay",
"relatedSectionId": "mk19_a_gm_s10_7_1"
},
"gm167": {
"id": "gm167",
"bookId": "gm",
"question": "Treatment of established pressure injuries",
"answer": "Wound care, protein supplements, pressure-reducing surfaces, hydrocolloid and foam dressings",
"relatedSectionId": "mk19_a_gm_s10_7_2"
},
"gm168": {
"id": "gm168",
"bookId": "gm",
"question": "Prerequisite for genetic testing",
"answer": "Genetic counseling",
"relatedSectionId": "mk19_a_gm_s11_3"
},
"gm2_1": {
"id": "gm2_1",
"bookId": "gm2",
"question": "Lead-time bias",
"answer": "Survival time appears longer because the screened patient was diagnosed earlier",
"relatedSectionId": "mk19_b_gm_s1_2_1"
},
"gm2_2": {
"id": "gm2_2",
"bookId": "gm2",
"question": "Length-time bias",
"answer": "Survival time appears longer because screening detects indolent disease",
"relatedSectionId": "mk19_b_gm_s1_2_1"
},
"gm2_3": {
"id": "gm2_3",
"bookId": "gm2",
"question": "Indication for one-time abdominal aortic aneurysm screening",
"answer": "Men aged 65-75 years who have ever smoked",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_1"
},
"gm2_4": {
"id": "gm2_4",
"bookId": "gm2",
"question": "Screening for CAD in low-risk asymptomatic patients",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_2"
},
"gm2_5": {
"id": "gm2_5",
"bookId": "gm2",
"question": "Asymptomatic patients to screen for carotid stenosis",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_2"
},
"gm2_6": {
"id": "gm2_6",
"bookId": "gm2",
"question": "Population appropriate for depression screening",
"answer": "All adults, including pregnant and postpartum women",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_4"
},
"gm2_7": {
"id": "gm2_7",
"bookId": "gm2",
"question": "USPSTF criterion for DM screening in patients aged 35-70 years",
"answer": "Obesity/overweight",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_5"
},
"gm2_8": {
"id": "gm2_8",
"bookId": "gm2",
"question": "USPSTF-recommended means of calculating CV risk",
"answer": "Pooled Cohort Equations",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_6"
},
"gm2_9": {
"id": "gm2_9",
"bookId": "gm2",
"question": "USPSTF-recommended BP screening frequency in adults ≥40 years of age",
"answer": "Annually",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_7"
},
"gm2_10": {
"id": "gm2_10",
"bookId": "gm2",
"question": "Age to begin osteoporosis screening in average-risk women",
"answer": "65 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_1_10"
},
"gm2_11": {
"id": "gm2_11",
"bookId": "gm2",
"question": "Chlamydia and gonorrhea screening indication for women",
"answer": "All sexually active women ≤24 years of age",
"relatedSectionId": "mk19_b_gm_s1_2_3_2"
},
"gm2_12": {
"id": "gm2_12",
"bookId": "gm2",
"question": "Hepatitis C routine screening criteria",
"answer": "All patients aged 18-79 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_2"
},
"gm2_13": {
"id": "gm2_13",
"bookId": "gm2",
"question": "HIV screening frequency for average-risk persons",
"answer": "One-time screening",
"relatedSectionId": "mk19_b_gm_s1_2_3_2"
},
"gm2_14": {
"id": "gm2_14",
"bookId": "gm2",
"question": "CDC-recommended HIV screening frequency for MSM",
"answer": "At least annually",
"relatedSectionId": "mk19_b_gm_s1_2_3_2"
},
"gm2_15": {
"id": "gm2_15",
"bookId": "gm2",
"question": "USPSTF screening criterion for intimate partner violence",
"answer": "Women of childbearing age",
"relatedSectionId": "mk19_b_gm_s1_2_3_4"
},
"gm2_16": {
"id": "gm2_16",
"bookId": "gm2",
"question": "Age range with clear benefit from screening mammography",
"answer": "Age 50-74 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_1"
},
"gm2_17": {
"id": "gm2_17",
"bookId": "gm2",
"question": "Breast cancer screening for average-risk women with increased breast density",
"answer": "Mammography",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_1"
},
"gm2_18": {
"id": "gm2_18",
"bookId": "gm2",
"question": "Indication for prostate cancer screening in men aged 55-69 years",
"answer": "Patient preference for screening",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_2"
},
"gm2_19": {
"id": "gm2_19",
"bookId": "gm2",
"question": "Recommended frequency of screening colonoscopy in average-risk adults",
"answer": "Every 10 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_3"
},
"gm2_20": {
"id": "gm2_20",
"bookId": "gm2",
"question": "USPSTF-recommended strategy for choosing colorectal cancer screening test",
"answer": "Use test most likely to be completed",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_3"
},
"gm2_21": {
"id": "gm2_21",
"bookId": "gm2",
"question": "American Cancer Society preferred cervical screening strategy",
"answer": "High-risk HPV screening every 5 years starting at age 25 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_4"
},
"gm2_22": {
"id": "gm2_22",
"bookId": "gm2",
"question": "USPSTF cervical cancer screening strategy for women aged 21-29 years",
"answer": "Cytology every 3 years",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_4"
},
"gm2_23": {
"id": "gm2_23",
"bookId": "gm2",
"question": "Age to stop cervical cancer screening in non–high-risk women",
"answer": "Age 65 years if prior screening is adequate",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_4"
},
"gm2_24": {
"id": "gm2_24",
"bookId": "gm2",
"question": "Cervical cancer screening after hysterectomy for benign disease",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s1_2_3_5_4"
},
"gm2_25": {
"id": "gm2_25",
"bookId": "gm2",
"question": "Indication for annual influenza vaccination",
"answer": "All adults",
"relatedSectionId": "mk19_b_gm_s1_3_1_1"
},
"gm2_26": {
"id": "gm2_26",
"bookId": "gm2",
"question": "Influenza formulation recommended for adults ≥65 years of age",
"answer": "Inactivated (standard or high dose) or recombinant influenza vaccine",
"relatedSectionId": "mk19_b_gm_s1_3_1_1"
},
"gm2_27": {
"id": "gm2_27",
"bookId": "gm2",
"question": "Recommended frequency of Td booster in adults",
"answer": "Every 10 years",
"relatedSectionId": "mk19_b_gm_s1_3_1_2"
},
"gm2_28": {
"id": "gm2_28",
"bookId": "gm2",
"question": "Tdap vaccination recommendation for pregnant women",
"answer": "Between 27 weeks' and 36 weeks' gestation for every pregnancy",
"relatedSectionId": "mk19_b_gm_s1_3_1_2"
},
"gm2_29": {
"id": "gm2_29",
"bookId": "gm2",
"question": "Indication for recombinant zoster vaccine",
"answer": "Age 50 years or older or 19-49 years and immunodeficient/immunocompromised",
"relatedSectionId": "mk19_b_gm_s1_3_2_1"
},
"gm2_30": {
"id": "gm2_30",
"bookId": "gm2",
"question": "Pneumococcal vaccination for immunocompetent patients older than 65 years of age",
"answer": "PCV20 alone or PCV15 followed by PPSV23 at least 1 year later",
"relatedSectionId": "mk19_b_gm_s1_3_2_2"
},
"gm2_32": {
"id": "gm2_32",
"bookId": "gm2",
"question": "Age indications for HPV vaccination",
"answer": "11-12 years or between 13 and 26 years",
"relatedSectionId": "mk19_b_gm_s1_3_2_3"
},
"gm2_33": {
"id": "gm2_33",
"bookId": "gm2",
"question": "Role of adding aspirin in patient on anticoagulation for primary prevention of ASCVD",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s1_4"
},
"gm2_34": {
"id": "gm2_34",
"bookId": "gm2",
"question": "Recommended minimum weekly physical activity",
"answer": "150-300 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity",
"relatedSectionId": "mk19_b_gm_s1_5_4"
},
"gm2_35": {
"id": "gm2_35",
"bookId": "gm2",
"question": "Four-step quality improvement method",
"answer": "Plan-Do-Study-Act (PDSA) cycle",
"relatedSectionId": "mk19_b_gm_s2_3_1"
},
"gm2_36": {
"id": "gm2_36",
"bookId": "gm2",
"question": "Means of determining VTE in hospitalized patient",
"answer": "Validated risk assessment model (e.g., Padua Prediction Score)",
"relatedSectionId": "mk19_b_gm_s3_3"
},
"gm2_37": {
"id": "gm2_37",
"bookId": "gm2",
"question": "Strategies for preventing delirium in hospitalized patients",
"answer": "Visual/hearing devices, pain control, limit psychoactive medications, reorientation, mobilization, decrease sleep disruption",
"relatedSectionId": "mk19_b_gm_s3_3"
},
"gm2_38": {
"id": "gm2_38",
"bookId": "gm2",
"question": "Preoperative laboratory testing in patients with CKD",
"answer": "Serum electrolyte and creatinine levels",
"relatedSectionId": "mk19_b_gm_s4_1_1"
},
"gm2_39": {
"id": "gm2_39",
"bookId": "gm2",
"question": "Indication for preoperative urinalysis",
"answer": "Suspected UTI, planned urologic procedure",
"relatedSectionId": "mk19_b_gm_s4_1_1"
},
"gm2_40": {
"id": "gm2_40",
"bookId": "gm2",
"question": "Routine preoperative laboratory testing in low-risk surgery (cataract surgery, hernia repair)",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s4_1_1"
},
"gm2_41": {
"id": "gm2_41",
"bookId": "gm2",
"question": "Initial preoperative assessment of patients with ≥1% risk for MACE",
"answer": "Assessment of functional capacity",
"relatedSectionId": "mk19_b_gm_s4_2_1"
},
"gm2_42": {
"id": "gm2_42",
"bookId": "gm2",
"question": "Indication for preoperative echocardiography in patients with valvular disease",
"answer": "Moderate to severe valve disease without TTE within last year or change in clinical status",
"relatedSectionId": "mk19_b_gm_s4_2_1"
},
"gm2_43": {
"id": "gm2_43",
"bookId": "gm2",
"question": "Indications for cardiac catheterization prior to noncardiac surgery",
"answer": "Same as those for patients not undergoing surgery",
"relatedSectionId": "mk19_b_gm_s4_2_2_1"
},
"gm2_44": {
"id": "gm2_44",
"bookId": "gm2",
"question": "Perioperative management of chronic β-blocker therapy",
"answer": "Continue β-blocker",
"relatedSectionId": "mk19_b_gm_s4_2_2_1"
},
"gm2_45": {
"id": "gm2_45",
"bookId": "gm2",
"question": "Patients who should undergo preoperative screening for OSA",
"answer": "All patients",
"relatedSectionId": "mk19_b_gm_s4_3_1"
},
"gm2_46": {
"id": "gm2_46",
"bookId": "gm2",
"question": "Only indication for routine preoperative spirometry",
"answer": "Planned lung resection",
"relatedSectionId": "mk19_b_gm_s4_3_1"
},
"gm2_47": {
"id": "gm2_47",
"bookId": "gm2",
"question": "Hospital VTE prophylaxis following hip fracture or total knee/hip arthroplasty",
"answer": "Concomitant mechanical and pharmacologic prophylaxis",
"relatedSectionId": "mk19_b_gm_s4_4_1"
},
"gm2_48": {
"id": "gm2_48",
"bookId": "gm2",
"question": "Role of preoperative placement of IVC filter in VTE prophylaxis",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s4_4_1"
},
"gm2_49": {
"id": "gm2_49",
"bookId": "gm2",
"question": "Time to stop DOACs preoperatively",
"answer": "2-3 days before surgery",
"relatedSectionId": "mk19_b_gm_s4_4_2"
},
"gm2_50": {
"id": "gm2_50",
"bookId": "gm2",
"question": "Indications for perioperative bridging anticoagulation in patients with atrial fibrillation",
"answer": "Very high CHA<sub>2</sub>DS<sub>2</sub>-VASc score, recent thromboembolic event, mechanical heart valve",
"relatedSectionId": "mk19_b_gm_s4_4_2"
},
"gm2_51": {
"id": "gm2_51",
"bookId": "gm2",
"question": "Typical time to restart DOACs postoperatively after major surgery",
"answer": "48-72 hours",
"relatedSectionId": "mk19_b_gm_s4_4_2"
},
"gm2_52": {
"id": "gm2_52",
"bookId": "gm2",
"question": "Minimum preoperative DAPT duration after bare metal stent placement",
"answer": "14-30 days",
"relatedSectionId": "mk19_b_gm_s4_4_3"
},
"gm2_53": {
"id": "gm2_53",
"bookId": "gm2",
"question": "Minimum preoperative DAPT duration after drug-eluting stent placement",
"answer": "3-6 months",
"relatedSectionId": "mk19_b_gm_s4_4_3"
},
"gm2_54": {
"id": "gm2_54",
"bookId": "gm2",
"question": "Perioperative management of aspirin for CVD",
"answer": "Stop aspirin 5 days preoperatively",
"relatedSectionId": "mk19_b_gm_s4_4_3"
},
"gm2_55": {
"id": "gm2_55",
"bookId": "gm2",
"question": "Postoperative transfusion threshold in orthopedic and cardiac surgery patients",
"answer": "Hemoglobin level of 8 g/dL (80 g/L)",
"relatedSectionId": "mk19_b_gm_s4_4_4"
},
"gm2_56": {
"id": "gm2_56",
"bookId": "gm2",
"question": "Perioperative management of untreated, asymptomatic mild hypothyroidism",
"answer": "Proceed to surgery without further testing/treatment",
"relatedSectionId": "mk19_b_gm_s4_5_2"
},
"gm2_57": {
"id": "gm2_57",
"bookId": "gm2",
"question": "Absolute contraindications to elective surgery in liver disease",
"answer": "MELD score &gt;20",
"relatedSectionId": "mk19_b_gm_s4_7"
},
"gm2_58": {
"id": "gm2_58",
"bookId": "gm2",
"question": "Postoperative rigidity, fever, confusion, and autonomic instability in patient with Parkinson disease",
"answer": "Parkinsonism-hyperpyrexia syndrome (dopamine agonist withdrawal)",
"relatedSectionId": "mk19_b_gm_s4_8"
},
"gm2_59": {
"id": "gm2_59",
"bookId": "gm2",
"question": "Time to delay elective noncardiac surgery after stroke or TIA",
"answer": "At least 6 months",
"relatedSectionId": "mk19_b_gm_s4_8"
},
"gm2_60": {
"id": "gm2_60",
"bookId": "gm2",
"question": "Perioperative management of biologic agents for rheumatologic disease",
"answer": "Withhold for one dosing cycle preoperatively; perform surgery at end of cycle",
"relatedSectionId": "mk19_b_gm_s4_9_1"
},
"gm2_61": {
"id": "gm2_61",
"bookId": "gm2",
"question": "Nutrition factors predictive of poor surgical outcomes",
"answer": "15% weight loss over 6 months, BMI &lt;18.5, serum albumin level &lt;3.0 g/dL (30 g/L)",
"relatedSectionId": "mk19_b_gm_s4_10_1"
},
"gm2_62": {
"id": "gm2_62",
"bookId": "gm2",
"question": "Waist circumference associated with increased risk of DM, ASCVD, and mortality",
"answer": "≥40 inches in men, ≥35 inches in women",
"relatedSectionId": "mk19_b_gm_s5_1"
},
"gm2_63": {
"id": "gm2_63",
"bookId": "gm2",
"question": "Indication for weight loss pharmacotherapy after unsuccessful lifestyle modification trial",
"answer": "BMI ≥30 or BMI ≥27 with obesity-associated comorbid condition",
"relatedSectionId": "mk19_b_gm_s5_3_2"
},
"gm2_64": {
"id": "gm2_64",
"bookId": "gm2",
"question": "BMI threshold for bariatric surgery in patients with comorbidities",
"answer": "≥35",
"relatedSectionId": "mk19_b_gm_s5_3_3"
},
"gm2_65": {
"id": "gm2_65",
"bookId": "gm2",
"question": "BMI threshold for bariatric surgery in patients with no comorbidities",
"answer": "≥40",
"relatedSectionId": "mk19_b_gm_s5_3_3"
},
"gm2_66": {
"id": "gm2_66",
"bookId": "gm2",
"question": "Universal vitamin deficiency after bariatric surgery",
"answer": "Vitamin D",
"relatedSectionId": "mk19_b_gm_s5_3_3_2"
},
"gm2_67": {
"id": "gm2_67",
"bookId": "gm2",
"question": "First-line pharmacotherapy for ED",
"answer": "PDE-5 inhibitors",
"relatedSectionId": "mk19_b_gm_s6_1_1"
},
"gm2_68": {
"id": "gm2_68",
"bookId": "gm2",
"question": "Contraindication to PDE-5 inhibitors for ED",
"answer": "Nitrate therapy",
"relatedSectionId": "mk19_b_gm_s6_1_1"
},
"gm2_69": {
"id": "gm2_69",
"bookId": "gm2",
"question": "Most effective long-term pharmacologic therapy for premature ejaculation",
"answer": "Combination of SSRI and a PDE-5 inhibitor",
"relatedSectionId": "mk19_b_gm_s6_1_2"
},
"gm2_70": {
"id": "gm2_70",
"bookId": "gm2",
"question": "Indication for testosterone replacement therapy",
"answer": "Low testosterone level accompanied by evidence of androgen deficiency",
"relatedSectionId": "mk19_b_gm_s6_3"
},
"gm2_71": {
"id": "gm2_71",
"bookId": "gm2",
"question": "Criteria for diagnosis of androgen deficiency",
"answer": "Suggestive symptoms/signs with two early morning serum total testosterone levels &lt;300 ng/dL (10.4 nmol/L)",
"relatedSectionId": "mk19_b_gm_s6_3"
},
"gm2_72": {
"id": "gm2_72",
"bookId": "gm2",
"question": "Initial drug therapy for LUTS",
"answer": "α-Blocker",
"relatedSectionId": "mk19_b_gm_s6_4"
},
"gm2_73": {
"id": "gm2_73",
"bookId": "gm2",
"question": "Role of 5α-reductase inhibitor therapy for LUTS",
"answer": "Second-line to α-blocker therapy",
"relatedSectionId": "mk19_b_gm_s6_4"
},
"gm2_74": {
"id": "gm2_74",
"bookId": "gm2",
"question": "Testicular pain and absent cremasteric reflex",
"answer": "Testicular torsion",
"relatedSectionId": "mk19_b_gm_s6_5"
},
"gm2_75": {
"id": "gm2_75",
"bookId": "gm2",
"question": "Testicular pain relieved with scrotal elevation",
"answer": "Epididymitis",
"relatedSectionId": "mk19_b_gm_s6_5"
},
"gm2_76": {
"id": "gm2_76",
"bookId": "gm2",
"question": "Antibiotics for epididymitis in men ≤35 years",
"answer": "Ceftriaxone and doxycycline",
"relatedSectionId": "mk19_b_gm_s6_5"
},
"gm2_77": {
"id": "gm2_77",
"bookId": "gm2",
"question": "Treatment of epididymitis in older men with no STI risk",
"answer": "Levofloxacin",
"relatedSectionId": "mk19_b_gm_s6_5"
},
"gm2_78": {
"id": "gm2_78",
"bookId": "gm2",
"question": "“Bag of worms” scrotal mass smaller with elevation",
"answer": "Varicocele",
"relatedSectionId": "mk19_b_gm_s6_6"
},
"gm2_79": {
"id": "gm2_79",
"bookId": "gm2",
"question": "Irritative voiding, perineal pain, fever",
"answer": "Acute prostatitis",
"relatedSectionId": "mk19_b_gm_s6_7"
},
"gm2_80": {
"id": "gm2_80",
"bookId": "gm2",
"question": "Treatment of acute bacterial prostatitis not requiring IV therapy",
"answer": "Trimethoprim-sulfamethoxazole, ciprofloxacin, or levofloxacin",
"relatedSectionId": "mk19_b_gm_s6_7"
},
"gm2_81": {
"id": "gm2_81",
"bookId": "gm2",
"question": "Management of suspicious breast mass with negative imaging findings",
"answer": "Biopsy",
"relatedSectionId": "mk19_b_gm_s7_1_1"
},
"gm2_82": {
"id": "gm2_82",
"bookId": "gm2",
"question": "Initial imaging test for breast mass in women ≥30 years",
"answer": "Mammography",
"relatedSectionId": "mk19_b_gm_s7_1_1"
},
"gm2_83": {
"id": "gm2_83",
"bookId": "gm2",
"question": "Initial imaging test for breast mass in women &lt;30 years",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_b_gm_s7_1_1"
},
"gm2_84": {
"id": "gm2_84",
"bookId": "gm2",
"question": "Breast imaging test of choice for pregnant women",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_b_gm_s7_1_1"
},
"gm2_85": {
"id": "gm2_85",
"bookId": "gm2",
"question": "Premenstrual breast pain resolving with menstrual cycle onset",
"answer": "Cyclic mastalgia",
"relatedSectionId": "mk19_b_gm_s7_1_2"
},
"gm2_86": {
"id": "gm2_86",
"bookId": "gm2",
"question": "Management of cyclic mastalgia",
"answer": "Reassurance, appropriate breast support, topical NSAID",
"relatedSectionId": "mk19_b_gm_s7_1_2"
},
"gm2_87": {
"id": "gm2_87",
"bookId": "gm2",
"question": "Hormonal contraception options when estrogen is contraindicated",
"answer": "Progestin-containing injection, implant, or pill; IUD",
"relatedSectionId": "mk19_b_gm_s7_2_1_1"
},
"gm2_88": {
"id": "gm2_88",
"bookId": "gm2",
"question": "Most effective emergency contraception",
"answer": "Copper IUD within 5 days of intercourse",
"relatedSectionId": "mk19_b_gm_s7_2_1_4"
},
"gm2_89": {
"id": "gm2_89",
"bookId": "gm2",
"question": "Medications for emergency contraception",
"answer": "Levonorgestrel (3-day window), ulipristal (5-day window)",
"relatedSectionId": "mk19_b_gm_s7_2_1_4"
},
"gm2_90": {
"id": "gm2_90",
"bookId": "gm2",
"question": "Immunizations avoided during pregnancy",
"answer": "Live vaccines (varicella, HPV, MMR, live attenuated influenza, live attenuated zoster)",
"relatedSectionId": "mk19_b_gm_s7_2_2"
},
"gm2_91": {
"id": "gm2_91",
"bookId": "gm2",
"question": "First test for premenopausal AUB",
"answer": "Pregnancy test",
"relatedSectionId": "mk19_b_gm_s7_3_1_1"
},
"gm2_92": {
"id": "gm2_92",
"bookId": "gm2",
"question": "Imaging test for premenopausal AUB",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_b_gm_s7_3_1_1"
},
"gm2_93": {
"id": "gm2_93",
"bookId": "gm2",
"question": "Ultrasound finding that warrants endometrial biopsy in postmenopausal AUB",
"answer": "Endometrial stripe &gt;4 mm",
"relatedSectionId": "mk19_b_gm_s7_3_1_1"
},
"gm2_94": {
"id": "gm2_94",
"bookId": "gm2",
"question": "Evaluation of peri- and postmenopausal vaginal bleeding",
"answer": "Pelvic ultrasonography, endometrial biopsy",
"relatedSectionId": "mk19_b_gm_s7_3_1_1"
},
"gm2_95": {
"id": "gm2_95",
"bookId": "gm2",
"question": "Treatment of anovulatory AUB when fertility is desired",
"answer": "Medroxyprogesterone acetate",
"relatedSectionId": "mk19_b_gm_s7_3_1_2"
},
"gm2_96": {
"id": "gm2_96",
"bookId": "gm2",
"question": "Initial treatment of primary dysmenorrhea",
"answer": "NSAIDs or contraception (e.g., estrogen-progesterone and progesterone-only methods)",
"relatedSectionId": "mk19_b_gm_s7_3_2"
},
"gm2_97": {
"id": "gm2_97",
"bookId": "gm2",
"question": "Vulvar dryness and pale, dry vaginal walls with decreased rugae",
"answer": "Genitourinary syndrome of menopause (vaginal atrophy)",
"relatedSectionId": "mk19_b_gm_s7_4_1"
},
"gm2_98": {
"id": "gm2_98",
"bookId": "gm2",
"question": "Nonhormonal drugs for vasomotor symptoms of menopause",
"answer": "SSRIs, SNRIs, gabapentin",
"relatedSectionId": "mk19_b_gm_s7_4_2_1"
},
"gm2_99": {
"id": "gm2_99",
"bookId": "gm2",
"question": "Treatment of genitourinary syndrome of menopause",
"answer": "Moisturizers, lubricants, topical estrogen",
"relatedSectionId": "mk19_b_gm_s7_4_2_2"
},
"gm2_100": {
"id": "gm2_100",
"bookId": "gm2",
"question": "Necessary test for women of reproductive age presenting with acute pelvic pain",
"answer": "Pregnancy test",
"relatedSectionId": "mk19_b_gm_s7_5_1"
},
"gm2_101": {
"id": "gm2_101",
"bookId": "gm2",
"question": "Criteria for diagnosis of any female sexual disorder",
"answer": "Persistent symptoms and distress &gt;75% of time for ≥6 months",
"relatedSectionId": "mk19_b_gm_s7_6"
},
"gm2_102": {
"id": "gm2_102",
"bookId": "gm2",
"question": "FDA-approved pharmacologic treatments for female sexual dysfunction",
"answer": "Flibanserin, bremelanotide",
"relatedSectionId": "mk19_b_gm_s7_6"
},
"gm2_103": {
"id": "gm2_103",
"bookId": "gm2",
"question": "Treatment of asymptomatic vaginal candidiasis",
"answer": "None",
"relatedSectionId": "mk19_b_gm_s7_7_2"
},
"gm2_104": {
"id": "gm2_104",
"bookId": "gm2",
"question": "Clinical diagnosis of bacterial vaginosis",
"answer": "Any three: vaginal pH &gt;4.5; thin, homogenous discharge; positive whiff test result; 20% clue cells",
"relatedSectionId": "mk19_b_gm_s7_7_2"
},
"gm2_105": {
"id": "gm2_105",
"bookId": "gm2",
"question": "Treatment of uncomplicated, symptomatic vulvovaginal candidiasis",
"answer": "Topical imidazole or topical triazole or oral fluconazole",
"relatedSectionId": "mk19_b_gm_s7_7_2"
},
"gm2_106": {
"id": "gm2_106",
"bookId": "gm2",
"question": "Preferred diagnostic test for trichomoniasis",
"answer": "Nucleic acid amplification testing",
"relatedSectionId": "mk19_b_gm_s7_7_3"
},
"gm2_107": {
"id": "gm2_107",
"bookId": "gm2",
"question": "Vaginitis that requires partner treatment",
"answer": "Trichomoniasis",
"relatedSectionId": "mk19_b_gm_s7_7_3"
},
"gm2_108": {
"id": "gm2_108",
"bookId": "gm2",
"question": "Mucopurulent discharge, eyelash debris, eyelid matting",
"answer": "Bacterial conjunctivitis",
"relatedSectionId": "mk19_b_gm_s8_2_1"
},
"gm2_109": {
"id": "gm2_109",
"bookId": "gm2",
"question": "Pharmacologic treatment of bacterial conjunctivitis",
"answer": "Topical trimethoprim-polymyxin B or erythromycin",
"relatedSectionId": "mk19_b_gm_s8_2_1"
},
"gm2_110": {
"id": "gm2_110",
"bookId": "gm2",
"question": "Severe eye pain, photophobia, scleral edema/redness",
"answer": "Scleritis",
"relatedSectionId": "mk19_b_gm_s8_2_3"
},
"gm2_111": {
"id": "gm2_111",
"bookId": "gm2",
"question": "Eye pain, photophobia, decreased vision, ciliary flush",
"answer": "Anterior uveitis (iritis)",
"relatedSectionId": "mk19_b_gm_s8_2_4"
},
"gm2_112": {
"id": "gm2_112",
"bookId": "gm2",
"question": "Earliest symptom of primary open-angle glaucoma",
"answer": "Peripheral visual field loss",
"relatedSectionId": "mk19_b_gm_s8_6_1"
},
"gm2_113": {
"id": "gm2_113",
"bookId": "gm2",
"question": "Acute eye pain, halos around lights, nausea/vomiting",
"answer": "Acute angle-closure glaucoma",
"relatedSectionId": "mk19_b_gm_s8_6_2"
},
"gm2_114": {
"id": "gm2_114",
"bookId": "gm2",
"question": "Drusen and neovascularization",
"answer": "Wet AMD",
"relatedSectionId": "mk19_b_gm_s8_7"
},
"gm2_115": {
"id": "gm2_115",
"bookId": "gm2",
"question": "Acute painful vision loss, afferent pupillary defect, central scotoma",
"answer": "Optic neuritis",
"relatedSectionId": "mk19_b_gm_s8_8"
},
"gm2_116": {
"id": "gm2_116",
"bookId": "gm2",
"question": "Painless partial visual field loss, unilateral flashing lights/floaters",
"answer": "Retinal detachment",
"relatedSectionId": "mk19_b_gm_s8_9"
},
"gm2_117": {
"id": "gm2_117",
"bookId": "gm2",
"question": "Approach to sudden-onset hearing loss (within 72 hours)",
"answer": "Urgent audiology referral, MRI, consideration of glucocorticoids",
"relatedSectionId": "mk19_b_gm_s9_1"
},
"gm2_118": {
"id": "gm2_118",
"bookId": "gm2",
"question": "Indicators of complicated otitis media",
"answer": "Fever, posterior ear pain, facial nerve paralysis",
"relatedSectionId": "mk19_b_gm_s9_3"
},
"gm2_119": {
"id": "gm2_119",
"bookId": "gm2",
"question": "Tenderness with pushing on the tragus, pulling on the pinna",
"answer": "Acute otitis externa",
"relatedSectionId": "mk19_b_gm_s9_3"
},
"gm2_120": {
"id": "gm2_120",
"bookId": "gm2",
"question": "Treatment of malignant otitis externa",
"answer": "Systemic antibiotics, urgent referral to otolaryngology",
"relatedSectionId": "mk19_b_gm_s9_3"
},
"gm2_121": {
"id": "gm2_121",
"bookId": "gm2",
"question": "Evaluation of recurrent unilateral epistaxis",
"answer": "Nasal endoscopy",
"relatedSectionId": "mk19_b_gm_s9_5"
},
"gm2_122": {
"id": "gm2_122",
"bookId": "gm2",
"question": "Indications for antibiotics in acute rhinosinusitis",
"answer": "Symptoms &gt;10 days; severe symptoms/high fever ≥3 days; worsening symptoms after initial improvement",
"relatedSectionId": "mk19_b_gm_s9_6_2"
},
"gm2_123": {
"id": "gm2_123",
"bookId": "gm2",
"question": "First-line treatment of allergic rhinitis",
"answer": "Intranasal glucocorticoid monotherapy",
"relatedSectionId": "mk19_b_gm_s9_6_3"
},
"gm2_124": {
"id": "gm2_124",
"bookId": "gm2",
"question": "Treatment of rhinitis medicamentosa",
"answer": "Cessation of topical decongestant and addition of intranasal glucocorticoids",
"relatedSectionId": "mk19_b_gm_s9_6_3"
},
"gm2_125": {
"id": "gm2_125",
"bookId": "gm2",
"question": "Centor criteria",
"answer": "Fever by history, tonsillar exudates, tender anterior cervical lymphadenopathy, no cough",
"relatedSectionId": "mk19_b_gm_s9_6_4"
},
"gm2_126": {
"id": "gm2_126",
"bookId": "gm2",
"question": "First-line therapy for GAS pharyngitis",
"answer": "Penicillin or amoxicillin",
"relatedSectionId": "mk19_b_gm_s9_6_4"
},
"gm2_127": {
"id": "gm2_127",
"bookId": "gm2",
"question": "Number of Centor criteria suggesting testing for bacterial pharyngitis",
"answer": "Three (consider with two)",
"relatedSectionId": "mk19_b_gm_s9_6_4"
},
"gm2_128": {
"id": "gm2_128",
"bookId": "gm2",
"question": "Difficulty managing oral secretions, severe odynophagia/dysphagia, tachypnea, stridor",
"answer": "Epiglottitis",
"relatedSectionId": "mk19_b_gm_s9_7"
},
"gm2_129": {
"id": "gm2_129",
"bookId": "gm2",
"question": "Topical drug combination to avoid in fungal treatment",
"answer": "Glucocorticoid-antifungal combination",
"relatedSectionId": "mk19_b_gm_s10_2_3"
},
"gm2_130": {
"id": "gm2_130",
"bookId": "gm2",
"question": "Primary atopic dermatitis treatment",
"answer": "Topical glucocorticoids, non–soap-based cleansers and moisturizers",
"relatedSectionId": "mk19_b_gm_s10_3_1"
},
"gm2_131": {
"id": "gm2_131",
"bookId": "gm2",
"question": "Glucocorticoid treatment duration for severe contact dermatitis",
"answer": "2 to 3 weeks",
"relatedSectionId": "mk19_b_gm_s10_3_2_1"
},
"gm2_132": {
"id": "gm2_132",
"bookId": "gm2",
"question": "Eczema characterized by vesicles on sides of fingers",
"answer": "Dyshidrotic (pompholyx)",
"relatedSectionId": "mk19_b_gm_s10_3_3"
},
"gm2_133": {
"id": "gm2_133",
"bookId": "gm2",
"question": "Hand dermatitis accompanied by foot involvement",
"answer": "Tinea (two feet-one hand syndrome)",
"relatedSectionId": "mk19_b_gm_s10_3_3"
},
"gm2_134": {
"id": "gm2_134",
"bookId": "gm2",
"question": "Over-the-counter treatment of seborrheic dermatitis",
"answer": "Selenium sulfide or zinc pyrithione shampoos",
"relatedSectionId": "mk19_b_gm_s10_3_4"
},
"gm2_135": {
"id": "gm2_135",
"bookId": "gm2",
"question": "Dermatitis involving skin folds",
"answer": "Intertrigo",
"relatedSectionId": "mk19_b_gm_s10_3_6"
},
"gm2_136": {
"id": "gm2_136",
"bookId": "gm2",
"question": "Edema, erythema, pruritus on the lower legs",
"answer": "Stasis dermatitis",
"relatedSectionId": "mk19_b_gm_s10_3_7"
},
"gm2_137": {
"id": "gm2_137",
"bookId": "gm2",
"question": "Individual urticarial lesions lasting &gt;24 hours, fever, joint pain",
"answer": "Urticarial vasculitis",
"relatedSectionId": "mk19_b_gm_s10_4"
},
"gm2_138": {
"id": "gm2_138",
"bookId": "gm2",
"question": "Initial diagnostic evaluation for cause of urticaria",
"answer": "None unless history suggests specific cause",
"relatedSectionId": "mk19_b_gm_s10_4"
},
"gm2_139": {
"id": "gm2_139",
"bookId": "gm2",
"question": "Typical time of onset of exanthematous drug eruption",
"answer": "First or second week after drug exposure",
"relatedSectionId": "mk19_b_gm_s10_5_1"
},
"gm2_140": {
"id": "gm2_140",
"bookId": "gm2",
"question": "Circinate plaques occurring at same location with repeat exposure",
"answer": "Fixed drug reaction",
"relatedSectionId": "mk19_b_gm_s10_5_2"
},
"gm2_141": {
"id": "gm2_141",
"bookId": "gm2",
"question": "Typical rash of DIHS",
"answer": "Morbilliform exanthem starting on face/upper trunk and spreading distally",
"relatedSectionId": "mk19_b_gm_s10_5_3"
},
"gm2_142": {
"id": "gm2_142",
"bookId": "gm2",
"question": "DIHS treatment",
"answer": "Discontinue causative drug, glucocorticoids",
"relatedSectionId": "mk19_b_gm_s10_5_3"
},
"gm2_143": {
"id": "gm2_143",
"bookId": "gm2",
"question": "Key features of SJS and TEN",
"answer": "Full-thickness epidermal necrosis with mucous membrane involvement",
"relatedSectionId": "mk19_b_gm_s10_5_5"
},
"gm2_144": {
"id": "gm2_144",
"bookId": "gm2",
"question": "Areas of involvement for SJS/TEN vs. erythema multiforme",
"answer": "SJS/TEN: trunk and face; erythema multiforme: extremities",
"relatedSectionId": "mk19_b_gm_s10_5_5"
},
"gm2_145": {
"id": "gm2_145",
"bookId": "gm2",
"question": "Facial pustules within several days of starting antibiotics",
"answer": "Acute generalized exanthematous pustulosis",
"relatedSectionId": "mk19_b_gm_s10_5_6"
},
"gm2_146": {
"id": "gm2_146",
"bookId": "gm2",
"question": "Malignant diseases most commonly associated with pruritus",
"answer": "Hodgkin lymphoma, polycythemia vera",
"relatedSectionId": "mk19_b_gm_s10_6"
},
"gm2_147": {
"id": "gm2_147",
"bookId": "gm2",
"question": "Treatment of pruritis from inflammatory skin conditions",
"answer": "Topical glucocorticoids and emollients",
"relatedSectionId": "mk19_b_gm_s10_6"
},
"gm2_148": {
"id": "gm2_148",
"bookId": "gm2",
"question": "Primary treatment of comedonal and inflammatory acne",
"answer": "Topical retinoids",
"relatedSectionId": "mk19_b_gm_s10_7_1"
},
"gm2_149": {
"id": "gm2_149",
"bookId": "gm2",
"question": "Topical acne treatments safe in pregnancy",
"answer": "Clindamycin, azelaic acid, erythromycin",
"relatedSectionId": "mk19_b_gm_s10_7_1"
},
"gm2_150": {
"id": "gm2_150",
"bookId": "gm2",
"question": "Treatment for severe nodulocystic or recalcitrant acne",
"answer": "Oral isotretinoin",
"relatedSectionId": "mk19_b_gm_s10_7_1"
},
"gm2_151": {
"id": "gm2_151",
"bookId": "gm2",
"question": "Pink papules and pustules on central face in middle-aged to older patients",
"answer": "Rosacea",
"relatedSectionId": "mk19_b_gm_s10_7_2"
},
"gm2_152": {
"id": "gm2_152",
"bookId": "gm2",
"question": "Topical treatments for papulopustular rosacea",
"answer": "Metronidazole, azelaic acid, ivermectin",
"relatedSectionId": "mk19_b_gm_s10_7_2"
},
"gm2_153": {
"id": "gm2_153",
"bookId": "gm2",
"question": "Depigmented, symmetric well-demarcated macules without scale",
"answer": "Vitiligo",
"relatedSectionId": "mk19_b_gm_s10_8_1"
},
"gm2_154": {
"id": "gm2_154",
"bookId": "gm2",
"question": "Flaccid oral/mucosal bullae leaving erosions upon rupture",
"answer": "Pemphigus vulgaris",
"relatedSectionId": "mk19_b_gm_s10_9_1"
},
"gm2_155": {
"id": "gm2_155",
"bookId": "gm2",
"question": "Blistering disease associated with urticarial plaques progressing to tense bullae",
"answer": "Bullous pemphigoid",
"relatedSectionId": "mk19_b_gm_s10_9_2"
},
"gm2_156": {
"id": "gm2_156",
"bookId": "gm2",
"question": "Increased skin fragility of hands and hypertrichosis",
"answer": "Porphyria cutanea tarda",
"relatedSectionId": "mk19_b_gm_s10_10_1"
},
"gm2_157": {
"id": "gm2_157",
"bookId": "gm2",
"question": "Diagnostic test for porphyria cutanea tarda",
"answer": "Plasma or urine porphyrin levels",
"relatedSectionId": "mk19_b_gm_s10_10_1"
},
"gm2_158": {
"id": "gm2_158",
"bookId": "gm2",
"question": "Pruritic skin-colored papules appearing within hours of sun exposure",
"answer": "Polymorphous light eruption",
"relatedSectionId": "mk19_b_gm_s10_10_3"
},
"gm2_159": {
"id": "gm2_159",
"bookId": "gm2",
"question": "Most common idiopathic photosensitivity disorder",
"answer": "Polymorphus light eruption",
"relatedSectionId": "mk19_b_gm_s10_10_3"
},
"gm2_160": {
"id": "gm2_160",
"bookId": "gm2",
"question": "Infection-related skin erosions with honey-colored crust",
"answer": "Impetigo",
"relatedSectionId": "mk19_b_gm_s10_11_1_1"
},
"gm2_161": {
"id": "gm2_161",
"bookId": "gm2",
"question": "Topical treatment for impetigo",
"answer": "Mupirocin or retapamulin",
"relatedSectionId": "mk19_b_gm_s10_11_1_1"
},
"gm2_162": {
"id": "gm2_162",
"bookId": "gm2",
"question": "Annular scaly patch with central clearing",
"answer": "Tinea infection",
"relatedSectionId": "mk19_b_gm_s10_11_2"
},
"gm2_163": {
"id": "gm2_163",
"bookId": "gm2",
"question": "Diagnostic procedure for tinea",
"answer": "KOH examination of scale",
"relatedSectionId": "mk19_b_gm_s10_11_2"
},
"gm2_164": {
"id": "gm2_164",
"bookId": "gm2",
"question": "Treatment of dermatophytosis on non–hair-bearing skin",
"answer": "Topical terbinafine or imidazole cream",
"relatedSectionId": "mk19_b_gm_s10_11_2"
},
"gm2_165": {
"id": "gm2_165",
"bookId": "gm2",
"question": "Treatment of dermatophytosis on hair-bearing skin",
"answer": "Oral antifungal agents (terbinafine, itraconazole)",
"relatedSectionId": "mk19_b_gm_s10_11_2"
},
"gm2_166": {
"id": "gm2_166",
"bookId": "gm2",
"question": "Characteristics of candidal intertrigo",
"answer": "Erythematous patches with satellite macerated pustules",
"relatedSectionId": "mk19_b_gm_s10_11_3_1"
},
"gm2_167": {
"id": "gm2_167",
"bookId": "gm2",
"question": "Asymptomatic hyperpigmented oval macules on trunk",
"answer": "Pityriasis versicolor",
"relatedSectionId": "mk19_b_gm_s10_11_3_2"
},
"gm2_168": {
"id": "gm2_168",
"bookId": "gm2",
"question": "Sexually transmitted umbilicated flesh-colored papules",
"answer": "Molluscum contagiosum",
"relatedSectionId": "mk19_b_gm_s10_11_4_1"
},
"gm2_169": {
"id": "gm2_169",
"bookId": "gm2",
"question": "Shingles therapies",
"answer": "Acyclovir, valacyclovir, famciclovir",
"relatedSectionId": "mk19_b_gm_s10_11_4_2"
},
"gm2_170": {
"id": "gm2_170",
"bookId": "gm2",
"question": "Rash associated with single annular plaque with fine scaling",
"answer": "Pityriasis rosea (herald patch)",
"relatedSectionId": "mk19_b_gm_s10_11_4_3"
},
"gm2_171": {
"id": "gm2_171",
"bookId": "gm2",
"question": "Cutaneous finding pathognomonic for scabies",
"answer": "Burrows",
"relatedSectionId": "mk19_b_gm_s10_12_2"
},
"gm2_172": {
"id": "gm2_172",
"bookId": "gm2",
"question": "Pruritic papules and burrows in interdigital spaces",
"answer": "Scabies",
"relatedSectionId": "mk19_b_gm_s10_12_2"
},
"gm2_173": {
"id": "gm2_173",
"bookId": "gm2",
"question": "Postscabetic pruritus",
"answer": "Persistence of scabietic pruritus without reinfection",
"relatedSectionId": "mk19_b_gm_s10_12_2"
},
"gm2_174": {
"id": "gm2_174",
"bookId": "gm2",
"question": "Treatment of scabies",
"answer": "Permethrin or ivermectin",
"relatedSectionId": "mk19_b_gm_s10_12_2"
},
"gm2_175": {
"id": "gm2_175",
"bookId": "gm2",
"question": "Linearly arranged pruritic papules found in the morning",
"answer": "Bed bug bites",
"relatedSectionId": "mk19_b_gm_s10_12_3"
},
"gm2_176": {
"id": "gm2_176",
"bookId": "gm2",
"question": "Well-circumscribed round patches of nonscarring acute hair loss",
"answer": "Alopecia areata",
"relatedSectionId": "mk19_b_gm_s10_14_1"
},
"gm2_177": {
"id": "gm2_177",
"bookId": "gm2",
"question": "Alopecia secondary to hair twisting/pulling",
"answer": "Traumatic alopecia",
"relatedSectionId": "mk19_b_gm_s10_14_1"
},
"gm2_178": {
"id": "gm2_178",
"bookId": "gm2",
"question": "Treatment of acute paronychia",
"answer": "Warm compresses; incision and drainage; oral antibiotics in severe cases",
"relatedSectionId": "mk19_b_gm_s10_15_1_2"
},
"gm2_179": {
"id": "gm2_179",
"bookId": "gm2",
"question": "Nail findings of psoriasis",
"answer": "Pitting, onycholysis, “oil spots,” nail plate thickening",
"relatedSectionId": "mk19_b_gm_s10_15_2"
},
"gm2_180": {
"id": "gm2_180",
"bookId": "gm2",
"question": "Longitudinal brown pigmentation of nail plate",
"answer": "Melanonychia",
"relatedSectionId": "mk19_b_gm_s10_15_4"
},
"gm2_181": {
"id": "gm2_181",
"bookId": "gm2",
"question": "“Stuck on” brown or black papules/plaques",
"answer": "Seborrheic keratosis",
"relatedSectionId": "mk19_b_gm_s10_16_1"
},
"gm2_182": {
"id": "gm2_182",
"bookId": "gm2",
"question": "Tan papule on leg that “dimples” when squeezed",
"answer": "Dermatofibroma",
"relatedSectionId": "mk19_b_gm_s10_16_3"
},
"gm2_183": {
"id": "gm2_183",
"bookId": "gm2",
"question": "Pigmented macule with a surrounding hypopigmentation",
"answer": "Halo nevus",
"relatedSectionId": "mk19_b_gm_s10_16_4"
},
"gm2_184": {
"id": "gm2_184",
"bookId": "gm2",
"question": "Risk associated with multiple dysplastic nevi",
"answer": "Melanoma",
"relatedSectionId": "mk19_b_gm_s10_16_5"
},
"gm2_185": {
"id": "gm2_185",
"bookId": "gm2",
"question": "Cutaneous squamous cell carcinoma precursor",
"answer": "Actinic keratosis",
"relatedSectionId": "mk19_b_gm_s10_17_1"
},
"gm2_186": {
"id": "gm2_186",
"bookId": "gm2",
"question": "Pink, scaly indurated plaque skin cancer",
"answer": "Squamous cell carcinoma",
"relatedSectionId": "mk19_b_gm_s10_17_2"
},
"gm2_187": {
"id": "gm2_187",
"bookId": "gm2",
"question": "Rapidly growing volcaniform skin tumor",
"answer": "Keratoacanthoma",
"relatedSectionId": "mk19_b_gm_s10_17_2"
},
"gm2_188": {
"id": "gm2_188",
"bookId": "gm2",
"question": "Primary prognostic feature for melanoma",
"answer": "Depth of invasion (Breslow depth)",
"relatedSectionId": "mk19_b_gm_s10_17_4"
},
"gm2_189": {
"id": "gm2_189",
"bookId": "gm2",
"question": "ABCDEs of melanoma",
"answer": "Asymmetry, irregular Border, multiple Colors, Diameter &gt;6 mm, Evolution",
"relatedSectionId": "mk19_b_gm_s10_17_4"
},
"gm2_190": {
"id": "gm2_190",
"bookId": "gm2",
"question": "Blue-black nodular skin cancer",
"answer": "Nodular melanoma",
"relatedSectionId": "mk19_b_gm_s10_17_4"
},
"gm2_191": {
"id": "gm2_191",
"bookId": "gm2",
"question": "Primary treatment of localized psoriasis",
"answer": "Topical glucocorticoids",
"relatedSectionId": "mk19_b_gm_s10_18_1"
},
"gm2_192": {
"id": "gm2_192",
"bookId": "gm2",
"question": "Three-color targetoid lesions on face and acral sites",
"answer": "Erythema multiforme",
"relatedSectionId": "mk19_b_gm_s10_18_3"
},
"gm2_193": {
"id": "gm2_193",
"bookId": "gm2",
"question": "Pregnancy-related panniculitis of anterior legs",
"answer": "Erythema nodosum",
"relatedSectionId": "mk19_b_gm_s10_18_4"
},
"gm2_194": {
"id": "gm2_194",
"bookId": "gm2",
"question": "Most common cause of erythrodermic psoriasis flare",
"answer": "Discontinuation of systemic glucocorticoids",
"relatedSectionId": "mk19_b_gm_s10_18_5"
},
"gm2_195": {
"id": "gm2_195",
"bookId": "gm2",
"question": "Adverse reaction to systemic glucocorticoids in psoriasis",
"answer": "Erythroderma",
"relatedSectionId": "mk19_b_gm_s10_18_5"
},
"gm2_196": {
"id": "gm2_196",
"bookId": "gm2",
"question": "Hematologic conditions associated with Sweet syndrome",
"answer": "Myelodysplastic syndrome, AML",
"relatedSectionId": "mk19_b_gm_s10_18_6"
},
"hm1": {
"id": "hm1",
"bookId": "hm",
"question": "Isolated mild asymptomatic neutropenia in a patient of African descent",
"answer": "Benign ethnic neutropenia",
"relatedSectionId": "mk19_b_hm_s1_1"
},
"hm2": {
"id": "hm2",
"bookId": "hm",
"question": "Treatment to shorten recovery time in drug-induced neutropenia with active infection",
"answer": "Granulocyte-colony stimulating factor (G-CSF)",
"relatedSectionId": "mk19_b_hm_s1_1"
},
"hm3": {
"id": "hm3",
"bookId": "hm",
"question": "Duration of smoking-induced neutrophilia following smoking cessation",
"answer": "≥1 year",
"relatedSectionId": "mk19_b_hm_s1_2"
},
"hm4": {
"id": "hm4",
"bookId": "hm",
"question": "Optimal therapy for severe aplastic anemia in younger patients",
"answer": "Allogeneic HSCT",
"relatedSectionId": "mk19_b_hm_s2_2_1"
},
"hm5": {
"id": "hm5",
"bookId": "hm",
"question": "Infectious cause of aplastic anemia",
"answer": "Parvovirus B19",
"relatedSectionId": "mk19_b_hm_s2_2_2"
},
"hm6": {
"id": "hm6",
"bookId": "hm",
"question": "Initial treatment of chronic-phase CML",
"answer": "Tyrosine kinase inhibitor",
"relatedSectionId": "mk19_b_hm_s2_3_1"
},
"hm7": {
"id": "hm7",
"bookId": "hm",
"question": "Hemoglobin &gt;16.5 g/dL, hypercellular bone marrow, positive <i>JAK2</i>",
"answer": "PV",
"relatedSectionId": "mk19_b_hm_s2_3_2"
},
"hm8": {
"id": "hm8",
"bookId": "hm",
"question": "Hematologic complication of testosterone supplementation",
"answer": "Polycythemia",
"relatedSectionId": "mk19_b_hm_s2_3_2"
},
"hm9": {
"id": "hm9",
"bookId": "hm",
"question": "PV therapy for patients intolerant of first-line agents",
"answer": "Ruxolitinib",
"relatedSectionId": "mk19_b_hm_s2_3_2"
},
"hm10": {
"id": "hm10",
"bookId": "hm",
"question": "Treatment of asymptomatic ET in older patients",
"answer": "Hydroxyurea and low-dose aspirin",
"relatedSectionId": "mk19_b_hm_s2_3_3"
},
"hm11": {
"id": "hm11",
"bookId": "hm",
"question": "Common deficiency causing thrombocythemia",
"answer": "Iron",
"relatedSectionId": "mk19_b_hm_s2_3_3"
},
"hm12": {
"id": "hm12",
"bookId": "hm",
"question": "Eosinophilia and end-organ damage",
"answer": "HES",
"relatedSectionId": "mk19_b_hm_s2_3_5"
},
"hm13": {
"id": "hm13",
"bookId": "hm",
"question": "Therapy of primary HES with the <i>PDGFR-α</i> or <i>-β</i> mutation",
"answer": "Imatinib",
"relatedSectionId": "mk19_b_hm_s2_3_5"
},
"hm14": {
"id": "hm14",
"bookId": "hm",
"question": "Ineffective hematopoiesis, hypercellular marrow, peripheral cytopenia",
"answer": "MDS",
"relatedSectionId": "mk19_b_hm_s2_4"
},
"hm15": {
"id": "hm15",
"bookId": "hm",
"question": "MDS gold standard diagnostic test",
"answer": "Bone marrow biopsy",
"relatedSectionId": "mk19_b_hm_s2_4"
},
"hm16": {
"id": "hm16",
"bookId": "hm",
"question": "MDS therapy that decreases transfusion requirements and AML conversion risk",
"answer": "Hypomethylating agent (azacytidine or decitabine)",
"relatedSectionId": "mk19_b_hm_s2_4"
},
"hm17": {
"id": "hm17",
"bookId": "hm",
"question": "−5q MDS treatment",
"answer": "Lenalidomide",
"relatedSectionId": "mk19_b_hm_s2_4"
},
"hm18": {
"id": "hm18",
"bookId": "hm",
"question": "Pancytopenia, promyelocytes, and DIC",
"answer": "Acute promyelocytic leukemia",
"relatedSectionId": "mk19_b_hm_s2_5_1"
},
"hm19": {
"id": "hm19",
"bookId": "hm",
"question": "Acute promyelocytic leukemia treatment",
"answer": "All-<i>trans</i> retinoic acid",
"relatedSectionId": "mk19_b_hm_s2_5_1"
},
"hm20": {
"id": "hm20",
"bookId": "hm",
"question": "ESA-treatment target hemoglobin level in ESKD",
"answer": "10-11 g/dL",
"relatedSectionId": "mk19_b_hm_s2_6"
},
"hm21": {
"id": "hm21",
"bookId": "hm",
"question": "Most common indications for autologous HSCT",
"answer": "Multiple myeloma, relapsed non-Hodgkin lymphoma",
"relatedSectionId": "mk19_b_hm_s2_7"
},
"hm22": {
"id": "hm22",
"bookId": "hm",
"question": "MGUS with unexplained kidney disease",
"answer": "MGRS",
"relatedSectionId": "mk19_b_hm_s3_2"
},
"hm23": {
"id": "hm23",
"bookId": "hm",
"question": "Test for lytic lesions in MM",
"answer": "PET scan or MRI",
"relatedSectionId": "mk19_b_hm_s3_2"
},
"hm24": {
"id": "hm24",
"bookId": "hm",
"question": "Monoclonal protein &lt;3 g/dL, clonal plasma cells &lt;10% of marrow cellularity, no end-organ damage",
"answer": "MGUS",
"relatedSectionId": "mk19_b_hm_s3_3"
},
"hm25": {
"id": "hm25",
"bookId": "hm",
"question": "Hypercalcemia, kidney failure, anemia, bone lesions, rouleaux formation",
"answer": "MM",
"relatedSectionId": "mk19_b_hm_s3_4_1"
},
"hm26": {
"id": "hm26",
"bookId": "hm",
"question": "Two main causes of kidney disease in MM",
"answer": "Hypercalcemia and cast nephropathy",
"relatedSectionId": "mk19_b_hm_s3_4_1"
},
"hm27": {
"id": "hm27",
"bookId": "hm",
"question": "Recommended test for lytic lesions in myeloma when whole-body, low-dose CT scan is negative",
"answer": "Whole-body MRI",
"relatedSectionId": "mk19_b_hm_s3_4_2"
},
"hm28": {
"id": "hm28",
"bookId": "hm",
"question": "MM preferred treatment",
"answer": "Autologous HSCT",
"relatedSectionId": "mk19_b_hm_s3_4_3"
},
"hm29": {
"id": "hm29",
"bookId": "hm",
"question": "Lenalidomide unique toxicity",
"answer": "VTE",
"relatedSectionId": "mk19_b_hm_s3_4_3"
},
"hm30": {
"id": "hm30",
"bookId": "hm",
"question": "Bisphosphonate that improves survival in MM",
"answer": "Zoledronic acid",
"relatedSectionId": "mk19_b_hm_s3_4_3"
},
"hm31": {
"id": "hm31",
"bookId": "hm",
"question": "Treatment of MM-related hypogammaglobulinemia and recurrent infections",
"answer": "IVIG",
"relatedSectionId": "mk19_b_hm_s3_4_3"
},
"hm32": {
"id": "hm32",
"bookId": "hm",
"question": "PCD with monoclonal protein exceeding limit for MGUS, no other symptoms, no end-organ damage",
"answer": "Smoldering myeloma",
"relatedSectionId": "mk19_b_hm_s3_4_3"
},
"hm33": {
"id": "hm33",
"bookId": "hm",
"question": "Nephrotic syndrome, cardiomegaly, macroglossia",
"answer": "Systemic amyloidosis",
"relatedSectionId": "mk19_b_hm_s3_5"
},
"hm34": {
"id": "hm34",
"bookId": "hm",
"question": "Less invasive tissue biopsy for systemic amyloidosis",
"answer": "Abdominal fat pad",
"relatedSectionId": "mk19_b_hm_s3_5"
},
"hm35": {
"id": "hm35",
"bookId": "hm",
"question": "AL amyloidosis preferred treatment",
"answer": "Autologous HSCT",
"relatedSectionId": "mk19_b_hm_s3_5"
},
"hm36": {
"id": "hm36",
"bookId": "hm",
"question": "IgM paraprotein, hyperviscosity",
"answer": "Waldenström macroglobulinemia",
"relatedSectionId": "mk19_b_hm_s3_6"
},
"hm37": {
"id": "hm37",
"bookId": "hm",
"question": "Symptomatic hyperviscosity treatment",
"answer": "Plasmapheresis",
"relatedSectionId": "mk19_b_hm_s3_6"
},
"hm38": {
"id": "hm38",
"bookId": "hm",
"question": "Erythrocyte index correlating with uniformity or variability in erythrocyte size",
"answer": "RDW",
"relatedSectionId": "mk19_b_hm_s4_1"
},
"hm39": {
"id": "hm39",
"bookId": "hm",
"question": "Typical cause of iron deficiency in men and postmenopausal women",
"answer": "GI blood loss",
"relatedSectionId": "mk19_b_hm_s4_2_1"
},
"hm40": {
"id": "hm40",
"bookId": "hm",
"question": "Medication and dosing frequency for iron therapy",
"answer": "Once-daily or alternate-day ferrous sulfate",
"relatedSectionId": "mk19_b_hm_s4_2_1"
},
"hm41": {
"id": "hm41",
"bookId": "hm",
"question": "Malabsorption-related iron deficiency treatment",
"answer": "IV iron",
"relatedSectionId": "mk19_b_hm_s4_2_1"
},
"hm42": {
"id": "hm42",
"bookId": "hm",
"question": "Normochromic, normocytic anemia; elevated ferritin; low iron and TIBC",
"answer": "Anemia of inflammation",
"relatedSectionId": "mk19_b_hm_s4_2_2"
},
"hm43": {
"id": "hm43",
"bookId": "hm",
"question": "Treatment in anemia of inflammation",
"answer": "Treat underlying cause",
"relatedSectionId": "mk19_b_hm_s4_2_2"
},
"hm44": {
"id": "hm44",
"bookId": "hm",
"question": "Thalassemia blood smear",
"answer": "Microcytosis, nucleated erythrocytes, target cells",
"relatedSectionId": "mk19_b_hm_s4_2_3"
},
"hm45": {
"id": "hm45",
"bookId": "hm",
"question": "Microcytic anemia, normal hemoglobin electrophoresis, normal iron",
"answer": "α-thalassemia trait",
"relatedSectionId": "mk19_b_hm_s4_2_3_1"
},
"hm46": {
"id": "hm46",
"bookId": "hm",
"question": "Microcytic anemia, increased hemoglobin A<sub>2</sub> and F",
"answer": "β-thalassemia minor",
"relatedSectionId": "mk19_b_hm_s4_2_3_2"
},
"hm47": {
"id": "hm47",
"bookId": "hm",
"question": "Pathogenesis of CKD-related anemia",
"answer": "Erythropoietin deficiency",
"relatedSectionId": "mk19_b_hm_s4_2_4"
},
"hm48": {
"id": "hm48",
"bookId": "hm",
"question": "Autoimmune gastritis and intrinsic factor deficiency causing vitamin B<sub>12</sub> deficiency",
"answer": "Pernicious anemia",
"relatedSectionId": "mk19_b_hm_s4_2_5"
},
"hm49": {
"id": "hm49",
"bookId": "hm",
"question": "Confirms vitamin B<sub>12</sub> deficiency when cobalamin level is borderline",
"answer": "Elevated serum methylmalonic acid",
"relatedSectionId": "mk19_b_hm_s4_2_5"
},
"hm50": {
"id": "hm50",
"bookId": "hm",
"question": "Macrocytic anemia, malnutrition, alcohol dependence",
"answer": "Folate deficiency",
"relatedSectionId": "mk19_b_hm_s4_2_6"
},
"hm51": {
"id": "hm51",
"bookId": "hm",
"question": "Confirms folate deficiency when serum folate level is normal",
"answer": "Elevated serum homocysteine level",
"relatedSectionId": "mk19_b_hm_s4_2_6"
},
"hm52": {
"id": "hm52",
"bookId": "hm",
"question": "Low hemoglobin level with indirect hyperbilirubinemia, elevated lactate dehydrogenase, low haptoglobin",
"answer": "Hemolytic anemia",
"relatedSectionId": "mk19_b_hm_s4_3"
},
"hm53": {
"id": "hm53",
"bookId": "hm",
"question": "Chronic hemolytic anemia, spherocytes, negative DAT",
"answer": "Hereditary spherocytosis",
"relatedSectionId": "mk19_b_hm_s4_3_1_1"
},
"hm54": {
"id": "hm54",
"bookId": "hm",
"question": "Hemolytic anemia, bite cells, Heinz bodies",
"answer": "G6PD deficiency",
"relatedSectionId": "mk19_b_hm_s4_3_1_2"
},
"hm55": {
"id": "hm55",
"bookId": "hm",
"question": "Treatment of SCD with frequent pain events, severe symptomatic anemia, previous ACS, or stroke",
"answer": "Hydroxyurea",
"relatedSectionId": "mk19_b_hm_s4_3_1_3_1"
},
"hm56": {
"id": "hm56",
"bookId": "hm",
"question": "Fever, tachypnea, hypoxia, cough, dyspnea, pulmonary infiltrates in patients with SCD",
"answer": "ACS",
"relatedSectionId": "mk19_b_hm_s4_3_1_3_1"
},
"hm57": {
"id": "hm57",
"bookId": "hm",
"question": "Preoperative transfusion therapy for SCD",
"answer": "Simple transfusion with target hemoglobin 10 g/dL",
"relatedSectionId": "mk19_b_hm_s4_3_1_3_2"
},
"hm58": {
"id": "hm58",
"bookId": "hm",
"question": "Transfusion therapy for ACS and ARDS in SCD",
"answer": "Exchange transfusion",
"relatedSectionId": "mk19_b_hm_s4_3_1_3_2"
},
"hm59": {
"id": "hm59",
"bookId": "hm",
"question": "Episodic hemolysis, marrow aplasia, unusual site of thrombosis, erythrocytes lacking CD55 and CD59",
"answer": "PNH",
"relatedSectionId": "mk19_b_hm_s4_3_1_5"
},
"hm60": {
"id": "hm60",
"bookId": "hm",
"question": "PNH diagnostic test",
"answer": "Flow cytometry (demonstrates loss of CD55 and CD59)",
"relatedSectionId": "mk19_b_hm_s4_3_1_5"
},
"hm61": {
"id": "hm61",
"bookId": "hm",
"question": "Hemolytic anemia, spherocytes, positive DAT",
"answer": "Warm autoimmune hemolytic anemia",
"relatedSectionId": "mk19_b_hm_s4_3_2_1"
},
"hm62": {
"id": "hm62",
"bookId": "hm",
"question": "Agglutinated erythrocytes, DAT showing C3",
"answer": "Cold agglutinin autoimmune hemolytic anemia",
"relatedSectionId": "mk19_b_hm_s4_3_2_1"
},
"hm63": {
"id": "hm63",
"bookId": "hm",
"question": "Cold agglutinin hemolytic anemia treatment",
"answer": "Rituximab",
"relatedSectionId": "mk19_b_hm_s4_3_2_1_2"
},
"hm64": {
"id": "hm64",
"bookId": "hm",
"question": "Hemochromatosis screening tests",
"answer": "Transferrin saturation, serum ferritin",
"relatedSectionId": "mk19_b_hm_s5_1"
},
"hm65": {
"id": "hm65",
"bookId": "hm",
"question": "Arthralgia, sexual dysfunction, MCP hook-like osteophytes",
"answer": "Hereditary hemochromatosis",
"relatedSectionId": "mk19_b_hm_s5_1"
},
"hm66": {
"id": "hm66",
"bookId": "hm",
"question": "Hereditary hemochromatosis treatment",
"answer": "Phlebotomy",
"relatedSectionId": "mk19_b_hm_s5_1"
},
"hm67": {
"id": "hm67",
"bookId": "hm",
"question": "Secondary iron overload treatment",
"answer": "Iron chelation",
"relatedSectionId": "mk19_b_hm_s5_2"
},
"hm68": {
"id": "hm68",
"bookId": "hm",
"question": "Iron overload associated with cutaneous blisters and hypertrichosis",
"answer": "Porphyria cutanea tarda",
"relatedSectionId": "mk19_b_hm_s5_2"
},
"hm69": {
"id": "hm69",
"bookId": "hm",
"question": "Management of porphyria cutanea tarda",
"answer": "Phlebotomy",
"relatedSectionId": "mk19_b_hm_s5_2"
},
"hm70": {
"id": "hm70",
"bookId": "hm",
"question": "Spurious cause of isolated thrombocytopenia",
"answer": "Platelet clumping",
"relatedSectionId": "mk19_b_hm_s6_2"
},
"hm71": {
"id": "hm71",
"bookId": "hm",
"question": "Common infectious causes of ITP",
"answer": "HIV, hepatitis C, <i>H. pylori</i>",
"relatedSectionId": "mk19_b_hm_s6_3_2_2"
},
"hm72": {
"id": "hm72",
"bookId": "hm",
"question": "ITP treatment",
"answer": "IVIG or glucocorticoids",
"relatedSectionId": "mk19_b_hm_s6_3_2_2"
},
"hm73": {
"id": "hm73",
"bookId": "hm",
"question": "Additional testing in most patients with thrombocytopenia and low 4T score",
"answer": "None",
"relatedSectionId": "mk19_b_hm_s6_3_2_3"
},
"hm74": {
"id": "hm74",
"bookId": "hm",
"question": "Confirmatory test for HIT when EIA is positive",
"answer": "Serotonin release or heparin-induced platelet aggregation assay",
"relatedSectionId": "mk19_b_hm_s6_3_2_3"
},
"hm75": {
"id": "hm75",
"bookId": "hm",
"question": "HIT drug treatment",
"answer": "Argatroban or rivaroxaban",
"relatedSectionId": "mk19_b_hm_s6_3_2_3"
},
"hm76": {
"id": "hm76",
"bookId": "hm",
"question": "Hemolysis, thrombocytopenia, ADAMTS13 deficiency",
"answer": "TTP",
"relatedSectionId": "mk19_b_hm_s6_3_2_4"
},
"hm77": {
"id": "hm77",
"bookId": "hm",
"question": "TTP treatment",
"answer": "Plasma exchange, glucocorticoids, rituximab",
"relatedSectionId": "mk19_b_hm_s6_3_2_4"
},
"hm78": {
"id": "hm78",
"bookId": "hm",
"question": "Most common cause of classic HUS",
"answer": "Shiga toxin–producing <i>Escherichia coli</i>",
"relatedSectionId": "mk19_b_hm_s6_3_2_5"
},
"hm79": {
"id": "hm79",
"bookId": "hm",
"question": "Treatment of atypical HUS",
"answer": "Plasma exchange plus eculizumab",
"relatedSectionId": "mk19_b_hm_s6_3_2_5"
},
"hm80": {
"id": "hm80",
"bookId": "hm",
"question": "Initial evaluation of suspected platelet dysfunction",
"answer": "Platelet function analyzer",
"relatedSectionId": "mk19_b_hm_s6_4_2"
},
"hm81": {
"id": "hm81",
"bookId": "hm",
"question": "Test to evaluate for a factor inhibitor in patients with prolonged aPTT",
"answer": "Mixing study",
"relatedSectionId": "mk19_b_hm_s7_2"
},
"hm82": {
"id": "hm82",
"bookId": "hm",
"question": "Findings diagnostic of hemophilia A or B",
"answer": "Prolonged aPTT (corrects with mixing study), normal PT and CBC",
"relatedSectionId": "mk19_b_hm_s7_3_1"
},
"hm83": {
"id": "hm83",
"bookId": "hm",
"question": "Inherited cause of mucosal bleeding; normal PT, aPTT, and platelets",
"answer": "von Willebrand disease",
"relatedSectionId": "mk19_b_hm_s7_3_2"
},
"hm84": {
"id": "hm84",
"bookId": "hm",
"question": "Type 1 von Willebrand disease treatment",
"answer": "Desmopressin",
"relatedSectionId": "mk19_b_hm_s7_3_2"
},
"hm85": {
"id": "hm85",
"bookId": "hm",
"question": "Thrombocytopenia, prolonged aPTT and PT, elevated INR, hypofibrinogenemia, and elevated D-dimer level",
"answer": "DIC",
"relatedSectionId": "mk19_b_hm_s7_4_2"
},
"hm86": {
"id": "hm86",
"bookId": "hm",
"question": "Common causes of vitamin K deficiency",
"answer": "Poor oral intake, antibiotics, malabsorption",
"relatedSectionId": "mk19_b_hm_s7_4_3"
},
"hm87": {
"id": "hm87",
"bookId": "hm",
"question": "Vitamin K deficiency-related coagulation profile",
"answer": "Normal aPTT, elevated PT",
"relatedSectionId": "mk19_b_hm_s7_4_3"
},
"hm88": {
"id": "hm88",
"bookId": "hm",
"question": "Mechanical causes of acquired von Willebrand disease",
"answer": "Prosthetic heart valves, native valvular disease, left ventricular assist devices",
"relatedSectionId": "mk19_b_hm_s7_4_4"
},
"hm89": {
"id": "hm89",
"bookId": "hm",
"question": "Prolonged aPTT, low factor VIII, no correction with mixing study",
"answer": "Acquired hemophilia",
"relatedSectionId": "mk19_b_hm_s7_4_5"
},
"hm90": {
"id": "hm90",
"bookId": "hm",
"question": "Treatment of factor VIII-inhibitor–related bleeding",
"answer": "Activated factor VII, activated PCC, or recombinant porcine factor VIII",
"relatedSectionId": "mk19_b_hm_s7_4_5"
},
"hm91": {
"id": "hm91",
"bookId": "hm",
"question": "Treatment of DIC-related hypofibrinogenemia",
"answer": "Cryoprecipitate",
"relatedSectionId": "mk19_b_hm_s8_2_1_3"
},
"hm92": {
"id": "hm92",
"bookId": "hm",
"question": "Warfarin-related life-threatening bleeding treatment",
"answer": "PCC",
"relatedSectionId": "mk19_b_hm_s8_2_2"
},
"hm93": {
"id": "hm93",
"bookId": "hm",
"question": "Hemoglobin transfusion threshold for most patients",
"answer": "&lt;7 g/dL",
"relatedSectionId": "mk19_b_hm_s8_3"
},
"hm94": {
"id": "hm94",
"bookId": "hm",
"question": "Indications for a transfusion threshold &gt;7 g/dL",
"answer": "Acute coronary syndrome, acute stroke, hemodynamic instability, active bleeding",
"relatedSectionId": "mk19_b_hm_s8_3"
},
"hm95": {
"id": "hm95",
"bookId": "hm",
"question": "Transfusion, dyspnea, elevated JVD, elevated BNP",
"answer": "TACO",
"relatedSectionId": "mk19_b_hm_s8_4_2_1"
},
"hm96": {
"id": "hm96",
"bookId": "hm",
"question": "Noncardiogenic pulmonary edema 6 hours after transfusion",
"answer": "TRALI",
"relatedSectionId": "mk19_b_hm_s8_4_2_2"
},
"hm97": {
"id": "hm97",
"bookId": "hm",
"question": "Transfusion for warm autoimmune hemolytic anemia without cross-match compatible blood",
"answer": "ABO and Rh-matched transfusion",
"relatedSectionId": "mk19_b_hm_s8_5"
},
"hm98": {
"id": "hm98",
"bookId": "hm",
"question": "Deficiency causing heparin resistance and VTE",
"answer": "Antithrombin deficiency",
"relatedSectionId": "mk19_b_hm_s9_2_2_3"
},
"hm99": {
"id": "hm99",
"bookId": "hm",
"question": "Predisposing condition for warfarin-related skin necrosis",
"answer": "Protein C deficiency",
"relatedSectionId": "mk19_b_hm_s9_2_2_4"
},
"hm100": {
"id": "hm100",
"bookId": "hm",
"question": "Cancer screening with unprovoked VTE",
"answer": "Age- and sex-appropriate screening",
"relatedSectionId": "mk19_b_hm_s9_2_3_2"
},
"hm101": {
"id": "hm101",
"bookId": "hm",
"question": "VTE prevention in high-risk APLAS",
"answer": "Warfarin",
"relatedSectionId": "mk19_b_hm_s9_2_3_4"
},
"hm102": {
"id": "hm102",
"bookId": "hm",
"question": "Genetic testing for abdominal thrombosis, splenomegaly, portal hypertension",
"answer": "\n        <i>JAK2</i>\n      ",
"relatedSectionId": "mk19_b_hm_s9_2_3_5"
},
"hm103": {
"id": "hm103",
"bookId": "hm",
"question": "Patients requiring extended VTE prophylaxis after discharge",
"answer": "Cancer undergoing surgery, knee arthroplasty, hip fracture repair or replacement",
"relatedSectionId": "mk19_b_hm_s9_3_1"
},
"hm104": {
"id": "hm104",
"bookId": "hm",
"question": "Initial step in evaluating low-risk PE",
"answer": "PERC",
"relatedSectionId": "mk19_b_hm_s9_3_2"
},
"hm105": {
"id": "hm105",
"bookId": "hm",
"question": "Testing indicated for moderate to high probability Wells score for DVT and PE",
"answer": "Duplex imaging for DVT, CT angiography for PE",
"relatedSectionId": "mk19_b_hm_s9_3_2"
},
"hm106": {
"id": "hm106",
"bookId": "hm",
"question": "Outpatient drug treatment of low-risk PE",
"answer": "Apixaban, rivaroxaban",
"relatedSectionId": "mk19_b_hm_s9_3_3"
},
"hm107": {
"id": "hm107",
"bookId": "hm",
"question": "Treatment of massive PE with shock",
"answer": "Thrombolytic therapy",
"relatedSectionId": "mk19_b_hm_s9_3_3"
},
"hm109": {
"id": "hm109",
"bookId": "hm",
"question": "Unprovoked VTE treatment duration",
"answer": "Extended",
"relatedSectionId": "mk19_b_hm_s9_3_3"
},
"hm111": {
"id": "hm111",
"bookId": "hm",
"question": "Treatment of acute proximal DVT or PE when anticoagulation is contraindicated",
"answer": "IVC filter",
"relatedSectionId": "mk19_b_hm_s9_3_3"
},
"hm112": {
"id": "hm112",
"bookId": "hm",
"question": "Anticoagulation for distal DVT without symptoms or risk factors for extension",
"answer": "None",
"relatedSectionId": "mk19_b_hm_s9_3_3"
},
"hm113": {
"id": "hm113",
"bookId": "hm",
"question": "Post-DVT pain, edema, stasis dermatitis",
"answer": "Postthrombotic syndrome",
"relatedSectionId": "mk19_b_hm_s9_3_4"
},
"hm114": {
"id": "hm114",
"bookId": "hm",
"question": "Treatment of superficial vein thrombosis with other thrombophilic risks",
"answer": "Fondaparinux",
"relatedSectionId": "mk19_b_hm_s9_4_1"
},
"hm115": {
"id": "hm115",
"bookId": "hm",
"question": "Risk factors for upper extremity DVT",
"answer": "Central venous catheter, malignancy",
"relatedSectionId": "mk19_b_hm_s9_4_3"
},
"hm116": {
"id": "hm116",
"bookId": "hm",
"question": "Emergent reversal of unfractionated heparin",
"answer": "Protamine sulfate",
"relatedSectionId": "mk19_b_hm_s9_5_1_1"
},
"hm117": {
"id": "hm117",
"bookId": "hm",
"question": "Management of warfarin over-anticoagulation, INR &gt;10, no bleeding",
"answer": "Stop warfarin, give oral vitamin K",
"relatedSectionId": "mk19_b_hm_s9_5_2_1"
},
"hm118": {
"id": "hm118",
"bookId": "hm",
"question": "Management of life-threatening bleeding in patients taking oral Xa inhibitors",
"answer": "4-factor PCC or andexanet alfa",
"relatedSectionId": "mk19_b_hm_s9_5_2_2"
},
"hm119": {
"id": "hm119",
"bookId": "hm",
"question": "Dabigatran reversal agent",
"answer": "Idarucizumab",
"relatedSectionId": "mk19_b_hm_s9_5_2_2"
},
"hm120": {
"id": "hm120",
"bookId": "hm",
"question": "SCD-related pulmonary vascular complication of pregnancy",
"answer": "Pulmonary hypertension",
"relatedSectionId": "mk19_b_hm_s10_2"
},
"hm121": {
"id": "hm121",
"bookId": "hm",
"question": "Mild asymptomatic thrombocytopenia late in pregnancy",
"answer": "Gestational thrombocytopenia",
"relatedSectionId": "mk19_b_hm_s10_3_1"
},
"hm122": {
"id": "hm122",
"bookId": "hm",
"question": "Safe ITP platelet threshold during pregnancy",
"answer": "&gt;30,000/µL",
"relatedSectionId": "mk19_b_hm_s10_3_2"
},
"hm123": {
"id": "hm123",
"bookId": "hm",
"question": "Treatment of pre-eclampsia–related thrombocytopenia",
"answer": "Delivery",
"relatedSectionId": "mk19_b_hm_s10_3_3"
},
"id1": {
"id": "id1",
"bookId": "id",
"question": "Most common cause of recurrent viral meningitis",
"answer": "HSV-2",
"relatedSectionId": "mk19_a_id_s1_1_1"
},
"id2": {
"id": "id2",
"bookId": "id",
"question": "<i>Neisseria</i> not covered by quadrivalent meningococcal vaccine",
"answer": "Serogroup B",
"relatedSectionId": "mk19_a_id_s1_1_2"
},
"id3": {
"id": "id3",
"bookId": "id",
"question": "Meningitis, uveitis, rash, red conjunctivae, lymphadenopathy, hepatosplenomegaly after freshwater exposure",
"answer": "Leptospirosis",
"relatedSectionId": "mk19_a_id_s1_1_2"
},
"id4": {
"id": "id4",
"bookId": "id",
"question": "CSF WBC &gt;1000/µL, neutrophil predominance, glucose &lt;40 mg/dL",
"answer": "Bacterial meningitis",
"relatedSectionId": "mk19_a_id_s1_1_2_1"
},
"id5": {
"id": "id5",
"bookId": "id",
"question": "Antibiotics for bacterial meningitis, age &gt;50 years",
"answer": "Ampicillin plus ceftriaxone plus vancomycin",
"relatedSectionId": "mk19_a_id_s1_1_2_2"
},
"id6": {
"id": "id6",
"bookId": "id",
"question": "Adjuvant bacterial meningitis treatment",
"answer": "Dexamethasone",
"relatedSectionId": "mk19_a_id_s1_1_2_2"
},
"id7": {
"id": "id7",
"bookId": "id",
"question": "Most common causes of chronic meningitis",
"answer": "TB and fungi",
"relatedSectionId": "mk19_a_id_s1_1_3"
},
"id8": {
"id": "id8",
"bookId": "id",
"question": "Meningitis, cranial neuropathies, mental status changes, SIADH",
"answer": "TB meningitis",
"relatedSectionId": "mk19_a_id_s1_1_3_1"
},
"id9": {
"id": "id9",
"bookId": "id",
"question": "Empiric treatment for TB meningitis",
"answer": "4-drug anti-TB therapy plus dexamethasone",
"relatedSectionId": "mk19_a_id_s1_1_3_1"
},
"id10": {
"id": "id10",
"bookId": "id",
"question": "Empiric antibiotic therapy for health care–associated meningitis",
"answer": "Vancomycin plus cefepime, ceftazidime, or meropenem",
"relatedSectionId": "mk19_a_id_s1_1_4"
},
"id11": {
"id": "id11",
"bookId": "id",
"question": "Back pain, lower extremity weakness, bladder dysfunction",
"answer": "Spinal epidural abscess",
"relatedSectionId": "mk19_a_id_s1_2_3"
},
"id12": {
"id": "id12",
"bookId": "id",
"question": "Treatment for spinal epidural abscess with neurologic symptoms",
"answer": "Drainage and antibiotics",
"relatedSectionId": "mk19_a_id_s1_2_3"
},
"id13": {
"id": "id13",
"bookId": "id",
"question": "Diagnostic test for VZV encephalitis",
"answer": "CSF PCR",
"relatedSectionId": "mk19_a_id_s1_3_1_2"
},
"id14": {
"id": "id14",
"bookId": "id",
"question": "Noninfectious encephalitis associated with behavior changes",
"answer": "Anti-NMDAR encephalitis",
"relatedSectionId": "mk19_a_id_s1_3_2"
},
"id15": {
"id": "id15",
"bookId": "id",
"question": "Salt water exposure, cellulitis with hemorrhage bullae",
"answer": "<i>Vibrio vulnificus</i>, <i>Vibrio parahaemolyticus</i> infection",
"relatedSectionId": "mk19_a_id_s2_1"
},
"id16": {
"id": "id16",
"bookId": "id",
"question": "Chronic skin infection after contact with fish tanks, fish, shellfish",
"answer": "\n        <i>Mycobacterium marinum</i>\n      ",
"relatedSectionId": "mk19_a_id_s2_1"
},
"id17": {
"id": "id17",
"bookId": "id",
"question": "Treatment for mild nonpurulent cellulitis",
"answer": "Clindamycin, penicillin, cephalosporin, dicloxacillin",
"relatedSectionId": "mk19_a_id_s2_2"
},
"id18": {
"id": "id18",
"bookId": "id",
"question": "Treatment for group A <i>Streptococcus</i> necrotizing fasciitis",
"answer": "Surgical debridement, penicillin and clindamycin",
"relatedSectionId": "mk19_a_id_s2_3"
},
"id19": {
"id": "id19",
"bookId": "id",
"question": "Treatment for purulent skin infection with systemic signs of infection",
"answer": "Incision and drainage, then trimethoprim-sulfamethoxazole or doxycycline",
"relatedSectionId": "mk19_a_id_s2_4"
},
"id20": {
"id": "id20",
"bookId": "id",
"question": "Antibiotic treatment for severe cat bite",
"answer": "Piperacillin-tazobactam, ampicillin-sulbactam, imipenem, or meropenem",
"relatedSectionId": "mk19_a_id_s2_5"
},
"id21": {
"id": "id21",
"bookId": "id",
"question": "Prophylactic antibiotic treatment for a complicated dog bite",
"answer": "Amoxicillin-clavulanate",
"relatedSectionId": "mk19_a_id_s2_5"
},
"id22": {
"id": "id22",
"bookId": "id",
"question": "Vaccination assessment following animal bite",
"answer": "Rabies and tetanus",
"relatedSectionId": "mk19_a_id_s2_5"
},
"id23": {
"id": "id23",
"bookId": "id",
"question": "Vaccination assessment following human bite",
"answer": "Tetanus, hepatitis B",
"relatedSectionId": "mk19_a_id_s2_6"
},
"id24": {
"id": "id24",
"bookId": "id",
"question": "Imaging for all new diabetic foot infections",
"answer": "Plain radiography",
"relatedSectionId": "mk19_a_id_s2_7"
},
"id25": {
"id": "id25",
"bookId": "id",
"question": "Treatment for streptococcal toxic shock syndrome",
"answer": "Penicillin and clindamycin",
"relatedSectionId": "mk19_a_id_s2_8"
},
"id26": {
"id": "id26",
"bookId": "id",
"question": "Treatment for MSSA toxic shock syndrome",
"answer": "Nafcillin and clindamycin",
"relatedSectionId": "mk19_a_id_s2_8"
},
"id27": {
"id": "id27",
"bookId": "id",
"question": "Treatment for MRSA toxic shock syndrome",
"answer": "Linezolid or vancomycin plus clindamycin",
"relatedSectionId": "mk19_a_id_s2_8"
},
"id28": {
"id": "id28",
"bookId": "id",
"question": "Cause of CAP with livestock exposure",
"answer": "<i>Coxiella burnetii</i> infection (Q fever), <i>Francisella tularensis</i> (pneumonic tularemia)",
"relatedSectionId": "mk19_a_id_s3_2"
},
"id29": {
"id": "id29",
"bookId": "id",
"question": "Diagnostic studies for causative organism in outpatients with CAP",
"answer": "None",
"relatedSectionId": "mk19_a_id_s3_3"
},
"id30": {
"id": "id30",
"bookId": "id",
"question": "CAP antibiotics to avoid in pregnant patients",
"answer": "Quinolones and tetracyclines",
"relatedSectionId": "mk19_a_id_s3_4"
},
"id31": {
"id": "id31",
"bookId": "id",
"question": "Treatment for outpatient CAP in otherwise healthy patients",
"answer": "Amoxicillin, doxycycline, or a macrolide (if pneumococcal resistance &lt;25%)",
"relatedSectionId": "mk19_a_id_s3_4_2"
},
"id32": {
"id": "id32",
"bookId": "id",
"question": "ICU CAP treatment",
"answer": "3rd-generation cephalosporin or ampicillin-sulbactam plus a macrolide or quinolone",
"relatedSectionId": "mk19_a_id_s3_4_2"
},
"id33": {
"id": "id33",
"bookId": "id",
"question": "Treatment duration for uncomplicated CAP with rapid clinical improvement",
"answer": "5 days",
"relatedSectionId": "mk19_a_id_s3_4_2"
},
"id34": {
"id": "id34",
"bookId": "id",
"question": "Timeframe to begin prophylactic antibiotics for Lyme disease",
"answer": "Within 72 hours if tick attached ≥36 hours",
"relatedSectionId": "mk19_a_id_s4_1"
},
"id35": {
"id": "id35",
"bookId": "id",
"question": "Testing for patient with erythema migrans and tick exposure",
"answer": "None",
"relatedSectionId": "mk19_a_id_s4_1_1"
},
"id36": {
"id": "id36",
"bookId": "id",
"question": "Manifestations of Lyme carditis",
"answer": "AV nodal block",
"relatedSectionId": "mk19_a_id_s4_1_2"
},
"id37": {
"id": "id37",
"bookId": "id",
"question": "Manifestations of neuroborreliosis",
"answer": "Meningitis, facial palsy, radiculopathy",
"relatedSectionId": "mk19_a_id_s4_1_2"
},
"id39": {
"id": "id39",
"bookId": "id",
"question": "Persistent debilitating symptoms after Lyme disease treatment",
"answer": "Post–Lyme disease syndrome",
"relatedSectionId": "mk19_a_id_s4_1_4"
},
"id40": {
"id": "id40",
"bookId": "id",
"question": "Intra-erythrocyte ring or tetrad inclusions",
"answer": "<i>Babesia</i> infection",
"relatedSectionId": "mk19_a_id_s4_2"
},
"id41": {
"id": "id41",
"bookId": "id",
"question": "Treatment for mild babesiosis",
"answer": "Atovaquone plus azithromycin",
"relatedSectionId": "mk19_a_id_s4_2"
},
"id42": {
"id": "id42",
"bookId": "id",
"question": "Self-limited rash illness associated with Lone Star tick (<i>Amblyomma americanum</i>)",
"answer": "STARI",
"relatedSectionId": "mk19_a_id_s4_3"
},
"id43": {
"id": "id43",
"bookId": "id",
"question": "HME peripheral blood smear finding",
"answer": "Morulae",
"relatedSectionId": "mk19_a_id_s4_4"
},
"id44": {
"id": "id44",
"bookId": "id",
"question": "Hallmark finding in Rocky Mountain spotted fever",
"answer": "Delayed macular rash around ankles and wrists followed by central spread, progressing to petechiae or purpura",
"relatedSectionId": "mk19_a_id_s4_5"
},
"id45": {
"id": "id45",
"bookId": "id",
"question": "Testing beyond urinalysis for women with uncomplicated UTI",
"answer": "None",
"relatedSectionId": "mk19_a_id_s5_2"
},
"id46": {
"id": "id46",
"bookId": "id",
"question": "Indications for asymptomatic bacteruria screening",
"answer": "Pregnancy or planned invasive urologic procedure",
"relatedSectionId": "mk19_a_id_s5_3_1"
},
"id47": {
"id": "id47",
"bookId": "id",
"question": "Treatment for uncomplicated pyelonephritis",
"answer": "7 days ciprofloxacin or 5 days levofloxacin",
"relatedSectionId": "mk19_a_id_s5_3_3"
},
"id48": {
"id": "id48",
"bookId": "id",
"question": "Pyelonephritis indications for imaging",
"answer": "Fever lasting &gt;72 hours, persistent bacteremia",
"relatedSectionId": "mk19_a_id_s5_3_3"
},
"id49": {
"id": "id49",
"bookId": "id",
"question": "Prophylactic antibiotic indications in women with recurrent UTI",
"answer": "≥3 UTIs in 12 months or ≥2 in 6 months",
"relatedSectionId": "mk19_a_id_s5_3_4"
},
"id50": {
"id": "id50",
"bookId": "id",
"question": "Outpatient treatment for prostatitis",
"answer": "Fluoroquinolone antibiotic or trimethoprim-sulfamethoxazole",
"relatedSectionId": "mk19_a_id_s5_3_5"
},
"id51": {
"id": "id51",
"bookId": "id",
"question": "Medication risk factor for active TB",
"answer": "TNF-α inhibitors",
"relatedSectionId": "mk19_a_id_s6_2"
},
"id52": {
"id": "id52",
"bookId": "id",
"question": "Preferred TB test in patient with BCG vaccination",
"answer": "Interferon-γ release assay",
"relatedSectionId": "mk19_a_id_s6_4_1"
},
"id53": {
"id": "id53",
"bookId": "id",
"question": "Positive tuberculin skin test in patient with no TB risk factors",
"answer": "≥15 mm",
"relatedSectionId": "mk19_a_id_s6_4_1"
},
"id54": {
"id": "id54",
"bookId": "id",
"question": "Positive tuberculin skin test in HIV-positive patient",
"answer": "≥5 mm",
"relatedSectionId": "mk19_a_id_s6_4_1"
},
"id55": {
"id": "id55",
"bookId": "id",
"question": "Test following positive TB sputum smear",
"answer": "NAAT",
"relatedSectionId": "mk19_a_id_s6_4_2"
},
"id56": {
"id": "id56",
"bookId": "id",
"question": "Initial treatment of <i>M. tuberculosis</i> infection",
"answer": "INH, rifampin, pyrazinamide, and ethambutol",
"relatedSectionId": "mk19_a_id_s6_5_2"
},
"id57": {
"id": "id57",
"bookId": "id",
"question": "Infection control for hospitalized TB patients",
"answer": "Airborne isolation",
"relatedSectionId": "mk19_a_id_s6_6"
},
"id58": {
"id": "id58",
"bookId": "id",
"question": "CDC criteria for pulmonary TB that is no longer contagious",
"answer": "Treated for 2 weeks, clinical improvement, 3 negative sputum smears collected 8 hours apart",
"relatedSectionId": "mk19_a_id_s6_6"
},
"id59": {
"id": "id59",
"bookId": "id",
"question": "Most common cause of pulmonary NTM in U.S.",
"answer": "<i>Mycobacterium avium</i> complex",
"relatedSectionId": "mk19_a_id_s7_1"
},
"id60": {
"id": "id60",
"bookId": "id",
"question": "Therapeutic drug class for invasive candidiasis without CNS or eye involvement",
"answer": "Echinocandin",
"relatedSectionId": "mk19_a_id_s8_1"
},
"id61": {
"id": "id61",
"bookId": "id",
"question": "Risk factors for invasive aspergillosis",
"answer": "Neutropenia, HSCT, solid organ transplant, hematologic malignancy",
"relatedSectionId": "mk19_a_id_s8_2"
},
"id62": {
"id": "id62",
"bookId": "id",
"question": "Ground-glass attenuation surrounding nodule on lung CT",
"answer": "“Halo sign” associated with invasive aspergillosis",
"relatedSectionId": "mk19_a_id_s8_2"
},
"id63": {
"id": "id63",
"bookId": "id",
"question": "First-line treatment for invasive aspergillosis",
"answer": "Voriconazole",
"relatedSectionId": "mk19_a_id_s8_2"
},
"id64": {
"id": "id64",
"bookId": "id",
"question": "CSF test highly sensitive for cryptococcal meningitis",
"answer": "Cryptococcal antigen",
"relatedSectionId": "mk19_a_id_s8_3"
},
"id65": {
"id": "id65",
"bookId": "id",
"question": "Induction therapy for cryptococcal meningitis",
"answer": "Amphotericin B and flucytosine",
"relatedSectionId": "mk19_a_id_s8_3"
},
"id66": {
"id": "id66",
"bookId": "id",
"question": "Sensitive assay for acute and disseminated histoplasmosis",
"answer": "<i>Histoplasma</i> urinary antigen",
"relatedSectionId": "mk19_a_id_s8_4"
},
"id67": {
"id": "id67",
"bookId": "id",
"question": "Initial treatment for disseminated histoplasmosis",
"answer": "Liposomal amphotericin B",
"relatedSectionId": "mk19_a_id_s8_4"
},
"id68": {
"id": "id68",
"bookId": "id",
"question": "Clinical syndromes of coccidioidomycosis",
"answer": "Acute or chronic pulmonary infection, cutaneous infection, meningitis",
"relatedSectionId": "mk19_a_id_s8_5"
},
"id69": {
"id": "id69",
"bookId": "id",
"question": "Treatment for symptomatic coccidioidomycosis",
"answer": "Fluconazole",
"relatedSectionId": "mk19_a_id_s8_5"
},
"id70": {
"id": "id70",
"bookId": "id",
"question": "Fungal infection of cutaneous and lymphocutaneous tissue",
"answer": "Sporotrichosis",
"relatedSectionId": "mk19_a_id_s8_7"
},
"id71": {
"id": "id71",
"bookId": "id",
"question": "Pathognomonic finding for rhinocerebral mucormycosis",
"answer": "Black eschar of the nose/palate",
"relatedSectionId": "mk19_a_id_s8_8"
},
"id72": {
"id": "id72",
"bookId": "id",
"question": "Five major clinical forms of mucormycosis",
"answer": "Rhinocerebral, pulmonary, abdominal/pelvic/GI, primary cutaneous, disseminated",
"relatedSectionId": "mk19_a_id_s8_8"
},
"id73": {
"id": "id73",
"bookId": "id",
"question": "<i>Chlamydia</i> screening and diagnostic test",
"answer": "Urine or genital swab NAAT",
"relatedSectionId": "mk19_a_id_s9_2"
},
"id74": {
"id": "id74",
"bookId": "id",
"question": "Gonorrhea screening and diagnostic test",
"answer": "Urine or genital swab NAAT",
"relatedSectionId": "mk19_a_id_s9_3"
},
"id75": {
"id": "id75",
"bookId": "id",
"question": "Recommended treatment for uncomplicated urogenital gonococcal infection if chlamydia infection ruled out",
"answer": "Ceftriaxone 500 mg IM once",
"relatedSectionId": "mk19_a_id_s9_3"
},
"id77": {
"id": "id77",
"bookId": "id",
"question": "Causes of epididymitis in younger sexually active men",
"answer": "Gonorrhea and chlamydia",
"relatedSectionId": "mk19_a_id_s9_5_4"
},
"id78": {
"id": "id78",
"bookId": "id",
"question": "Diagnostic test for suspected genital herpes simplex infection",
"answer": "NAAT",
"relatedSectionId": "mk19_a_id_s9_6_1"
},
"id79": {
"id": "id79",
"bookId": "id",
"question": "Initial treatment of primary genital herpes simplex infection",
"answer": "Acyclovir, valacyclovir, or famciclovir",
"relatedSectionId": "mk19_a_id_s9_6_1"
},
"id80": {
"id": "id80",
"bookId": "id",
"question": "Painless, indurated genital ulcer",
"answer": "Chancre of primary syphilis",
"relatedSectionId": "mk19_a_id_s9_6_2"
},
"id81": {
"id": "id81",
"bookId": "id",
"question": "Most common manifestation of secondary syphilis",
"answer": "Rash with involvement of palms and soles",
"relatedSectionId": "mk19_a_id_s9_6_2"
},
"id82": {
"id": "id82",
"bookId": "id",
"question": "Lab testing for genital warts",
"answer": "None",
"relatedSectionId": "mk19_a_id_s9_7"
},
"id83": {
"id": "id83",
"bookId": "id",
"question": "Most cost-effective, specific imaging test for osteomyelitis",
"answer": "Plain radiography",
"relatedSectionId": "mk19_a_id_s10_2_1"
},
"id84": {
"id": "id84",
"bookId": "id",
"question": "Osteomyelitis imaging after negative radiography",
"answer": "MRI with and without contrast",
"relatedSectionId": "mk19_a_id_s10_2_1"
},
"id85": {
"id": "id85",
"bookId": "id",
"question": "Antibiotics for osteomyelitis and retained orthopedic hardware",
"answer": "Rifampin plus a second antistaphylococcal agent",
"relatedSectionId": "mk19_a_id_s10_3"
},
"id86": {
"id": "id86",
"bookId": "id",
"question": "Risk factors for diabetic foot ulcer–related osteomyelitis",
"answer": "Exposed bone, diameter &gt;2 cm, nonhealing",
"relatedSectionId": "mk19_a_id_s10_4"
},
"id87": {
"id": "id87",
"bookId": "id",
"question": "Diagnostic test for diabetic foot infection",
"answer": "Bone biopsy",
"relatedSectionId": "mk19_a_id_s10_4"
},
"id88": {
"id": "id88",
"bookId": "id",
"question": "Risk factors for vertebral osteomyelitis",
"answer": "Older age, immunocompromise, indwelling catheters, hemodialysis, injection drug use",
"relatedSectionId": "mk19_a_id_s10_5"
},
"id89": {
"id": "id89",
"bookId": "id",
"question": "Nonimaging test for all patients with vertebral osteomyelitis",
"answer": "Blood culture",
"relatedSectionId": "mk19_a_id_s10_5"
},
"id90": {
"id": "id90",
"bookId": "id",
"question": "Most common organism causing vertebral osteomyelitis",
"answer": "\n        <i>S. aureus</i>\n      ",
"relatedSectionId": "mk19_a_id_s10_5"
},
"id91": {
"id": "id91",
"bookId": "id",
"question": "Conditions warranting empiric antibiotics in vertebral osteomyelitis",
"answer": "Severe sepsis, progressive neurologic deficit, spinal instability, epidural abscess",
"relatedSectionId": "mk19_a_id_s10_5"
},
"id92": {
"id": "id92",
"bookId": "id",
"question": "Fever of unknown origin definition",
"answer": "Fever ≥38.3 °C for ≥3 weeks undiagnosed after 2 office visits",
"relatedSectionId": "mk19_a_id_s11_1"
},
"id93": {
"id": "id93",
"bookId": "id",
"question": "Antibodies associated with potential anaphylaxis to blood products",
"answer": "Anti-IgA IgE antibodies",
"relatedSectionId": "mk19_a_id_s12_2_1"
},
"id94": {
"id": "id94",
"bookId": "id",
"question": "Conditions for which patients with CVID are at increased risk",
"answer": "Autoimmune disease, inflammatory bowel disease, noncaseating granulomas, bronchiectasis, malignancy",
"relatedSectionId": "mk19_a_id_s12_2_2"
},
"id95": {
"id": "id95",
"bookId": "id",
"question": "Contraindicated vaccines in CVID",
"answer": "Any live vaccine",
"relatedSectionId": "mk19_a_id_s12_2_2"
},
"id96": {
"id": "id96",
"bookId": "id",
"question": "Early complement deficiency infection risk",
"answer": "Encapsulated organisms",
"relatedSectionId": "mk19_a_id_s12_2_3"
},
"id97": {
"id": "id97",
"bookId": "id",
"question": "Noninfectious disease risk in early complement deficiency",
"answer": "SLE",
"relatedSectionId": "mk19_a_id_s12_2_3"
},
"id98": {
"id": "id98",
"bookId": "id",
"question": "Inhalational anthrax characteristic chest radiograph finding",
"answer": "Widened mediastinum",
"relatedSectionId": "mk19_a_id_s13_2"
},
"id99": {
"id": "id99",
"bookId": "id",
"question": "Postexposure treatment for bioterrorism-related anthrax",
"answer": "Ciprofloxacin, levofloxacin, or doxycycline",
"relatedSectionId": "mk19_a_id_s13_2"
},
"id100": {
"id": "id100",
"bookId": "id",
"question": "Prophylactic treatment for smallpox exposure",
"answer": "Vaccinia immunization",
"relatedSectionId": "mk19_a_id_s13_3"
},
"id101": {
"id": "id101",
"bookId": "id",
"question": "Gram-negative coccobacilli with “safety pin” shape",
"answer": "\n        <i>Yersinia pestis</i>\n      ",
"relatedSectionId": "mk19_a_id_s13_4"
},
"id103": {
"id": "id103",
"bookId": "id",
"question": "The “4 Ds” of botulism",
"answer": "Diplopia, dysarthria, dysphonia, dysphagia",
"relatedSectionId": "mk19_a_id_s13_5"
},
"id104": {
"id": "id104",
"bookId": "id",
"question": "Malaria infections associated with potentially high levels of parasitemia",
"answer": "<i>P. falciparum</i> and <i>P. knowlesi</i>",
"relatedSectionId": "mk19_a_id_s14_2"
},
"id105": {
"id": "id105",
"bookId": "id",
"question": "Most common cause of febrile illness in returning travelers",
"answer": "Malaria",
"relatedSectionId": "mk19_a_id_s14_2"
},
"id106": {
"id": "id106",
"bookId": "id",
"question": "Fever, relative bradycardia, abdominal pain, “rose spot” rash",
"answer": "Typhoid fever",
"relatedSectionId": "mk19_a_id_s14_3"
},
"id107": {
"id": "id107",
"bookId": "id",
"question": "Indications for travelers' diarrhea prophylaxis",
"answer": "IBD or immunocompromise",
"relatedSectionId": "mk19_a_id_s14_4"
},
"id108": {
"id": "id108",
"bookId": "id",
"question": "Treatment of severe travelers' diarrhea in SE Asia",
"answer": "Azithromycin",
"relatedSectionId": "mk19_a_id_s14_4"
},
"id109": {
"id": "id109",
"bookId": "id",
"question": "Treatment of severe travelers' diarrhea in places other than S/SE Asia",
"answer": "A fluoroquinolone, rifaximin, or rifamycin",
"relatedSectionId": "mk19_a_id_s14_4"
},
"id110": {
"id": "id110",
"bookId": "id",
"question": "Mosquito-borne febrile disease with severe lumbosacral pain",
"answer": "Dengue fever",
"relatedSectionId": "mk19_a_id_s14_5"
},
"id111": {
"id": "id111",
"bookId": "id",
"question": "Major complication of Zika virus infection in women",
"answer": "Fetal malformation",
"relatedSectionId": "mk19_a_id_s14_5"
},
"id112": {
"id": "id112",
"bookId": "id",
"question": "Diagnostic test for early Zika virus infection",
"answer": "Reverse transcriptase PCR on serum and urine",
"relatedSectionId": "mk19_a_id_s14_5"
},
"id113": {
"id": "id113",
"bookId": "id",
"question": "Hepatitis A prophylaxis given within 1-2 weeks of travel",
"answer": "Single-dose hepatitis A vaccine",
"relatedSectionId": "mk19_a_id_s14_6"
},
"id114": {
"id": "id114",
"bookId": "id",
"question": "Treatment of uncomplicated brucellosis",
"answer": "Extended doxycycline plus rifampin or gentamicin",
"relatedSectionId": "mk19_a_id_s14_8"
},
"id115": {
"id": "id115",
"bookId": "id",
"question": "Evaluation of watery diarrhea of &lt;3 days' duration in healthy patients",
"answer": "None",
"relatedSectionId": "mk19_a_id_s15_1"
},
"id116": {
"id": "id116",
"bookId": "id",
"question": "Common source of <i>Campylobacter</i> infection",
"answer": "Undercooked poultry",
"relatedSectionId": "mk19_a_id_s15_2"
},
"id117": {
"id": "id117",
"bookId": "id",
"question": "GI illness from reptiles and amphibians",
"answer": "Nontyphoidal salmonella",
"relatedSectionId": "mk19_a_id_s15_4"
},
"id118": {
"id": "id118",
"bookId": "id",
"question": "Treatment of uncomplicated <i>Salmonella</i> infection in patients aged &lt;50 years",
"answer": "Supportive care",
"relatedSectionId": "mk19_a_id_s15_4"
},
"id119": {
"id": "id119",
"bookId": "id",
"question": "High-risk features for invasive <i>Salmonella</i> infection",
"answer": "Age &gt;50, prosthetic implants, ASCVD, immunocompromise",
"relatedSectionId": "mk19_a_id_s15_4"
},
"id120": {
"id": "id120",
"bookId": "id",
"question": "Cause of hemorrhagic colitis after consuming contaminated beef",
"answer": "Enterohemorrhagic <i>E. coli</i>",
"relatedSectionId": "mk19_a_id_s15_5"
},
"id121": {
"id": "id121",
"bookId": "id",
"question": "Treatment for enterohemorrhagic <i>E. coli</i>",
"answer": "Supportive care",
"relatedSectionId": "mk19_a_id_s15_5"
},
"id122": {
"id": "id122",
"bookId": "id",
"question": "GI infection that can mimic appendicitis",
"answer": "\n        <i>Yersinia enterocolitica</i>\n      ",
"relatedSectionId": "mk19_a_id_s15_6"
},
"id123": {
"id": "id123",
"bookId": "id",
"question": "Rapid sensitive and specific test for <i>C. difficile</i> colitis",
"answer": "NAAT for <i>C. difficile</i> toxin genes",
"relatedSectionId": "mk19_a_id_s15_8"
},
"id124": {
"id": "id124",
"bookId": "id",
"question": "Treatment for severe <i>C. difficile</i> colitis",
"answer": "Oral fidaxomicin (preferred) or oral vancomycin",
"relatedSectionId": "mk19_a_id_s15_8"
},
"id125": {
"id": "id125",
"bookId": "id",
"question": "Treatment of fulminant <i>C. difficile</i> colitis",
"answer": "Oral vancomycin, IV metronidazole; vancomycin enema if ileus is present",
"relatedSectionId": "mk19_a_id_s15_8"
},
"id126": {
"id": "id126",
"bookId": "id",
"question": "Treatment for giardiasis",
"answer": "Metronidazole, tinidazole, or nitazoxanide",
"relatedSectionId": "mk19_a_id_s15_10_1"
},
"id127": {
"id": "id127",
"bookId": "id",
"question": "Cause of swimming pool–related diarrhea",
"answer": "\n        <i>Cryptosporidium</i>\n      ",
"relatedSectionId": "mk19_a_id_s15_10_2"
},
"id128": {
"id": "id128",
"bookId": "id",
"question": "Initial treatment of amebiasis",
"answer": "Metronidazole or tinidazole",
"relatedSectionId": "mk19_a_id_s15_10_3"
},
"id129": {
"id": "id129",
"bookId": "id",
"question": "Protozoan cause of traveler's diarrhea in tropical and subtropical areas",
"answer": "\n        <i>Cyclospora</i>\n      ",
"relatedSectionId": "mk19_a_id_s15_10_4"
},
"id130": {
"id": "id130",
"bookId": "id",
"question": "Common organ-specific manifestations of CMV infection",
"answer": "Pneumonia, encephalitis, esophagitis, colitis",
"relatedSectionId": "mk19_a_id_s16_3_2_1"
},
"id131": {
"id": "id131",
"bookId": "id",
"question": "Preemptive management for CMV infection after HSCT",
"answer": "NAAT monitoring for CMV viremia",
"relatedSectionId": "mk19_a_id_s16_3_2_1"
},
"id132": {
"id": "id132",
"bookId": "id",
"question": "Cause of posttransplant lymphoproliferative disorder",
"answer": "EBV infection",
"relatedSectionId": "mk19_a_id_s16_3_2_1"
},
"id133": {
"id": "id133",
"bookId": "id",
"question": "Posttransplant fever in the middle to late period, lymphadenopathy, extranodal mass",
"answer": "Posttransplant lymphoproliferative disorder",
"relatedSectionId": "mk19_a_id_s16_3_2_1"
},
"id134": {
"id": "id134",
"bookId": "id",
"question": "Most significant risk factor for <i>C. difficile</i> colitis",
"answer": "Antibiotic therapy",
"relatedSectionId": "mk19_a_id_s16_3_2_2"
},
"id135": {
"id": "id135",
"bookId": "id",
"question": "Prevention of fungal infection after HSCT",
"answer": "Posaconazole or voriconazole",
"relatedSectionId": "mk19_a_id_s16_4"
},
"id136": {
"id": "id136",
"bookId": "id",
"question": "Foundation of infection prevention",
"answer": "Hand hygiene",
"relatedSectionId": "mk19_a_id_s17_2"
},
"id137": {
"id": "id137",
"bookId": "id",
"question": "Treatment of asymptomatic catheter-associated bacteriuria",
"answer": "None",
"relatedSectionId": "mk19_a_id_s17_3_1"
},
"id138": {
"id": "id138",
"bookId": "id",
"question": "Initial management of CAUTI",
"answer": "Remove catheter",
"relatedSectionId": "mk19_a_id_s17_3_2"
},
"id139": {
"id": "id139",
"bookId": "id",
"question": "Diagnostic testing for SSI",
"answer": "Culture of drainage, purulent fluid, and infected tissue",
"relatedSectionId": "mk19_a_id_s17_4_1"
},
"id140": {
"id": "id140",
"bookId": "id",
"question": "Surgeries requiring preop nasal screening for <i>S. aureus</i>",
"answer": "Cardiothoracic and orthopedic",
"relatedSectionId": "mk19_a_id_s17_4_3"
},
"id141": {
"id": "id141",
"bookId": "id",
"question": "Impact of continuing SSI prophylactic antibiotics postoperatively",
"answer": "None",
"relatedSectionId": "mk19_a_id_s17_4_3"
},
"id142": {
"id": "id142",
"bookId": "id",
"question": "Management for uncomplicated coagulase-negative <i>Staphylococcus</i> CLABSI",
"answer": "Remove catheter and repeat blood cultures",
"relatedSectionId": "mk19_a_id_s17_5_2"
},
"id143": {
"id": "id143",
"bookId": "id",
"question": "Treatment duration for uncomplicated non-<i>S. aureus</i> CLABSI",
"answer": "7-14 days",
"relatedSectionId": "mk19_a_id_s17_5_2"
},
"id144": {
"id": "id144",
"bookId": "id",
"question": "Daily protocol to prevent CLABSI",
"answer": "Assessment of ongoing need for central line",
"relatedSectionId": "mk19_a_id_s17_5_3"
},
"id145": {
"id": "id145",
"bookId": "id",
"question": "Treatment for MSSA bacteremia",
"answer": "Penicillinase-resistant semisynthetic penicillin or first-generation cephalosporin",
"relatedSectionId": "mk19_a_id_s17_6"
},
"id146": {
"id": "id146",
"bookId": "id",
"question": "Desired vancomycin MIC for <i>S. aureus</i> bacteremia",
"answer": "≤2 µg/mL",
"relatedSectionId": "mk19_a_id_s17_6"
},
"id147": {
"id": "id147",
"bookId": "id",
"question": "Treatment duration for VAP",
"answer": "≤7 days",
"relatedSectionId": "mk19_a_id_s17_7_2"
},
"id148": {
"id": "id148",
"bookId": "id",
"question": "HIV postexposure treatment",
"answer": "Tenofovir, emtricitabine, and dolutegravir or raltegravir",
"relatedSectionId": "mk19_a_id_s18_1"
},
"id149": {
"id": "id149",
"bookId": "id",
"question": "PrEP for HIV",
"answer": "Tenofovir plus emtricitabine",
"relatedSectionId": "mk19_a_id_s18_1"
},
"id150": {
"id": "id150",
"bookId": "id",
"question": "Positive HIV antigen/antibody, negative differentiation immunoassay, positive RNA NAAT",
"answer": "Acute HIV infection",
"relatedSectionId": "mk19_a_id_s18_3"
},
"id151": {
"id": "id151",
"bookId": "id",
"question": "Positive antigen/antibody but negative differentiation immunoassay and HIV RNA",
"answer": "False-positive HIV test",
"relatedSectionId": "mk19_a_id_s18_3"
},
"id152": {
"id": "id152",
"bookId": "id",
"question": "Pneumococcal vaccination in HIV",
"answer": "13-valent PCV and 23-valent PPSV",
"relatedSectionId": "mk19_a_id_s18_4_2"
},
"id153": {
"id": "id153",
"bookId": "id",
"question": "Indications to stop pneumocystis prophylaxis in HIV-treated patients",
"answer": "CD4 count ≥200/µL for ≥3 months",
"relatedSectionId": "mk19_a_id_s18_4_2"
},
"id154": {
"id": "id154",
"bookId": "id",
"question": "“Unmasking” of a previous infection after initiating HIV treatment",
"answer": "Immune reconstitution inflammatory syndrome",
"relatedSectionId": "mk19_a_id_s18_5_4"
},
"id155": {
"id": "id155",
"bookId": "id",
"question": "Management of ART during immune reconstitution inflammatory syndrome",
"answer": "Continue ART",
"relatedSectionId": "mk19_a_id_s18_5_4"
},
"id156": {
"id": "id156",
"bookId": "id",
"question": "Treatment of oropharyngeal candidiasis",
"answer": "Oral fluconazole",
"relatedSectionId": "mk19_a_id_s18_5_5"
},
"id157": {
"id": "id157",
"bookId": "id",
"question": "CD4 count associated with increased risk for pneumocystis pneumonia",
"answer": "&lt;200/µL",
"relatedSectionId": "mk19_a_id_s18_5_5"
},
"id158": {
"id": "id158",
"bookId": "id",
"question": "CD4 count associated with increased risk for toxoplasmosis",
"answer": "&lt;100/µL",
"relatedSectionId": "mk19_a_id_s18_5_5"
},
"id159": {
"id": "id159",
"bookId": "id",
"question": "CD4 count associated with increased risk for MAC infection",
"answer": "&lt;50/µL",
"relatedSectionId": "mk19_a_id_s18_5_5"
},
"id160": {
"id": "id160",
"bookId": "id",
"question": "Painless violaceous skin nodules in AIDS patient",
"answer": "Kaposi sarcoma",
"relatedSectionId": "mk19_a_id_s18_5_5"
},
"id161": {
"id": "id161",
"bookId": "id",
"question": "Recommended time to initiate ART for HIV infection",
"answer": "When patient is ready, at any CD4 count",
"relatedSectionId": "mk19_a_id_s18_6_1"
},
"id162": {
"id": "id162",
"bookId": "id",
"question": "Preferred HIV ART regimen for most patients",
"answer": "2 nucleoside reverse transcriptase inhibitors with an integrase strand transfer inhibitor",
"relatedSectionId": "mk19_a_id_s18_6_2"
},
"id163": {
"id": "id163",
"bookId": "id",
"question": "Specialized viral testing after HIV diagnosis",
"answer": "Genotype viral resistance",
"relatedSectionId": "mk19_a_id_s18_6_3"
},
"id164": {
"id": "id164",
"bookId": "id",
"question": "Management of ART during pregnancy",
"answer": "Continue ART",
"relatedSectionId": "mk19_a_id_s18_7"
},
"id165": {
"id": "id165",
"bookId": "id",
"question": "Neuraminidase inhibitor treatments for influenza",
"answer": "Oseltamivir (oral), zanamivir (nasal), peramivir (IV)",
"relatedSectionId": "mk19_a_id_s19_1_3"
},
"id166": {
"id": "id166",
"bookId": "id",
"question": "Characteristics of varicella rash",
"answer": "Centripetal distribution of macules, papules, vesicles at various stages of development",
"relatedSectionId": "mk19_a_id_s19_3_2_2"
},
"id167": {
"id": "id167",
"bookId": "id",
"question": "Painful ear canal vesicles and Bell palsy",
"answer": "Herpes zoster oticus (Ramsay Hunt)",
"relatedSectionId": "mk19_a_id_s19_3_2_2"
},
"id168": {
"id": "id168",
"bookId": "id",
"question": "Prophylaxis for CMV infection",
"answer": "Valganciclovir",
"relatedSectionId": "mk19_a_id_s19_3_4"
},
"id169": {
"id": "id169",
"bookId": "id",
"question": "Musculoskeletal side effect of fluoroquinolone antibiotics",
"answer": "Tendinitis and tendon rupture",
"relatedSectionId": "mk19_a_id_s20_2"
},
"id170": {
"id": "id170",
"bookId": "id",
"question": "Daptomycin outpatient therapy monitoring",
"answer": "Weekly creatinine and creatine kinase",
"relatedSectionId": "mk19_a_id_s20_5"
},
"np1": {
"id": "np1",
"bookId": "np",
"question": "Common medications that decrease creatinine secretion",
"answer": "Cimetidine, trimethoprim",
"relatedSectionId": "mk19_a_np_s1_1_1_1"
},
"np2": {
"id": "np2",
"bookId": "np",
"question": "Preferred marker of glomerular filtration when creatinine is likely inaccurate",
"answer": "Cystatin C",
"relatedSectionId": "mk19_a_np_s1_1_1_2"
},
"np3": {
"id": "np3",
"bookId": "np",
"question": "Urine dipstick positive for blood, no RBCs in sediment",
"answer": "Myoglobinuria or hemoglobinuria",
"relatedSectionId": "mk19_a_np_s1_2_1_3"
},
"np4": {
"id": "np4",
"bookId": "np",
"question": "Implication of glucosuria with no hyperglycemia",
"answer": "Proximal tubular dysfunction",
"relatedSectionId": "mk19_a_np_s1_2_1_5"
},
"np5": {
"id": "np5",
"bookId": "np",
"question": "Dipstick results predictive of UTI",
"answer": "Positive leukocyte esterase and nitrates",
"relatedSectionId": "mk19_a_np_s1_2_1_7"
},
"np6": {
"id": "np6",
"bookId": "np",
"question": "Urine sediment with dysmorphic erythrocytes",
"answer": "Glomerular bleeding or glomerulonephritis",
"relatedSectionId": "mk19_a_np_s1_2_2_1"
},
"np7": {
"id": "np7",
"bookId": "np",
"question": "Presence of erythrocyte casts",
"answer": "Glomerulonephritis",
"relatedSectionId": "mk19_a_np_s1_2_2_5"
},
"np8": {
"id": "np8",
"bookId": "np",
"question": "Presence of pigmented or granular (muddy brown) casts",
"answer": "Acute tubular necrosis",
"relatedSectionId": "mk19_a_np_s1_2_2_5"
},
"np9": {
"id": "np9",
"bookId": "np",
"question": "Confirming test for light chain proteinuria",
"answer": "Urine protein electrophoresis",
"relatedSectionId": "mk19_a_np_s1_2_3"
},
"np10": {
"id": "np10",
"bookId": "np",
"question": "Urinalysis clue for urinary tract malignancy",
"answer": "Nonglomerular hematuria",
"relatedSectionId": "mk19_a_np_s1_2_4"
},
"np11": {
"id": "np11",
"bookId": "np",
"question": "Urinalysis clues for glomerular hematuria",
"answer": "Dysmorphic erythrocytes, erythrocyte casts, proteinuria",
"relatedSectionId": "mk19_a_np_s1_2_4"
},
"np12": {
"id": "np12",
"bookId": "np",
"question": "Imaging test for suspected nephrolithiasis in patients with negative ultrasound",
"answer": "Noncontrast helical CT",
"relatedSectionId": "mk19_a_np_s1_3"
},
"np13": {
"id": "np13",
"bookId": "np",
"question": "Serum osmolality calculation",
"answer": "2 × Na<sup>+</sup> + Glucose/18 + BUN/2.8",
"relatedSectionId": "mk19_a_np_s2_1"
},
"np14": {
"id": "np14",
"bookId": "np",
"question": "Most common cause of hypertonic hyponatremia",
"answer": "Hyperglycemia",
"relatedSectionId": "mk19_a_np_s2_2_1_1_1"
},
"np15": {
"id": "np15",
"bookId": "np",
"question": "Isovolemic hypotonic hyponatremia and urine osmolality &lt;100 mOsm/kg H<sub>2</sub>O",
"answer": "Psychogenic polydipsia",
"relatedSectionId": "mk19_a_np_s2_2_1_1_3"
},
"np16": {
"id": "np16",
"bookId": "np",
"question": "Treatment of acute symptomatic hyponatremia",
"answer": "100 mL of 3% saline",
"relatedSectionId": "mk19_a_np_s2_2_1_2"
},
"np17": {
"id": "np17",
"bookId": "np",
"question": "Rate of correction for chronic isovolemic hypotonic hyponatremia",
"answer": "&lt;8-10 mEq/L in 24 hours",
"relatedSectionId": "mk19_a_np_s2_2_1_2"
},
"np18": {
"id": "np18",
"bookId": "np",
"question": "Drug therapy for isovolemic hypotonic hyponatremia",
"answer": "Demeclocycline or tolvaptan",
"relatedSectionId": "mk19_a_np_s2_2_1_2"
},
"np19": {
"id": "np19",
"bookId": "np",
"question": "Hypernatremia, elevated serum osmolality, inability to concentrate urine",
"answer": "Diabetes insipidus",
"relatedSectionId": "mk19_a_np_s2_2_2_1"
},
"np20": {
"id": "np20",
"bookId": "np",
"question": "Distinguishing central from nephrogenic diabetes insipidus",
"answer": "Response to desmopressin",
"relatedSectionId": "mk19_a_np_s2_2_2_1"
},
"np21": {
"id": "np21",
"bookId": "np",
"question": "Rate of correction for chronic hypernatremia",
"answer": "10-12 mEq/L in 24 hours",
"relatedSectionId": "mk19_a_np_s2_2_2_2"
},
"np22": {
"id": "np22",
"bookId": "np",
"question": "Drug therapy for lithium-induced nephrogenic diabetes insipidus",
"answer": "Amiloride",
"relatedSectionId": "mk19_a_np_s2_2_2_2"
},
"np23": {
"id": "np23",
"bookId": "np",
"question": "ECG findings in hypokalemia",
"answer": "ST-segment depression, decreased T waves, positive U-wave amplitude",
"relatedSectionId": "mk19_a_np_s2_3_1"
},
"np24": {
"id": "np24",
"bookId": "np",
"question": "Electrolyte cause of refractory hypokalemia",
"answer": "Hypomagnesemia",
"relatedSectionId": "mk19_a_np_s2_3_1_1"
},
"np25": {
"id": "np25",
"bookId": "np",
"question": "ECG sine wave pattern",
"answer": "Severe hyperkalemia",
"relatedSectionId": "mk19_a_np_s2_3_2_1"
},
"np26": {
"id": "np26",
"bookId": "np",
"question": "Causes of pseudohyperkalemia",
"answer": "Extreme leukocytosis and thrombocythemia",
"relatedSectionId": "mk19_a_np_s2_3_2_1"
},
"np27": {
"id": "np27",
"bookId": "np",
"question": "Immediate treatment of severe hyperkalemia",
"answer": "IV calcium gluconate and insulin (with or without glucose)",
"relatedSectionId": "mk19_a_np_s2_3_2_2"
},
"np28": {
"id": "np28",
"bookId": "np",
"question": "Treatment of severe hypermagnesemia",
"answer": "IV saline and calcium",
"relatedSectionId": "mk19_a_np_s2_5_2_2"
},
"np29": {
"id": "np29",
"bookId": "np",
"question": "Compensation for metabolic acidosis",
"answer": "PCO<sub>2</sub> = (1.5) [HCO<sub>3</sub>] + 8 ± 2",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np30": {
"id": "np30",
"bookId": "np",
"question": "Compensation for metabolic alkalosis",
"answer": "1 mEq ↑ HCO<sub>3</sub> results in 0.7 mm Hg ↑ PCO<sub>2</sub>",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np31": {
"id": "np31",
"bookId": "np",
"question": "Acute respiratory acidosis compensation",
"answer": "1 mEq ↑ HCO<sub>3</sub> for each 10 mm Hg ↑ PCO<sub>2</sub>",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np32": {
"id": "np32",
"bookId": "np",
"question": "Chronic respiratory acidosis compensation",
"answer": "3.5 mEq ↑ HCO<sub>3</sub> for each 10 mm Hg ↑ PCO<sub>2</sub>",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np33": {
"id": "np33",
"bookId": "np",
"question": "Acute respiratory alkalosis compensation",
"answer": "2 mEq ↓ HCO<sub>3</sub> for each 10 mm Hg ↓ PCO<sub>2</sub>",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np34": {
"id": "np34",
"bookId": "np",
"question": "Chronic respiratory alkalosis compensation",
"answer": "4-5 mEq ↓ HCO<sub>3</sub> for each 10 mm Hg ↓ PCO<sub>2</sub>",
"relatedSectionId": "mk19_a_np_s3_1"
},
"np35": {
"id": "np35",
"bookId": "np",
"question": "Albumin-corrected anion gap",
"answer": "Anion Gap + 2.5 × (Normal Albumin − Measured Albumin)",
"relatedSectionId": "mk19_a_np_s3_2_1"
},
"np36": {
"id": "np36",
"bookId": "np",
"question": "Δ-Δ ratio calculation",
"answer": "(Anion Gap − 12)/(25 – Bicarbonate)",
"relatedSectionId": "mk19_a_np_s3_2_1"
},
"np37": {
"id": "np37",
"bookId": "np",
"question": "Diagnosis for anion gap acidosis and Δ-Δ ratio &lt;0.5-1",
"answer": "Concurrent metabolic acidosis",
"relatedSectionId": "mk19_a_np_s3_2_1"
},
"np38": {
"id": "np38",
"bookId": "np",
"question": "Diagnosis for anion gap acidosis and Δ-Δ ratio &gt;2",
"answer": "Concurrent metabolic alkalosis",
"relatedSectionId": "mk19_a_np_s3_2_1"
},
"np39": {
"id": "np39",
"bookId": "np",
"question": "CNS depression, increased anion gap metabolic acidosis, increased osmolar gap",
"answer": "Ethylene glycol or methanol toxicity",
"relatedSectionId": "mk19_a_np_s3_2_2"
},
"np40": {
"id": "np40",
"bookId": "np",
"question": "Treatment of alcoholic ketoacidosis",
"answer": "Thiamine followed by 5% dextrose in saline",
"relatedSectionId": "mk19_a_np_s3_2_2"
},
"np41": {
"id": "np41",
"bookId": "np",
"question": "Increased anion gap metabolic acidosis and short-bowel syndrome",
"answer": "D-lactic acidosis",
"relatedSectionId": "mk19_a_np_s3_2_2"
},
"np42": {
"id": "np42",
"bookId": "np",
"question": "Treatment of ethylene glycol toxicity",
"answer": "IV fluids, fomepizole, hemodialysis",
"relatedSectionId": "mk19_a_np_s3_2_2"
},
"np43": {
"id": "np43",
"bookId": "np",
"question": "Urine anion gap calculation",
"answer": "(Urine Na<sup>+</sup> + Urine K<sup>+</sup>) – Urine Cl<sup>-</sup>",
"relatedSectionId": "mk19_a_np_s3_2_3"
},
"np44": {
"id": "np44",
"bookId": "np",
"question": "Diagnosis for normal anion gap metabolic acidosis with positive urine anion gap",
"answer": "Distal RTA",
"relatedSectionId": "mk19_a_np_s3_2_3"
},
"np45": {
"id": "np45",
"bookId": "np",
"question": "Glycosuria, phosphaturia, aminoaciduria, hypouricemia, RTA",
"answer": "Fanconi syndrome",
"relatedSectionId": "mk19_a_np_s3_2_3_1"
},
"np46": {
"id": "np46",
"bookId": "np",
"question": "Type 2 (proximal) RTA treatment",
"answer": "Bicarbonate ± thiazide diuretic",
"relatedSectionId": "mk19_a_np_s3_2_3_1"
},
"np47": {
"id": "np47",
"bookId": "np",
"question": "Normal anion gap metabolic acidosis, positive urine anion gap, urine pH &gt; 6, hypokalemia",
"answer": "Type 1 (hypokalemic distal) RTA",
"relatedSectionId": "mk19_a_np_s3_2_3_2"
},
"np48": {
"id": "np48",
"bookId": "np",
"question": "Type 1 (hypokalemic distal) RTA treatment",
"answer": "Potassium citrate",
"relatedSectionId": "mk19_a_np_s3_2_3_2"
},
"np49": {
"id": "np49",
"bookId": "np",
"question": "Normal anion gap metabolic acidosis, positive urine anion gap, hyperkalemia, urine pH &lt;5.5",
"answer": "Type 4 (hyperkalemic distal) RTA",
"relatedSectionId": "mk19_a_np_s3_2_3_3"
},
"np50": {
"id": "np50",
"bookId": "np",
"question": "Causes of metabolic alkalosis, hypovolemia, low urine chloride",
"answer": "Vomiting, diuretic use",
"relatedSectionId": "mk19_a_np_s3_3"
},
"np51": {
"id": "np51",
"bookId": "np",
"question": "Metabolic alkalosis, normal volume status, urine chloride &gt;15 mEq/L",
"answer": "Diuretic use, Bartter and Gitelman syndromes",
"relatedSectionId": "mk19_a_np_s3_3"
},
"np52": {
"id": "np52",
"bookId": "np",
"question": "Acid-base disorder associated with elevated PaCO<sub>2</sub>",
"answer": "Respiratory acidosis or metabolic alkalosis",
"relatedSectionId": "mk19_a_np_s3_4"
},
"np53": {
"id": "np53",
"bookId": "np",
"question": "Acid-base disorder associated with low PaCO<sub>2</sub>",
"answer": "Respiratory alkalosis or metabolic acidosis",
"relatedSectionId": "mk19_a_np_s3_5"
},
"np54": {
"id": "np54",
"bookId": "np",
"question": "BP high in doctor's office, normal otherwise",
"answer": "White coat hypertension",
"relatedSectionId": "mk19_a_np_s4_3_4_1"
},
"np55": {
"id": "np55",
"bookId": "np",
"question": "BP normal in doctor's office, elevated otherwise",
"answer": "Masked hypertension",
"relatedSectionId": "mk19_a_np_s4_3_4_1"
},
"np57": {
"id": "np57",
"bookId": "np",
"question": "Preferred thiazide to treat hypertension",
"answer": "Chlorthalidone",
"relatedSectionId": "mk19_a_np_s4_7_2_3_1"
},
"np58": {
"id": "np58",
"bookId": "np",
"question": "Diagnostic test for white coat hypertension",
"answer": "Ambulatory or home BP monitoring",
"relatedSectionId": "mk19_a_np_s4_8"
},
"np59": {
"id": "np59",
"bookId": "np",
"question": "Initial treatment of white coat hypertension",
"answer": "Lifestyle modification",
"relatedSectionId": "mk19_a_np_s4_8"
},
"np60": {
"id": "np60",
"bookId": "np",
"question": "Diagnostic test for masked hypertension",
"answer": "Ambulatory or home BP monitoring",
"relatedSectionId": "mk19_a_np_s4_9"
},
"np61": {
"id": "np61",
"bookId": "np",
"question": "First-line treatment of high BP in euvolemic CKD",
"answer": "ACE inhibitor or ARB",
"relatedSectionId": "mk19_a_np_s4_11_1_4"
},
"np62": {
"id": "np62",
"bookId": "np",
"question": "Systolic BP goal in CKD",
"answer": "&lt;130 mm Hg",
"relatedSectionId": "mk19_a_np_s4_11_1_4"
},
"np63": {
"id": "np63",
"bookId": "np",
"question": "Acceptable increase in serum creatinine when taking an ACE inhibitor",
"answer": "25%-30%",
"relatedSectionId": "mk19_a_np_s4_11_1_4"
},
"np64": {
"id": "np64",
"bookId": "np",
"question": "eGFR threshold to begin loop diuretic for BP control",
"answer": "&lt;20-30 mL/min/1.73 m<sup>2</sup>",
"relatedSectionId": "mk19_a_np_s4_11_1_4"
},
"np65": {
"id": "np65",
"bookId": "np",
"question": "Abrupt onset of hypertension in women aged &lt;35 years",
"answer": "Fibromuscular dysplasia",
"relatedSectionId": "mk19_a_np_s4_11_2_3"
},
"np66": {
"id": "np66",
"bookId": "np",
"question": "Treatment of atherosclerotic renal artery stenosis",
"answer": "Medical management",
"relatedSectionId": "mk19_a_np_s4_11_2_4"
},
"np67": {
"id": "np67",
"bookId": "np",
"question": "Indications for primary hyperaldosteronism screening",
"answer": "Resistant high BP, hypokalemia, adrenal mass, or stroke at age &lt;40 years",
"relatedSectionId": "mk19_a_np_s4_11_3"
},
"np68": {
"id": "np68",
"bookId": "np",
"question": "Initial screening test for primary hyperaldosteronism",
"answer": "PAC/PRA",
"relatedSectionId": "mk19_a_np_s4_11_3"
},
"np69": {
"id": "np69",
"bookId": "np",
"question": "Systolic BP target for hypertensive emergency, acute organ injury",
"answer": "&lt;140 mm Hg in first hour",
"relatedSectionId": "mk19_a_np_s4_13"
},
"np70": {
"id": "np70",
"bookId": "np",
"question": "Systolic BP target hypertensive emergency, aortic dissection",
"answer": "&lt;120 mm Hg in first hour",
"relatedSectionId": "mk19_a_np_s4_13"
},
"np71": {
"id": "np71",
"bookId": "np",
"question": "Acceptable hypertension drugs during pregnancy",
"answer": "Methyldopa, nifedipine, labetalol",
"relatedSectionId": "mk19_a_np_s4_14_1"
},
"np72": {
"id": "np72",
"bookId": "np",
"question": "Treatment of hypertension with DM and albuminuria",
"answer": "ACE inhibitor or ARB",
"relatedSectionId": "mk19_a_np_s4_14_2"
},
"np73": {
"id": "np73",
"bookId": "np",
"question": "PPI-related kidney disease",
"answer": "Chronic tubulointerstitial nephritis",
"relatedSectionId": "mk19_a_np_s5_2"
},
"np74": {
"id": "np74",
"bookId": "np",
"question": "Infection in kidney transplant patient mimicking acute rejection with interstitial nephritis",
"answer": "BK polyoma virus",
"relatedSectionId": "mk19_a_np_s5_3_2"
},
"np75": {
"id": "np75",
"bookId": "np",
"question": "Hypertension, hyperuricemia, recurrent gout",
"answer": "Lead nephropathy",
"relatedSectionId": "mk19_a_np_s5_3_6"
},
"np76": {
"id": "np76",
"bookId": "np",
"question": "Toxicity from herbs containing aristolochic acid",
"answer": "Balkan endemic nephropathy",
"relatedSectionId": "mk19_a_np_s5_3_8"
},
"np77": {
"id": "np77",
"bookId": "np",
"question": "Elements of the nephrotic syndrome",
"answer": "Proteinuria &gt;3500 mg/d, hypoalbuminemia, hypercholesterolemia, edema",
"relatedSectionId": "mk19_a_np_s6_2_1"
},
"np78": {
"id": "np78",
"bookId": "np",
"question": "Standard treatment of the nephrotic syndrome",
"answer": "ACE inhibitor or ARB, diuretics, statin",
"relatedSectionId": "mk19_a_np_s6_2_1"
},
"np79": {
"id": "np79",
"bookId": "np",
"question": "Initial manifestation of diabetic kidney disease",
"answer": "Albuminuria",
"relatedSectionId": "mk19_a_np_s6_3_1_2"
},
"np80": {
"id": "np80",
"bookId": "np",
"question": "When to initiate screening for diabetic kidney disease in T2DM",
"answer": "Upon diagnosis",
"relatedSectionId": "mk19_a_np_s6_3_1_3"
},
"np81": {
"id": "np81",
"bookId": "np",
"question": "When to initiate screening for diabetic kidney disease in T1DM",
"answer": "5 years after diagnosis",
"relatedSectionId": "mk19_a_np_s6_3_1_3"
},
"np82": {
"id": "np82",
"bookId": "np",
"question": "Hypertension management for diabetic kidney disease",
"answer": "ACE inhibitor or ARB",
"relatedSectionId": "mk19_a_np_s6_3_1_4"
},
"np84": {
"id": "np84",
"bookId": "np",
"question": "Obesity-related glomerular disease",
"answer": "Secondary FSGS",
"relatedSectionId": "mk19_a_np_s6_3_2_1"
},
"np86": {
"id": "np86",
"bookId": "np",
"question": "Antibody associated with primary membranous nephropathy",
"answer": "Anti-PLA2R",
"relatedSectionId": "mk19_a_np_s6_3_3_3"
},
"np87": {
"id": "np87",
"bookId": "np",
"question": "Indication for immunosuppression for primary membranous nephropathy",
"answer": "No remission after 6-12 months",
"relatedSectionId": "mk19_a_np_s6_3_3_4"
},
"np88": {
"id": "np88",
"bookId": "np",
"question": "Treatment for minimal change glomerulopathy",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_a_np_s6_3_4_4"
},
"np89": {
"id": "np89",
"bookId": "np",
"question": "Pathology of RPGN",
"answer": "Extensive glomerular crescents",
"relatedSectionId": "mk19_a_np_s6_4_1_1"
},
"np90": {
"id": "np90",
"bookId": "np",
"question": "Common presentation of anti-GBM antibody disease",
"answer": "RPGN plus pulmonary hemorrhage",
"relatedSectionId": "mk19_a_np_s6_4_2_2"
},
"np91": {
"id": "np91",
"bookId": "np",
"question": "Treatment of anti-GBM antibody disease",
"answer": "Plasmapheresis, pulsed steroids, cyclophosphamide",
"relatedSectionId": "mk19_a_np_s6_4_2_4"
},
"np92": {
"id": "np92",
"bookId": "np",
"question": "Most common cause of RPGN in older adults",
"answer": "ANCA-associated glomerulonephritis",
"relatedSectionId": "mk19_a_np_s6_4_3_1"
},
"np93": {
"id": "np93",
"bookId": "np",
"question": "Initial therapy of ANCA-associated glomerulonephritis with alveolar hemorrhage",
"answer": "High-dose glucocorticoids and plasmapheresis",
"relatedSectionId": "mk19_a_np_s6_4_3_4"
},
"np94": {
"id": "np94",
"bookId": "np",
"question": "Immune complex–mediated glomerulonephritis with normal complement levels",
"answer": "IgA nephropathy",
"relatedSectionId": "mk19_a_np_s6_4_4"
},
"np95": {
"id": "np95",
"bookId": "np",
"question": "Recurrent gross hematuria coexistent with URI",
"answer": "IgA nephropathy",
"relatedSectionId": "mk19_a_np_s6_4_4_1_2"
},
"np96": {
"id": "np96",
"bookId": "np",
"question": "Treatment of IgA nephropathy",
"answer": "ACE inhibitor or ARB",
"relatedSectionId": "mk19_a_np_s6_4_4_1_4"
},
"np97": {
"id": "np97",
"bookId": "np",
"question": "Rash, arthralgia, abdominal pain, kidney disease",
"answer": "IgA vasculitis (Henoch-Schönlein purpura)",
"relatedSectionId": "mk19_a_np_s6_4_4_2"
},
"np98": {
"id": "np98",
"bookId": "np",
"question": "Diagnostic tests for IgA vasculitis",
"answer": "Kidney or skin biopsy",
"relatedSectionId": "mk19_a_np_s6_4_4_2"
},
"np99": {
"id": "np99",
"bookId": "np",
"question": "Diagnostic test for SLE and kidney disease",
"answer": "Kidney biopsy",
"relatedSectionId": "mk19_a_np_s6_4_4_3_3"
},
"np100": {
"id": "np100",
"bookId": "np",
"question": "Preferred initial immunotherapy for lupus nephritis classes III, IV, V",
"answer": "Mycophenolate mofetil",
"relatedSectionId": "mk19_a_np_s6_4_4_3_4"
},
"np101": {
"id": "np101",
"bookId": "np",
"question": "Criteria for MGUS plus renal insufficiency",
"answer": "Monoclonal gammopathy of renal significance",
"relatedSectionId": "mk19_a_np_s7_4"
},
"np102": {
"id": "np102",
"bookId": "np",
"question": "Chronic inflammatory disease, nephrotic syndrome, CHF",
"answer": "AA amyloidosis",
"relatedSectionId": "mk19_a_np_s7_6"
},
"np103": {
"id": "np103",
"bookId": "np",
"question": "Genetic markers for ADPKD",
"answer": "<i>PKD1</i> and <i>PKD2</i> genes",
"relatedSectionId": "mk19_a_np_s8_1_1_1"
},
"np104": {
"id": "np104",
"bookId": "np",
"question": "Initial screening for ADPKD",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_a_np_s8_1_1_1"
},
"np105": {
"id": "np105",
"bookId": "np",
"question": "ADPKD-associated intracranial disease",
"answer": "Aneurysms",
"relatedSectionId": "mk19_a_np_s8_1_1_2"
},
"np106": {
"id": "np106",
"bookId": "np",
"question": "Screening test for patients with ADPKD",
"answer": "Cerebral MR angiography",
"relatedSectionId": "mk19_a_np_s8_1_1_3"
},
"np107": {
"id": "np107",
"bookId": "np",
"question": "Glomerular disease, sensorineural hearing loss, ocular disease",
"answer": "Hereditary nephritis (Alport disease)",
"relatedSectionId": "mk19_a_np_s8_2_2_1"
},
"np108": {
"id": "np108",
"bookId": "np",
"question": "Benign hereditary glomerular disease, hematuria, minimal proteinuria",
"answer": "Thin glomerular basement membrane disease",
"relatedSectionId": "mk19_a_np_s8_2_2_2"
},
"np109": {
"id": "np109",
"bookId": "np",
"question": "Prerenal AKI FE<sub>Na</sub>",
"answer": "&lt;1%",
"relatedSectionId": "mk19_a_np_s9_4"
},
"np110": {
"id": "np110",
"bookId": "np",
"question": "ATN FE<sub>Na</sub>",
"answer": "&gt;2%",
"relatedSectionId": "mk19_a_np_s9_4"
},
"np111": {
"id": "np111",
"bookId": "np",
"question": "Urine sediment in ATN",
"answer": "Granular (muddy brown) casts, renal epithelial cells",
"relatedSectionId": "mk19_a_np_s9_5_2_1"
},
"np112": {
"id": "np112",
"bookId": "np",
"question": "Most common cause of hospital-acquired AKI",
"answer": "ATN",
"relatedSectionId": "mk19_a_np_s9_5_2_1_2"
},
"np113": {
"id": "np113",
"bookId": "np",
"question": "Acute kidney injury, elevated serum CK; hyperkalemia; hypocalcemia",
"answer": "Rhabdomyolysis",
"relatedSectionId": "mk19_a_np_s9_5_2_1_3"
},
"np114": {
"id": "np114",
"bookId": "np",
"question": "Initial treatment of rhabdomyolysis",
"answer": "IV normal saline",
"relatedSectionId": "mk19_a_np_s9_5_2_1_3"
},
"np115": {
"id": "np115",
"bookId": "np",
"question": "AKI, fever, rash, eosinophilia",
"answer": "Acute interstitial nephritis",
"relatedSectionId": "mk19_a_np_s9_5_2_2"
},
"np116": {
"id": "np116",
"bookId": "np",
"question": "Skin findings of AKI-related atheroemboli",
"answer": "Livedo reticularis/blue toe",
"relatedSectionId": "mk19_a_np_s9_5_2_4"
},
"np117": {
"id": "np117",
"bookId": "np",
"question": "Urinalysis finding in ethylene glycol toxicity",
"answer": "Calcium oxalate crystals",
"relatedSectionId": "mk19_a_np_s9_5_2_5"
},
"np118": {
"id": "np118",
"bookId": "np",
"question": "Postrenal AKI imaging tests",
"answer": "Ultrasonography or noncontrast CT",
"relatedSectionId": "mk19_a_np_s9_5_3"
},
"np119": {
"id": "np119",
"bookId": "np",
"question": "Prevention of contrast-induced nephropathy",
"answer": "IV isotonic saline; minimize contrast exposure",
"relatedSectionId": "mk19_a_np_s9_6_1"
},
"np120": {
"id": "np120",
"bookId": "np",
"question": "Decreased kidney function and diuretic-resistant HF",
"answer": "Cardiorenal syndrome",
"relatedSectionId": "mk19_a_np_s9_6_2"
},
"np121": {
"id": "np121",
"bookId": "np",
"question": "Confirmatory test for abdominal compartment syndrome",
"answer": "Intra-abdominal pressure measurement",
"relatedSectionId": "mk19_a_np_s9_6_5"
},
"np122": {
"id": "np122",
"bookId": "np",
"question": "Diagnostic imaging for nephrolithiasis",
"answer": "Noncontrast helical CT",
"relatedSectionId": "mk19_a_np_s10_3"
},
"np123": {
"id": "np123",
"bookId": "np",
"question": "Urine pH associated with struvite stones",
"answer": "&gt;7.5",
"relatedSectionId": "mk19_a_np_s10_4_2"
},
"np124": {
"id": "np124",
"bookId": "np",
"question": "Recommended urine output to prevent recurrent stones",
"answer": "&gt;2500 mL/d",
"relatedSectionId": "mk19_a_np_s10_5"
},
"np125": {
"id": "np125",
"bookId": "np",
"question": "Treatment of calcium oxalate stones associated with malabsorption",
"answer": "Potassium citrate",
"relatedSectionId": "mk19_a_np_s10_5"
},
"np126": {
"id": "np126",
"bookId": "np",
"question": "Treatment of struvite stone",
"answer": "Removal",
"relatedSectionId": "mk19_a_np_s10_5"
},
"np127": {
"id": "np127",
"bookId": "np",
"question": "Treatment of hypercalciuria and nephrolithiasis",
"answer": "Thiazide diuretic",
"relatedSectionId": "mk19_a_np_s10_5"
},
"np128": {
"id": "np128",
"bookId": "np",
"question": "Antihypertensive drugs contraindicated in pregnancy",
"answer": "ACE inhibitors, ARBs, direct renin inhibitors",
"relatedSectionId": "mk19_a_np_s11_2_1"
},
"np129": {
"id": "np129",
"bookId": "np",
"question": "Pregnancy &gt;20 weeks' gestation, hypertension, proteinuria",
"answer": "Preeclampsia",
"relatedSectionId": "mk19_a_np_s11_2_4"
},
"np130": {
"id": "np130",
"bookId": "np",
"question": "Leading cause of death in patients with CKD",
"answer": "Cardiovascular disease",
"relatedSectionId": "mk19_a_np_s12_6_1"
},
"np131": {
"id": "np131",
"bookId": "np",
"question": "End-stage kidney disease, bone pain, normal calcium and phosphorus, suppressed PTH",
"answer": "Adynamic bone disease",
"relatedSectionId": "mk19_a_np_s12_6_2_4_2"
},
"np132": {
"id": "np132",
"bookId": "np",
"question": "Hemoglobin threshold for ESA in CKD",
"answer": "&lt;10 g/dL",
"relatedSectionId": "mk19_a_np_s12_6_3"
},
"np133": {
"id": "np133",
"bookId": "np",
"question": "Electrolyte therapy that delays CKD progression",
"answer": "Sodium bicarbonate",
"relatedSectionId": "mk19_a_np_s12_6_4"
},
"np134": {
"id": "np134",
"bookId": "np",
"question": "CKD indication for bicarbonate therapy",
"answer": "Bicarbonate &lt;22 mEq/L",
"relatedSectionId": "mk19_a_np_s12_6_4"
},
"np135": {
"id": "np135",
"bookId": "np",
"question": "Preferred therapy for ESKD that increases duration and quality of life and decreases costs",
"answer": "Kidney transplantation",
"relatedSectionId": "mk19_a_np_s12_9_2"
},
"np136": {
"id": "np136",
"bookId": "np",
"question": "eGFR threshold for kidney transplant evaluation",
"answer": "15 to 29 mL/min/1.73 m<sup>2</sup>",
"relatedSectionId": "mk19_a_np_s12_9_2_1"
},
"np137": {
"id": "np137",
"bookId": "np",
"question": "Painful, necrotic skin lesions; small vessel calcification; ESKD",
"answer": "Calciphylaxis",
"relatedSectionId": "mk19_a_np_s12_9_3_4"
},
"nr1": {
"id": "nr1",
"bookId": "nr",
"question": "Red flags for secondary headache",
"answer": "Focal neurologic findings, worst/progressive headache, new headache after age 50 years, thunderclap headache, onset after exertion",
"relatedSectionId": "mk19_a_nr_s1_1"
},
"nr2": {
"id": "nr2",
"bookId": "nr",
"question": "Imaging for reversible cerebral vasoconstriction syndrome",
"answer": "Brain and neck MRA or CTA",
"relatedSectionId": "mk19_a_nr_s1_2_1"
},
"nr3": {
"id": "nr3",
"bookId": "nr",
"question": "Thrombosis-associated painful ophthalmoplegia, proptosis, chemosis",
"answer": "Cavernous sinus thrombosis",
"relatedSectionId": "mk19_a_nr_s1_2_1"
},
"nr4": {
"id": "nr4",
"bookId": "nr",
"question": "Acute neck pain, eye pain, partial Horner syndrome, ipsilateral cerebral ischemia",
"answer": "Carotid artery dissection",
"relatedSectionId": "mk19_a_nr_s1_2_1"
},
"nr5": {
"id": "nr5",
"bookId": "nr",
"question": "Woman of childbearing age with obesity, headaches, visual symptoms, pulsatile tinnitus",
"answer": "Idiopathic intracranial hypertension",
"relatedSectionId": "mk19_a_nr_s1_2_2"
},
"nr6": {
"id": "nr6",
"bookId": "nr",
"question": "Drug treatment for idiopathic intracranial hypertension",
"answer": "Acetazolamide",
"relatedSectionId": "mk19_a_nr_s1_2_2"
},
"nr7": {
"id": "nr7",
"bookId": "nr",
"question": "Initial treatment for intracranial hypotension",
"answer": "Epidural blood patch",
"relatedSectionId": "mk19_a_nr_s1_2_3"
},
"nr8": {
"id": "nr8",
"bookId": "nr",
"question": "Trigeminal neuralgia treatment",
"answer": "Carbamazepine",
"relatedSectionId": "mk19_a_nr_s1_2_4"
},
"nr9": {
"id": "nr9",
"bookId": "nr",
"question": "Monthly pain medication threshold for diagnosis of medication overuse headache",
"answer": "≥10 days/month for triptans, ergot alkaloids, opioids, or combination analgesics; ≥15 days/month for simple analgesics",
"relatedSectionId": "mk19_a_nr_s1_2_5"
},
"nr10": {
"id": "nr10",
"bookId": "nr",
"question": "Refractory daily headaches with triptans, ergot alkaloids, opioids, or combination analgesics ≥10 days/month",
"answer": "Medication overuse headache",
"relatedSectionId": "mk19_a_nr_s1_2_5"
},
"nr11": {
"id": "nr11",
"bookId": "nr",
"question": "Mnemonic for migraine characteristics",
"answer": "POUND (Pulsatile quality of headache, One-day duration, Unilateral location, Nausea/vomiting, Disabling intensity)",
"relatedSectionId": "mk19_a_nr_s1_3_1_1"
},
"nr12": {
"id": "nr12",
"bookId": "nr",
"question": "Migraine treatment when unresponsive to NSAIDs",
"answer": "Triptans",
"relatedSectionId": "mk19_a_nr_s1_3_1_2"
},
"nr13": {
"id": "nr13",
"bookId": "nr",
"question": "Drug prophylaxis for migraine",
"answer": "Metoprolol, propranolol, timolol, divalproex sodium, topiramate",
"relatedSectionId": "mk19_a_nr_s1_3_1_3"
},
"nr14": {
"id": "nr14",
"bookId": "nr",
"question": "Tension-type headache treatments",
"answer": "Acetaminophen, aspirin, NSAIDs, caffeine-containing compounds",
"relatedSectionId": "mk19_a_nr_s1_3_2"
},
"nr15": {
"id": "nr15",
"bookId": "nr",
"question": "Cluster headache prophylaxis options",
"answer": "Verapamil, galcanezumab",
"relatedSectionId": "mk19_a_nr_s1_3_3"
},
"nr16": {
"id": "nr16",
"bookId": "nr",
"question": "Initial TBI imaging test",
"answer": "Noncontrast head CT",
"relatedSectionId": "mk19_a_nr_s2_1"
},
"nr17": {
"id": "nr17",
"bookId": "nr",
"question": "Arterial O<sub>2</sub> and BP goals in severe head injury",
"answer": "Arterial Po<sub>2</sub> &gt;60 mm Hg, SBP &gt;90 mm Hg",
"relatedSectionId": "mk19_a_nr_s2_1_2"
},
"nr18": {
"id": "nr18",
"bookId": "nr",
"question": "Signs of basilar skull fracture",
"answer": "Bilateral periorbital or mastoid bruising, hemotympanum",
"relatedSectionId": "mk19_a_nr_s2_1_2"
},
"nr19": {
"id": "nr19",
"bookId": "nr",
"question": "Head injury, lucid interval, neurologic deterioration",
"answer": "Epidural hematoma",
"relatedSectionId": "mk19_a_nr_s2_1_3"
},
"nr20": {
"id": "nr20",
"bookId": "nr",
"question": "Acute subdural hematoma surgery indications",
"answer": "Hematoma ≥10 mm, GCS score &lt;9, pupillary asymmetry/fixation",
"relatedSectionId": "mk19_a_nr_s2_1_3"
},
"nr21": {
"id": "nr21",
"bookId": "nr",
"question": "Temporal lobe epilepsy symptoms",
"answer": "Aura, loss of awareness, staring, behavior arrest, amnesia",
"relatedSectionId": "mk19_a_nr_s3_2_1"
},
"nr22": {
"id": "nr22",
"bookId": "nr",
"question": "Seizure, tunnel vision, &lt;1 min loss of consciousness, immediate recovery",
"answer": "Convulsive syncope",
"relatedSectionId": "mk19_a_nr_s3_3_2"
},
"nr23": {
"id": "nr23",
"bookId": "nr",
"question": "Evaluation of first unprovoked seizure",
"answer": "MRI and EEG",
"relatedSectionId": "mk19_a_nr_s3_3_2"
},
"nr24": {
"id": "nr24",
"bookId": "nr",
"question": "Features of psychogenic nonepileptic spells",
"answer": "Closed eyes, long duration of waxing/waning shaking, no postictal confusion",
"relatedSectionId": "mk19_a_nr_s3_3_2"
},
"nr25": {
"id": "nr25",
"bookId": "nr",
"question": "Test for psychogenic nonepileptic spells",
"answer": "Video EEG monitoring",
"relatedSectionId": "mk19_a_nr_s3_3_2_1"
},
"nr26": {
"id": "nr26",
"bookId": "nr",
"question": "Confirmatory test for nonconvulsive status epilepticus",
"answer": "Continuous EEG monitoring",
"relatedSectionId": "mk19_a_nr_s3_3_3_2"
},
"nr27": {
"id": "nr27",
"bookId": "nr",
"question": "Unprovoked seizure treatment indications",
"answer": "2 unprovoked seizures or 1 unprovoked seizure with EEG or MRI abnormalities",
"relatedSectionId": "mk19_a_nr_s3_3_4"
},
"nr28": {
"id": "nr28",
"bookId": "nr",
"question": "Seizures not treated with antiepilepsy drugs",
"answer": "Alcohol- or benzodiazepine-withdrawal seizures",
"relatedSectionId": "mk19_a_nr_s3_4_1"
},
"nr29": {
"id": "nr29",
"bookId": "nr",
"question": "Antiepileptic drugs with mood-stabilizing effects",
"answer": "Lamotrigine, valproic acid",
"relatedSectionId": "mk19_a_nr_s3_4_1_1"
},
"nr30": {
"id": "nr30",
"bookId": "nr",
"question": "Seizure type requiring lifelong treatment",
"answer": "Juvenile myoclonic epilepsy",
"relatedSectionId": "mk19_a_nr_s3_4_1_2"
},
"nr31": {
"id": "nr31",
"bookId": "nr",
"question": "Test to determine candidacy for epilepsy surgery",
"answer": "Video EEG monitoring",
"relatedSectionId": "mk19_a_nr_s3_5_2"
},
"nr32": {
"id": "nr32",
"bookId": "nr",
"question": "First-line treatments for epilepsy in older patients",
"answer": "Gabapentin, lamotrigine, levetiracetam",
"relatedSectionId": "mk19_a_nr_s3_6_1"
},
"nr33": {
"id": "nr33",
"bookId": "nr",
"question": "Epilepsy drug therapy for reproductive-age women",
"answer": "Levetiracetam or lamotrigine",
"relatedSectionId": "mk19_a_nr_s3_6_2_1"
},
"nr34": {
"id": "nr34",
"bookId": "nr",
"question": "Status epilepticus therapy for a fosphenytoin-intolerant patient",
"answer": "IV valproic acid, IV levetiracetam",
"relatedSectionId": "mk19_a_nr_s3_7_1"
},
"nr35": {
"id": "nr35",
"bookId": "nr",
"question": "First-line treatment of convulsive status epilepticus",
"answer": "IV benzodiazepines, then IV fosphenytoin",
"relatedSectionId": "mk19_a_nr_s3_7_1"
},
"nr36": {
"id": "nr36",
"bookId": "nr",
"question": "Test for suspected subarachnoid hemorrhage and normal head CT",
"answer": "Lumbar puncture",
"relatedSectionId": "mk19_a_nr_s4_2"
},
"nr37": {
"id": "nr37",
"bookId": "nr",
"question": "Initial TIA vascular study",
"answer": "Carotid duplex ultrasonography",
"relatedSectionId": "mk19_a_nr_s4_3_1"
},
"nr38": {
"id": "nr38",
"bookId": "nr",
"question": "Expedited evaluation for TIA",
"answer": "ICA imaging and monitoring for atrial fibrillation",
"relatedSectionId": "mk19_a_nr_s4_3_1"
},
"nr39": {
"id": "nr39",
"bookId": "nr",
"question": "Outpatient test for embolic stroke of unknown source",
"answer": "Prolonged rhythm monitoring",
"relatedSectionId": "mk19_a_nr_s4_3_2_4"
},
"nr40": {
"id": "nr40",
"bookId": "nr",
"question": "Potential physical exam findings in subarachnoid hemorrhage",
"answer": "Confusion, somnolence, nuchal rigidity, unilateral pupillary dilation, subhyaloid hemorrhages on funduscopy",
"relatedSectionId": "mk19_a_nr_s4_3_3_1"
},
"nr41": {
"id": "nr41",
"bookId": "nr",
"question": "Time to initiation of VTE prophylaxis after hemorrhagic stroke with no evidence of active bleeding",
"answer": "48 hours",
"relatedSectionId": "mk19_a_nr_s4_4_1_1"
},
"nr42": {
"id": "nr42",
"bookId": "nr",
"question": "Goal BP after stroke thrombolysis",
"answer": "&lt;180/105 mm Hg",
"relatedSectionId": "mk19_a_nr_s4_4_1_1"
},
"nr43": {
"id": "nr43",
"bookId": "nr",
"question": "Short-term acute therapy for cardioembolic stroke before anticoagulation",
"answer": "Aspirin",
"relatedSectionId": "mk19_a_nr_s4_4_2"
},
"nr44": {
"id": "nr44",
"bookId": "nr",
"question": "Target SBP in intracerebral hemorrhage",
"answer": "140 mm Hg",
"relatedSectionId": "mk19_a_nr_s4_4_3_1"
},
"nr45": {
"id": "nr45",
"bookId": "nr",
"question": "Indication for surgical evacuation in intracerebral hemorrhage",
"answer": "Cerebellar hemorrhage &gt;3 cm",
"relatedSectionId": "mk19_a_nr_s4_4_3_1"
},
"nr46": {
"id": "nr46",
"bookId": "nr",
"question": "Drug treatment of subarachnoid hemorrhage",
"answer": "Nimodipine",
"relatedSectionId": "mk19_a_nr_s4_4_3_2"
},
"nr47": {
"id": "nr47",
"bookId": "nr",
"question": "Indications for posterior circulation aneurysm surgery",
"answer": "Symptomatic aneurysms, aneurysms &gt;7 mm",
"relatedSectionId": "mk19_a_nr_s4_5_1"
},
"nr48": {
"id": "nr48",
"bookId": "nr",
"question": "Indication for stenting in intracranial atherosclerosis for secondary stroke prevention",
"answer": "None",
"relatedSectionId": "mk19_a_nr_s4_5_1"
},
"nr49": {
"id": "nr49",
"bookId": "nr",
"question": "Management of asymptomatic carotid stenosis &lt;80%",
"answer": "Statin therapy",
"relatedSectionId": "mk19_a_nr_s4_5_1"
},
"nr50": {
"id": "nr50",
"bookId": "nr",
"question": "Asymptomatic ICA revascularization indication",
"answer": "Stenosis &gt;80%",
"relatedSectionId": "mk19_a_nr_s4_5_1"
},
"nr51": {
"id": "nr51",
"bookId": "nr",
"question": "Antiplatelets for secondary prevention of stroke",
"answer": "Aspirin, clopidogrel, or aspirin-dipyridamole",
"relatedSectionId": "mk19_a_nr_s4_5_2_1"
},
"nr52": {
"id": "nr52",
"bookId": "nr",
"question": "Threshold stenosis for carotid endarterectomy for secondary stroke prevention",
"answer": "70%",
"relatedSectionId": "mk19_a_nr_s4_5_2_2"
},
"nr53": {
"id": "nr53",
"bookId": "nr",
"question": "Treatment of ischemic stroke–related symptomatic cerebral edema",
"answer": "Decompressive hemicraniectomy",
"relatedSectionId": "mk19_a_nr_s4_7_1"
},
"nr54": {
"id": "nr54",
"bookId": "nr",
"question": "CSF findings that predict Alzheimer disease",
"answer": "Decreased Aβ42 peptide, increased tau protein and p-tau",
"relatedSectionId": "mk19_a_nr_s5_2"
},
"nr55": {
"id": "nr55",
"bookId": "nr",
"question": "Blood tests for slowly progressive dementia",
"answer": "Serum chemistries, CBC, vitamin B<sub>12</sub>, TSH; consider RPR",
"relatedSectionId": "mk19_a_nr_s5_2"
},
"nr56": {
"id": "nr56",
"bookId": "nr",
"question": "Cognitive decline greater than expected for age without significant functional disability",
"answer": "MCI",
"relatedSectionId": "mk19_a_nr_s5_4"
},
"nr57": {
"id": "nr57",
"bookId": "nr",
"question": "Medication to prevent progression of MCI to dementia",
"answer": "None",
"relatedSectionId": "mk19_a_nr_s5_4_1"
},
"nr58": {
"id": "nr58",
"bookId": "nr",
"question": "Mild to moderate Alzheimer disease drug treatment",
"answer": "Acetylcholinesterase inhibitors donepezil, rivastigmine, galantamine",
"relatedSectionId": "mk19_a_nr_s5_5_1_1_2"
},
"nr59": {
"id": "nr59",
"bookId": "nr",
"question": "Cholinesterase inhibitor contraindications",
"answer": "Bradycardia, sick sinus syndrome, LBBB",
"relatedSectionId": "mk19_a_nr_s5_5_1_1_2"
},
"nr60": {
"id": "nr60",
"bookId": "nr",
"question": "Diagnosis suggested by dementia, apathy, disinhibition, changes in eating behaviors, hyperorality, compulsiveness",
"answer": "Behavioral-variant frontotemporal dementia",
"relatedSectionId": "mk19_a_nr_s5_5_1_2"
},
"nr61": {
"id": "nr61",
"bookId": "nr",
"question": "Diagnosis suggested by language loss before cognitive dysfunction",
"answer": "Language-variant frontotemporal dementia (primary progressive aphasia)",
"relatedSectionId": "mk19_a_nr_s5_5_1_2"
},
"nr62": {
"id": "nr62",
"bookId": "nr",
"question": "Cognitive slowing, disorganized thought processing, parkinsonism after head trauma",
"answer": "Traumatic encephalopathy syndrome",
"relatedSectionId": "mk19_a_nr_s5_5_1_4"
},
"nr63": {
"id": "nr63",
"bookId": "nr",
"question": "Effect of first-generation neuroleptics in dementia with Lewy bodies",
"answer": "Worsening of symptoms resembling neuroleptic malignant syndrome",
"relatedSectionId": "mk19_a_nr_s5_5_2_1"
},
"nr64": {
"id": "nr64",
"bookId": "nr",
"question": "Medication for behavioral symptoms of dementia with Lewy bodies",
"answer": "Acetylcholinesterase inhibitors",
"relatedSectionId": "mk19_a_nr_s5_5_2_1_2"
},
"nr65": {
"id": "nr65",
"bookId": "nr",
"question": "Procedure confirming normal pressure hydrocephalus diagnosis",
"answer": "Lumbar puncture with opening pressure and large-volume CSF removal",
"relatedSectionId": "mk19_a_nr_s5_5_2_2_1"
},
"nr66": {
"id": "nr66",
"bookId": "nr",
"question": "MRI finding of normal pressure hydrocephalus",
"answer": "Ventriculomegaly",
"relatedSectionId": "mk19_a_nr_s5_5_2_2_1"
},
"nr67": {
"id": "nr67",
"bookId": "nr",
"question": "Two major signs of vascular cognitive impairment",
"answer": "Early gait impairment, pseudobulbar affect (“emotional incontinence”)",
"relatedSectionId": "mk19_a_nr_s5_5_2_3"
},
"nr68": {
"id": "nr68",
"bookId": "nr",
"question": "Treatment of vascular cognitive impairment",
"answer": "Cerebrovascular risk factor modification and acetylcholinesterase inhibitors",
"relatedSectionId": "mk19_a_nr_s5_5_2_3_2"
},
"nr69": {
"id": "nr69",
"bookId": "nr",
"question": "Rapidly progressive dementia, myoclonus, gait problems, visual compromise",
"answer": "Creutzfeldt-Jakob disease",
"relatedSectionId": "mk19_a_nr_s5_5_2_4"
},
"nr70": {
"id": "nr70",
"bookId": "nr",
"question": "Risk of antipsychotic agents in dementia",
"answer": "Increased mortality in older persons",
"relatedSectionId": "mk19_a_nr_s5_5_3"
},
"nr71": {
"id": "nr71",
"bookId": "nr",
"question": "Dopamine transporter scan indication",
"answer": "Differentiate Parkinson disease from essential tremor or drug-induced parkinsonism",
"relatedSectionId": "mk19_a_nr_s6_2_1_2"
},
"nr72": {
"id": "nr72",
"bookId": "nr",
"question": "Screening for backward falls in Parkinson disease",
"answer": "Pull test",
"relatedSectionId": "mk19_a_nr_s6_2_1_3"
},
"nr73": {
"id": "nr73",
"bookId": "nr",
"question": "Indication for deep brain stimulation in Parkinson disease",
"answer": "Responsive to but intolerant of carbidopa-levodopa",
"relatedSectionId": "mk19_a_nr_s6_2_1_4"
},
"nr74": {
"id": "nr74",
"bookId": "nr",
"question": "Adverse events associated with dopamine agonists",
"answer": "Psychosis, impulse control disorder, sleep attacks, confusion",
"relatedSectionId": "mk19_a_nr_s6_2_1_4"
},
"nr75": {
"id": "nr75",
"bookId": "nr",
"question": "Initial Parkinson disease therapy for patients aged &lt;60 years with high dyskinesia risk",
"answer": "Pramipexole or ropinirole",
"relatedSectionId": "mk19_a_nr_s6_2_1_4"
},
"nr76": {
"id": "nr76",
"bookId": "nr",
"question": "Initial Parkinson disease therapy for motor symptoms",
"answer": "Levodopa",
"relatedSectionId": "mk19_a_nr_s6_2_1_4"
},
"nr77": {
"id": "nr77",
"bookId": "nr",
"question": "Parkinsonism, cerebellar ataxia, dysautonomia, falls",
"answer": "Multiple system atrophy",
"relatedSectionId": "mk19_a_nr_s6_2_2"
},
"nr78": {
"id": "nr78",
"bookId": "nr",
"question": "Action and rest tremor, dystonia, a null point",
"answer": "Dystonic tremor",
"relatedSectionId": "mk19_a_nr_s6_3_1"
},
"nr79": {
"id": "nr79",
"bookId": "nr",
"question": "Essential tremor drug treatment",
"answer": "Propranolol, primidone, or topiramate",
"relatedSectionId": "mk19_a_nr_s6_3_1"
},
"nr80": {
"id": "nr80",
"bookId": "nr",
"question": "Nonrandom, repetitive, directional twisting and posturing movements",
"answer": "Dystonia",
"relatedSectionId": "mk19_a_nr_s6_3_2"
},
"nr81": {
"id": "nr81",
"bookId": "nr",
"question": "Chorea, ataxia, psychiatric disease",
"answer": "Huntington disease",
"relatedSectionId": "mk19_a_nr_s6_3_3"
},
"nr82": {
"id": "nr82",
"bookId": "nr",
"question": "Myoclonus after hypoxic brain injury",
"answer": "Posthypoxic myoclonus",
"relatedSectionId": "mk19_a_nr_s6_3_4"
},
"nr83": {
"id": "nr83",
"bookId": "nr",
"question": "Drug therapies for Tourette syndrome",
"answer": "Clonidine, guanfacine, topiramate, levetiracetam, tetrabenazine",
"relatedSectionId": "mk19_a_nr_s6_3_5"
},
"nr84": {
"id": "nr84",
"bookId": "nr",
"question": "Sleep disorder and triple-flexion leg kicks",
"answer": "Periodic limb movements of sleep",
"relatedSectionId": "mk19_a_nr_s6_3_6"
},
"nr85": {
"id": "nr85",
"bookId": "nr",
"question": "Restless leg syndrome evaluation",
"answer": "Iron studies",
"relatedSectionId": "mk19_a_nr_s6_3_6"
},
"nr86": {
"id": "nr86",
"bookId": "nr",
"question": "Diagnostic test for periodic limb movements of sleep",
"answer": "Polysomnography",
"relatedSectionId": "mk19_a_nr_s6_3_6"
},
"nr87": {
"id": "nr87",
"bookId": "nr",
"question": "Dopamine-blocking agent–related movement disorder",
"answer": "Tardive dyskinesia",
"relatedSectionId": "mk19_a_nr_s6_3_7_1"
},
"nr88": {
"id": "nr88",
"bookId": "nr",
"question": "Dopamine-blocking therapy, fever, confusion, rigidity, elevated CK",
"answer": "Neuroleptic malignant syndrome",
"relatedSectionId": "mk19_a_nr_s6_3_7_2"
},
"nr89": {
"id": "nr89",
"bookId": "nr",
"question": "MS exacerbation treatment",
"answer": "High-dose glucocorticoids",
"relatedSectionId": "mk19_a_nr_s7_3_2"
},
"nr90": {
"id": "nr90",
"bookId": "nr",
"question": "First-line treatment of relapsing-remitting MS",
"answer": "Glatiramer acetate or interferon beta",
"relatedSectionId": "mk19_a_nr_s7_3_3"
},
"nr91": {
"id": "nr91",
"bookId": "nr",
"question": "Secondary progressive MS treatment",
"answer": "Mitoxantrone",
"relatedSectionId": "mk19_a_nr_s7_3_3"
},
"nr92": {
"id": "nr92",
"bookId": "nr",
"question": "Primary progressive MS treatment",
"answer": "Ocrelizumab",
"relatedSectionId": "mk19_a_nr_s7_3_3"
},
"nr93": {
"id": "nr93",
"bookId": "nr",
"question": "Required monitoring with fingolimod therapy",
"answer": "Ophthalmic examinations (macular edema)",
"relatedSectionId": "mk19_a_nr_s7_3_3"
},
"nr94": {
"id": "nr94",
"bookId": "nr",
"question": "Neurologic complication of natalizumab therapy",
"answer": "Multifocal leukoencephalopathy",
"relatedSectionId": "mk19_a_nr_s7_3_3"
},
"nr95": {
"id": "nr95",
"bookId": "nr",
"question": "MS fatigue drug treatment",
"answer": "Modafinil, armodafinil, amantadine",
"relatedSectionId": "mk19_a_nr_s7_3_4"
},
"nr96": {
"id": "nr96",
"bookId": "nr",
"question": "MS medication for impaired mobility",
"answer": "Dalfampridine",
"relatedSectionId": "mk19_a_nr_s7_3_4"
},
"nr97": {
"id": "nr97",
"bookId": "nr",
"question": "Test for suspected spinal cord compression",
"answer": "Emergent MRI",
"relatedSectionId": "mk19_a_nr_s8_2_2"
},
"nr98": {
"id": "nr98",
"bookId": "nr",
"question": "Treatment for metastatic spinal cord compression",
"answer": "Glucocorticoids, decompressive surgery, or radiation therapy",
"relatedSectionId": "mk19_a_nr_s8_2_3"
},
"nr99": {
"id": "nr99",
"bookId": "nr",
"question": "Complete myelitis, no CSF oligoclonal bands or IgG index, no brain MRI lesions",
"answer": "Idiopathic transverse myelitis",
"relatedSectionId": "mk19_a_nr_s8_3_1"
},
"nr100": {
"id": "nr100",
"bookId": "nr",
"question": "Initial treatment of idiopathic transverse myelitis",
"answer": "IV methylprednisolone",
"relatedSectionId": "mk19_a_nr_s8_3_1"
},
"nr101": {
"id": "nr101",
"bookId": "nr",
"question": "Treatment of refractory idiopathic transverse myelitis",
"answer": "Plasmapheresis and/or cyclophosphamide",
"relatedSectionId": "mk19_a_nr_s8_3_1"
},
"nr102": {
"id": "nr102",
"bookId": "nr",
"question": "Common causes of subacute combined degeneration",
"answer": "Vitamin B<sub>12</sub> and copper deficiencies",
"relatedSectionId": "mk19_a_nr_s8_3_2"
},
"nr103": {
"id": "nr103",
"bookId": "nr",
"question": "Syndrome of progressive weakness with spasticity, reduced vibration/position sense, ataxia",
"answer": "Subacute combined degeneration",
"relatedSectionId": "mk19_a_nr_s8_3_2"
},
"nr104": {
"id": "nr104",
"bookId": "nr",
"question": "Flaccid paralysis after prolonged aortic surgery",
"answer": "Anterior spinal artery infarct",
"relatedSectionId": "mk19_a_nr_s8_3_3"
},
"nr105": {
"id": "nr105",
"bookId": "nr",
"question": "Carpal tunnel syndrome surgery indications",
"answer": "Weakness, thenar atrophy, refractory pain, active denervation on EMG",
"relatedSectionId": "mk19_a_nr_s9_2_2_1"
},
"nr106": {
"id": "nr106",
"bookId": "nr",
"question": "Bell palsy treatment",
"answer": "Prednisone",
"relatedSectionId": "mk19_a_nr_s9_2_2_3"
},
"nr107": {
"id": "nr107",
"bookId": "nr",
"question": "Subacute transient shoulder pain followed by progressive weakness",
"answer": "Idiopathic brachial plexopathy",
"relatedSectionId": "mk19_a_nr_s9_2_2_4"
},
"nr108": {
"id": "nr108",
"bookId": "nr",
"question": "Diabetes-related acute truncal dermatomal pain and paresthesia",
"answer": "Diabetic mononeuropathy",
"relatedSectionId": "mk19_a_nr_s9_2_3_1"
},
"nr109": {
"id": "nr109",
"bookId": "nr",
"question": "Test for Miller-Fisher variant of GBS",
"answer": "Antibodies to GQ1b ganglioside protein",
"relatedSectionId": "mk19_a_nr_s9_2_3_3_1"
},
"nr110": {
"id": "nr110",
"bookId": "nr",
"question": "Respiratory function monitoring in GBS",
"answer": "Serial FVC and negative inspiratory force",
"relatedSectionId": "mk19_a_nr_s9_2_3_3_1"
},
"nr111": {
"id": "nr111",
"bookId": "nr",
"question": "Guillain-Barré syndrome treatment",
"answer": "Plasmapheresis or IVIG",
"relatedSectionId": "mk19_a_nr_s9_2_3_3_1"
},
"nr112": {
"id": "nr112",
"bookId": "nr",
"question": "Peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes",
"answer": "POEMS syndrome",
"relatedSectionId": "mk19_a_nr_s9_2_3_5"
},
"nr113": {
"id": "nr113",
"bookId": "nr",
"question": "Familial amyloidosis genetic test",
"answer": "Transthyretin (<i>TTR</i>) genetic testing",
"relatedSectionId": "mk19_a_nr_s9_2_3_6"
},
"nr114": {
"id": "nr114",
"bookId": "nr",
"question": "Upper and lower motor neuron signs without sensory involvement",
"answer": "ALS",
"relatedSectionId": "mk19_a_nr_s9_3"
},
"nr115": {
"id": "nr115",
"bookId": "nr",
"question": "ALS drug treatment",
"answer": "Riluzole, edaravone",
"relatedSectionId": "mk19_a_nr_s9_3"
},
"nr116": {
"id": "nr116",
"bookId": "nr",
"question": "Initial treatment of ocular and mild generalized myasthenia",
"answer": "Pyridostigmine",
"relatedSectionId": "mk19_a_nr_s9_4_1"
},
"nr117": {
"id": "nr117",
"bookId": "nr",
"question": "Medications that may exacerbate myasthenia gravis",
"answer": "Aminoglycosides, fluoroquinolones, magnesium, β-blockers, hydroxychloroquine",
"relatedSectionId": "mk19_a_nr_s9_4_1"
},
"nr118": {
"id": "nr118",
"bookId": "nr",
"question": "Antibody test in myasthenia gravis with weakness of cervical extension",
"answer": "Anti–muscle-specific kinase (MuSK)",
"relatedSectionId": "mk19_a_nr_s9_4_1"
},
"nr119": {
"id": "nr119",
"bookId": "nr",
"question": "Treatment of immune-mediated necrotizing myopathy",
"answer": "Prednisone and discontinuation of statin",
"relatedSectionId": "mk19_a_nr_s9_5_2"
},
"nr120": {
"id": "nr120",
"bookId": "nr",
"question": "Exercise-induced weakness, cramping, myoglobinuria",
"answer": "McArdle disease",
"relatedSectionId": "mk19_a_nr_s9_5_5"
},
"nr121": {
"id": "nr121",
"bookId": "nr",
"question": "Meningioma resection indications",
"answer": "Neurologic deficits, drug-resistant seizures, severe headaches, peritumoral edema",
"relatedSectionId": "mk19_a_nr_s10_3_1"
},
"nr122": {
"id": "nr122",
"bookId": "nr",
"question": "Test in biopsy-inaccessible suspected primary CNS lymphoma",
"answer": "Vitreous fluid sampling",
"relatedSectionId": "mk19_a_nr_s10_3_3"
},
"nr123": {
"id": "nr123",
"bookId": "nr",
"question": "Emergent treatment of brain tumor–related herniation",
"answer": "Dexamethasone",
"relatedSectionId": "mk19_a_nr_s10_4_2"
},
"nr124": {
"id": "nr124",
"bookId": "nr",
"question": "Emergent treatment of brain herniation",
"answer": "Elevation of the head of the bed, hyperventilation, mannitol, glucocorticoids",
"relatedSectionId": "mk19_a_nr_s10_4_2"
},
"nr125": {
"id": "nr125",
"bookId": "nr",
"question": "Initial treatment of PE in primary brain tumor",
"answer": "IV heparin",
"relatedSectionId": "mk19_a_nr_s10_4_3"
},
"nr126": {
"id": "nr126",
"bookId": "nr",
"question": "VTE treatment in CNS malignancy",
"answer": "Therapeutic anticoagulation",
"relatedSectionId": "mk19_a_nr_s10_4_3"
},
"nr127": {
"id": "nr127",
"bookId": "nr",
"question": "Autoimmune cause of choreoathetosis, psychosis, seizures, autonomic instability",
"answer": "Anti-NMDAR antibody encephalitis",
"relatedSectionId": "mk19_a_nr_s10_5"
},
"nr128": {
"id": "nr128",
"bookId": "nr",
"question": "New-onset status epilepticus, subacute progressive confusion, normal MRI",
"answer": "Autoimmune limbic encephalitis",
"relatedSectionId": "mk19_a_nr_s10_5"
},
"on1": {
"id": "on1",
"bookId": "on",
"question": "Preferred term for “progression-free survival”",
"answer": "“Progression-free interval”",
"relatedSectionId": "mk19_a_on_s1_5"
},
"on2": {
"id": "on2",
"bookId": "on",
"question": "Checkpoint inhibitor toxicity",
"answer": "Autoimmune disease",
"relatedSectionId": "mk19_a_on_s1_6_3"
},
"on3": {
"id": "on3",
"bookId": "on",
"question": "Prevention of <i>BRCA</i>-mutation ovarian cancer",
"answer": "Bilateral salpingo-oophorectomy",
"relatedSectionId": "mk19_a_on_s2_3"
},
"on4": {
"id": "on4",
"bookId": "on",
"question": "Genetic mutation indication for annual mammography and breast MRI",
"answer": "<i>BRCA</i> gene mutation",
"relatedSectionId": "mk19_a_on_s2_3"
},
"on5": {
"id": "on5",
"bookId": "on",
"question": "Treatment of breast cancer with <i>HER2</i> overexpression",
"answer": "Trastuzumab",
"relatedSectionId": "mk19_a_on_s2_4"
},
"on6": {
"id": "on6",
"bookId": "on",
"question": "Mammogram features of ductal carcinoma in situ",
"answer": "Calcifications",
"relatedSectionId": "mk19_a_on_s2_5_1"
},
"on7": {
"id": "on7",
"bookId": "on",
"question": "Treatment of extensive ductal carcinoma in situ",
"answer": "Mastectomy",
"relatedSectionId": "mk19_a_on_s2_5_1"
},
"on8": {
"id": "on8",
"bookId": "on",
"question": "Surgical breast cancer staging with clinically negative axillary nodes",
"answer": "Sentinel node biopsy",
"relatedSectionId": "mk19_a_on_s2_5_2"
},
"on9": {
"id": "on9",
"bookId": "on",
"question": "Scaly red rash with ulceration of the nipple and areola",
"answer": "Paget disease of the breast",
"relatedSectionId": "mk19_a_on_s2_5_2"
},
"on10": {
"id": "on10",
"bookId": "on",
"question": "Antiestrogen therapy not effective in premenopausal women",
"answer": "Aromatase inhibitors (letrozole, anastrozole)",
"relatedSectionId": "mk19_a_on_s2_6_1"
},
"on11": {
"id": "on11",
"bookId": "on",
"question": "Duration of postmenopausal breast cancer endocrine therapy",
"answer": "5-10 years",
"relatedSectionId": "mk19_a_on_s2_6_1"
},
"on12": {
"id": "on12",
"bookId": "on",
"question": "Breast cancer hormone therapy associated with musculoskeletal syndrome",
"answer": "Aromatase inhibitors (letrozole, anastrozole)",
"relatedSectionId": "mk19_a_on_s2_6_1"
},
"on13": {
"id": "on13",
"bookId": "on",
"question": "Adjuvant treatment of premenopausal, hormone receptor-positive, low-risk breast cancer",
"answer": "Tamoxifen",
"relatedSectionId": "mk19_a_on_s2_6_1"
},
"on14": {
"id": "on14",
"bookId": "on",
"question": "Treatment of premenopausal hormone receptor–positive, high-risk early breast cancer",
"answer": "Ovarian suppression (leuprolide) plus antiestrogen therapy (exemestane)",
"relatedSectionId": "mk19_a_on_s2_6_1"
},
"on15": {
"id": "on15",
"bookId": "on",
"question": "Adverse effects of trastuzumab",
"answer": "Infusion reactions and cardiomyopathy",
"relatedSectionId": "mk19_a_on_s2_6_2"
},
"on16": {
"id": "on16",
"bookId": "on",
"question": "Fertility preservation in women undergoing adjuvant chemotherapy",
"answer": "Oocyte or embryo banking",
"relatedSectionId": "mk19_a_on_s2_6_2"
},
"on17": {
"id": "on17",
"bookId": "on",
"question": "Breast cancer mimic of infectious mastitis",
"answer": "Inflammatory breast cancer",
"relatedSectionId": "mk19_a_on_s2_7"
},
"on18": {
"id": "on18",
"bookId": "on",
"question": "Role of routine breast cancer surveillance blood tests and imaging studies",
"answer": "None",
"relatedSectionId": "mk19_a_on_s2_8"
},
"on19": {
"id": "on19",
"bookId": "on",
"question": "Management of lymphedema after axillary dissection",
"answer": "Physical therapy",
"relatedSectionId": "mk19_a_on_s2_8"
},
"on20": {
"id": "on20",
"bookId": "on",
"question": "Management of nocturnal hot flushes post breast cancer therapy",
"answer": "Gabapentin",
"relatedSectionId": "mk19_a_on_s2_8"
},
"on21": {
"id": "on21",
"bookId": "on",
"question": "Treatment of breast cancer with bone metastases",
"answer": "Chemotherapy and bisphosphonates",
"relatedSectionId": "mk19_a_on_s2_9"
},
"on22": {
"id": "on22",
"bookId": "on",
"question": "Painful bone metastases treatment",
"answer": "Radiation therapy",
"relatedSectionId": "mk19_a_on_s2_9"
},
"on23": {
"id": "on23",
"bookId": "on",
"question": "Diagnostic management of presumed breast cancer metastases",
"answer": "Biopsy, assess hormone receptor and <i>HER2</i> status",
"relatedSectionId": "mk19_a_on_s2_9"
},
"on24": {
"id": "on24",
"bookId": "on",
"question": "Most common ovarian cancer susceptibility genes",
"answer": "<i>BRCA</i> and mismatch repair genes",
"relatedSectionId": "mk19_a_on_s3_1"
},
"on25": {
"id": "on25",
"bookId": "on",
"question": "Genetic testing for women with epithelial ovarian cancer",
"answer": "<i>BRCA1</i> and <i>BRCA2</i>",
"relatedSectionId": "mk19_a_on_s3_1"
},
"on26": {
"id": "on26",
"bookId": "on",
"question": "Criteria for genetic testing in women with ovarian cancer",
"answer": "Should be offered to all women with ovarian cancer",
"relatedSectionId": "mk19_a_on_s3_1"
},
"on27": {
"id": "on27",
"bookId": "on",
"question": "Treatment of stage III ovarian cancer after surgical debulking",
"answer": "IV and intraperitoneal chemotherapy",
"relatedSectionId": "mk19_a_on_s3_4"
},
"on28": {
"id": "on28",
"bookId": "on",
"question": "Ovarian cancer posttreatment surveillance",
"answer": "History and physical exam",
"relatedSectionId": "mk19_a_on_s3_5"
},
"on29": {
"id": "on29",
"bookId": "on",
"question": "Effective cervical cancer prevention",
"answer": "HPV vaccination",
"relatedSectionId": "mk19_a_on_s4_1"
},
"on30": {
"id": "on30",
"bookId": "on",
"question": "Fertility-preserving treatment of stage IA cervical cancer",
"answer": "Conization",
"relatedSectionId": "mk19_a_on_s4_2"
},
"on31": {
"id": "on31",
"bookId": "on",
"question": "Cervical cancer posttreatment surveillance",
"answer": "History and physical examination",
"relatedSectionId": "mk19_a_on_s4_3"
},
"on32": {
"id": "on32",
"bookId": "on",
"question": "Role of PET scans in colorectal cancer management",
"answer": "None",
"relatedSectionId": "mk19_a_on_s5_1_1"
},
"on33": {
"id": "on33",
"bookId": "on",
"question": "Stage I rectal cancer treatment",
"answer": "Surgical resection",
"relatedSectionId": "mk19_a_on_s5_1_2_1"
},
"on34": {
"id": "on34",
"bookId": "on",
"question": "Stage II or III rectal cancer adjuvant treatment options",
"answer": "Irradiation or chemotherapy",
"relatedSectionId": "mk19_a_on_s5_1_2_1"
},
"on35": {
"id": "on35",
"bookId": "on",
"question": "Low-risk stage I-II colorectal cancer adjuvant treatment",
"answer": "None",
"relatedSectionId": "mk19_a_on_s5_1_2_1"
},
"on36": {
"id": "on36",
"bookId": "on",
"question": "Treatment of oligometastatic colorectal cancer",
"answer": "Surgical resection",
"relatedSectionId": "mk19_a_on_s5_1_2_2"
},
"on37": {
"id": "on37",
"bookId": "on",
"question": "Stage III colorectal cancer adjuvant treatment",
"answer": "Chemotherapy (e.g., FOLFOX)",
"relatedSectionId": "mk19_a_on_s5_1_2_2"
},
"on38": {
"id": "on38",
"bookId": "on",
"question": "Role of routine radiation therapy for colon cancer",
"answer": "None",
"relatedSectionId": "mk19_a_on_s5_1_2_2"
},
"on39": {
"id": "on39",
"bookId": "on",
"question": "Genetic studies for metastatic colorectal cancer",
"answer": "<i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i>, mismatch repair genes",
"relatedSectionId": "mk19_a_on_s5_1_3"
},
"on40": {
"id": "on40",
"bookId": "on",
"question": "Major chemotherapeutic agent for most metastatic colorectal cancers",
"answer": "5-FU",
"relatedSectionId": "mk19_a_on_s5_1_3"
},
"on41": {
"id": "on41",
"bookId": "on",
"question": "Panitumumab and cetuximab common skin adverse effect",
"answer": "Acneiform rash (painful)",
"relatedSectionId": "mk19_a_on_s5_1_3"
},
"on42": {
"id": "on42",
"bookId": "on",
"question": "Antibody that potentiates metastatic colon cancer chemotherapy",
"answer": "Bevacizumab",
"relatedSectionId": "mk19_a_on_s5_1_3"
},
"on43": {
"id": "on43",
"bookId": "on",
"question": "Anal cancer associated virus",
"answer": "HPV",
"relatedSectionId": "mk19_a_on_s5_2"
},
"on44": {
"id": "on44",
"bookId": "on",
"question": "Treatment of locally invasive advanced anal cancer",
"answer": "Irradiation and concurrent chemotherapy",
"relatedSectionId": "mk19_a_on_s5_2"
},
"on45": {
"id": "on45",
"bookId": "on",
"question": "Role of surgery for anal cancer",
"answer": "Local recurrence or incomplete response to irradiation and chemotherapy",
"relatedSectionId": "mk19_a_on_s5_2"
},
"on46": {
"id": "on46",
"bookId": "on",
"question": "Role of routine PET scans in pancreatic cancer management",
"answer": "None",
"relatedSectionId": "mk19_a_on_s5_3"
},
"on47": {
"id": "on47",
"bookId": "on",
"question": "Resected pancreatic cancer adjuvant treatment",
"answer": "Chemotherapy (gemcitabine, capecitabine)",
"relatedSectionId": "mk19_a_on_s5_3"
},
"on48": {
"id": "on48",
"bookId": "on",
"question": "Procedure to determine esophageal cancer depth and involved lymph nodes",
"answer": "Endoscopic ultrasound",
"relatedSectionId": "mk19_a_on_s5_4"
},
"on49": {
"id": "on49",
"bookId": "on",
"question": "Hormonal testing for upper gastrointestinal tumors",
"answer": "\n        <i>HER2</i>\n      ",
"relatedSectionId": "mk19_a_on_s5_4"
},
"on50": {
"id": "on50",
"bookId": "on",
"question": "Infection associated with gastric mucosa-associated lymphoid tissue lymphoma",
"answer": "\n        <i>Helicobacter pylori</i>\n      ",
"relatedSectionId": "mk19_a_on_s5_5"
},
"on51": {
"id": "on51",
"bookId": "on",
"question": "Liver metastases, diarrhea, facial flushing",
"answer": "Gastrointestinal neuroendocrine tumor",
"relatedSectionId": "mk19_a_on_s5_6"
},
"on52": {
"id": "on52",
"bookId": "on",
"question": "Initial management of nonfunctional metastatic neuroendocrine tumors",
"answer": "Observation",
"relatedSectionId": "mk19_a_on_s5_6"
},
"on53": {
"id": "on53",
"bookId": "on",
"question": "Genetic marker in gastrointestinal stromal tumors",
"answer": "Overexpression of <i>KIT</i> gene",
"relatedSectionId": "mk19_a_on_s5_7"
},
"on54": {
"id": "on54",
"bookId": "on",
"question": "Therapy following resection of high-risk gastrointestinal stromal tumors",
"answer": "Imatinib",
"relatedSectionId": "mk19_a_on_s5_7"
},
"on55": {
"id": "on55",
"bookId": "on",
"question": "Assessment of pulmonary reserve before lung cancer lobectomy",
"answer": "FEV<sub>1</sub> and DLCO",
"relatedSectionId": "mk19_a_on_s6_1_1"
},
"on56": {
"id": "on56",
"bookId": "on",
"question": "Treatment of nonresectable early-stage lung cancer",
"answer": "Irradiation",
"relatedSectionId": "mk19_a_on_s6_1_1"
},
"on57": {
"id": "on57",
"bookId": "on",
"question": "Stage II-III NSCLC treatment",
"answer": "Surgery and cisplatin-based chemotherapy",
"relatedSectionId": "mk19_a_on_s6_1_1"
},
"on58": {
"id": "on58",
"bookId": "on",
"question": "Metastatic NSCLC treatment in absence of driver mutations",
"answer": "Platinum-based chemotherapy",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on59": {
"id": "on59",
"bookId": "on",
"question": "Genetic testing for all nonsquamous metastatic NSCLC",
"answer": "<i>EGFR</i>, <i>ALK</i>, <i>ROS1</i> genes",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on60": {
"id": "on60",
"bookId": "on",
"question": "Treatment of EGFR-positive NSCLC",
"answer": "Erlotinib or osimertinib",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on61": {
"id": "on61",
"bookId": "on",
"question": "Metastatic NSCLC cancer treatment after response to first-line chemotherapy",
"answer": "Maintenance chemotherapy",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on62": {
"id": "on62",
"bookId": "on",
"question": "Treatment of metastatic NSCLC positive for <i>PD-L1</i>",
"answer": "Pembrolizumab",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on63": {
"id": "on63",
"bookId": "on",
"question": "Testing for all patients with metastatic NSCLC to guide therapy",
"answer": "<i>PDL1</i> expression",
"relatedSectionId": "mk19_a_on_s6_1_3"
},
"on64": {
"id": "on64",
"bookId": "on",
"question": "Treatment of limited SCLC",
"answer": "Concurrent chemotherapy and irradiation",
"relatedSectionId": "mk19_a_on_s6_2"
},
"on65": {
"id": "on65",
"bookId": "on",
"question": "SCLC staging procedures",
"answer": "Bone scan; brain MRI; chest, abdomen, pelvis CT",
"relatedSectionId": "mk19_a_on_s6_2"
},
"on66": {
"id": "on66",
"bookId": "on",
"question": "Complication of cranial irradiation in older patients with SCLC",
"answer": "Cognitive impairment",
"relatedSectionId": "mk19_a_on_s6_2"
},
"on67": {
"id": "on67",
"bookId": "on",
"question": "Infectious agent with increased risk of oropharynx cancers",
"answer": "HPV",
"relatedSectionId": "mk19_a_on_s7_1"
},
"on68": {
"id": "on68",
"bookId": "on",
"question": "Biopsy procedure for suspected head and neck cancer",
"answer": "Fine-needle aspiration",
"relatedSectionId": "mk19_a_on_s7_3"
},
"on69": {
"id": "on69",
"bookId": "on",
"question": "Oropharynx cancer with positive p16 stain",
"answer": "HPV positive",
"relatedSectionId": "mk19_a_on_s7_3"
},
"on70": {
"id": "on70",
"bookId": "on",
"question": "Treatment of locally advanced head and neck cancer",
"answer": "Irradiation plus either cetuximab or chemotherapy",
"relatedSectionId": "mk19_a_on_s7_4"
},
"on71": {
"id": "on71",
"bookId": "on",
"question": "Therapy of advanced programmed death ligand 1–positive head and neck cancer",
"answer": "Pembrolizumab alone with platinum chemotherapy",
"relatedSectionId": "mk19_a_on_s7_6"
},
"on72": {
"id": "on72",
"bookId": "on",
"question": "Genetic testing for metastatic prostate cancer",
"answer": "<i>BRCA</i> gene mutation",
"relatedSectionId": "mk19_a_on_s8_1_2"
},
"on73": {
"id": "on73",
"bookId": "on",
"question": "Treatment of high-risk prostate cancer",
"answer": "Combined radiation and GnRH therapy",
"relatedSectionId": "mk19_a_on_s8_1_3"
},
"on74": {
"id": "on74",
"bookId": "on",
"question": "Nontreatment option for low-risk prostate cancer",
"answer": "Active surveillance",
"relatedSectionId": "mk19_a_on_s8_1_3"
},
"on75": {
"id": "on75",
"bookId": "on",
"question": "Management of asymptomatic early-stage prostate cancer with multiple comorbidities",
"answer": "Observation",
"relatedSectionId": "mk19_a_on_s8_1_3"
},
"on76": {
"id": "on76",
"bookId": "on",
"question": "Bone complication of androgen deprivation therapy",
"answer": "Osteoporosis",
"relatedSectionId": "mk19_a_on_s8_1_3"
},
"on77": {
"id": "on77",
"bookId": "on",
"question": "Prevent flare reactions when starting GnRH agonist for metastatic prostate cancer",
"answer": "Antiandrogen therapy",
"relatedSectionId": "mk19_a_on_s8_1_4"
},
"on78": {
"id": "on78",
"bookId": "on",
"question": "Lower fracture risk in men with castrate-resistant metastatic prostate cancer",
"answer": "Bisphosphonates or denosumab",
"relatedSectionId": "mk19_a_on_s8_1_4"
},
"on79": {
"id": "on79",
"bookId": "on",
"question": "Surgical approach to diagnose testicular cancer",
"answer": "Radical inguinal orchiectomy",
"relatedSectionId": "mk19_a_on_s8_2"
},
"on80": {
"id": "on80",
"bookId": "on",
"question": "Most common site of testicular cancer metastases",
"answer": "Retroperitoneal lymph nodes",
"relatedSectionId": "mk19_a_on_s8_2"
},
"on81": {
"id": "on81",
"bookId": "on",
"question": "Tumor markers to evaluate testicular mass",
"answer": "α-fetoprotein and β-HCG",
"relatedSectionId": "mk19_a_on_s8_2"
},
"on82": {
"id": "on82",
"bookId": "on",
"question": "Primary treatment of metastatic renal cell carcinoma",
"answer": "Nephrectomy",
"relatedSectionId": "mk19_a_on_s8_3"
},
"on83": {
"id": "on83",
"bookId": "on",
"question": "Erythrocytosis, markedly elevated erythropoietin, hematuria",
"answer": "Renal cell cancer",
"relatedSectionId": "mk19_a_on_s8_3"
},
"on84": {
"id": "on84",
"bookId": "on",
"question": "Primary treatment of muscle-invasive bladder cancer",
"answer": "Cystectomy",
"relatedSectionId": "mk19_a_on_s8_4"
},
"on85": {
"id": "on85",
"bookId": "on",
"question": "Infection associated with Burkitt lymphoma",
"answer": "Epstein-Barr virus",
"relatedSectionId": "mk19_a_on_s9_1"
},
"on86": {
"id": "on86",
"bookId": "on",
"question": "Diagnostic procedure for suspected lymphoma",
"answer": "Lymph node excisional or core biopsy",
"relatedSectionId": "mk19_a_on_s9_2"
},
"on87": {
"id": "on87",
"bookId": "on",
"question": "Asymptomatic advanced-stage follicular lymphoma management",
"answer": "Observation",
"relatedSectionId": "mk19_a_on_s9_4_1_1"
},
"on88": {
"id": "on88",
"bookId": "on",
"question": "Follicular lymphoma, new systemic symptoms, progression of localized disease",
"answer": "Transformed follicular lymphoma",
"relatedSectionId": "mk19_a_on_s9_4_1_1"
},
"on89": {
"id": "on89",
"bookId": "on",
"question": "Management of transformed follicular lymphoma",
"answer": "Biopsy, then appropriate treatment of new lymphoma",
"relatedSectionId": "mk19_a_on_s9_4_1_1"
},
"on90": {
"id": "on90",
"bookId": "on",
"question": "Treatment of <i>H pylori</i>-associated gastric MALT",
"answer": "PPI plus antibiotics",
"relatedSectionId": "mk19_a_on_s9_4_1_2"
},
"on91": {
"id": "on91",
"bookId": "on",
"question": "Elevated lymphocyte count, smudge cells, lymphadenopathy",
"answer": "CLL",
"relatedSectionId": "mk19_a_on_s9_4_1_3"
},
"on92": {
"id": "on92",
"bookId": "on",
"question": "Test to establish the diagnosis of CLL",
"answer": "Peripheral blood flow cytometry",
"relatedSectionId": "mk19_a_on_s9_4_1_3"
},
"on93": {
"id": "on93",
"bookId": "on",
"question": "Common CLL-related autoimmune diseases",
"answer": "Hemolytic anemia and ITP",
"relatedSectionId": "mk19_a_on_s9_4_1_3"
},
"on94": {
"id": "on94",
"bookId": "on",
"question": "B-cell disorder, cytopenia, splenomegaly, characteristic lymphocyte morphology",
"answer": "Hairy cell leukemia",
"relatedSectionId": "mk19_a_on_s9_4_1_4"
},
"on95": {
"id": "on95",
"bookId": "on",
"question": "Treatment of hairy cell leukemia",
"answer": "Cladribine or pentostatin",
"relatedSectionId": "mk19_a_on_s9_4_1_4"
},
"on96": {
"id": "on96",
"bookId": "on",
"question": "Management of double-hit lymphoma",
"answer": "Aggressive chemotherapy, up-front autologous HSCT",
"relatedSectionId": "mk19_a_on_s9_4_2_1"
},
"on97": {
"id": "on97",
"bookId": "on",
"question": "Management of most advanced-stage large B-cell lymphomas",
"answer": "Rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)",
"relatedSectionId": "mk19_a_on_s9_4_2_1"
},
"on98": {
"id": "on98",
"bookId": "on",
"question": "Young man from Africa with large jaw mass",
"answer": "Burkitt lymphoma",
"relatedSectionId": "mk19_a_on_s9_4_2_3"
},
"on99": {
"id": "on99",
"bookId": "on",
"question": "Dav 1 complication of Burkitt lymphoma",
"answer": "Tumor lysis syndrome",
"relatedSectionId": "mk19_a_on_s9_4_2_3"
},
"on100": {
"id": "on100",
"bookId": "on",
"question": "Erythroderma, circulating malignant T cells",
"answer": "Sézary syndrome",
"relatedSectionId": "mk19_a_on_s9_4_3_1"
},
"on101": {
"id": "on101",
"bookId": "on",
"question": "Lymphoma, Reed-Sternberg cells",
"answer": "Hodgkin lymphoma",
"relatedSectionId": "mk19_a_on_s9_5"
},
"on102": {
"id": "on102",
"bookId": "on",
"question": "Staging of Hodgkin lymphoma",
"answer": "Physical exam, PET/CT",
"relatedSectionId": "mk19_a_on_s9_5"
},
"on103": {
"id": "on103",
"bookId": "on",
"question": "Likely primary of poorly differentiated carcinoma presenting as midline lymphadenopathy",
"answer": "Germ cell cancer",
"relatedSectionId": "mk19_a_on_s10_3_1"
},
"on104": {
"id": "on104",
"bookId": "on",
"question": "Tumor markers to assess poorly differentiated CUP with mediastinal adenopathy",
"answer": "α-fetoprotein and β-HCG",
"relatedSectionId": "mk19_a_on_s10_3_1"
},
"on105": {
"id": "on105",
"bookId": "on",
"question": "Likely primary of CUP presenting as isolated cervical lymphadenopathy",
"answer": "Head and neck cancer",
"relatedSectionId": "mk19_a_on_s10_3_2"
},
"on106": {
"id": "on106",
"bookId": "on",
"question": "Likely primary of isolated axillary lymph-node adenocarcinoma in a woman",
"answer": "Stage II breast cancer",
"relatedSectionId": "mk19_a_on_s10_3_2"
},
"on107": {
"id": "on107",
"bookId": "on",
"question": "Treatment of CUP with poor performance status",
"answer": "Hospice care",
"relatedSectionId": "mk19_a_on_s10_4"
},
"on108": {
"id": "on108",
"bookId": "on",
"question": "Treatment of widely metastatic melanoma",
"answer": "Checkpoint immunotherapy (nivolumab, pembrolizumab)",
"relatedSectionId": "mk19_a_on_s11_1"
},
"on109": {
"id": "on109",
"bookId": "on",
"question": "Localized melanoma prognostic determinant",
"answer": "Depth of tumor invasion",
"relatedSectionId": "mk19_a_on_s11_1"
},
"on110": {
"id": "on110",
"bookId": "on",
"question": "Syndrome of dyspnea, facial swelling, and mediastinal mass",
"answer": "Superior vena cava syndrome",
"relatedSectionId": "mk19_a_on_s12_1_1"
},
"on111": {
"id": "on111",
"bookId": "on",
"question": "Initial treatment of symptomatic brain metastases",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_a_on_s12_1_3"
},
"on112": {
"id": "on112",
"bookId": "on",
"question": "Metastatic spinal cord compression treatment",
"answer": "Glucocorticoids, then surgery and irradiation",
"relatedSectionId": "mk19_a_on_s12_1_3_2"
},
"on113": {
"id": "on113",
"bookId": "on",
"question": "Treatment of rapidly recurring malignant pleural effusion",
"answer": "Indwelling pleural catheter or pleurodesis",
"relatedSectionId": "mk19_a_on_s12_1_4"
},
"on114": {
"id": "on114",
"bookId": "on",
"question": "Tumor lysis syndrome prophylaxis",
"answer": "Rasburicase, IV hydration",
"relatedSectionId": "mk19_a_on_s12_2_1"
},
"on115": {
"id": "on115",
"bookId": "on",
"question": "Treatment of symptomatic hypercalcemia of malignancy",
"answer": "IV normal saline, calcitonin, bisphosphate (zoledronic acid)",
"relatedSectionId": "mk19_a_on_s12_2_2"
},
"on116": {
"id": "on116",
"bookId": "on",
"question": "Secondary prevention of chemotherapy-related febrile neutropenia",
"answer": "G-CSF",
"relatedSectionId": "mk19_a_on_s13_1_1_1"
},
"on117": {
"id": "on117",
"bookId": "on",
"question": "Risks of erythropoietin in treating cancer-related anemia",
"answer": "Cancer progression, VTE",
"relatedSectionId": "mk19_a_on_s13_1_1_2"
},
"on118": {
"id": "on118",
"bookId": "on",
"question": "Standard antiemetic regimen for moderate-to-severe emetogenic chemotherapy",
"answer": "Ondansetron or palonosetron plus glucocorticoids",
"relatedSectionId": "mk19_a_on_s13_1_2"
},
"on119": {
"id": "on119",
"bookId": "on",
"question": "Chemotherapeutic agents causing hand-foot syndrome",
"answer": "5-FU and capecitabine",
"relatedSectionId": "mk19_a_on_s13_1_3"
},
"on120": {
"id": "on120",
"bookId": "on",
"question": "Chemotherapeutic agent most commonly associated with acute kidney injury",
"answer": "Cisplatin",
"relatedSectionId": "mk19_a_on_s13_1_5"
},
"on121": {
"id": "on121",
"bookId": "on",
"question": "Prerequisite to chemotherapy in reproductive-age men and women",
"answer": "Fertility preservation counseling",
"relatedSectionId": "mk19_a_on_s13_2_1_3"
},
"on122": {
"id": "on122",
"bookId": "on",
"question": "Chest wall radiation–associated cancer",
"answer": "Breast cancer",
"relatedSectionId": "mk19_a_on_s13_2_2"
},
"pm1": {
"id": "pm1",
"bookId": "pm",
"question": "Positive bronchial challenge test result",
"answer": "≥20% FEV<sub>1</sub> reduction",
"relatedSectionId": "mk19_b_pm_s1_1_2"
},
"pm2": {
"id": "pm2",
"bookId": "pm",
"question": "Diagnosis suggested by TLC &lt;80% of predicted",
"answer": "Restrictive lung disease",
"relatedSectionId": "mk19_b_pm_s1_1_4"
},
"pm4": {
"id": "pm4",
"bookId": "pm",
"question": "Test for allergic asthma",
"answer": "Skin prick or allergen-specific IgE",
"relatedSectionId": "mk19_b_pm_s2_1_5"
},
"pm5": {
"id": "pm5",
"bookId": "pm",
"question": "Test for suspected cough-variant asthma with normal spirometry",
"answer": "Methacholine challenge test",
"relatedSectionId": "mk19_b_pm_s2_1_5_2"
},
"pm6": {
"id": "pm6",
"bookId": "pm",
"question": "Test for exercise-induced bronchoconstriction",
"answer": "Methacholine or exercise bronchial challenge test",
"relatedSectionId": "mk19_b_pm_s2_1_5_3"
},
"pm8": {
"id": "pm8",
"bookId": "pm",
"question": "Test for occupational asthma",
"answer": "Spirometry before and after workplace exposure",
"relatedSectionId": "mk19_b_pm_s2_1_5_4"
},
"pm9": {
"id": "pm9",
"bookId": "pm",
"question": "Diagnosis suggested by asthma, sinusitis, nasal polyp",
"answer": "Aspirin-exacerbated respiratory disease",
"relatedSectionId": "mk19_b_pm_s2_1_5_6"
},
"pm10": {
"id": "pm10",
"bookId": "pm",
"question": "Diagnostic tests for allergic bronchopulmonary aspergillosis",
"answer": "<i>Aspergillus</i>-specific IgE and IgG; <i>Aspergillus</i> antigen skin test",
"relatedSectionId": "mk19_b_pm_s2_1_5_7"
},
"pm11": {
"id": "pm11",
"bookId": "pm",
"question": "Treatment for mild persistent asthma",
"answer": "SABA and low-dose inhaled glucocorticoids",
"relatedSectionId": "mk19_b_pm_s2_1_6"
},
"pm12": {
"id": "pm12",
"bookId": "pm",
"question": "Indicators of well-controlled asthma",
"answer": "Daytime symptoms &lt;2 times/week, nighttime symptoms &lt;2 times/month",
"relatedSectionId": "mk19_b_pm_s2_1_6"
},
"pm13": {
"id": "pm13",
"bookId": "pm",
"question": "Treatment for uncontrolled severe eosinophilic phenotype asthma",
"answer": "Mepolizumab, reslizumab, or benralizumab",
"relatedSectionId": "mk19_b_pm_s2_1_6_2"
},
"pm14": {
"id": "pm14",
"bookId": "pm",
"question": "Most effective class of asthma controller medications",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_b_pm_s2_1_6_2"
},
"pm15": {
"id": "pm15",
"bookId": "pm",
"question": "Asthma monotherapy associated with increased mortality",
"answer": "LABA",
"relatedSectionId": "mk19_b_pm_s2_1_6_2"
},
"pm16": {
"id": "pm16",
"bookId": "pm",
"question": "Asthma indication for adding LAMA",
"answer": "Poor control on glucocorticoids/LABA",
"relatedSectionId": "mk19_b_pm_s2_1_6_2"
},
"pm17": {
"id": "pm17",
"bookId": "pm",
"question": "Treatment for poorly controlled asthma, elevated IgE, and allergies",
"answer": "Omalizumab",
"relatedSectionId": "mk19_b_pm_s2_1_6_2"
},
"pm18": {
"id": "pm18",
"bookId": "pm",
"question": "Lifestyle interventions for asthma",
"answer": "Allergen control, weight loss, no smoking",
"relatedSectionId": "mk19_b_pm_s2_1_6_3"
},
"pm19": {
"id": "pm19",
"bookId": "pm",
"question": "Change in SABA and inhaled glucocorticoid asthma treatment during pregnancy",
"answer": "None",
"relatedSectionId": "mk19_b_pm_s2_1_9"
},
"pm20": {
"id": "pm20",
"bookId": "pm",
"question": "Indication for COPD screening in asymptomatic patients",
"answer": "None",
"relatedSectionId": "mk19_b_pm_s2_2_7"
},
"pm21": {
"id": "pm21",
"bookId": "pm",
"question": "Postbronchodilator FEV<sub>1</sub>/FVC value consistent with COPD",
"answer": "&lt;0.7",
"relatedSectionId": "mk19_b_pm_s2_2_7"
},
"pm22": {
"id": "pm22",
"bookId": "pm",
"question": "Initial treatment for mild COPD",
"answer": "Short-acting bronchodilator",
"relatedSectionId": "mk19_b_pm_s2_2_9"
},
"pm23": {
"id": "pm23",
"bookId": "pm",
"question": "Add-on therapy to short-acting bronchodilators in COPD",
"answer": "LABA and/or LAMA",
"relatedSectionId": "mk19_b_pm_s2_2_9_2"
},
"pm24": {
"id": "pm24",
"bookId": "pm",
"question": "Treatment for severe COPD",
"answer": "Triple inhaler therapy with LABA, LAMA, inhaled glucocorticoid",
"relatedSectionId": "mk19_b_pm_s2_2_9_2_2"
},
"pm25": {
"id": "pm25",
"bookId": "pm",
"question": "PDE-4 inhibitor to reduce severe COPD exacerbations and chronic bronchitis symptoms",
"answer": "Roflumilast",
"relatedSectionId": "mk19_b_pm_s2_2_9_2_5"
},
"pm26": {
"id": "pm26",
"bookId": "pm",
"question": "Antibiotic class for severe COPD with frequent exacerbations",
"answer": "Macrolide",
"relatedSectionId": "mk19_b_pm_s2_2_9_2_7"
},
"pm27": {
"id": "pm27",
"bookId": "pm",
"question": "Recommended vaccinations for all patients with chronic lung disease",
"answer": "PPSV23 and annual influenza",
"relatedSectionId": "mk19_b_pm_s2_2_9_2_8"
},
"pm29": {
"id": "pm29",
"bookId": "pm",
"question": "COPD indications for supplemental oxygen",
"answer": "P<small>O</small><sub>2</sub> ≤55 mm Hg, O<sub>2</sub> saturation ≤88%",
"relatedSectionId": "mk19_b_pm_s2_2_9_3_2"
},
"pm30": {
"id": "pm30",
"bookId": "pm",
"question": "Emphysema amenable to lung reduction surgery",
"answer": "Upper lobe predominant",
"relatedSectionId": "mk19_b_pm_s2_2_9_4_1"
},
"pm31": {
"id": "pm31",
"bookId": "pm",
"question": "Role of sputum culture in COPD exacerbation",
"answer": "None",
"relatedSectionId": "mk19_b_pm_s2_2_10_3"
},
"pm32": {
"id": "pm32",
"bookId": "pm",
"question": "Glucocorticoid treatment for moderate to severe COPD exacerbation",
"answer": "Oral prednisone 40 mg for 5 days",
"relatedSectionId": "mk19_b_pm_s2_2_10_4"
},
"pm33": {
"id": "pm33",
"bookId": "pm",
"question": "COPD indication for systemic glucocorticoid",
"answer": "Acute COPD exacerbation",
"relatedSectionId": "mk19_b_pm_s2_2_10_4"
},
"pm34": {
"id": "pm34",
"bookId": "pm",
"question": "Pulmonary infections suggestive of bronchiectasis",
"answer": "<i>Pseudomonas aeruginosa</i>, <i>Aspergillus</i>, non-TB mycobacteria",
"relatedSectionId": "mk19_b_pm_s2_3_3"
},
"pm35": {
"id": "pm35",
"bookId": "pm",
"question": "Common symptoms of bronchiectasis",
"answer": "Chronic productive cough, frequent respiratory infections",
"relatedSectionId": "mk19_b_pm_s2_3_3"
},
"pm36": {
"id": "pm36",
"bookId": "pm",
"question": "Bronchiectasis CT findings",
"answer": "Bronchial wall thickening, cysts, dilated airways without distal tapering",
"relatedSectionId": "mk19_b_pm_s2_3_4"
},
"pm37": {
"id": "pm37",
"bookId": "pm",
"question": "Empiric antibiotic class for bronchiectasis exacerbation",
"answer": "Fluoroquinolone",
"relatedSectionId": "mk19_b_pm_s2_3_5_1"
},
"pm38": {
"id": "pm38",
"bookId": "pm",
"question": "Diagnosis suggested by chronic productive cough, recurrent sinus and pulmonary infections, GI disease",
"answer": "Cystic fibrosis",
"relatedSectionId": "mk19_b_pm_s2_4_1"
},
"pm39": {
"id": "pm39",
"bookId": "pm",
"question": "Initial test for cystic fibrosis",
"answer": "Sweat chloride",
"relatedSectionId": "mk19_b_pm_s2_4_1"
},
"pm40": {
"id": "pm40",
"bookId": "pm",
"question": "Symptoms most suggestive of DPLD",
"answer": "Subacute/chronic nonproductive cough and dyspnea",
"relatedSectionId": "mk19_b_pm_s3_2"
},
"pm43": {
"id": "pm43",
"bookId": "pm",
"question": "High-prevalence condition in young patients with DPLD",
"answer": "Connective tissue disease",
"relatedSectionId": "mk19_b_pm_s3_3_2"
},
"pm44": {
"id": "pm44",
"bookId": "pm",
"question": "Most common DPLD associated with autoimmune disorders",
"answer": "Nonspecific interstitial pneumonia",
"relatedSectionId": "mk19_b_pm_s3_3_2"
},
"pm45": {
"id": "pm45",
"bookId": "pm",
"question": "Diagnosis suggested by environmental exposure, fever, fatigue, cough",
"answer": "Acute hypersensitivity pneumonitis",
"relatedSectionId": "mk19_b_pm_s3_3_3"
},
"pm46": {
"id": "pm46",
"bookId": "pm",
"question": "Treatment for severe radiation pneumonitis",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_b_pm_s3_3_5"
},
"pm47": {
"id": "pm47",
"bookId": "pm",
"question": "DPLD commonly associated with clubbing",
"answer": "Idiopathic pulmonary fibrosis",
"relatedSectionId": "mk19_b_pm_s3_4_1"
},
"pm48": {
"id": "pm48",
"bookId": "pm",
"question": "Treatment for IPF",
"answer": "Nintedanib or pirfenidone",
"relatedSectionId": "mk19_b_pm_s3_4_1"
},
"pm49": {
"id": "pm49",
"bookId": "pm",
"question": "Diagnosis suggested by subacute cough, fever, malaise, patchy infiltrates unresponsive to antibiotics",
"answer": "Cryptogenic organizing pneumonia",
"relatedSectionId": "mk19_b_pm_s3_4_3"
},
"pm50": {
"id": "pm50",
"bookId": "pm",
"question": "DPLD mimic of ARDS",
"answer": "Acute interstitial pneumonia",
"relatedSectionId": "mk19_b_pm_s3_4_4"
},
"pm51": {
"id": "pm51",
"bookId": "pm",
"question": "Diagnosis suggested by asymptomatic bilateral hilar lymphadenopathy",
"answer": "Pulmonary sarcoidosis",
"relatedSectionId": "mk19_b_pm_s3_5"
},
"pm52": {
"id": "pm52",
"bookId": "pm",
"question": "Sarcoidosis management for asymptomatic patients without organ dysfunction",
"answer": "Observation",
"relatedSectionId": "mk19_b_pm_s3_5"
},
"pm53": {
"id": "pm53",
"bookId": "pm",
"question": "Most common causes of pleural effusion",
"answer": "Heart failure, pneumonia, malignancy",
"relatedSectionId": "mk19_b_pm_s5_1"
},
"pm54": {
"id": "pm54",
"bookId": "pm",
"question": "Most sensitive test for small pleural effusions",
"answer": "Ultrasonography",
"relatedSectionId": "mk19_b_pm_s5_1_1_2"
},
"pm55": {
"id": "pm55",
"bookId": "pm",
"question": "Underlying causes of neutrophil-predominant pleural effusion",
"answer": "Acute pneumonia, PE",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_1"
},
"pm56": {
"id": "pm56",
"bookId": "pm",
"question": "Most common causes of lymphocyte-predominant pleural effusion",
"answer": "TB, cancer",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_1"
},
"pm57": {
"id": "pm57",
"bookId": "pm",
"question": "Treatment for complicated parapneumonic effusion",
"answer": "Thoracostomy tube drainage",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_2"
},
"pm58": {
"id": "pm58",
"bookId": "pm",
"question": "Pleural fluid pH and glucose level characteristic of complicated parapneumonic effusion",
"answer": "pH &lt;7.2, glucose &lt;60 mg/d",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_2"
},
"pm59": {
"id": "pm59",
"bookId": "pm",
"question": "Diagnoses suggested by elevated pleural fluid amylase",
"answer": "Pancreatitis, esophageal rupture",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_2"
},
"pm60": {
"id": "pm60",
"bookId": "pm",
"question": "Pleural fluid enzyme test for TB",
"answer": "Adenosine deaminase",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_3"
},
"pm61": {
"id": "pm61",
"bookId": "pm",
"question": "Pleural-fluid LDH level in exudative pleural effusion",
"answer": "&gt;2/3 upper limit of normal for serum LDH",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_4"
},
"pm62": {
"id": "pm62",
"bookId": "pm",
"question": "Ratio of pleural fluid LDH level to serum LDH level in exudative pleural effusion",
"answer": "&gt;0.6",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_4"
},
"pm63": {
"id": "pm63",
"bookId": "pm",
"question": "Number of pleural fluid cytology exams for maximum yield",
"answer": "Two",
"relatedSectionId": "mk19_b_pm_s5_1_1_4_4"
},
"pm64": {
"id": "pm64",
"bookId": "pm",
"question": "Management for malignant pleural effusion",
"answer": "Repeat thoracentesis, indwelling pleural catheter, or chemical pleurodesis",
"relatedSectionId": "mk19_b_pm_s5_1_2_2"
},
"pm65": {
"id": "pm65",
"bookId": "pm",
"question": "Diagnosis suggested by respiratory distress, unilateral absent breath sounds, tracheal deviation",
"answer": "Tension pneumothorax",
"relatedSectionId": "mk19_b_pm_s5_2_1"
},
"pm67": {
"id": "pm67",
"bookId": "pm",
"question": "PSP indication for pleurodesis",
"answer": "Second ipsilateral occurrence",
"relatedSectionId": "mk19_b_pm_s5_2_2"
},
"pm68": {
"id": "pm68",
"bookId": "pm",
"question": "Treatment after first occurrence of SSP",
"answer": "Pleurodesis",
"relatedSectionId": "mk19_b_pm_s5_2_2"
},
"pm69": {
"id": "pm69",
"bookId": "pm",
"question": "Emergency treatment for tension pneumothorax",
"answer": "Needle thoracostomy",
"relatedSectionId": "mk19_b_pm_s5_2_2"
},
"pm70": {
"id": "pm70",
"bookId": "pm",
"question": "Common causes of PH",
"answer": "Left-sided heart disease, hypoxic lung disease",
"relatedSectionId": "mk19_b_pm_s6_1"
},
"pm71": {
"id": "pm71",
"bookId": "pm",
"question": "Initial test for PH",
"answer": "Transthoracic echocardiography",
"relatedSectionId": "mk19_b_pm_s6_1_1"
},
"pm72": {
"id": "pm72",
"bookId": "pm",
"question": "Initial imaging for CTEPH",
"answer": "V/Q scan",
"relatedSectionId": "mk19_b_pm_s6_1_1"
},
"pm73": {
"id": "pm73",
"bookId": "pm",
"question": "Systemic sclerosis variant associated with PAH",
"answer": "Limited cutaneous systemic sclerosis",
"relatedSectionId": "mk19_b_pm_s6_2"
},
"pm74": {
"id": "pm74",
"bookId": "pm",
"question": "Test before advanced PAH therapy",
"answer": "Nitric oxide vasoreactivity testing",
"relatedSectionId": "mk19_b_pm_s6_2_2"
},
"pm75": {
"id": "pm75",
"bookId": "pm",
"question": "Treatment for vasoactive-positive PAH",
"answer": "CCB",
"relatedSectionId": "mk19_b_pm_s6_2_2"
},
"pm77": {
"id": "pm77",
"bookId": "pm",
"question": "Treatment for CTEPH",
"answer": "Pulmonary thromboendarterectomy and anticoagulation",
"relatedSectionId": "mk19_b_pm_s6_3_2"
},
"pm78": {
"id": "pm78",
"bookId": "pm",
"question": "First step in evaluating solid pulmonary nodule &gt;8 mm",
"answer": "Estimate risk of malignancy",
"relatedSectionId": "mk19_b_pm_s7_1_1"
},
"pm79": {
"id": "pm79",
"bookId": "pm",
"question": "Imaging for evaluation of solid lung nodule &gt;8 mm",
"answer": "CT and PET",
"relatedSectionId": "mk19_b_pm_s7_1_1"
},
"pm80": {
"id": "pm80",
"bookId": "pm",
"question": "Lung cancer associated with SIADH",
"answer": "SCLC",
"relatedSectionId": "mk19_b_pm_s7_2_1"
},
"pm81": {
"id": "pm81",
"bookId": "pm",
"question": "Criteria for lung cancer screening with low-dose CT",
"answer": "Age 50-80 years, asymptomatic, ≥20 pack-years, smoker in last 15 years",
"relatedSectionId": "mk19_b_pm_s7_2_3"
},
"pm82": {
"id": "pm82",
"bookId": "pm",
"question": "Most common asbestosis radiographic finding",
"answer": "Pleural plaques",
"relatedSectionId": "mk19_b_pm_s7_2_6"
},
"pm83": {
"id": "pm83",
"bookId": "pm",
"question": "Diagnosis suggested by asbestos exposure, chest pain, pleural effusion",
"answer": "Mesothelioma",
"relatedSectionId": "mk19_b_pm_s7_2_6"
},
"pm84": {
"id": "pm84",
"bookId": "pm",
"question": "Diagnostic test for mesothelioma",
"answer": "Pleural biopsy",
"relatedSectionId": "mk19_b_pm_s7_2_6"
},
"pm85": {
"id": "pm85",
"bookId": "pm",
"question": "Diagnosis suggested by anterior mediastinal mass, MG",
"answer": "Thymoma",
"relatedSectionId": "mk19_b_pm_s7_3_1"
},
"pm86": {
"id": "pm86",
"bookId": "pm",
"question": "Anterior mediastinal mass entities",
"answer": "Thymoma, teratoma, lymphoma, thyroid",
"relatedSectionId": "mk19_b_pm_s7_3_1"
},
"pm87": {
"id": "pm87",
"bookId": "pm",
"question": "Most common anterior mediastinal tumor",
"answer": "Thymoma",
"relatedSectionId": "mk19_b_pm_s7_3_1"
},
"pm88": {
"id": "pm88",
"bookId": "pm",
"question": "Most common middle mediastinal mass",
"answer": "Lymphadenopathy",
"relatedSectionId": "mk19_b_pm_s7_3_2"
},
"pm89": {
"id": "pm89",
"bookId": "pm",
"question": "Most common posterior mediastinal mass",
"answer": "Neurogenic neoplasms",
"relatedSectionId": "mk19_b_pm_s7_3_3"
},
"pm90": {
"id": "pm90",
"bookId": "pm",
"question": "First step in evaluating excessive daytime sleepiness",
"answer": "Actigraphy or sleep diary",
"relatedSectionId": "mk19_b_pm_s8_1"
},
"pm91": {
"id": "pm91",
"bookId": "pm",
"question": "Most common cause of excessive daytime sleepiness",
"answer": "Insufficient sleep syndrome",
"relatedSectionId": "mk19_b_pm_s8_1"
},
"pm92": {
"id": "pm92",
"bookId": "pm",
"question": "Preferred test for high-probability OSA",
"answer": "Home sleep testing",
"relatedSectionId": "mk19_b_pm_s8_3_3"
},
"pm93": {
"id": "pm93",
"bookId": "pm",
"question": "Conditions warranting in-lab polysomnography",
"answer": "Cardiopulmonary or neuromuscular disease",
"relatedSectionId": "mk19_b_pm_s8_3_3"
},
"pm94": {
"id": "pm94",
"bookId": "pm",
"question": "OSA symptom most responsive to treatment",
"answer": "Daytime sleepiness",
"relatedSectionId": "mk19_b_pm_s8_3_4"
},
"pm95": {
"id": "pm95",
"bookId": "pm",
"question": "Treatment for snoring and mild OSA",
"answer": "Weight loss",
"relatedSectionId": "mk19_b_pm_s8_3_4_1"
},
"pm96": {
"id": "pm96",
"bookId": "pm",
"question": "CPAP treatment alternative for mild/moderate OSA",
"answer": "Oral appliance",
"relatedSectionId": "mk19_b_pm_s8_3_4_3"
},
"pm97": {
"id": "pm97",
"bookId": "pm",
"question": "Diagnosis suggested by nocturnal absence of respiratory effort and airflow",
"answer": "CSA",
"relatedSectionId": "mk19_b_pm_s8_4_1"
},
"pm98": {
"id": "pm98",
"bookId": "pm",
"question": "Primary risk factor for CSA",
"answer": "Heart failure",
"relatedSectionId": "mk19_b_pm_s8_4_1"
},
"pm99": {
"id": "pm99",
"bookId": "pm",
"question": "Physical manifestation of CSA due to heart failure",
"answer": "Cheyne-Stokes breathing",
"relatedSectionId": "mk19_b_pm_s8_4_2"
},
"pm100": {
"id": "pm100",
"bookId": "pm",
"question": "Common drug cause of CSA",
"answer": "Opioids",
"relatedSectionId": "mk19_b_pm_s8_4_2"
},
"pm101": {
"id": "pm101",
"bookId": "pm",
"question": "OHS defining parameter",
"answer": "Daytime hypercapnia",
"relatedSectionId": "mk19_b_pm_s8_5_2"
},
"pm102": {
"id": "pm102",
"bookId": "pm",
"question": "Diagnosis suggested by headache, nausea, disturbed sleep at altitude",
"answer": "Acute mountain sickness",
"relatedSectionId": "mk19_b_pm_s9_2"
},
"pm103": {
"id": "pm103",
"bookId": "pm",
"question": "Medications for acute mountain sickness",
"answer": "Acetazolamide or dexamethasone",
"relatedSectionId": "mk19_b_pm_s9_2"
},
"pm104": {
"id": "pm104",
"bookId": "pm",
"question": "Treatment for high-altitude cerebral edema",
"answer": "Dexamethasone, oxygen, descent",
"relatedSectionId": "mk19_b_pm_s9_3"
},
"pm105": {
"id": "pm105",
"bookId": "pm",
"question": "Drug treatments for high-altitude pulmonary edema",
"answer": "Nifedipine, PDE-5 inhibitor",
"relatedSectionId": "mk19_b_pm_s9_3"
},
"pm106": {
"id": "pm106",
"bookId": "pm",
"question": "Possible complication in air travel for patients with asthma or COPD",
"answer": "Pneumothorax",
"relatedSectionId": "mk19_b_pm_s9_5"
},
"pm107": {
"id": "pm107",
"bookId": "pm",
"question": "Oxygen saturation level requiring supplemental O<sub>2</sub> during air travel",
"answer": "&lt;92%",
"relatedSectionId": "mk19_b_pm_s9_5"
},
"pm108": {
"id": "pm108",
"bookId": "pm",
"question": "Test to determine need for supplemental O<sub>2</sub> during air travel",
"answer": "Hypoxia altitude simulation testing",
"relatedSectionId": "mk19_b_pm_s9_5"
},
"pm109": {
"id": "pm109",
"bookId": "pm",
"question": "Preferred agents for continuous sedation during mechanical ventilation",
"answer": "Propofol, dexmedetomidine",
"relatedSectionId": "mk19_b_pm_s11_1_1"
},
"pm110": {
"id": "pm110",
"bookId": "pm",
"question": "Strategies to decrease delirium during mechanical ventilation",
"answer": "Daily interruptions of sedation and analgesia; protocolized light sedation",
"relatedSectionId": "mk19_b_pm_s11_1_1_1"
},
"pm111": {
"id": "pm111",
"bookId": "pm",
"question": "Nondrug management for ICU delirium",
"answer": "Mobilize patient early, remove catheters, provide visual and hearing aids",
"relatedSectionId": "mk19_b_pm_s11_1_1_2"
},
"pm113": {
"id": "pm113",
"bookId": "pm",
"question": "Only indications for benzodiazepines in delirium treatment",
"answer": "Alcohol withdrawal, seizures",
"relatedSectionId": "mk19_b_pm_s11_1_1_2"
},
"pm114": {
"id": "pm114",
"bookId": "pm",
"question": "Preferred route for nutrition in critically ill patients",
"answer": "Enteral",
"relatedSectionId": "mk19_b_pm_s11_1_2"
},
"pm115": {
"id": "pm115",
"bookId": "pm",
"question": "Timing of initiation of enteral nutrition in ICU",
"answer": "24-48 hours after admission",
"relatedSectionId": "mk19_b_pm_s11_1_2"
},
"pm116": {
"id": "pm116",
"bookId": "pm",
"question": "Nonventilatory oxygen support for acute hypoxemic respiratory failure",
"answer": "High-flow nasal cannula",
"relatedSectionId": "mk19_b_pm_s11_1_6_1_1"
},
"pm117": {
"id": "pm117",
"bookId": "pm",
"question": "Ventilation mode that improves survival in neuromuscular disease",
"answer": "NPPV",
"relatedSectionId": "mk19_b_pm_s11_1_7_1_1"
},
"pm118": {
"id": "pm118",
"bookId": "pm",
"question": "Contraindications to NPPV",
"answer": "Altered mental status, increased secretions, vomiting, inability to protect airway",
"relatedSectionId": "mk19_b_pm_s11_1_7_1_1"
},
"pm119": {
"id": "pm119",
"bookId": "pm",
"question": "Assessment test before liberation from mechanical ventilation",
"answer": "Spontaneous breathing trial",
"relatedSectionId": "mk19_b_pm_s11_1_7_2_1"
},
"pm120": {
"id": "pm120",
"bookId": "pm",
"question": "Role of synchronized intermittent mandatory ventilation in ventilator weaning",
"answer": "None",
"relatedSectionId": "mk19_b_pm_s11_1_7_2_1"
},
"pm121": {
"id": "pm121",
"bookId": "pm",
"question": "Prevention of extubation failure in high-risk patients",
"answer": "Early NPPV",
"relatedSectionId": "mk19_b_pm_s11_1_7_2_1"
},
"pm122": {
"id": "pm122",
"bookId": "pm",
"question": "Type of IV catheter with highest flow rate",
"answer": "Peripheral wide-bore",
"relatedSectionId": "mk19_b_pm_s11_1_9"
},
"pm123": {
"id": "pm123",
"bookId": "pm",
"question": "Target MAP in septic shock",
"answer": "65 mm Hg",
"relatedSectionId": "mk19_b_pm_s11_1_10"
},
"pm124": {
"id": "pm124",
"bookId": "pm",
"question": "Bedside tool to evaluate ICU-acquired weakness",
"answer": "Medical Research Council muscle scale",
"relatedSectionId": "mk19_b_pm_s11_2_1"
},
"pm125": {
"id": "pm125",
"bookId": "pm",
"question": "Basic strategies to minimize ICU-acquired weakness",
"answer": "Early mobilization, glucose control",
"relatedSectionId": "mk19_b_pm_s11_2_1"
},
"pm126": {
"id": "pm126",
"bookId": "pm",
"question": "Physiology of hypoxemic respiratory failure not improving with oxygen",
"answer": "V/Q mismatch",
"relatedSectionId": "mk19_b_pm_s12_1_2"
},
"pm127": {
"id": "pm127",
"bookId": "pm",
"question": "Most common complication of smoke inhalation injury",
"answer": "Pneumonia",
"relatedSectionId": "mk19_b_pm_s12_1_3"
},
"pm128": {
"id": "pm128",
"bookId": "pm",
"question": "Common causes of systemic toxicity in smoke inhalation",
"answer": "Carbon monoxide, cyanide",
"relatedSectionId": "mk19_b_pm_s12_1_3"
},
"pm129": {
"id": "pm129",
"bookId": "pm",
"question": "Primary treatment for ARDS",
"answer": "Mechanical ventilation with PEEP",
"relatedSectionId": "mk19_b_pm_s12_1_4_1"
},
"pm130": {
"id": "pm130",
"bookId": "pm",
"question": "ARDS tidal volume",
"answer": "4-8 mL/kg predicted body weight",
"relatedSectionId": "mk19_b_pm_s12_1_4_1"
},
"pm131": {
"id": "pm131",
"bookId": "pm",
"question": "Treatment for PE with hemodynamic collapse",
"answer": "Thrombolytic therapy",
"relatedSectionId": "mk19_b_pm_s12_1_9"
},
"pm132": {
"id": "pm132",
"bookId": "pm",
"question": "Ventilatory treatment of acute hypercapnic respiratory failure attributable to OHS",
"answer": "BPAP",
"relatedSectionId": "mk19_b_pm_s12_1_10_1_2"
},
"pm133": {
"id": "pm133",
"bookId": "pm",
"question": "Measures in ventilatory assessment of neuromuscular weakness",
"answer": "Maximum inspiratory and expiratory pressures, positional changes in vital capacity",
"relatedSectionId": "mk19_b_pm_s12_1_10_2"
},
"pm135": {
"id": "pm135",
"bookId": "pm",
"question": "Timing of antibiotic therapy in suspected sepsis",
"answer": "Within first hour",
"relatedSectionId": "mk19_b_pm_s12_3_2"
},
"pm136": {
"id": "pm136",
"bookId": "pm",
"question": "Initial fluid resuscitation bolus for sepsis",
"answer": "30 mL/kg of crystalloid solution",
"relatedSectionId": "mk19_b_pm_s12_3_3_1"
},
"pm137": {
"id": "pm137",
"bookId": "pm",
"question": "First-line vasopressor for septic shock",
"answer": "Norepinephrine",
"relatedSectionId": "mk19_b_pm_s12_3_3_1"
},
"pm138": {
"id": "pm138",
"bookId": "pm",
"question": "Treatment for shock refractory to fluids and vasopressors",
"answer": "Hydrocortisone",
"relatedSectionId": "mk19_b_pm_s12_3_3_3"
},
"pm139": {
"id": "pm139",
"bookId": "pm",
"question": "Treatment for anaphylaxis",
"answer": "Epinephrine",
"relatedSectionId": "mk19_b_pm_s13_1"
},
"pm140": {
"id": "pm140",
"bookId": "pm",
"question": "Treatment for nonexertional heat stroke",
"answer": "Evaporative cooling",
"relatedSectionId": "mk19_b_pm_s13_2_1"
},
"pm141": {
"id": "pm141",
"bookId": "pm",
"question": "Diagnosis suggested by hyperthermia, rigidity, inhaled anesthetic",
"answer": "Malignant hyperthermia",
"relatedSectionId": "mk19_b_pm_s13_2_2"
},
"pm142": {
"id": "pm142",
"bookId": "pm",
"question": "Treatment for malignant hyperthermia",
"answer": "Discontinue triggering agent, begin active cooling, administer dantrolene",
"relatedSectionId": "mk19_b_pm_s13_2_2"
},
"pm143": {
"id": "pm143",
"bookId": "pm",
"question": "Diagnosis suggested by hyperthermia, hyperreflexia, dysautonomia, mental status changes",
"answer": "Serotonin syndrome",
"relatedSectionId": "mk19_b_pm_s13_2_3"
},
"pm144": {
"id": "pm144",
"bookId": "pm",
"question": "Diagnosis suggested by hyperthermia, mental status changes, dysautonomia, muscle rigidity, neuroleptic drug use",
"answer": "Neuroleptic malignant syndrome",
"relatedSectionId": "mk19_b_pm_s13_2_3"
},
"pm145": {
"id": "pm145",
"bookId": "pm",
"question": "Treatment for cardiac arrest with hypothermia",
"answer": "Prolonged CPR and active rewarming",
"relatedSectionId": "mk19_b_pm_s13_3"
},
"pm146": {
"id": "pm146",
"bookId": "pm",
"question": "Treatment for isopropyl alcohol ingestion",
"answer": "Supportive care",
"relatedSectionId": "mk19_b_pm_s13_4_1"
},
"pm147": {
"id": "pm147",
"bookId": "pm",
"question": "Diagnosis suggested by CNS depression, increased osmolar gap, normal anion gap",
"answer": "Isopropyl alcohol ingestion",
"relatedSectionId": "mk19_b_pm_s13_4_1"
},
"pm148": {
"id": "pm148",
"bookId": "pm",
"question": "Drug treatment for methanol and ethylene glycol poisoning",
"answer": "Fomepizole",
"relatedSectionId": "mk19_b_pm_s13_4_1"
},
"pm149": {
"id": "pm149",
"bookId": "pm",
"question": "Diagnostic test for carbon monoxide exposure",
"answer": "Arterial blood gases, including co-oximetry",
"relatedSectionId": "mk19_b_pm_s13_4_2"
},
"pm150": {
"id": "pm150",
"bookId": "pm",
"question": "Carboxyhemoglobin level indication for hyperbaric therapy",
"answer": "&gt;25%",
"relatedSectionId": "mk19_b_pm_s13_4_2"
},
"pm151": {
"id": "pm151",
"bookId": "pm",
"question": "Treatment for cyanide poisoning",
"answer": "Hydroxocobalamin",
"relatedSectionId": "mk19_b_pm_s13_4_3"
},
"pm152": {
"id": "pm152",
"bookId": "pm",
"question": "Treatment for benzodiazepine overdose",
"answer": "Supportive care (not flumazenil)",
"relatedSectionId": "mk19_b_pm_s13_4_4"
},
"pm153": {
"id": "pm153",
"bookId": "pm",
"question": "Treatment for opioid overdose",
"answer": "Naloxone",
"relatedSectionId": "mk19_b_pm_s13_4_4"
},
"rm1": {
"id": "rm1",
"bookId": "rm",
"question": "First tests in acute monoarthritis",
"answer": "Joint aspiration and synovial fluid analysis",
"relatedSectionId": "mk19_b_rm_s1_3_1"
},
"rm2": {
"id": "rm2",
"bookId": "rm",
"question": "Diseases characterized by inflammation of axial skeleton, enthesitis, positive HLA-B27",
"answer": "Spondyloarthritis (ankylosing spondylitis, psoriatic arthritis, IBD-associated arthritis, reactive arthritis)",
"relatedSectionId": "mk19_b_rm_s1_4"
},
"rm3": {
"id": "rm3",
"bookId": "rm",
"question": "Most sensitive imaging test for bony erosions",
"answer": "CT",
"relatedSectionId": "mk19_b_rm_s1_7_2"
},
"rm4": {
"id": "rm4",
"bookId": "rm",
"question": "Imaging test in suspected spondyloarthritis with normal radiograph",
"answer": "MRI of SI joint",
"relatedSectionId": "mk19_b_rm_s1_7_3"
},
"rm5": {
"id": "rm5",
"bookId": "rm",
"question": "Noninflammatory synovial cell count",
"answer": "&lt;2000/µL",
"relatedSectionId": "mk19_b_rm_s1_8"
},
"rm6": {
"id": "rm6",
"bookId": "rm",
"question": "Indications for prophylactic bisphosphonate therapy in chronic glucocorticoid therapy",
"answer": "Age &gt;40 years, moderate-high risk for osteoporotic fractures, taking ≥2.5 mg of prednisone for ≥3 months",
"relatedSectionId": "mk19_b_rm_s2_2_1"
},
"rm7": {
"id": "rm7",
"bookId": "rm",
"question": "Safest drug treatment in elderly patients with OA",
"answer": "Topical NSAIDs",
"relatedSectionId": "mk19_b_rm_s2_2_2"
},
"rm8": {
"id": "rm8",
"bookId": "rm",
"question": "Coadministration with colchicine reduces hepatic catabolism and could lead to colchicine overdose",
"answer": "CYP3A4 inhibitors (such as clarithromycin and fluconazole)",
"relatedSectionId": "mk19_b_rm_s2_2_3"
},
"rm9": {
"id": "rm9",
"bookId": "rm",
"question": "Hematologic complications of methotrexate",
"answer": "Megaloblastic anemia, pancytopenia",
"relatedSectionId": "mk19_b_rm_s2_4_1_1"
},
"rm10": {
"id": "rm10",
"bookId": "rm",
"question": "Therapy to decrease methotrexate complications",
"answer": "Folic acid",
"relatedSectionId": "mk19_b_rm_s2_4_1_1"
},
"rm11": {
"id": "rm11",
"bookId": "rm",
"question": "Risk assessment for azathioprine-induced myelosuppression",
"answer": "Thiopurine methyltransferase enzyme testing",
"relatedSectionId": "mk19_b_rm_s2_4_1_5"
},
"rm12": {
"id": "rm12",
"bookId": "rm",
"question": "Concomitant use with azathioprine is contraindicated",
"answer": "Xanthine oxidase inhibitors (allopurinol, febuxostat)",
"relatedSectionId": "mk19_b_rm_s2_4_1_5"
},
"rm13": {
"id": "rm13",
"bookId": "rm",
"question": "First-line therapy for lupus nephritis",
"answer": "Mycophenolate mofetil",
"relatedSectionId": "mk19_b_rm_s2_4_1_7"
},
"rm14": {
"id": "rm14",
"bookId": "rm",
"question": "Highly teratogenic RA medications",
"answer": "Methotrexate, leflunomide",
"relatedSectionId": "mk19_b_rm_s2_6"
},
"rm15": {
"id": "rm15",
"bookId": "rm",
"question": "Preferred therapy if immunosuppressive agent is imperative in SLE during pregnancy",
"answer": "Azathioprine",
"relatedSectionId": "mk19_b_rm_s2_6"
},
"rm16": {
"id": "rm16",
"bookId": "rm",
"question": "Screening before TNF inhibitor therapy",
"answer": "Tuberculin skin testing or interferon-γ release assay",
"relatedSectionId": "mk19_b_rm_s2_7"
},
"rm17": {
"id": "rm17",
"bookId": "rm",
"question": "Common nonpharmacologic measure for osteoarthritis",
"answer": "Physical therapy",
"relatedSectionId": "mk19_b_rm_s2_8_1"
},
"rm18": {
"id": "rm18",
"bookId": "rm",
"question": "Common modifiable risk factor for RA",
"answer": "Cigarette smoking",
"relatedSectionId": "mk19_b_rm_s3_1_2"
},
"rm19": {
"id": "rm19",
"bookId": "rm",
"question": "Most specific serologic test for RA",
"answer": "Anti–cyclic citrullinated peptide antibody",
"relatedSectionId": "mk19_b_rm_s3_2_2"
},
"rm20": {
"id": "rm20",
"bookId": "rm",
"question": "RA radiographic findings",
"answer": "Periarticular osteopenia, marginal erosions, joint-space narrowing",
"relatedSectionId": "mk19_b_rm_s3_2_3"
},
"rm21": {
"id": "rm21",
"bookId": "rm",
"question": "Preoperative imaging in long-standing RA",
"answer": "Cervical spine radiography to assess for atlantoaxial subluxation",
"relatedSectionId": "mk19_b_rm_s3_2_3"
},
"rm22": {
"id": "rm22",
"bookId": "rm",
"question": "Most common ocular manifestation in RA",
"answer": "Dry eye (keratoconjunctivitis sicca)",
"relatedSectionId": "mk19_b_rm_s3_3_3"
},
"rm23": {
"id": "rm23",
"bookId": "rm",
"question": "RA pleuritis pH and glucose values",
"answer": "pH &lt;7.3, pleural fluid glucose &lt;60 mg/dL",
"relatedSectionId": "mk19_b_rm_s3_3_4"
},
"rm24": {
"id": "rm24",
"bookId": "rm",
"question": "RA cause of hoarseness, sore throat, dysphagia, stridor",
"answer": "Cricoarytenoid arthritis",
"relatedSectionId": "mk19_b_rm_s3_3_4"
},
"rm25": {
"id": "rm25",
"bookId": "rm",
"question": "The major cause of excess death in patients with RA",
"answer": "Atherosclerotic heart disease",
"relatedSectionId": "mk19_b_rm_s3_3_5"
},
"rm26": {
"id": "rm26",
"bookId": "rm",
"question": "RA, neutropenia, splenomegaly",
"answer": "Felty syndrome",
"relatedSectionId": "mk19_b_rm_s3_3_6"
},
"rm27": {
"id": "rm27",
"bookId": "rm",
"question": "Benefits of treating RA to remission or low disease activity",
"answer": "Less radiographic damage, reduced CV risk, increased work productivity",
"relatedSectionId": "mk19_b_rm_s3_4_1"
},
"rm28": {
"id": "rm28",
"bookId": "rm",
"question": "Preferred initial monotherapy for RA",
"answer": "Methotrexate",
"relatedSectionId": "mk19_b_rm_s3_4_2_1"
},
"rm29": {
"id": "rm29",
"bookId": "rm",
"question": "Major benefit of NSAIDs in RA",
"answer": "Symptom control",
"relatedSectionId": "mk19_b_rm_s3_4_3"
},
"rm30": {
"id": "rm30",
"bookId": "rm",
"question": "Most important modifiable risk factor for knee OA",
"answer": "Obesity",
"relatedSectionId": "mk19_b_rm_s4_2"
},
"rm31": {
"id": "rm31",
"bookId": "rm",
"question": "Most commonly involved joints in erosive OA",
"answer": "DIP and PIP",
"relatedSectionId": "mk19_b_rm_s4_3_1_1"
},
"rm32": {
"id": "rm32",
"bookId": "rm",
"question": "Radiographic findings in erosive OA",
"answer": "Symmetric central interphalangeal joint erosions with “gull-wing” deformity",
"relatedSectionId": "mk19_b_rm_s4_3_1_1"
},
"rm33": {
"id": "rm33",
"bookId": "rm",
"question": "Factors differentiating diffuse idiopathic skeletal hyperostosis from ankylosing spondylitis",
"answer": "Noninflammatory back pain and lack of SI joint involvement",
"relatedSectionId": "mk19_b_rm_s4_3_3"
},
"rm34": {
"id": "rm34",
"bookId": "rm",
"question": "Radiographic findings in diffuse idiopathic skeletal hyperostosis",
"answer": "Confluent right-sided spinal ligamentous ossification of ≥4 contiguous vertebral levels",
"relatedSectionId": "mk19_b_rm_s4_3_3"
},
"rm35": {
"id": "rm35",
"bookId": "rm",
"question": "First imaging modality to assess inflammatory arthritis and OA",
"answer": "Radiography",
"relatedSectionId": "mk19_b_rm_s4_4_2"
},
"rm36": {
"id": "rm36",
"bookId": "rm",
"question": "Radiographic findings in OA",
"answer": "Asymmetric joint-space narrowing, osteophytes, subchondral sclerosis",
"relatedSectionId": "mk19_b_rm_s4_4_2"
},
"rm37": {
"id": "rm37",
"bookId": "rm",
"question": "Nonpharmacologic treatment for knee OA",
"answer": "Leg muscle strengthening exercise program",
"relatedSectionId": "mk19_b_rm_s4_6_1"
},
"rm38": {
"id": "rm38",
"bookId": "rm",
"question": "Goal of OA drug therapy",
"answer": "Symptom control",
"relatedSectionId": "mk19_b_rm_s4_6_2"
},
"rm39": {
"id": "rm39",
"bookId": "rm",
"question": "Common adverse effect of topical NSAIDs",
"answer": "Skin irritation and rash",
"relatedSectionId": "mk19_b_rm_s4_6_2_1"
},
"rm40": {
"id": "rm40",
"bookId": "rm",
"question": "Antidepressant for knee OA",
"answer": "Duloxetine",
"relatedSectionId": "mk19_b_rm_s4_6_2_1"
},
"rm41": {
"id": "rm41",
"bookId": "rm",
"question": "OA indications for arthroscopic surgery",
"answer": "Symptomatic mechanical disorder or joint buckling/instability/locking",
"relatedSectionId": "mk19_b_rm_s4_6_3"
},
"rm42": {
"id": "rm42",
"bookId": "rm",
"question": "Widespread chronic pain, nonrestorative sleep, fatigue, cognitive dysfunction",
"answer": "Fibromyalgia",
"relatedSectionId": "mk19_b_rm_s5_2"
},
"rm43": {
"id": "rm43",
"bookId": "rm",
"question": "Nonpharmacologic fibromyalgia therapy",
"answer": "Disease education, aerobic exercise, psychosocial support",
"relatedSectionId": "mk19_b_rm_s5_3_1"
},
"rm44": {
"id": "rm44",
"bookId": "rm",
"question": "Pharmacologic treatment for fibromyalgia",
"answer": "Gabapentin, pregabalin, duloxetine, milnacipran, tricyclic antidepressants",
"relatedSectionId": "mk19_b_rm_s5_3_2"
},
"rm45": {
"id": "rm45",
"bookId": "rm",
"question": "Treatments for fibromyalgia with depression",
"answer": "Duloxetine, milnacipran, tricyclic antidepressants",
"relatedSectionId": "mk19_b_rm_s5_3_2"
},
"rm46": {
"id": "rm46",
"bookId": "rm",
"question": "Spondyloarthritis most strongly associated with HLA-B27",
"answer": "Ankylosing spondylitis",
"relatedSectionId": "mk19_b_rm_s6_2_1"
},
"rm47": {
"id": "rm47",
"bookId": "rm",
"question": "Spondyloarthritis most frequently involving SI joints",
"answer": "Ankylosing spondylitis",
"relatedSectionId": "mk19_b_rm_s6_3_1"
},
"rm48": {
"id": "rm48",
"bookId": "rm",
"question": "Common sites of enthesitis in psoriatic arthritis",
"answer": "Achilles tendon, plantar fascia",
"relatedSectionId": "mk19_b_rm_s6_3_2"
},
"rm49": {
"id": "rm49",
"bookId": "rm",
"question": "IBD-related arthritis that parallels IBD activity",
"answer": "Spondyloarthritis",
"relatedSectionId": "mk19_b_rm_s6_3_3"
},
"rm50": {
"id": "rm50",
"bookId": "rm",
"question": "Acute peripheral oligoarticular arthritis with enthesitis and dactylitis",
"answer": "Reactive arthritis",
"relatedSectionId": "mk19_b_rm_s6_3_4"
},
"rm51": {
"id": "rm51",
"bookId": "rm",
"question": "Initial evaluation of patient with suspected ankylosing spondylitis",
"answer": "Radiography of the SI joint",
"relatedSectionId": "mk19_b_rm_s6_4_2"
},
"rm52": {
"id": "rm52",
"bookId": "rm",
"question": "Radiographic findings in psoriatic arthritis",
"answer": "DIP joint involvement, pencil-in-cup deformity",
"relatedSectionId": "mk19_b_rm_s6_4_2"
},
"rm53": {
"id": "rm53",
"bookId": "rm",
"question": "First-line treatment of ankylosing spondylitis",
"answer": "NSAIDs",
"relatedSectionId": "mk19_b_rm_s6_5_2"
},
"rm54": {
"id": "rm54",
"bookId": "rm",
"question": "Biologic therapies for IBD bowel and joint symptoms",
"answer": "TNF inhibitors",
"relatedSectionId": "mk19_b_rm_s6_5_5"
},
"rm55": {
"id": "rm55",
"bookId": "rm",
"question": "SLE-related annular rash with central clearing or erythematous plaques and papules",
"answer": "Subacute cutaneous lupus erythematosus (SCLE)",
"relatedSectionId": "mk19_b_rm_s7_2"
},
"rm56": {
"id": "rm56",
"bookId": "rm",
"question": "Cause of subacute hip pain in SLE",
"answer": "Osteonecrosis",
"relatedSectionId": "mk19_b_rm_s7_2_2"
},
"rm57": {
"id": "rm57",
"bookId": "rm",
"question": "Severe neuropsychiatric manifestations of SLE",
"answer": "Seizures, psychosis",
"relatedSectionId": "mk19_b_rm_s7_2_4"
},
"rm58": {
"id": "rm58",
"bookId": "rm",
"question": "Life-threatening pulmonary manifestations of SLE",
"answer": "Lupus pneumonitis and diffuse alveolar hemorrhage",
"relatedSectionId": "mk19_b_rm_s7_2_6"
},
"rm59": {
"id": "rm59",
"bookId": "rm",
"question": "Clinical manifestations of acute lupus pneumonitis",
"answer": "Cough, dyspnea, fever, hypoxemia, pleuritic chest pain, pulmonary infiltrates",
"relatedSectionId": "mk19_b_rm_s7_2_6"
},
"rm60": {
"id": "rm60",
"bookId": "rm",
"question": "Antibody testing for thrombotic risk in SLE",
"answer": "Antiphospholipid antibodies/lupus anticoagulant, anti–β<sub>2</sub>-glycoprotein, anticardiolipin antibodies",
"relatedSectionId": "mk19_b_rm_s7_2_7"
},
"rm61": {
"id": "rm61",
"bookId": "rm",
"question": "Inflammatory marker that may be normal in active SLE",
"answer": "C-reactive protein",
"relatedSectionId": "mk19_b_rm_s7_3_2"
},
"rm62": {
"id": "rm62",
"bookId": "rm",
"question": "Laboratory findings in acute SLE flare",
"answer": "Elevated ESR and anti–double-stranded DNA antibody titer, low complement levels",
"relatedSectionId": "mk19_b_rm_s7_3_2"
},
"rm63": {
"id": "rm63",
"bookId": "rm",
"question": "Drug therapy for all patients with SLE",
"answer": "Hydroxychloroquine",
"relatedSectionId": "mk19_b_rm_s7_4"
},
"rm64": {
"id": "rm64",
"bookId": "rm",
"question": "SLE indications for high-dose glucocorticoids",
"answer": "Profound cytopenias, class III/IV nephritis, seizures, psychosis",
"relatedSectionId": "mk19_b_rm_s7_4"
},
"rm65": {
"id": "rm65",
"bookId": "rm",
"question": "Rheumatologic diseases most commonly associated with secondary Sjögren syndrome",
"answer": "RA and SLE",
"relatedSectionId": "mk19_b_rm_s8"
},
"rm66": {
"id": "rm66",
"bookId": "rm",
"question": "Malignancy associated with Sjögren syndrome",
"answer": "Non-Hodgkin lymphoma",
"relatedSectionId": "mk19_b_rm_s8_2"
},
"rm67": {
"id": "rm67",
"bookId": "rm",
"question": "Antibodies specific for primary Sjögren syndrome",
"answer": "Anti-Ro/SSA autoantibodies",
"relatedSectionId": "mk19_b_rm_s8_3"
},
"rm68": {
"id": "rm68",
"bookId": "rm",
"question": "Test for suspected Sjögren syndrome with negative anti-Ro/SSA antibodies",
"answer": "Lip biopsy",
"relatedSectionId": "mk19_b_rm_s8_3"
},
"rm69": {
"id": "rm69",
"bookId": "rm",
"question": "Initial management of sicca symptoms",
"answer": "Artificial tears and sugar-free candies",
"relatedSectionId": "mk19_b_rm_s8_4"
},
"rm70": {
"id": "rm70",
"bookId": "rm",
"question": "Malignancy screening in dermatomyositis and polymyositis",
"answer": "Age- and sex-appropriate cancer screening",
"relatedSectionId": "mk19_b_rm_s9_4_5"
},
"rm71": {
"id": "rm71",
"bookId": "rm",
"question": "Pathognomonic dermatomyositis rashes",
"answer": "Gottron papules and heliotrope rashes",
"relatedSectionId": "mk19_b_rm_s9_5_1"
},
"rm72": {
"id": "rm72",
"bookId": "rm",
"question": "Antibodies associated with antisynthetase syndrome",
"answer": "Anti–aminoacyl-tRNA synthetase (commonly anti–Jo-1)",
"relatedSectionId": "mk19_b_rm_s9_5_3"
},
"rm73": {
"id": "rm73",
"bookId": "rm",
"question": "Interstitial lung disease, Raynaud phenomenon, inflammatory arthritis, mechanic's hands",
"answer": "Antisynthetase syndrome",
"relatedSectionId": "mk19_b_rm_s9_5_3"
},
"rm74": {
"id": "rm74",
"bookId": "rm",
"question": "Acute severe myopathy and anti-HMG Co-A reductase antibodies",
"answer": "Immune-mediated necrotizing myopathy",
"relatedSectionId": "mk19_b_rm_s9_5_4"
},
"rm75": {
"id": "rm75",
"bookId": "rm",
"question": "Insidious onset of proximal and distal symmetric muscle weakness",
"answer": "Inclusion body myositis",
"relatedSectionId": "mk19_b_rm_s9_5_5"
},
"rm76": {
"id": "rm76",
"bookId": "rm",
"question": "Sensitive serum marker of muscle pathology",
"answer": "Creatine kinase level",
"relatedSectionId": "mk19_b_rm_s9_6_2"
},
"rm77": {
"id": "rm77",
"bookId": "rm",
"question": "Polymyositis and dermatomyositis treatment",
"answer": "Glucocorticoids",
"relatedSectionId": "mk19_b_rm_s9_7"
},
"rm78": {
"id": "rm78",
"bookId": "rm",
"question": "Most common early manifestation of systemic sclerosis",
"answer": "Raynaud phenomenon",
"relatedSectionId": "mk19_b_rm_s10_1"
},
"rm79": {
"id": "rm79",
"bookId": "rm",
"question": "CREST syndrome",
"answer": "Limited cutaneous systemic sclerosis",
"relatedSectionId": "mk19_b_rm_s10_2"
},
"rm80": {
"id": "rm80",
"bookId": "rm",
"question": "Pulmonary vascular disease in limited cutaneous systemic sclerosis",
"answer": "Pulmonary arterial hypertension",
"relatedSectionId": "mk19_b_rm_s10_2"
},
"rm81": {
"id": "rm81",
"bookId": "rm",
"question": "Common cause of GI bleeding in systemic sclerosis",
"answer": "Gastric antral vascular ectasia",
"relatedSectionId": "mk19_b_rm_s10_3_5"
},
"rm82": {
"id": "rm82",
"bookId": "rm",
"question": "Diarrhea, bloating, and malabsorption in systemic sclerosis",
"answer": "Small intestinal bacterial overgrowth",
"relatedSectionId": "mk19_b_rm_s10_3_5"
},
"rm83": {
"id": "rm83",
"bookId": "rm",
"question": "Risk factors for scleroderma renal crisis",
"answer": "Diffuse cutaneous systemic sclerosis, glucocorticoid use, anti-RNA polymerase III antibodies",
"relatedSectionId": "mk19_b_rm_s10_3_6"
},
"rm84": {
"id": "rm84",
"bookId": "rm",
"question": "Systemic sclerosis, AKI, severe hypertension, microangiopathic hemolytic anemia, thrombocytopenia, proteinuria",
"answer": "Scleroderma renal crisis",
"relatedSectionId": "mk19_b_rm_s10_3_6"
},
"rm85": {
"id": "rm85",
"bookId": "rm",
"question": "Disease-related cause of death in diffuse cutaneous systemic sclerosis",
"answer": "Interstitial lung disease",
"relatedSectionId": "mk19_b_rm_s10_3_7"
},
"rm86": {
"id": "rm86",
"bookId": "rm",
"question": "Treatment of scleroderma renal crisis",
"answer": "Captopril",
"relatedSectionId": "mk19_b_rm_s10_4"
},
"rm87": {
"id": "rm87",
"bookId": "rm",
"question": "Treatment of systemic sclerosis–related interstitial lung disease",
"answer": "Mycophenolate mofetil",
"relatedSectionId": "mk19_b_rm_s10_4"
},
"rm88": {
"id": "rm88",
"bookId": "rm",
"question": "Manifestation of ≥2 of the following: SLE, polymyositis, systemic sclerosis",
"answer": "Mixed connective tissue disease",
"relatedSectionId": "mk19_b_rm_s11_1"
},
"rm89": {
"id": "rm89",
"bookId": "rm",
"question": "Mixed connective tissue disease antibody",
"answer": "Anti–U1-ribonucleoprotein antibodies",
"relatedSectionId": "mk19_b_rm_s11_2"
},
"rm90": {
"id": "rm90",
"bookId": "rm",
"question": "Major cause of death in mixed connective tissue disease",
"answer": "Pulmonary arterial hypertension",
"relatedSectionId": "mk19_b_rm_s11_3"
},
"rm91": {
"id": "rm91",
"bookId": "rm",
"question": "Pulmonary manifestations of mixed connective tissue disease",
"answer": "Pulmonary arterial hypertension, interstitial lung disease",
"relatedSectionId": "mk19_b_rm_s11_3"
},
"rm92": {
"id": "rm92",
"bookId": "rm",
"question": "Soft-tissue manifestations of acute gout",
"answer": "Acute bursitis, periarthritis, gouty panniculitis/cellulitis",
"relatedSectionId": "mk19_b_rm_s12_1_3_1"
},
"rm93": {
"id": "rm93",
"bookId": "rm",
"question": "Gout radiographic findings",
"answer": "Punched-out lesions with overhanging edges of cortical bone",
"relatedSectionId": "mk19_b_rm_s12_1_4"
},
"rm94": {
"id": "rm94",
"bookId": "rm",
"question": "Gold standard for diagnosis of gout",
"answer": "Negatively birefringent, needle-like crystals within neutrophils",
"relatedSectionId": "mk19_b_rm_s12_1_4"
},
"rm95": {
"id": "rm95",
"bookId": "rm",
"question": "Treatment of gouty cellulitis",
"answer": "NSAIDs, colchicine, or glucocorticoids",
"relatedSectionId": "mk19_b_rm_s12_1_5_1"
},
"rm96": {
"id": "rm96",
"bookId": "rm",
"question": "Genetic testing in a patient at high risk for allopurinol sensitivity",
"answer": "HLA-B*58:01 allele",
"relatedSectionId": "mk19_b_rm_s12_1_5_2_1"
},
"rm97": {
"id": "rm97",
"bookId": "rm",
"question": "IV treatment of recalcitrant tophaceous gout",
"answer": "Pegloticase",
"relatedSectionId": "mk19_b_rm_s12_1_5_2_3"
},
"rm98": {
"id": "rm98",
"bookId": "rm",
"question": "Prophylactic therapies when initiating urate-lowering treatment",
"answer": "Colchicine, low-dose glucocorticoids, or low-dose NSAIDs",
"relatedSectionId": "mk19_b_rm_s12_1_5_3"
},
"rm99": {
"id": "rm99",
"bookId": "rm",
"question": "Cause of CPP crystal arthritis in young patient",
"answer": "Hyperparathyroidism, hemochromatosis, hypophosphatasia, or hypomagnesemia",
"relatedSectionId": "mk19_b_rm_s12_2_1"
},
"rm100": {
"id": "rm100",
"bookId": "rm",
"question": "Acute knee arthritis, OA, chondrocalcinosis",
"answer": "Acute CPP crystal arthritis (pseudogout)",
"relatedSectionId": "mk19_b_rm_s12_2_2_2"
},
"rm101": {
"id": "rm101",
"bookId": "rm",
"question": "Inflammatory destructive arthritis of shoulder in elderly women",
"answer": "Basic calcium phosphate deposition (“Milwaukee shoulder”)",
"relatedSectionId": "mk19_b_rm_s12_3"
},
"rm102": {
"id": "rm102",
"bookId": "rm",
"question": "Synovial fluid leukocyte count in infectious arthritis",
"answer": "&gt;50,000/µL",
"relatedSectionId": "mk19_b_rm_s13_1_2"
},
"rm103": {
"id": "rm103",
"bookId": "rm",
"question": "Tenosynovitis, migratory polyarthralgia, and vesiculopustular rash",
"answer": "Disseminated gonococcal infection",
"relatedSectionId": "mk19_b_rm_s13_2_2_1"
},
"rm104": {
"id": "rm104",
"bookId": "rm",
"question": "Risk factors for nongonococcal gram-negative joint infections",
"answer": "Injection drug use, advanced age, immunocompromised state",
"relatedSectionId": "mk19_b_rm_s13_2_2_2"
},
"rm105": {
"id": "rm105",
"bookId": "rm",
"question": "Test for possible tuberculosis monoarthritis with unrevealing synovial fluid analysis",
"answer": "Synovial biopsy",
"relatedSectionId": "mk19_b_rm_s13_2_4"
},
"rm106": {
"id": "rm106",
"bookId": "rm",
"question": "Self-limited acute arthritis of hands, feet, wrists, knees",
"answer": "Parvovirus B19 infection",
"relatedSectionId": "mk19_b_rm_s13_2_6_3"
},
"rm107": {
"id": "rm107",
"bookId": "rm",
"question": "Most common agent causing prosthetic joint infection",
"answer": "\n        <i>Staphylococcus aureus</i>\n      ",
"relatedSectionId": "mk19_b_rm_s13_2_7"
},
"rm108": {
"id": "rm108",
"bookId": "rm",
"question": "Treatment of bacterial joint infection",
"answer": "Antimicrobial therapy and joint drainage",
"relatedSectionId": "mk19_b_rm_s13_3"
},
"rm109": {
"id": "rm109",
"bookId": "rm",
"question": "Time window for temporal artery biopsy in giant cell arteritis after starting glucocorticoids",
"answer": "Up to 4 weeks",
"relatedSectionId": "mk19_b_rm_s14_2_1_2"
},
"rm110": {
"id": "rm110",
"bookId": "rm",
"question": "Treatment of suspected giant cell arteritis",
"answer": "Immediate high-dose glucocorticoids",
"relatedSectionId": "mk19_b_rm_s14_2_1_3"
},
"rm111": {
"id": "rm111",
"bookId": "rm",
"question": "Dose of prednisone pathognomonically effective in polymyalgia rheumatica",
"answer": "12.5-20 mg/d",
"relatedSectionId": "mk19_b_rm_s14_2_2_3"
},
"rm112": {
"id": "rm112",
"bookId": "rm",
"question": "Prednisone dose for relapse of polymyalgia rheumatica",
"answer": "Last dose that controlled disease",
"relatedSectionId": "mk19_b_rm_s14_2_2_3"
},
"rm113": {
"id": "rm113",
"bookId": "rm",
"question": "Arm claudication and valve regurgitation in young patient",
"answer": "Takayasu arteritis",
"relatedSectionId": "mk19_b_rm_s14_2_3_2"
},
"rm114": {
"id": "rm114",
"bookId": "rm",
"question": "Constitutional symptoms, purpura, cutaneous ulcers, hypertension",
"answer": "Polyarteritis nodosa",
"relatedSectionId": "mk19_b_rm_s14_3_1_2"
},
"rm115": {
"id": "rm115",
"bookId": "rm",
"question": "Treatment of primary CNS angiitis",
"answer": "Cyclophosphamide with high-dose glucocorticoids",
"relatedSectionId": "mk19_b_rm_s14_3_2_3"
},
"rm116": {
"id": "rm116",
"bookId": "rm",
"question": "Cardiovascular sequela of Kawasaki disease",
"answer": "Coronary artery aneurysm",
"relatedSectionId": "mk19_b_rm_s14_3_3"
},
"rm117": {
"id": "rm117",
"bookId": "rm",
"question": "The three forms of ANCA-associated vasculitis",
"answer": "Granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis",
"relatedSectionId": "mk19_b_rm_s14_4"
},
"rm118": {
"id": "rm118",
"bookId": "rm",
"question": "Most effective treatment for preventing relapse in granulomatosis with polyangiitis",
"answer": "Rituximab",
"relatedSectionId": "mk19_b_rm_s14_4_1_1_3"
},
"rm119": {
"id": "rm119",
"bookId": "rm",
"question": "Treatment of life-threatening granulomatosis with polyangiitis",
"answer": "Glucocorticoids plus cyclophosphamide or rituximab",
"relatedSectionId": "mk19_b_rm_s14_4_1_1_3"
},
"rm120": {
"id": "rm120",
"bookId": "rm",
"question": "Main causes of death in granulomatosis with polyangiitis",
"answer": "Kidney failure and infection",
"relatedSectionId": "mk19_b_rm_s14_4_1_1_3"
},
"rm121": {
"id": "rm121",
"bookId": "rm",
"question": "Pulmonary hemorrhage, pauci-immune glomerulonephritis, positive p-ANCA",
"answer": "Microscopic polyangiitis",
"relatedSectionId": "mk19_b_rm_s14_4_1_2_2"
},
"rm122": {
"id": "rm122",
"bookId": "rm",
"question": "Cause of nonblanching palpable purpura",
"answer": "Immune complex–mediated vasculitis",
"relatedSectionId": "mk19_b_rm_s14_4_2"
},
"rm123": {
"id": "rm123",
"bookId": "rm",
"question": "Infectious cause of mixed cryoglobulinemia",
"answer": "Hepatitis C virus infection",
"relatedSectionId": "mk19_b_rm_s14_4_2_1_1"
},
"rm124": {
"id": "rm124",
"bookId": "rm",
"question": "Palpable purpura, peripheral neuropathy, arthritis, hepatitis C",
"answer": "Cryoglobulinemic vasculitis",
"relatedSectionId": "mk19_b_rm_s14_4_2_1_1"
},
"rm125": {
"id": "rm125",
"bookId": "rm",
"question": "Purpura, abdominal pain, arthralgia",
"answer": "IgA vasculitis (Henoch-Schönlein purpura)",
"relatedSectionId": "mk19_b_rm_s14_4_2_2_2"
},
"rm126": {
"id": "rm126",
"bookId": "rm",
"question": "Painful oral and genital ulcers, uveitis, DVT",
"answer": "Behçet syndrome",
"relatedSectionId": "mk19_b_rm_s15_1"
},
"rm127": {
"id": "rm127",
"bookId": "rm",
"question": "Cause of dyspnea and wheezing in relapsing polychondritis",
"answer": "Tracheal ring and bronchial stenosis",
"relatedSectionId": "mk19_b_rm_s15_2"
},
"rm128": {
"id": "rm128",
"bookId": "rm",
"question": "Uveitis, arthritis, inflammatory destruction of ear pinna",
"answer": "Relapsing polychondritis",
"relatedSectionId": "mk19_b_rm_s15_2"
},
"rm129": {
"id": "rm129",
"bookId": "rm",
"question": "Fever, pharyngitis, rash, adenopathy, hepatosplenomegaly, elevated serum ferritin",
"answer": "Adult-onset Still disease",
"relatedSectionId": "mk19_b_rm_s15_4"
},
"rm130": {
"id": "rm130",
"bookId": "rm",
"question": "Bilateral hilar adenopathy, arthritis, erythema nodosum",
"answer": "Löfgren syndrome",
"relatedSectionId": "mk19_b_rm_s15_5"
},
"rm131": {
"id": "rm131",
"bookId": "rm",
"question": "Immune-mediated tumefaction, fibrosis, and dysfunction of organs",
"answer": "IgG4-related disease",
"relatedSectionId": "mk19_b_rm_s15_6"
},
"rm132": {
"id": "rm132",
"bookId": "rm",
"question": "Diagnostic test for suspected IgG4-related disease",
"answer": "Biopsy of involved tissue",
"relatedSectionId": "mk19_b_rm_s15_6"
}
}